177 Глава 7. Оказание амбулаторной диабетической помощи детям и подросткам с диабетом . . . вала «Руководство по клинической практике» с главами по сахарному диабету 1-го и 2-го типа ного сахара, например конфет или кукурузного сиропа с высоким содержанием фруктозы. Ниже приведено краткое описание некоторых специфических черт, на которые стоит обращать


Чтобы посмотреть этот PDF файл с форматированием и разметкой, скачайте его и откройте на своем компьютере.
Translated and reprinted by
( \n\r\n\b   \t\r\f
\b ISPAD \t \n \f\f\r\n \t\n\f\n
\n22 \n/\r \f#:"  \f" # \f\r" ;  ISPAD
 616.379-008.64-053.2
\b\b 57.334
.6,23\t81
© International Society for Pediatric and Adolescent
Diabetes FISPADG, 2015
© )\f \f\f\rC# # \r'#"#\t #"\r## «)»,
\r\f  \r# \t', 2016
����© ('\f"@\t \r «*+?-&\f#»,
ISBN 978-5-9704-4051-3
\b\t
\n# \rE# # / :'# . . . . . . . . . . . . . . . . . . . . . . . .6
�" \r\f"\r. ="#  « ISPAD  ##
\r"#» 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 1.
� \r\f#, %#\f##\t # ##$#\t /\r
\f#:"  \f" # \f\r" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14

)' /\r \f#:" 1- "#  \f" # \f\r" . . . . . . .44

\n/\r \f#:" 2- "#  \f" # \f\r" . . . . . . . . . . . . .61

4.
#"# # #  /\r \f#:"
 \f" # \f\r" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .109
 5.
K# /\r \f#:", : #$#\f'
F#"' #:\r'G,  \f" # \f\r" . . . . . . . . . . . . . . . . . . . . . . .149
 6.
=\r :#\t \r# /\r \f#:"  \f"
# \f\r" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .177

� '# :"\r \f#:"# E# \f"\t
# \f\r"  \f#:" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .196

� $ # #"\r# "\r\t ###  \f"
# \f\r"  /\r \f#:" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .233

9.
(#"\r#\t \r# /\r \f#:"  \f"
# \f\r" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .262
 10.
� \r#'$#\t #"#\t \f" # \f\r"  /\r
\f#:" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .307
 11.
#:"## "$#\f' # #\r###
#\r\t\r "" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .351
 12.
� $ # \f# ####  \f"
# \f\r"  /\r \f#:" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .406
 13.
� :"# \f#\t \f" # \f\r"  /\r
\f#:" \r# ""JE#/ ':#\t/ . . . . . . . . . . . . . . . . . . . . . . . .434
 14.
)#'## \r'#  \f" # \f\r"
 /\r \f#:" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .457
 15.
=\f# \f" # \f\r"  /\r \f#:"
\r# /#\r\r##/ !"@"/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .503
 16.
#/#\t [email protected] \f"\t # \f\r"
 /\r \f#:" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .520
 17.
\n/\r \f#:"  \f\r" '\r" . . . . . . . . . . . . . . . . .547
 18.
&#\r#"## # \r#"##
C#\t \r# /\r \f#:"  \f" # \f\r" . . . . . . . . . . . . .574
 19.
\r# C#\t # $##\r "\t#\t
\r# /\r \f#:"  \f" # \f\r" . . . . . . . . . . . . . . . . . . . . . . . . .603
 20.
\f"  \r# /\f . . . . . . . . . . . . . . . . . . . . .623
\r#C#\t . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .626
\f$##  \r# /\f . . . . . . . . . . . . . . . . . . . . . . . . . . . .626
\n \t\n\f \n\f\r\b\t \t \n\b \b\b\t
„ \r" \r\f"  '\r#"\r#\r  -
#  )\f\r$##
) „ #"'#\r\rEJE# \r"
*-1 „ J\f: "#\f-1
*?\n „ \r "\r## /\r \f#:"
 „ \f'#\r#:#\t #"
-4 „ \f#"#\f#"#\f'-4
(&? „ #\f  "
K= „ #\r"#  ""#
K „ #\r"# #' ""#
K) „ :\t #'#\t @"\r
&=? „
#$#\f' "\r:\r \r\t"\r
&*\n „  /\r \f#:"
&L( „ \r" C\f #H$##
&M\n „ #$#\f''## /\r \f#:"
&O „ E C#\r #"
O\b „ @\t C#\r\t :'@ #
Q-## „ "\r@ \r"# Q\f\r
*?? „ \r\r@ J'"\r" ""
&* „ "\t #"\r# J'
O „ #E C#\r #"
 \b\t\n \f\r  \f \f\t \f\r
\n „ \r" "@ /\r \f#:"
(( „ "\t\t \fC\t #'#\t ##
\n „ /\r \f#:"
\n1 „ /\r \f#:" 1- "#
\n2 „ /\r \f#:" 2- "#
\n( „ "!# ## # \f
\n* „ "\r@ \r\t J'  \r#
\n&* „ "\t"@ #"\r# \r\t J'  \r#
\nR „ #\f\r ##"'/ \t##
?M „ "#'#\f#\f#
?\n „ "\r'#"\r "@ /\r \f#:"
" „ "\r\r"\t \r#:#\t #"
??* „ "#\r"\r \r
T\n „ $"\r@\t \r\t #"
AcAc „ $"$""
ADA „
American
 
\n \b\t
\f «\f\b\n\b\n\n ISPAD  \f\t\b\t\n\f \r\f\t\f» 2014 .
 \b\t\t\n. \f\r \b «\t\f\f\r\f\r ISPAD \t \b\f\b\t \b\b» 2014 .
10  \b\t\t\n. \f\r \b «\t\f\f\r\f\r ISPAD \t \b\f\b\t \b\b» 2014 .
 \b\t\t\n. \f\r \b «\t\f\f\r\f\r ISPAD \t \b\f\b\t \b\b» 2014 .
11



 1
\b \t\n \f\r   \f\n\r   \b\b\f, \n\r\b \n\b\r 
\b    \b \b  \n \r\b  \r  \n\b
 \b\t\n\t \f\r,   \t \r \t\r -
12  \b\t\t\n. \f\r \b «\t\f\f\r\f\r ISPAD \t \b\f\b\t \b\b» 2014 .
B\b\t\n \f\n\r \n\n\n\r \n\n  \n \n\t
\b\t\n \f\n\r \n\n\n\r \n\n  \n \n\b-
"# $\t \b\b \b\b\b 
 \b\t\t\n. \f\r \b «\t\f\f\r\f\r ISPAD \t \b\f\b\t \b\b» 2014 .
13
 \b\t\n \b\f\n\r
1 \t\t 2
 \r5\b\t, 6 \t57\t\t8 \t \f\n\n\t9\t\f:\t8
\n\r\b 5\t  5 \t 5\r\n\f
\f\f\t  \b  \f\t
15
\b\b:\t8 \t \r\f7\b5:\t\t



"\r:"@\t \r\f# \r\r@ J'"\r"

*#\r##\t, :\rC\t  "\r #"$##, \r#\r,
  "\r #$##, "\r, /#\r\r# !"@",
\r!#\t \f/"@ $##, \r:  \r:\rE# #

…"-\f#" \n   'z
…\n \f#"#\r  \r 6  C#'#z
…\t, \r\r#\rJE\t #\r##\t F5,5…8,5 @, ##
…""JE# \r!#\t, "#  /", "\r#\t '\r#"@-
…#@'# \r"/ \r\f", "#/  "!-

16 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
…\t'  \n "#"; "#"  ""\f\r:#' 65
\r\r"' FIA2Gz "#"  ## FIAAGz "#"  "\r\r"\r
$#-8, \r\tE $#  W-"# F‡nY8G. ## \f
…*?? FGz
…UbA1c FBG.

 \f#' # '## #\t \f"\t  \f'\r# 
"# ""#\r# \f\t \r\f#\t \f"# "@
\n, @ \n1 \r \r\f "\r"\t  %" \f\r FBG.
 !"#\t '\r" "# ""#\r# \f"
\r\f#"@  "/ \t/, \f  \r: "\r#$"@ #' 
# \f#'G # "@ ### \r#'#, 'JE# 
 \r5\b\t \t  \t\n\b\t
'" \r!#\t \f, C#\r # : :.
##. \n1 -\rC ""\t #: \r\r"\r
$\t\f  \b \b \t\t\b\f \t \t     \b...
17
5\t\b\n\t\n\f\t \f\r\t\r\t\t \n\r\b 5\t
 5\n\f7 \t 5\r\n\f7 \r\n


\rC "\rJE#\t "$#\f"## #\r\t\r

 #"\r" \r## #@'J" #' #  [email protected]
"# J"\r \f\t #'\r#\t \r\t J' # ". \r#
:\rC## ! \r\t J' $#" :/\f#
\r \r#"@  $##'#\r $"\r, #JE# "
#\t #\r### C" :"@ ,  \r# ### " 


…\r# """## #", \r#\r, \r#  :\rC-
…\r# ### :/"##/ #" \nz
…\r# :\rC## #\r###   "\r #$#-
18 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
 1.1
\f!!! !%"!! ";% !- [1, 2]
\t  \n   \t\n 
%\t\b& \f  \b\t\f\f  '  \f\t\b& \f   \f\t\n\t
19
\b\r\b\t \r\b\b\n\t \f =\f
\t \b\r\b\t \t\f7\t\t \b\f
## "E F*G \t\tJ"\t \rC" "\f# ""
"#\t \r!#\t \f :, "\r #J" " C\f
\r@ "' J' # \n m2q. * # ?*  \t\tJ"\t
###. * \t\t"\t '" \r! \f :
# J'. * # ?* #  :  \t\tJ"\t '###
\f##$#. $#"  * ### ?*  "\tE \r\t #"J"\t
 1.2
6!(!/"+ �(""!!3!+ (!#!/"!; %$?%!&
3\r

- ,  \b\t  \t\r  \r  \b\r\t\r:
\t) \t;
20 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
�A. %!/"! @
PAX4
KCNJ11
\n\n\r \r . 1.2
%\t\b& \f  \b\t\f\f  '  \f\t\b& \f   \f\t\n\t
21
\b\t\n \f \r . 1.2
Stiff-man syndrome
22 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...


\r@ J'  ' "E 5,6…6,9 @

\r\f\r#"@ \f#' /\r \f#:" F\f#' \fC

\f/\t "\r'\t J'  7,8 @

\f/\t "\r'\t J' 7,8…11,1 @

\f/\t "\r'\t J' : 11,1 @
\f\n\n\t9\t\f:\t8 \t5 \n\r\b 5\t
\t 5\r\t \f\r\t \r8:\t\t \r\b8 =\f
+"##\t ##$#\t \f#:" \r#\f  ":. 1.2,
\t#\t  \t\t\b\f \t \t  \b \t \b\r \b  \b\f... 23

"#\r'#"' FIA2G, ## FIAAG ### "\r\r"\r

 \r\f"\t. L# $#" " ##"\r#J,





24 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
 1.3
\f(!%!/"! ;!"!! ";% !- 1B !*, ";% !-
2B !* ! #%%% !- $ & ! *"
!"!\n51
1\t% % D
T\n\t\r \b\t# 9 \r \b
„„„
3\t
\t\t \f \b\t, \b „
#&% \t
 \t\t\nC
# [email protected]  \f+\r
'3  \b 5…[email protected]
\b \n\r\b 5\t 1B \t 
# W-" \fC\f C', "\r \f"  "# ## 
:@!#"  :J" \f#$#" ##. +"" "# \n F"#
 C', "\r \r#/\f#"  \r' #"#"@J # ###
(\t \f  \t\t\b\f \t \t 1- \t
25
C\f C'. +"##\t ':#\t \t\t"\t "\r,
C"@, "\r \rCJE \r\f, #\t #" # W-"# 
‡\r\t'##" " '\r"; "#"  ## FIAAG #  ‡nY8 E %\r-#\rJ"\t  \f" \f! 10 ",  "#"  [AD # IA-2 „ '\f, \r# "#"  [AD E %\r#\rJ"\t  \f m19q.\f\rC"@ "# \n1 \r\f\t"\t C"-# #; : 60  \r# \t  #\f#\t/  � # $#$# m20q.  50k \r# \t'  "#  $#"\r "# m21, 22qz \r\f# \r\f"#" \r#\f \r $### :#$## - U]A Dˆ # DŽ \r\f\tJ" "#J \r\f\rC"@ m23q. *"#    "@J \r# „ %" DˆB1{03;01-DŽA1{05;01-DŽB1{02;01 # DˆB1{04-DŽA1{03;01-DŽB1{03;02 FDˆ3Dˆ4 ## DŽ2DŽ8  \r# "\rG. *"#,
= \t/, \f ##\t \r"# "## \f\t \n1,  "#"
26 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
" "#/  \r#/\f#"\t #"@ \f  $#"# \r#
C"@ \f\r#/ \r \n,  " # \n2 #  \f#:"
F '  ":. 1.2G. = "/ \r#/, \f \n1 "\r"\t \rC,
6 \t57\t\t8 \n\r\b 5\t 1B \t 
= \r \r\f#!#/\t %#\f###/ #\f#\t/ \f:J"
$#$#\t  U]A  \r#J  \r#\f \r m51…54q.
#\tz  "\r \f, # \r#/\f#"\t  '## \t$,  
\f\r# „  " \r\t \f m49q ## \[email protected]#\r" " \f  \f m57…59q.
)\f \f\f\r \t\t\b\f\r \t 
27
8,5kG  \r#J  \f"@# CE#  \n F1,3…3,6kG m85…90q.
\t"# \r# \n1 \r \r#\r 4k \f\t \f",  "\r/
7\b\b\b \n\r\b 5\t
28 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
510152535455565
203040506070
\b\t\n
\t\t\t (\f\r\t)

\f\n
\n\t
(, \n, \b\n\t \n\t)
\b\t\t \n\t
\b ( \n! \t)
"\t
#\n$\t (\b\n%& '&-\t)
\n\t
\f\t *\t
+\t\r\t
./
$\n
\f\n\t%
\n
.\n\n
\n
8
9\r:\t
;\r
\t ('$  \t)
\n \n\t
\n\t\r
\b
'$%
!\n
\t
\b\t
&\t\n
\n\t
' (+\t)
!\t
\t (=\n  9\r$)
\b\n (;\n\t)
�\n\t (*\t\n)
;\n\t (\b\t-9\t)
;\t\t$%
#\n

'!\t \b\n\t
(;  #\n\t)
;\t\n\r
=\t&\t\r
+\t
.
+\t
 (;\t\t\n)
\t& (\t/\t&)
?!
\n
@\t
8!
=\t\t
9\t!\t „ \f\t #
*\t\t$\r \t 100 000 A-
\r!". 1.1.
'\b \f \n\t \t\r \r\t\t \b\t 2- \t \r\b \b 
\b\r  \n\t\r 6…2J . 7\t\n\t  \f \r\t,   \r\f \b\t, \t-
\t \r 5666 . (\t\b\t\t  \t\t \t \t \t\r\t D&\b\t\b $\b\t ^GK_)
% \f\t\t*\f\r \t\t\b\f\r \t 
29
30 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
\rJE#/ \f :H\f##$ ?)-"#"@ # 
7\t\b5\r\tL\b \n\r\b 5\t
)  \t\t\b\f\r \t 
31
7\f\t\n:\t5 \t \n\r\b 5\t
\t'\t  #$# ### #@'# J\r"##\f
32 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
LC\f \r##  &M\n \f" #"@ \f '\r"
\n\r\b 5\t, \n8\b\b \f\r\n7\t \t \f\n\t\b7\t
G, #/ \f' J\r"##\f,
  \b\t\b
\n\r\n\n8 \t \r\t\f7\t8
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. xorld Uealtu Vrganisation. De” nition and Diagnosis of Diabetes `ellitvs
and Inter|ediate Uyperglycae|ia; ˆeport of a xUVIDZ Xonsvltation. [ene~a,
Swit•erland; xorld Uealtu Vrganisation, 2006.
2. A|erican Diabetes Association. Diagnosis and classi”
cation of diabetes |ellitvs.
Diabetes Xare 2014; 37 FSvppl. 1G; S81…S90.
34 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
3. ‡eitler P, Zv ‰, Yandon N et al. Yype 2 diabetes in tue cuild and adolescent.
Pediatr Diabetes 2014; 15 FSvppl. 20G; 26…46.
4. A|erican Diabetes Association. Standards of |edical care in diabetes … 2014.
Diabetes Xare 2014; 37 FSvppl. 1G; S14…S80.
5. xorld Uealtu Vrgani•ation. }se of [lycated Uae|oglobin FUbA1cG in tue
Diagnosis of Diabetes `ellitvs. [ene~a, Swit•erland; xorld Uealtu Vrgani•ation, 2011.
6. Isla| SY, Abraua| A, Donaguve \X et al. Plateav of adiposity in Avstralian
cuildren diagnosed witu type 1 diabetes; a 20-year stvdy. Diabet`ed 2014; 31; 686…690.
7. \apellen Y`, [avscue ˆ, Dost A et al. Xuildren and adolescents witu type
1 diabetes in [er|any are |ore o~erweigut tuan uealtuy controls; resvlts co|paring
DPj database and XrescNet database. ‰ Pediatr ^ndocrinol `etab 2014; 27; 209…214.
8. ˆewers A, \lingens|itu [, Da~isXet al. Presence of diabetic ‚etoacidosis
at diagnosis of diabetes |ellitvs in yovtu; tue Searcu for Diabetes in hovtu Stvdy.
Pediatrics 2008; 121; e1258…e1266.
9. Dabelea D, ˆewers A, StaŠ ord ‰` et al. Yrends in tue pre~alence of ‚etoacidosis
at diabetes diagnosis; tue S^AˆXU for diabetes in yovtu stvdy. Pediatrics 2014; 133;
e938…e945.
10. Zendler x, Borowiec `, Baranows‚a-‰a•wiec‚a A et al. Pre~alence of |ono-
genic diabetes a|ongst Polisu cuildren after a nationwide genetic screening ca|paign.
Diabetologia 2012; 55; 2631…2635.
11. Irgens U}, `olnes ‰, ‰ouansson BB et al. Pre~alence of |onogenic diabetes in
tue popvlationbased Norwegian Xuilduood Diabetes ˆegistry. Diabetologia 2013; 56;
1512…1519.
12. Piuo‚er X, [illia| ]\, ^llard S et al. Pre~alence, cuaracteristics and clinical
diagnosis of |atvrity onset diabetes of tue yovng dve to |vtations in UNZ1A, UNZ4A,
and glvco‚inase; resvlts fro| tue S^AˆXU for Diabetes in hovtu. ‰ Xlin ^ndocrinol
`etab 2013; 98; 4055…4062.
13. [aller A, Stange Y, `vller [ et al. Incidence of cuilduood diabetes in cuildren
aged less tuan 15 years and its clinical and |etabolic cuaracteristics at tue ti|e of
diagnosis; data fro| tue Xuilduood Diabetes ˆegistry of Saony, [er|any. Uor| ˆes
Paediatr 2010; 74; 285…291.
14. [ill [j, `banya ‰X, ˆa|aiya \], Yesfaye S. A svb-Sauaran African perspec-
ti~e of diabetes. Diabetologia 2009; 52; 8…16.
15. Bar|an \\, Pre|alatua [, `ouan j. Yropical curonic pancreatitis. Postgrad
`ed ‰ 2003; 79; 606…615.
16. xat‚ins ˆA, ^~ans-`olina X, Blv| ‰S, Di|eglio ]A. ^stablisued and e|erg-
ing bio|ar‚ers for tue prediction of type 1 diabetes; a syste|atic re~iew. Yransl ˆes
2014; 164; 110…121.
17. Dabelea D, Piuo‚er X, Yalton ‰x et al. ^tiological approacu to cuaracteri•ation
of diabetes type; tue S^AˆXU for Diabetes in hovtu Stvdy. Diabetes Xare 2011; 34;
1628…1633.
18. ˆvbio-Xabe•as V, Uattersley A, N–olstad P et al. Yue diagnosis and |anage-
|ent of |onogenic diabetes in cuildren and adolescents. Pediatr Diabetes 2014; 15
FSvppl. 20G; 47…64.
  \b\t\b
19. Uowson ‰`,
Ste~ens
36 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
35. ˆicuardson S‰, xillco A, Bone A‰, Zovlis A\, `organ N[. capsid protein
~p1 i||vnostaining in pancreatic islets in uv|an type 1 diabetes. Diabetologia 2009;
52; 1143…1
36. Dotta Z, Xensini S, ~an Ualteren A[ et al. Xosac‚ie B4 ~irvs infection of beta
cells and natvral ‚iller cell insvlitis in recent-onset type 1 diabetic patients. Proc Natl
Acad Sci } S A 2007; 104; 5115…5120.
37. ˆicuardson S‰,
  \b\t\b
50. ]in xU, xang `X, xang x` et al. Incidence of and |ortality fro| type
I diabetes in Yaiwan fro| 1999 turovgu 2010; a nationwide couort stvdy. P]oS Vne
2014; 9; e86172.
51. Par‚ h. xuy is type 1 diabetes vnco||on in Asia— Ann N h Acad Sci 2006;
1079; 31…40.
52. Par‚ hS, xang Xh, \o \x et al. Xo|binations of U]A Dˆ and DŽ |olecvles
deter|ine tue svsceptibility to insvlin-dependent diabetes |ellitvs in \oreans. Uv|
I||vnol 1998; 59; 794…801.
53. I‚ega|i U, Zv–isawa Y, \awabata h, Noso S, Vgiuara Y. [enetics of type 1 dia-
betes; si|ilarities and diŠ
erences between Asian and Xavcasian popvlations. Ann N h
Acad Sci 2006; 1079; 51…59.
54. Svgiuara S. [enetic svsceptibility of cuilduood type 1 diabetes |ellitvs in ‰apan.
Pediatr ^ndocrinol ˆe~ 2012; 10 FSvppl. 1G; 62…71.
55. }ra‚a|i Y, Sv•v‚i ‰, hosuida A, Saito U, `vgisui|a U. Incidence of cuildren
witu slowly progressi~e for| of type 1 diabetes detected by tue vrine glvcose screening
at scuools in tue Yo‚yo |etropolitan area. Diabetes ˆes Xlin Pract 2008; 80; 473…476.
56. }ra‚a|i Y, hosuida A, Sv•v‚i ‰ et al. DiŠ
erences in pre~alence of antibodies to
[AD and IA-2 and tueir titers at diagnosis in cuildren witu slowly and rapidly progres-
si~e for|s of type 1 diabetes.Diabetes ˆes Xlin Pract 2009; 83; 89…93.
57. I|‚a|pe A\, [vlliford `X. Yrends in type 1 diabetes incidence in tue }\ in
0- to 14-year-olds and in 15- to 34-year-olds, 1991-2008. Diabet `ed 2011; 28; 811…814.
58. ‰aros•-Xuobot P, Polans‚a ‰, S•ad‚ows‚a A et al. ˆapid increase in tue inci-
dence of type 1 diabetes in Polisu cuildren fro| 1989 to 2004, and predictions for 2010
to 2025. Diabetologia 2011; 54; 508…515.
59. S‚ordis N, ^fstatuiov ^, \yria‚ides YX et al. ^pide|iology of type 1 diabetes
|ellitvs in Xyprvs; rising incidence at tue dawn of tue 21st centvry. Uor|ones FAtuensG
2012; 11; 86…93.
60. ]aron ‡, ]ewy U, xilder|an I et al. Seasonality of |ontu of birtu of cuildren
and adolescents witu type 1 diabetes |ellitvs in uo|ogenovs and ueterogeneovs popv-
lations. Isr `ed Assoc ‰ 2005; 7; 381…384.
61. \aun US, `organ Y`, Xase ]D et al. Association of type 1 diabetes witu
|ontu of birtu a|ong }.S. yovtu; tue S^AˆXU for Diabetes in hovtu Stvdy. Diabetes
Xare 2009; 32; 2010…2015.
62. xeets I, \avf|an ], jan der Avwera B et al. Seasonality in clinical onset of
type 1 diabetes in Belgian patients abo~e tue age of 10 is restricted to U]A-DŽ2DŽ8-
negati~e |ales, wuicu eplains tue |ale to fe|ale ecess in incidence. Diabetologia
2004; 47; 614…621.
63. xandell P^, Xarlsson AX. Yi|e trends and gender diŠ erences in incidence and
pre~alence of type 1 diabetes in Sweden. Xvrr Diabetes ˆe~ 2013; 9; 342…349.
64. Patterson XX, Daulvist [[, [yvrvs ^, [reen A, Soltes• [. Incidence trends
for cuilduood type 1 diabetes in ^vrope dvring 1989…2003 and predicted new cases
2005-20; a |vlticentre prospecti~e registration stvdy. ]ancet 2009; 373; 2027…2033.
65. Scuober ^, xalduoer Y, ˆa|i B, Uofer S. Incidence and ti|e trend of type
1 and type 2 diabetes in Avstrian cuildren 1999…2007. ‰ Pediatr 2009; 155; 190-3 e1.
38 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
66. Uaynes A, Bvlsara `\, Bower X, ‰ones Yx, Da~is ^A. Xyclical ~ariation in
tue incidence of cuilduood type 1 diabetes in xestern Avstralia F1985…2010G. Diabetes
Xare 2012; 35; 2300…2302.
67. Derrai‚ ‰[, ˆeed Px, ‰eŠ
eries X, Xvt” eld Sx, Uof|an P], Xvt”
eld xS.
Increasing incidence and age at diagnosis a|ong cuildren witu type 1 diabetes |ellitvs
o~er a 20-year period in Avc‚land FNew ‡ealandG. P]oS Vne 2012; 7; e32640.
68. Sipetic S, `a‚si|o~ic ‰, jla–inac U et al. ˆising incidence of type 1 diabetes in
Belgrade cuildren aged 0…14 years in tue period fro| 1982 to 2005. ‰^ndocrinol In~est
2013; 36; 307…312.
69. Brvno [, `avle `, Biggeri A et al. `ore tuan 20 years of registration of type
1 diabetes in Sardinian cuildren; te|poral ~ariations of incidence witu age, period of
diagnosis, and year of birtu. Diabetes 2013; 62; 3542…3546.
70. ]ip|an YU, ]e~itt \at• ]^, ˆatcliŠ
e S‰ et al. Increasing incidence of type
1 diabetes in yovtu; twenty years of tue Puiladelpuia Pediatric Diabetes ˆegistry.
Diabetes Xare 2013; 36; 1597…1603.
71. Yran Z, Stone `, Uvang Xh et al. Popvlationbased incidence of diabetes in
Avstralian yovtu aged 10-18 yr; increase in type 1 diabetes bvt not type 2 diabetes.
Pediatr Diabetes 2014; `ar 17. doi; 10.1111pedi.12131. m^pvb auead of printq.
72. ]awrence ‰`, I|peratore [, Dabelea D et al. Yrends in incidence of type
1 diabetes a|ong non-Uispanic xuite yovtu in tue }nited States, 2002-2009. Diabetes
2014; ‰vn 4. pii; DB™131891. m^pvb auead of printq.
73. [yvrvs ^\, Patterson X, Soltes• [. Ywenty-one years of prospecti~e incidence
of cuilduood type 1 diabetes in Uvngary … tue rising trend continves For pea‚s and
uigulands—G. Pediatr Diabetes 2012; 13; 21…25.
74. Xine‚ V, \vlicu `, Sv|ni‚ ‡. Yue incidence of type 1 diabetes in yovng X•ecu
cuildren stopped rising. Pediatr Diabetes 2012; 13; 559…563.
75. \raan ‰A, Xlaessen Z`AP, ^lliott \D et al. Popvlation based incidence of type
1 diabetes in New Sovtu xales Avstralia 1990-2010 - ua~e we reacued a plateav— FVral
AbstractG. Pediatr Diabetes 2011; 12 FSvppl. 15G; 25.
76. Uer|ann ˆ, \nip `, je˜ ola ˆ et al. Ye|poral cuanges in tue frevencies of
U]A genotypes in patients witu type 1 diabetes … indication of an increased en~iron-
|ental pressvre— Diabetologia 2003; 46; 420…425.
77. [illespie \`, Bain SX, Barnett AU et al. Yue rising incidence of cuilduood
type 1 diabetes and redvced contribvtion of uigu-ris‚ U]A uaplotypes. ]ancet 2004;
364; 1699…1700.
78. Zovrlanos S, jarney `D, Yait BD et al. Yue rising incidence of type 1 diabetes
is accovnted for by cases witu lower-ris‚ uv|an lev‚ocyte antigen genotypes. Diabetes
Xare 2008; 31; 1546…1549.
79. Ue||in‚i \, ]i _, Svndvist ‰, Svndvist \. Za|ilial association between
type 1 diabetes and otuer avtoi||vne and related diseases. Diabetologia 2009; 52;
1820…1828.
80. Par‚‚ola A, Uar‚onen Y, ˆyuanen S‰, Ilonen ‰, \nip `. ^tended fa|ily
uistory of type 1 diabetes and puenotype and genotype of newly diagnosed cuildren.
Diabetes Xare 2012; 36; 348…354.
  \b\t\b
81. Vl|os P, AUern ˆ, Ueaton DA et al. Yue signi”
cance of tue concordance
rate for type 1 FinsvlindependentG diabetes in identical twins. Diabetologia 1988; 31;
747…750.
82. Uar–vtsalo j, Podar Y, Yvo|ileuto ‰. Xv|vlati~e incidence of type 1 diabetes
in 10,168 siblings of Zinnisu yovng-onset type 1 diabetic patients. Diabetes 2005; 54;
563…569.
83. Stec‚ A\, Barriga \‰, ^|ery ]`, Ziallo-Scuarer ˆj, [ottlieb PA, ˆewers `‰.
Secondary attac‚ rate of type 1 diabetes in Xolorado fa|ilies. Diabetes Xare 2005; 28;
84. [illespie \`, Ait‚en ˆ‰, xilson I, xillia|s A‰, Bingley P‰. ^arly onset of
diabetes in tue proband is tue|a–or deter|inant of ris‚ in U]ADˆ3-DŽ2Dˆ4- DŽ8
siblings. Diabetes 2014; 63; 1041…1047.
85. [illespie \`, [ale ^A, Bingley P‰. Uigu fa|ilial ris‚ and genetic svsceptibility
in early onset cuilduood diabetes. Diabetes 2002; 51; 210…214.
86. [reen A, Scuober ^, Xuristo~ j et al. Za|ilial ris‚ of type 1 diabetes in
^vropean cuildren. Diabetologia 1998; 41; 1151…1156.
87. Dor|an ‰S, Steen‚iste Aˆ, V]eary ]A, `cXartuy B‰, ]oren•en Y, Zoley YP.
Yype 1 diabetes in oŠ
spring of parents witu type 1 diabetes; tue tip of an avtoi||vne
iceberg— Pediatr Diabetes 2000; 1; 17…22.
88. ^l Uasui|y `, Angelico `X, `artin BX, \rolews‚i AS, xarra| ‰U. Zactors
|odifying tue ris‚ of IDD` in oŠ spring of an IDD` parent. Diabetes 1995; 44;
89. ]oren•en Y, Pociot Z, Stilgren ] et al. Predictors of IDD` recvrrence ris‚
in oŠ spring of Danisu IDD` patients. Danisu IDD` ^pide|iology and [enetics
[rovp. Diabetologia 1998; 41; 666…673.
90. xarra| ‰U, \rolews‚i AS, [ottlieb `S, \aun Xˆ. DiŠ
erences in ris‚ of
insvlin-dependent diabetes in oŠ
spring of diabetic |otuers and diabetic fatuers. N ^ngl
‰ `ed 1984; 311; 149…152.
91. Uar–vtsalo j, ]a||i N, \ar~onen `, [roop PU. Age at onset of type 1 diabe-
tes in parents and recvrrence ris‚ in oŠ spring. Diabetes 2010; 59; 210…214.
92. Yattersall ˆ. `atvrity-onset diabetes of tue yovng; a clinical uistory. Diabet
`ed 1998; 15; 11…14.
93. Za–ans SS, Bell [I. `VDh; uistory, genetics, patuopuysiology, and clinical
decision |a‚ing. Diabetes Xare 2011; 34; 1878…1884.
94. Za–ans SS, Bell [I, Polons‚y \S. `olecvlar |ecuanis|s and clinical patuo-
puysiology of |atvrityonset diabetes of tue yovng. N ^ngl ‰ `ed 2001; 345; 971…980.
95. Yattersall ˆB, Za–ans SS. A diŠ
erence between tue inueritance of classical –v~e-
nile-onset and |atvrityonset type diabetes of yovng people. Diabetes 1975; 24; 44…53.
96. Awa x], Scuober ^, xiegand S et al. ˆeclassi”
cation of diabetes type in pediatric
patients initially classi”
ed as type 2 diabetes |ellitvs; 15 years followvp vsing rovtine data
fro| tue [er|anAvstrian DPj database. Diabetes ˆes Xlin Pract 2011; 94; 463…467.
97. `vrpuy ˆ, ^llard S, Uattersley AY. Xlinical i|plications of a |olecvlar genetic
classi”
cation of |onogenic beta-cell diabetes. Nat Xlin Pract ^ndocrinol `etab 2008;
4; 200…213.
40 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
98. ^dguill ^], Di ˆ‰, Zlanagan S^ et al. U]A genotyping svpports a nonavtoi|-
|vne etiology in patients diagnosed witu diabetes vnder tue age of 6 |ontus. Diabetes
2006; 55; 1895…1898.
99. Iafvsco D, Sta•i `A, Xoticuini ˆ et al. Per|anent diabetes |ellitvs in tue ”
rst
year of life. Diabetologia 2002; 45; 798…804.
100. ˆvbio-Xabe•as V, `inton ‰A, Xaswell ˆ et al. Xlinical ueterogeneity in
patients witu ZV_P3 |vtations presenting witu per|anent neonatal diabetes. Diabetes
Xare 2009; 32; 111…116.
101. ˆvbio-Xabe•as V, Zlanagan S^, Da|uvis A, Uattersley AY, ^llard S. \AYP
cuannel |vtations in infants witu per|anent diabetes diagnosed after 6 |ontus of life.
Pediatr Diabetes 2012; 13; 322…325.
102. ˆvbio-Xabe•as V, ^dguill ^], Argente ‰, Uattersley AY. Yesting for |ono-
genic diabetes a|ong cuildren and adolescents witu antibodynegati~e clinically de”
ned
Yype 1 diabetes. Diabet `ed 2009; 26; 1070…1074.
103. `oua|adi A, Xlar‚ ]`, ]ip‚in PU, `auone ^`, xod‚a ^], Plotnic‚
]P.`edical and de~elop|ental i|pact of transition fro| svbcvtaneovs insvlin to
oral glybvride in a 15-yr-old boy witu neonatal diabetes |ellitvs and inter|ediat-
eD^NDsyndro|e; etending tue age of \XN‰11 |vtation testing in neonatal D`.
Pediatr Diabetes 2010; 11; 203…207.
104. `assa V, Iafvsco D, DA|ato ^ et al. \XN‰11 acti~ating |vtations in Italian
patientswitu per|anent neonatal diabetes. Uv| `vtat 2005; 25; 22…27.
105. Iafvsco D, `assa V, Pasvino B et al. `ini|al incidence of neonatalinfancy
onset diabetes in Italy is 1;90,000 li~e birtus. Acta Diabetol 2012; 49; 405…408.
106. ~on `vulendaul \^, Uer‚enuoŠ
U. ]ong-ter| covrse of neonatal diabetes.
N ^ngl ‰ `ed 1995; 333; 704…708.
107. Ye|ple I\, [ardner ˆ‰, `ac‚ay D‰, Barber ‰X, ˆobinson DV, Suield ‰P.
Yransient neonatal diabetes; widening tue vnderstanding of tue etiopatuogenesis of
diabetes. Diabetes 2000; 49; 1359…1366.
108. [ardner ˆ‰, `ac‚ay D‰, `vngall A‰ et al. An i|printed locvs associated witu
transient neonatal diabetes |ellitvs. Uv| `ol [enet 2000; 9; 589…596.
109. Zlanagan S^, Patcu A`, `ac‚ay D‰ et al. `vtations in AYP-sensiti~e \š
cuannel genes cavse transient neonatal diabetes and per|anent diabetes in cuilduood
or advltuood. Diabetes 2007; 56; 1930…1937.
110. Ye|ple I\, Suield ‰P. 624 transient neonatal diabetes.ˆe~ ^ndocr`etab
Disord 2010; 11; 199…204. 111. [loyn A], Xv||ings ^A, ^dguill ^] et al. Per|anent
neonatal diabetes dve to paternal ger|line |osaicis| for an acti~ating |vtation of
tue \XN‰11 [ene encoding tue \ir6.2 svbvnit of tue beta-cell potassiv| adenosine
tripuospuate cuannel. ‰ Xlin ^ndocrinol `etab 2004; 89; 3932…3935.
112. `assa V, Iafvsco D, DA|ato ^ et al. \XN‰11 acti~ating |vtations in Italian
patientswitu per|anent neonatal diabetes. Uv| `vtat 2005; 25; 22…27.
113. Xolo|bo X, Por•io V, ]iv ` et al. Se~en |vtations in tue uv|an insvlin gene
lin‚ed to per|anent neonatalinfancy-onset diabetes |ellitvs. ‰ Xlin In~est 2008; 118;
2148…2156.
  \b\t\b
114. ^dguill ^], Zlanagan S^, Patcu A` et al. Insvlin |vtation screening in 1,044
patients witu diabetes; |vtations in tue INS gene are a co||on cavse of neonatal dia-
betes bvt a rare cavse of diabetes diagnosed in cuilduood or advltuood. Diabetes 2008;
57; 1034…1042.
115. Pola‚ `, Decuav|e A, Xa~e U et al. Uetero•ygovs |issense |vtations in tue
insvlin gene are lin‚ed to per|anent diabetes appearing in tue neonatal period or in
early infancy; a report fro| tue Zrencu ND FNeonatal DiabetesG Stvdy [rovp. Diabetes
2008; 57; 1115…1119.
116. Støy ‰, ^dguill ^], Zlanagan S^ et al. Insvlin gene |vtations as a cavse of
per|anent neonatal diabetes. Proc Natl Acad Sci } S A 2007; 104; 15040…15044.
117. [arin I, ^dguill ^], A‚er|an I et al. ˆecessi~e |vtations in tue INS gene
resvlt in neonatal diabetes turovgu redvced insvlin biosyntuesis. Proc Natl Acad Sci }
S A 2010; 107; 3105…3110.
118. N–olstad Pˆ, So~i‚ V, Xvesta-`vno• A et al. Neonatal diabetes |ellitvs dve
to co|plete glvco‚inase de”
ciency. N ^ngl ‰ `ed 2001; 344; 1588…1592.
119. ˆvbio-Xabe•as V, ^llard S. Diabetes |ellitvs in neonates and infants; genetic
ueterogeneity, clinical approacu to diagnosis, and tuerapevtic options. Uor| ˆes
Paediatr 2013; 80; 137…146.
120. StoŠ
ers DA, ‡in‚in NY, Stano–e~ic j, Xlar‚e x], Uabener ‰Z. Pancreatic
agenesis attribvtable to a single nvcleotide deletion in tue uv|an IPZ1 gene coding
sevence. Nat [enet 1997; 15; 106…110.
121. [villavsseav P‰, Dvbois-]aforgve D, `assin P et al. Ueterogeneity of diabetes
puenotype in patients witu 3243 bp |vtation of |itocuondrialDNA F|aternally inuer-
ited diabetes and deafness or`IDDG. Diabetes `etab 2004; 30; 181…186.
122. ]aloi-`icuelin `, `eas Y, A|bon~ille X et al. Yue clinical ~ariability of
|aternally inuerited diabetes and deafness is associated witu tue degree of ueteroplas|y
in blood lev‚ocytes. ‰ Xlin ^ndocrinol `etab 2009; 94; 3025…3030.
123. ˆeardon x, ˆoss ˆ‰, Sweeney `[ et al. Diabetes |ellitvs associated witu a
patuogenic point |vtation in |itocuondrial DNA. ]ancet 1992; 340; 1376…1379.
124. ~an den Vvweland ‰`, ]e|‚es UU, ˆvitenbee‚ x et al. `vtation in |ito-
cuondrial tˆNAF]evGF}}ˆG gene in a large pedigree witu |aternally trans|itted type
II diabetes |ellitvs and deafness. Nat[enet 1992; 1; 368…371.
125. `a••accara X, Iafvsco D, ]igvori ˆ et al. `itocuondrial diabetes in cuildren;
see‚ and yov will ” nd it. P]oS Vne 2012; 7; e34956.
126. ˆana `, `vnns XZ, Sel~advrai U, Donaguve \X, Xraig `^. Xystic ”
brosis-
related diabetes in cuildrengaps in tue e~idence— Nat ˆe~ ^ndocrinol 2010; 6; 371…378.
16 Pediatric Diabetes 2014; 15
127. ˆana `, `vnns XZ, Sel~advrai UX, et al. Increased detection of cystic-”
sis-related diabetes in Avstralia. Arcu Dis Xuild 2011; 96; 823…826.
128. Ua|eed S, `orton ‰ˆ, ‰aŠ e A et al. ^arly glvcose abnor|alities in cystic ”
sis are preceded by poor weigut gain. Diabetes Xare 2010; 33; 221…226.
129. xavgu N, ˆoyle P, Xraigie I et al. Screening for cystic ”
brosis-related diabetes;
a syste|atic re~iew. Uealtu Yecunol Assess 2012; 16 iii…i~, 1…179.
42 !\t\t 1. \b   \f , "   \t#\t \t\t\b\f \t \t    \r...
130. `oran A, Dvnit• ‰, Natuan B, Saeed A, Uol|e B, Yuo|as x. Xystic ”
brosis-
related diabetes; cvrrent trends in pre~alence, incidence, and |ortality. Diabetes Xare
2009; 32; 1626…1631.
131. `oran A, `illa X, Dvcret ˆ, Nair \S. Protein |etabolis| in clinically
stable advlt cystic ”
brosis patients witu abnor|al glvcose tolerance. Diabetes 2001; 50;
1336…1343.
132. `oran A, Pillay \, Be
c‚er D, Acer
ini X]. `anage|ent of cystic ”
brosis relat-
ed diabetes in cuildren and adolescents. Pediatr Diabetes 2014; 15 FSvppl. 20G; 65…76.
133. Berne X, Pollare Y, ]ituell U. ^Š
ects of antiuypertensi~e treat|ent on insvlin
sensiti~ity witu special reference to AX^ inuibitors. Diabetes Xare 1991; 14 FSvppl. 4G;
39…47.
134. jestri US, `aianv ], `oellering Dˆ, [ar~ey xY. Atypical antipsycuotic
drvgs directly i|pair insvlin action in adipocytes; eŠ
ects on glvcose transport, lipogen-
esis, and antilipolysis. Nevropsycuopuar|acology 2007; 32; 765…772.
135. Pvi XU, Bvrguen [A, Bow|an xP, Avr ˆ‰. ˆis‚ factors for uyperglyce|ia
in cuildren witu lev‚e|ia recei~ing ]-asparaginase and prednisone. ‰ Pediatr 1981; 99;
136. Dracuenberg XB, \lassen D\, xeir `ˆ et al. Islet cell da|age associated witu
tacroli|vs and cyclosporine; |orpuological featvres in pancreas allograft biopsies and
clinical correlation. Yransplantation 1999; 68; 396…402.
137. Al }•ri A, Stablein D`, Xoun A. Posttransplant diabetes |ellitvs in pediatric
renal transplant recipients; a report of tue Nortu A|erican Pediatric ˆenal Yransplant
Xooperati~e Stvdy FNAPˆYXSG. Yransplantation 2001; 72; 1020…1024.
138. `aes BD, \vypers D, `essiaen Y et al. Posttransplantation diabetes |ellitvs
in Z\-506-treated renal transplant recipients; analysis of incidence and ris‚ factors.
Yransplantation 2001; 72; 1655…1661.
139. Zirst `ˆ, [erber DA, Uariuaran S, \avf|an DB, Suapiro ˆ. Posttransplant
diabetes |ellitvs in ‚idney allograft recipients; incidence, ris‚ factors, and |anage-
|ent. Yransplantation 2002; 73; 379…386.
140. Bobo xj, Xooper xV, Stein X` et al. Antipsycuotics and tue ris‚ of type 2
diabetes |ellitvs in cuildren and yovtu. ‰A`A Psycuiatry 2013; 70; 1067…1075.
141. A|ed S, Dean U, Sellers ^A et al. ˆis‚ factors for |edication-indvced diabetes
and type 2 diabetes. ‰ Pediatr 2011; 159; 291…296.
142. Buisit‚vl D`, `orrow A], jini‚ AI, Suvlts ‰, ]ayland ‰X, ˆoun ˆ.
Pre~alence of stress uyperglyce|ia a|ong patients attending a pediatric e|ergency
depart|ent. ‰ Pediatr 1994; 124; 547…551.
143. jalerio [, Zran•ese A, Xarlin ^, Pecile P, Perini ˆ, Yenore A. Uigu pre~alence
of stress uyperglycae|ia in cuildren witu febrile sei•vres and trav|atic in–vries. Acta
Paediatr 2001; 90; 618…622.
144. [avglit• [[, Uerndon DN, \vlp [A, `eyer x‰ III, ‰escu‚e `[. Abnor|al
insvlin sensiti~ity persists vp to turee years in pediatric patients post-bvrn. ‰ Xlin
^ndocrinol `etab 2009; 94; 1656…1664.
145. Sa• ^}, V•en S, Si|se‚ [o‚sen D, Darcan S. Stress uyperglyce|ia in febrile
cuildren; relationsuip to prediabetes. `iner~a ^ndocrinol 2011; 36; 99…105.
  \b\t\b
146. xeiss S], Aleander ‰, Agvs `S. ^tre|e stress uyperglyce|ia dvring acvte
illness in a pediatric e|ergency depart|ent. Pediatr ^|erg Xare 2010; 26; 626…632.
147. Uers‚owit• ˆD, xolfsdorf ‰I, ˆi
c‚er AY et
al. Yransient uyperglyce|ia in
cuilduood; identi”
cation of a svbgrovp witu i||inent diabetes |ellitvs. Diabetes ˆes
1988; 9; 161…167.
148. Scuat• DA, \owa U, xinter x^, ˆiley x‰. Natvral uistory of incidental
uyperglyce|ia and glycosvria of cuilduood. ‰ Pediatr 1989; 115; 676…680.
149. jardi P, Sueuade N, ^t•ioni A et al. Stress uyperglyce|ia in cuilduood; a ~ery
uigu ris‚ grovp for tue de~elop|ent of type I diabetes. ‰ Pediatr 1990; 117; 75…77.
150. Uers‚owit•-Dv|ont ˆ, xolfsdorf ‰I, ‰ac‚son ˆA, ^isenbartu [S. Distinction
between transient uyperglyce|ia and early insvlin-dependent diabetes |ellitvs in
cuilduood; a prospecti~e stvdy of incidence and prognostic factors. ‰ Pediatr 1993; 123;
347…354.
151. Buis
it‚vl D`, jini‚ AI, `orrow A] et al. Prediabetic |ar‚ers in cuildren witu
stress uyperglyce|ia. Arcu Pediatr Adolesc `ed 1996; 150; 936…941.
152. Sueuadeu N, Vn A, \essel I et al. Stress uyperglyce|ia and tue ris‚ for tue
de~elop|ent of type 1 diabetes. ‰ Pediatr ^ndocrinol `etab 1997; 10; 283…286.
1 \t\t
9 \n\r\b 5\t 1B \t 
 5 \t 5\r\n\f
\t\f \t\r
\b\b:\t8 \t \r\f7\b5:\t\t






 \t\n\b\t \n5\t
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
\b\t\n\f8 \r5\r\n M\b\b\nL
DŽA1{01;01-DŽB{05;03 # DˆB1{07;01-DŽA1{02;01-DŽB1{03;03 m5q.
5\f\t\b\t\n\f\t \n\r\b 5\t




""#"  "\r\r"\r $#-8, \r\tE $# 
\r\t\n\f \r\r\n\n\t\r\b\t8
/ \b\b \b\t\f
�$ "# \r# C" "C @ #\f"##$#\r"@
/ # "##/ \r\r,  # "#"@ " #' \r$##
##  ""  "\r#J \r' J'. \r!#
\r \r\f\t"\t  ##\t \r$#\t #C 10- \r$"#\t
\f\t """JE '\r" # G '"  60k \r# \n1
\f## %" #'  \r"##/ $\t/ " :/\f#"#z
 \r\f"# \r \r\f"  C#"@ #' 
"#" # \r@ "\r""@J  J', "!#/
 «(\f##  \r#"# \f#:"-1», \f/ \r@
J' \r# \r\f## *?? '\t '", #:
" \r\f'JE# \r\r#\r# \n1 m12q. \b ", 
 \r\t J', # '#\t \n-"#\f # E\[email protected]
'  \r#J  \r',   #'\r## \f
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
\r9\t\f\t\f \n\r\b 5\t
\r\t\b8 \r9\t\f\t\f
("#\t, \t'  \r# \r#"#, #J"


(\b#\t\t \t\t\b\f \t \t

ˆ\r\f)\t\f', " #@'# #   #\f\r#'" '#  "  "#\t " \r\f# # #C \r# \t#\t \f ## @#/ #\f ""#" F"!# \r# „ 0,51z ( 96k „ 0,28…0,91G m34q. = \r/ C\f\r\f- #\f#\t YˆI[ˆ #'"\t '\f"# " #  2159 \f$  "## U]A  "# \r# #' \r'/ "\r L\r,  "C #' \n\r \r## # "\r## m35q. \f : \r\f #' \r/ C#\f/ \r'@"-",  # ##\t   \f/ #\f "\r/ "-"#"  '\r" 6 ",  '!# \r'##  :\r'## ""#"  "#, "\r  :\r' :# "-:\r \f\t "#\t " \r\f# #J#"@  [email protected] #\f\r-#'#\r #, # "/, " :  :\r' ":\r �\f\t "#\t  [email protected] : # m36q. \f #\f-# :\f" \r\fC"@\t \f #\t "@/ C#\f/ \r'@"", ".. \f $# '##\t ## \f#:"  '\r" 10 ". €
\r\t\b8 \r9\t\f\t\f

50
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
""#"  ## \r@\t ##"\r#\t 
)\t\f# \t \t\t\b\f \t \t 1- \t
51
 2.1
\f(!%!/"! ;!"!! ";% !- 1B !*
% ##% !%"!!
C\b\t   \n\t  \t, &   \t ,  &
52
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
5\t99\r\b:\t:\t8 \n\r\b 5\t 1B \t 2B \t 
\r\t \n\b\b\t\t 5\t\b







! \r@ \n-"#\f F "\r ' ':#\t
:\t\f\t \b ,  #\t\t «   \t»...
53
\n\t\b8 \r7\t\n\n\t8, \t\t 9 «75 7\n8:»,
\r\t \n\r\b7 5\t 1B \t 
54
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
:# # \r$#"\r #"##\rJE "\rG.
"#/ \r!#\r/ \r\t"\r/ ?-" # #
\r\b\t\n\f8 9 M\t\b\b\b \t\n\t7\n\t
 \t\b\n\t\b
 '##"# " %' ## : /\r"\r#'"\t
"#"@ "\f #'\r#\t \r\t \n-"#\f 'J", "
%\f\t \r$#\t ##  "\r :H \r\fC" #"@
"  "# \f \r#  \f 75k $#" m61q. = "\tE
\r\t "\r#\t %' ## ""\t \f#" \r
7\b\t
B\f\f 5M5\b M
  \b\t\b
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. Barrett ‰X, Xlayton D[, Xoncannon P et al. [eno|e-wide association stvdy
and |eta-analysis ”
nd tuat o~er 40 loci aŠ
ect ris‚ of type 1 diabetes. Nat[enet 2009;
41; 703…707.
2. Noble ‰A, jaldes A`, Xoo‚ `, \lit• x, Yuo|son [, ^rlicu UA. Yue role of
U]A class II genes in insvlin-dependent diabetes |ellitvs; |olecvlar analysis of 180
Xavcasian, |vltiple fa|ilies. A| ‰ Uv| [enet 1996; 59; 1134…1148.
3. ]a|bert AP, [illespie \`, Yuo|son [ et al. Absolvte ris‚ of cuilduood-onset
type 1 diabetes de”
ned by uv|an lev‚ocyte antigen class II genotype; a popvlation-
based stvdy in tue }nited \ingdo|. ‰ Xlin ^ndocrinol `etab 2004; 89; 4037…4043.
4. Ngvyen X, jarney `D, Uarrison ]X, `orauan [. De”
nition of uigu-ris‚ type
1 diabetes U]A-Dˆ and U]A-DŽ types vsing only turee single nvcleotide poly|or-
puis|s. Diabetes 2013; 62; 2135…2140.
5. ^rlicu U, jaldes A`, Noble ‰ et al. U]A Dˆ-DŽ uaplotypes and genotypes
and type 1 diabetes ris‚; analysis of tue type 1 diabetes genetics consortiv| fa|ilies.
Diabetes 2008; 57; 1084…1092.
6. xat‚ins ˆA, ^~ans-`olina X, Blv| ‰S, Di|eglio ]A. ^stablisued and e|erging
bio|ar‚ers for tue prediction of type 1 diabetes; a syste|atic re~iew. Yransl ˆes 2014;
pii; S1931-5244F14G00078-4.
56
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
7. Aly YA, Ide A, ‰auro|i `` et al. ^tre|e genetic ris‚ for type 1A diabetes. Proc
Natl Acad Sci }SA 2006; 103; 14074…14079.
8. Stec‚ A\, xong ˆ, xagner B et al. ^Š
ects of non-U]A gene poly|orpuis|s on
de~elop|ent of islet avtoi||vnity and type 1 diabetes in a popvlation witu uigu-ris‚
U]A-Dˆ, DŽ genotypes. Diabetes 2012; 61; 753…758.
9. ‡iegler A[, ˆewers `, Si|ell V. et al. Serocon~ersion to |vltiple islet avtoan-
tibodies and ris‚ of progression to diabetes in cuildren. ‰A`A 2013; 309; 2473…2479.
10. Bonifacio ^, \rv|sie‚ ‰, xin‚ler X, Yueis Z‰, ‡iegler A[. A strategy to ”
nd
gene co|binations tuat identify cuildren wuo progress rapidly to type 1 diabetes after
islet avtoantibody serocon~ersion. Acta Diabetol 2014; 51; 403…411.
11. DPY-1 Stvdy [rovp. ^Š
ects of insvlin in relati~es of patients witu type 1 diabe-
tes |ellitvs. N ^ngl ‰ `ed 2002; 346; 1685…1691.
12. _v P, xv h, ‡uv h et al. Prognostic perfor|ance of |etabolic indees in pre-
dicting onset of type 1 diabetes. Diabetes Xare 2010; 33; 2508…2513.
13. _v P, Bea| XA, Xvtubertson D et al. Prognostic accvracy of i||vnologic
and |etabolic |ar‚ers for type 1 diabetes in a uigu-ris‚ popvlation; recei~er operating
cuaracteristic analysis. Diabetes Xare 2012; 35; 1975…1980.
14. [illespie \`, Bain SX, Barnett AU et al. Yue rising incidence of cuilduood
type 1 diabetes and redvced contribvtion of uigu-ris‚U]Auaplotypes. ]ancet 2004;
364; 1699…1700.
15. Zovrlanos S, jarney `D, Yait BD et al. Yue rising incidence of type 1 diabetes
is accovnted for by cases witu lower-ris‚ uv|an lev‚ocyte antigen genotypes. Diabetes
Xare 2008; 31; 1546…1549.
16. Uer|ann ˆ, \nip `, je˜ ola ˆ et al. Ye|poral cuanges in tue frevencies of
U]A genotypes in patients witu type 1 diabetes…indication of an increased en~iron-
|ental pressvre— Diabetologia 2003; 46; 420…425.
17. `cIntosu ^D, `enser `A. A ”
fty-year follow-vp of congenital rvbella. ]ancet
1992; 340; 414…415.
18. Ya‚asv N, I‚e|a Y, \o|iya I, `i|vra [. Zorty-year obser~ation of 280
‰apanese patients witu congenital rvbella syndro|e. Diabetes Xare 2005; 28; 2331…
2332.
19. hevng [, ˆawlinson xD, Xraig `^. ^ntero~irvs infection and type 1 diabetes
|ellitvs … a syste|atic re~iew of |olecvlar stvdies. Br `ed ‰ 2011; 342; d35.
20. A‚erblo| U\, jirtanen S`, Ilonen ‰ et al. Dietary |anipvlation of beta cell
avtoi||vnity in infants at increased ris‚ of type 1 diabetes; a pilot stvdy. Diabetologia
2005; 48; 829…837.
21. Norris ‰`, Barriga \, \lingens|itu [ et al. Yi|ing of initial cereal eposvre in
infancy and ris‚ of islet avtoi||vnity. ‰A`A 2003; 290; 1713…1720.
22. ‡iegler A[, Scu|id S, Uvber D, Uv||el `, Bonifacio ^. ^arly infant feed-
ing and ris‚ of de~eloping type 1 diabetes-associated avtoantibodies. ‰A`A 2003; 290;
1721…1728.
23. Xardwell Xˆ, Stene ]X, ]vd~igsson ‰ et al. Breastfeeding and cuilduood-onset
type 1 diabetes; a pooled analysis of indi~idval participant data fro| 43 obser~ational
stvdies. Diabetes Xare 2012; 35; 2215…2225.
  \b\t\b
24. Norris ‰`, hin _, ]a|b `` et al. V|ega-3 polyvnsatvrated fatty acid inta‚e
and islet avtoi||vnity in cuildren at increased ris‚ for type 1 diabetes. ‰A`A 2007;
298; 1420…1428.
25. Yi•aovi \, \aabacui x, Ua|•aovi A, Ua|•aovi \. Xontribvtion of jDˆ poly-
|orpuis|s to type 1 diabetes svsceptibility; syste|atic re~iew of case-control stvdies
and |eta-analysis. ‰ Steroid Biocue| `ol Biol 2014; 143X; 240…249.
26. Si|pson `, Brady U, hin _ et al. No association of ~ita|in D inta‚e or
25-uydroy~ita|in D le~els in cuilduood witu ris‚ of islet avtoi||vnity and type
1 diabetes; tue Diabetes Avtoi||vnity Stvdy in tue hovng FDAIShG. Diabetologia
2011; 54; 2779…2788.
27. ˆaab ‰, [iannopovlov ^‡, Scuneider S et al. Pre~alence of ~ita|in D de”
ciency
in pre-type 1 diabetes and its association witu disease progression. Diabetologia 2014;
57; 902…908.
28. Xovper ‰‰, Beresford S, Uirte X et al. xeigut gain in early life predicts ris‚ of
islet avtoi||vnity in cuildren witu a ”
rst-degree relati~e witu type 1 diabetes.Diabetes
Xare 2009; 32; 94…99.
29. Zovrlanos S, Narendran P, Byrnes [B, Xol|an P[, Uarrison ]X. Insvlin
resistance is a ris‚ factor for progression to type 1 diabetes. Diabetologia 2004; 47;
1661…1667.
30. [rovp YS. Yue ^n~iron|ental Deter|inants of Diabetes in tue hovng
FY^DDhG Stvdy. Ann N h Acad Sci 2008; 1150; 1…13.
31. Penno `A, Xovper ‰‰, [raig `^ et al. ^n~iron|ental deter|inants of islet
avtoi||vnity F^NDIAG; a pregnancy to early life couort stvdy in cuildren at-ris‚ of
type 1 diabetes. B`X Pediatr 2013; 13; 124.
32. Uv||el S, P›
üger `, Uv||el `, Bonifacio ^, ‡iegler A[. Pri|ary dietary
inter~ention stvdy to redvce tue ris‚ of islet avtoi||vnity in cuildren at increased ris‚
for type 1 diabetes; tue BABhDI^Y stvdy. Diabetes Xare 2011; 34; 1301…1305.
33. jaarala V, Ilonen ‰, ˆvoutvla Y et al. ˆe|o~al of bo~ine insvlin fro| cows
|il‚ for|vla and early initiation of beta-cell avtoi||vnity in tue ZINDIA Pilot Stvdy.
Arcu Pediatr Adolesc `ed 2012; 166; 608…614.
34. \nip `, jirtanen S`, Seppa \ et al. Dietary inter~ention in infancy and later
signs of beta-cell avtoi||vnity. N ^ngl ‰ `ed 2010; 363; 1900…1908.
35. YˆI[ˆ Stvdy [rovp, A‚erblo| U\, \riscuer ‰ et al. Yue Yrial to ˆedvce
IDD` in tue [enetically at ˆis‚ FYˆI[ˆG stvdy; recrvit|ent, inter~ention and fol-
lowvp. Diabetologia 2011; 54; 627…633.
36. \nip `, A‚erblo| U\, Be
c‚er D et
al. Uydroly•ed infant for|vla and early
W-cell avtoi||vnity; a rando|i•ed clinical trial. ‰A`A 2014; 311; 2279…2287.
37. Xuase UP, ]escuec‚ ^, ˆaf‚in-`er~is ] et al. Nvtritional inter~ention to pre-
~ent FNIPG type 1 diabetes; a pilot trial. Infant Xuild Adolesc Nvtr 2009; 1; 98…107.
38. Acuenbacu P, Bar‚er ‰, Bonifacio ^, [rovp P-PS. `odvlating tue natvral uis-
tory of type 1 diabetes in cuildren at uigu genetic ris‚ by |vcosal insvlin i||vni•ation.
Xvrr Diab ˆep 2008; 8; 87…93.
39. [ale ^A, Bingley P‰, ^||ett X], Xollier Y. ^vropean nicotina|ide diabetes
inter~ention trial [. ^vropean Nicotina|ide Diabetes Inter~ention Yrial F^NDIYG; a
58
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
rando|ised controlled trial of nter~ention before tue onset of type 1 diabetes. ]ancet
2004; 363; 925…931.
40. S‚yler ‰S, \riscuer ‰P, xolfsdorf ‰ et al. ^Š
ects of oral insvlin in relati~es of
patients witu type 1 diabetes; tue diabetes pre~ention trial…type 1. Diabetes Xare 2005;
28; 1068…1076.
41. S‚yler ‰S. }pdate on worldwide eŠ
orts to pre~ent type 1 diabetes. Ann N h Acad
Sci 2008; 1150; 190…196.
42. Zovrlanos S, Perry X, [ellert SA et al. ^~idence tuat nasal insvlin indvces i||vne
tolerance to insvlin in advlts witu avtoi||vne diabetes. Diabetes 2011; 60; 1237…1245.
43. Uarrison ]X, Uoney|an `X, Steele X^ et al. Pancreatic beta-cell fvnction and
i||vne responses to insvlin after ad|inistration of intranasal insvlin to uv|ans at ris‚
for type 1 diabetes. Diabetes Xare 2004; 27; 2348…2355.
44. Uan `_, Xraig `^. ˆesearcu vsing avtologovs cord blood - ti|e for a policy
cuange. `ed ‰ Avst 013; 199; 288…299.
45. ^lding ]arsson U, jeui‚ \, Bell ˆ et al. ˆedvced pre~alence of diabetic ‚eto-
acidosis at diagnosis of type 1 diabetes in yovng cuildren participating in longitvdinal
follow-vp. Diabetes Xare 2011; 34; 2347…2352.
46. }suer-S|itu ‰A, Yuo|pson `‰, Suarp S‰, xalter Z`. Zactors associated witu
tue presence of diabetic ‚etoacidosis at diagnosis of diabetes in cuildren and yovng
advlts; a syste|atic re~iew. B`‰ 2011; 343; d4092.
47. xolfsdorf ‰, Xraig `^, Dane|an D et al. Diabetic ‚etoacidosis in cuildren and
adolescents witu diabetes. Pediatr Diabetes 2009; 10 FSvppl. 12G; 118…133.
48. ‡eitler P, Zv ‰, Yandon N, Nadeav \, }ra‚a|i Y, Bartlett Y, et al. Yype 2 dia-
betes in tue cuild and adolescent. Pediatric Diabetes.
49. \apellen Y`, [avscue ˆ, Dost A et al. Xuildren and adolescents witu type
1 diabetes in [er|any are |ore o~erweigut tuan uealtuy controls; resvlts co|paring
DPj database and XrescNet database. ‰ Pediatr ^ndocrinol `etab 2014; 27; 209…214.
50. Isla| SY, Abraua| A, Donaguve \X et al. Plateav of adiposity in Avstralian
cuildren diagnosed witu type 1 diabetes; a 20-year stvdy. Diabet `ed 2014; 31; 686…690.
51. ]o|bardo Z, jalen•ise `, xasniews‚a
  \b\t\b
56. Bowden SA, Dvc‚ ``, UoŠ |an ˆP. hovng cuildren F‘5 yrG and adolescents
F12 yrG witu type 1 diabetes |ellitvs ua~e low rate of partial re|ission; diabetic ‚eto-
acidosis is an i|portant ris‚ factor. Pediatr Diabetes 2008; 9; 197…201.
57. DXXY. ^Š ect of intensi~e tuerapy on residval beta-cell fvnction in patients
witu type 1 diabetes in tue diabetes control and co|plications trial. A rando|i•ed,
controlled trial. Yue Diabetes Xontrol and Xo|plications Yrial ˆesearcu [rovp. Ann
Intern `ed 1998; 128; 517…523.
58. Bvc‚ingua| B, Bec‚ ˆx, ˆvedy \‰ et al. ^Š
ecti~eness of early intensi~e
tuerapy on W-cell preser~ation in type 1 diabetes. Diabetes Xare 2013; 36; 4030…4035.
59. SteŠ es `x, Sibley S, ‰ac‚son `, Yuo|as x. Betacell fvnction and tue de~elop-
|ent of diabetes-related co|plications in tue diabetes control and co|plications trial.
Diabetes Xare 2003; 26; 832…836.
60. [reenbav| X‰, Bea| XA, Bovlware D et al. Zall in X-peptide dvring ”
rst 2
years fro| diagnosis; e~idence of at least two distinct puases fro| co|posite Yype 1
Diabetes YrialNet data. Diabetes 2012; 61; 2066…2073.
61. Vra| ˆA, ‰ones A[, Besser ˆ^ et al. Yue |a–ority of patients witu long-
dvration type 1 diabetes are insvlin |icrosecretors and ua~e fvnctioning beta cells.
Diabetologia 2014; 57; 187…191.
62. S‚yler ‰S, [reenbav| X‰, ]acuin ‰` et al. Yype 1 Diabetes YrialNet…an
international collaborati~e clinical trials networ‚. Ann N h Acad Sci 2008; 1150; 14…24.
63. jvdattv N\, Uerold \X. Yreat|ent of new onset type 1 diabetes witu tepli•v|-
ab; svccesses and pitfalls in de~elop|ent. ^pert Vpin Biol Yuer 2014; 14; 377…385.
64. Vrban Y, Bvndy B, Bec‚er D‰ et
al. Xo-sti|vlation |odvlation witu abatacept
in patients witu recent-onset type 1 diab
etes; a ra
ndo|ised,
ble-blind, placebocon-
trolled trial. ]ancet 2011; 378; 412…419.
65. Vrban Y, Bvndy B, Be
c‚er D‰ et
al. Xosti|vlation |odvlation witu abatacept in
patients witu recent-onset type 1 diabetes; follow-vp 1 year after cessation of treat|ent.
Diabetes Xare 2014; 37; 1069…1075.
66. Pesco~it• `D, [reenbav| X‰, Bvndy B et al. B-ly|puocyte depletion witu
ritvi|ab and W-cell fvnction; two-year resvlts. Diabetes Xare 2014; 37; 453…459.
67. Uagopian x, Zerry ˆ‰, Suerry N et al. Yepli•v|ab preser~es X-peptide in
60
!\t\t 2. +\t \t\t\b\f \t \t 1- \t    \r  \b
72. ]vd~igsson ‰, Xuéra|y `, Aelsson S et al. [ADtreat|ent of cuildren and
adolescents witu recent-onset Yype 1 diabetes preser~es residval insvlin secretion after
30 |ontus.Diabetes `etab ˆes ˆe~ 2014; 30; 405…414.
73. Ualler `‰, xasserfall XU, Uvl|e `A et al. Avtologovs v|bilical cord blood
transfvsion in yovng cuildren witu type 1 diabetes fails to preser~e X-peptide. Diabetes
Xare 2011; 34; 2567…2569.
74. Broo‚s-xorrell B, Pal|er ‰P. Pre~ention ~ersvs inter~ention of type 1 diabetes.
Xlin I||vnol 2013; 149; 332…338.
75. ]vd~igsson ‰. Xo|bination tuerapy for preser~ation of beta cell fvnction in type
1 diabetes; new attitvdes and strategies are neededœ. I||vnol ]ett 2014; 159; 30…35.
76. Suapiro A`, ]a‚ey ‰ˆ, ˆyan ^A et al. Islet transplantation in se~en patients
witu type 1 diabetes |ellitvs vsing a glvcocorticoid-free i||vnosvppressi~e regi|en.
N ^ngl ‰ `ed 2000; 343; 230…238.
77. ˆyan ^A, Paty Bx, Senior PA et al. Zi~e-year followvp after clinical islet trans-
plantation. Diabetes 2005; 54; 2060…2069.
78. Barton ZB, ˆi
c‚els `ˆ, Ale–andro ˆ et al. I|pro~e|ent in ovtco|es of clinical
islet transplantation; 1999…2010. Diabetes Xare 2012; 35; 1436…1445.
79. Bovwens ], Uovbra
c‚en I, `fopov
‰\. Yue vse of ste| cells for pancreatic
regeneration in diabetes |ellitvs. Nat ˆe~ ^ndocrinol 2013; 9; 598…606.
80. Xuuabra P, Bray|an \]. Ste| cell tuerapy to cvre type 1 diabetes; fro| uype
to uope. Ste| Xells Yransl `ed 2013; 2; 328…336.
1 \t\t
\n\r\b 5\t 2B \t   5 \t 5\r\n\f
62
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
\b\b:\t8 \t \r\f7\b5:\t\t
\n\f\r\t\b\t\b =\b \t 5\f \t \r  \r\t\n\f \r
\t\t8
\n\r\b 5\t 2B \t 


…\n\r## \t#/ \f\r"  \r@ J'   „

5\t\b\n\t\f \t  \r5\b\t \t  \n\r\b 5\t

…#' C" "#"@\t  ## \r\t J' "-
…\r# """## #" #' \f" "\r#"@  \f\r
…##$#" \fC '"@ : " C\f #' #@'-

…"# \r:\r"" '\r" \fC \r# C#\r## \r\f "\r-
…## "#" '"  \f#' \n1 # :/\f#"@
…## "#" '"  :/\f#"@ # ""-

\f\f\t  \b  \f\t
63

…= \r\t "# \f#' \f" #'\r#"@ \r@ "\r##-
…= \r\t "# \f#' \f" #'\r#"@ "!#
…= \r\t "# \f#' \f" \r\r#"@ $#" 
\n\r8 \r \t8



…\n"\t# $#",  "\r/ "@ #", C" "\r#-
…&":## ":#@ $#" F UbA1c ‘9k # :'
# "G  " "\r" \f" '"@ "\r-
I. #"@  500   "#  "# 7 \f. ?#"\r"@ \f' 
…&":## ":#@ $#" :/\f# ##
I. "\r@ \r"# Q\f\r FQ-##G
## :'@ ## 1 \r'  \f@ F"\r"\t \f'
II. K# "\r# C #"@ \f\r 
III. \r/\f  "\r## "\r# : C -
64
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b


5L\b8 \r \t8



:\b\f \n\n8\b\t8 \t 5\b\t :\t\b \n \n \n=\t7\t
\b\t87\t \t \nM\b\b\t87\t
 \f\t \f    \f \t \f  '\n \t \t\f...
Q"\r# #\r"# #' ""# FKG 
American Heart
Association
66
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
5\b\t
"#"\t  : '# \r: :E"
 #J  \r'#"/ # \r'#JE#/\t "\r/. = 2009 . ISPAD
\f" # \f\r" '\r" m18q. \n " :#$##
 \r5\b\t, \f\n\n\t9\t\f:\t8 \t \r\f\r\t\n\t\f\t
\n\r\b 5\t 2B \t  \n 5=7  757
\r\n
\t'  \f\r## :# \r!#\t#, /\r"\r# \f\t
##\r'#"""# m"##  \f##\f##\t, #\r"'#\t,
\b   \f , \t#\t  \t\b\t \b \t\t\b\f \t \t 2- \t...
 "#, \rCJE \r\f # : E". \n\r$#\t
Treatment Options for T2DM in Adolescents and Youth
„ YVDAhG
: \f\r: \r\f"  « ISPAD  ##
\n, # \r'@"" C\f #' #/ \r# """## \f'/
#" #\r### \fC \f"\rC\f"@\t  \f\r \f@


…1,75  F# 75 G :'\f J', \r"\r 

…\n \r\f# „ %" \r\f# \r\t J'
…\n#" \n JJ" #\r#J, #\f##J, "\r#J #

…:/\f# #@'"@ :\r"\rJ "\f#J,
"""JEJ "\f\r" «("#  "\rJ '
68
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
\f#:" #  C#\t#» FDXXYG # \r"##$#\rJ
$#@ \r\r "\f\r"#'$## #' 

C" :"@ "\r'#"\r #  \fC \r$#"@\t 

\r'@"" #\f# #\f"@"J"  'C
\r#'\f#"# \r'@"" *??  \f\r",
"\r\fJE#/ C#\r#, „ \r# \r\f## "\r/ *??
\r' @ \f@ \r\f \r'@"" "\t" 

#'  ""#". +" C  \f"\t  ###
"##""  $#"  "##  / "@/
'J", " ""#" \r#""J"  10…20k $#"
# %"# " \t$## m21, 28…32q. ## "#"
'\r"  !  "C#\r# # ##
\r"# \n1 F"\r  ", "'"$#\f'G, "
;\t\b\t \b\t \t \f  \t\t\b\f \t  2- \t   '...
\r\f\r\t\n\t\f :\t\b \n \n\r\b7 5\t7 2B \t 
\n 5=7  757 \r\n






= \n # L\r "#  / \t/ \n2  \f:J"  \f
""JE '\r" #  m35q. = '## #"$#\t #\t. = R##
15k \f"  \n2  #J" C#\r#\t m17, 37q.  # \f"  \n2
\t  " F‘120k #\f@ '"\t \f\t """JE


70
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b

\t77\b\b \n\r\b 5\t 2B \t 


&\f J\f#  C#"@# \r'@""# #' 

\r5\b\n\t \r\t \f\n\n\t9\t\f:\t\t

;\t\b\t \b\t \t \f  \t\t\b\f \t  2- \t   '...
71





\r55\tN 5\t\b\n\t\n\f\t \f\r\t\r\t\t O\b\r\b\t
\r\b\b\n\t \f =\f \t \t\f7\t\t \b\fQ

\r'#"## \r! \f :, \rJE#\t
72
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b



 "\r/ J\f C" :"@ ! \r@
##\r :# \r# \r@ *??, ",

" \t\t"\t \r"## "\r \r#"#\rJE

…*; \r@ J'  ' \r# "E „ 5,6…
…?*; \r@ J'  '  \r'# „ 7,8…
…UbA1c „ 5,8…6,4k.
""JEJ "\f\r" DXXY # \r"##$#\rJ
\b\t \n\r\b 5\t 2B \t  \n 5=7
 757 \r\n

. = " \r\t  \n1
 \f \t\t\b\f \t \t 2- \t   '   \b\t
73
@ " "\r"\t  @\t/  @!## \r\r#, \r#\r,
\r# #'#/ \r\t/ \f/\f,  \f" \r\f#"  #'# \r
:\r'#\t # /\f!## \r#"# \f#$# "\r/#\t m35q.










�3. :# F. "C «## \r\f" ISPAD  :-
74
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
#\t  \r \f#:"  #\f## YVDAh, :# $#@
\r\r##/ \t$# # \f"  " YVDAh; mportal.

\f#", #/ ### $#@ \r:"#,  "C





�:# :/\f#  @ \f\t ##\t \r#$#

 \f \t\t\b\f \t \t 2- \t   '   \b\t
75





"  \r\f" ISPAD  \f#""\r##.

76
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b








…\r## \f""# #E# # #"  # \f\rC-
…:# \r\f"# $#" \r#@ #"\r\r"$##
…\f\r## C"# \r#@ \f/\f \r\f#" 
…'#"# \f\r# J:/ \f"#C# F"#/  ""-
…E\r# #"#\t  \r##J,  \f # " C ",
…" @"\r/ #E/ \r\f"# # \r# \f  \r\t
…\f# \f# #"#\t # \f#"@ "#"# \f\t -
 \f \t\t\b\f \t \t 2- \t   '   \b\t
77
)#'#\t "#"@ „ C\t "\tJE\t  #\t.
\t\r "\r#\r# :"J" !#J "\r\t ' \r
J', @!#J \r\f-\f#"/ "\r \r#, #C#J
 " # !#J :E "\t#\t m54…56q. &\f J\f\t 
\t#  \r'# " \r\f \f  "#   60 #  \f@,
 :"@ \r'\r:" $###,  # "@
"@" C#'#. C :"@ \f  @# ## \f\r, "\r C"

\n"\t \r'\r:" # C\f \r\r




)#'#\t "#"@ \fC \f\f\rC#"@\t  @. +"

78
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b

…L"@ #[email protected] \r# \f, #\f"@"JE#  ", "
…\n* \f" \r\f#"@ \r\t\r. "" "\r\t
… "  C ### '"# \f"#",
…\r# "\r/ ':#\t/ ## \f \t\tJ"\t #"


 \f \t\t\b\f \t \t 2- \t   '   \b\t
79
; $!$D
HbE1c F GID
\t 
J\r $!$%
 HbE1c
GID
\t 

+\n$D
$
\n\t\t C
;\t\t\r%& D
+\n$D
$ \n\t\t
C
\n
2-& !
\n 1-& !
, \t !\n \b"1
 !\n\n\tB
\t\t
\f\tA\t\r A
!\r\t
$\n\t%/ C%/
K& (+J) \t
\n\r\t \t%&
\n\r\t !%&
\t,
/\t\n\t\n%
 \t\t
9\nC\t\r !\n$
$\n$\tD
9!%& \t
 \t
L\r \t
L\r \t
\f
;\t\t\r%&  …
\n\t\r  $\tD
1,2 J"M(
\r)
9\nC\r  \tA\t\r
A !\r\t +J
\n;# R.1.
%\b\b  \t\t \f  \b\t \f+  \t   \b\r\t
\r \r\t\t \b\t 5- \t
80
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b


…L# $#" ":## ":# FUbA1 ‘9k, #"
" "\r##. #"@ \f"  \f' 500 "  "#
7 \f. ?#"\r"@ \f'  500  1 \r'  \fJ  "# 3…4 \f
…L# $#" ":## ":#,  "\r:"\t #-
…\r/\f  "\r## "\r# C :' E-
…L# \r@ J' ""\t  \r\f/ \f#:"# 
 \f \t\t\b\f \t \t 2- \t   '   \b\t
81
5L\b \b\t
\r ## "\r\t \rE \f"#@, #





!"\t ##\r\f\t "##'$#\t J' 




82
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
"G. +" C #':C"@  :@!#" $#" \r#

\f"""#,  "C \r# \r\f## \r\f#\r##/
#\f#  "\r" E". \r# "\r#




 \f \t\t\b\f \t \t 2- \t   '   \b\t
83

…"# \t'#\t \r\r" @## \r-
… #"##\f\r##\f \r\f\t\t \r\fC#"@"@ \r-


…*###\t C" :"@ "\tC # \f#"@  '##"#
…##  ".


J"\t  \t\f\r# -\r$"\r#, "##\r# \r#
84
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b


\b \r\f \r\f#'#\r ## #"#




 \[email protected]' \r##\t  \t'#  'C"@J !





 \f \t\t\b\f \t \t 2- \t   '   \b\t
85








FS[]Y-2G
G. (#:#"\r S[]Y-2

\r"\r \r## ##:#"\r S[]Y-2 \t'  #-

86
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b

':"# #$#\t#  #", :

(\f# \r##\t ##:#"\r S[]Y-2  \f"  \r-
\n\r\b 5\t 2B \t  \t \t\b\n\t\b\r\t\n\b\b\nLN
\n \n=\t \b\t8 \t \nM\b\b\t8
\t  \r!# \r$##  #'## \f"# ##,
J\t  \f"#  J', ##\f # : :, 
"C  $## %\f"#\t \f. (#\r'#"""@ C"
\r'#"@\t  \r'/ "\t/, J\t "# #, !J #
\r'#"""@J :\fJ"   "#, # "\r #' #/, \r#\r
"# \t## # #"# \r #", :#JE
#\r$#J !$, \r\fCJ" \r#\r"@  #\r###J.
"""@ # /\r\t"@ "#"@"@  ##. ?, "@ #
C" :"@ \r'#""  ":# \f"#J ##, 
\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
87
\r'@""  @ :\f" \r#'\f#"@ :@! J' # \r# %"
/\r\t"@ ##J \r$#J \f#\t \r#'\f" :#,
\t'JE  \r, #,  \f"#, !"\t \r@


##\f \r!#\t F! \r@ "\r##$\r#\f,


88
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b







  \r##  \r#J  $$# &\n, "\r
Adult Treatment Panel
\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
89
M:#\t, ""JE# ##\r'#"""#, :
':#\t/ #'C  \r\f" ISPAD  #\r- # \r-
M\t\r\b\t
Z-score
\t \r\b\t8
#\f#\t \f#:" F}\PDSG, :"" !#J "\t#\t
  \n #\f## YVDAh \r# \f# \r\fC#"@"#
#\f#\t YVDAh  #$ C  # \r# :  (&?
90
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b



"#\t, \r\f"\t "@ #  [email protected] ##:#"\r )
…=C ""#"@, " \r# \r# ##:#"\r ) CE#-



\b9\r \t8
#\f#\t YVDAh #\r@:#\r#\t : \t  6,3k #'
\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
91



…+" "!# @:# # \r"## 30…299   \r'-
…+\r$#\t @:#  \r 20…199 #, #'\r\t\t 

92
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
…"\r #' \r\f\t" "\r, \r'  "  $#"

F"!# @:# # \r"## „ 300 G.


&#"\r# %\r$## @:# \f" \r\f#"@ \r' C\f
3…6  # "#"\r"@ \f' \r\r" \f \f"#C#\t #@
5\t\n\t \t57\t8
'#"""# # \n2. = /\f #\f#\t YVDAh \t#@, "
"# @ #' ""#, #\r"# FG FKG # !
\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
93


…/"\r# K  2,6 @ F100 \fGz
…/"\r# K= : 35 \f F0,91 @Gz
…"\r##$\r#\f  150 \f F1,7 @G.


…L# /"\r# K ""\t !, :/\f#
\r# \r /"\r# 100…129 \f „ #@

\r\f"\r#\r :'"@ # %"#"@ #\t





94
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b


\r\n\f\r \t \n\n5\t\n8 5\t\n9\b\f:\t8
'##\r#J : \f # \r!#J $## "\r:$#" #
\t$##. \r!\t %\f"#'##\t '\f#"$#\t \t\t"\t
\f#"@ "\r, \r\tJE# \r'#"# "\r\r' \r#
\n2. +\f"#@\t \f#$#\t „ \r# \r#' !
\r# \r\f-\f#"/ ':#, 'JE#  'C"@
\r\f-\f#"/ #'# m81q # #JE# "  "/ \f"
 '##"# " \r\t C#\r#\t # "# ##\r'#"""#.
\f m116q, \r\fJ \f#$#J, #CJ :"@ \r#"@
#'#J \r' m41q,  "C !J \r"\r#@J C""@
m117q. = %"# \r#'# \t\tJ"\t \r"### "\r# \r
\n\t\b5\r7 \t\f\t\n\b 8\t\b\t\f

\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
95




\b\fL\b8 M\t\r8 \bL \b\t
##/ ':# # \r\f# \f/ J\f, "\r\fJE#/
96
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
\f## YVDAh \r" @!# \f' ## \r\rE#
\n\t\n7\b \n \b\t
! \r@ \n-\r"# :, #"@/
#  '\r/ m92, 93q. =# #\r" C!J \r@ 
"' \t'/  \f#:" /\r##/ ':# #
m130q, \f#:"# \r"#"##, m131q, \f#$## W-" m132,
#"@/ $#"#, \f\t/ C#\r "@J,  " #
"\r \r' /#-’ # #"\r#-6, \r!J" ##J
##'$#J  ##'##/ \r/z "C :# \t
 , #\tJE#  " # #" # m134q.
\r ", \r\t\t"\t \r@ "##\r/ #/ "
\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
97

:\t \r  %#\f### # \r#"#
\f" \f#, #JE# \f  \n2, :\f"@ $#"

�\n\r## \f" # \f\r"  \n2  \n \r\f#"\t " :\r
#\r$## "#"@ /\r, " , %, /

5 \r\n\n\t8
"# # \f\r"#  \n2 \f\rC ! \r# :@!
\f\r# \r"\r" m140…144q, "\r C" !"@ :@
\r  C#'# # :"# "@ \f@"#, ! ##
#C "#", :#$ ## #\r#\t, #/"\r
':C\f# ## '"\rC"@, ""@ ## """# %\r##,


5\r\t \b\r\b\t8, \n8\b\b \n M\t\r\b\t7
\t \n\r\b7 5\t7 2B \t 





 '\r/ " 40 \f 50 "  \n2  \f:J"  \f '\r -
" '#"@ E "\rJ"\t \r\f#" ':#\t c
98
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
\n\f\r\t\b\t\b \b \n\r\b 5\t 2B \t 

…@'\t \f' "\rC\f"@, " %" "  :@!#"
…L# ':#  \r\r"\r, :@!#" @-

…+", :' #\t, \r "#"@ \n2  \f\r" #'-'
\t\t\b\f\r \t  2- \t  \f\f\b  \f\f*...
99

… \f" # \f\r" #' \r \r# C" :"@ :\rC
…*#\r"'#\t, \f###\f#\t # #\r@:#\r#\t " :"@

…# \f# #' E"JE#/ \f\t #' FJ' "E,
J'  "E, J' \r' 2   \r'# # UbA1cG 
\t\t"\t \f"" "#"@ # $##, #"\t
…-\rC E"" \t"@ "#"@ \r@/
\f\b9\t\f \t\b\r\n
100
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
\n \t\n\f \t\r\r
1. ˆosenbloo| A], hovng ˆS, ‰oe ‰ˆ, xinter x. ^|erging epide|ic of type 2
diabetes in yovtu. Diabetes Xare 1999; 22; 345…354.
2. A|erican Diabetes Association. Yype 2 diabetes in cuildren and adolescents;
consensvs conference report. Diabetes Xare 2000; 23; 381…389.
3. Dvncan [^. Pre~alence of diabetes and i|paired fasting glvcose le~els a|ong
}S adolescents; National Uealtu and Nvtrition ^a|ination Svr~ey. Arcu Pediatr
Adolesc `ed 1999…2002; 2006; 523…528.
4. Pinuas-Ua|iel V, ‡eitler P. Yue global spread of type 2 diabetes |ellitvs in cuil-
dren and adolescents. ‰ Pediatr 2005; 146; 693…700.
5. Dra‚e A‰, S|itu A, Betts Pˆ, Xrowne ^X, Sueild ‰P. Yype 2 diabetes in obese
wuite cuildren. Arcu Dis Xuild 2002; 86; 207…208.
6. \itagawa Y, Vwada `, }ra‚a|i Y, ha|avcui \. Increased incidence of non-
insvlin dependent diabetes |ellitvs a|ong ‰apanese scuool cuildren correlates witu an
increased inta‚e of ani|al protein and fat. Xlin Pediatr FPuilaG 1998; 37; 111…115.
7. ^utisua| S, Uattersley AY, Dvnger DB, Barrett Y[, [rovp BSfP^aDXY. Zirst
}\ svr~ey of paediatric type 2 diabetes and `VDh. Arcu Dis Xuild 2004; 89; 526…529.
8. Yue S^AˆXU for Diabetes in hovtu Stvdy [rovp. Incidence of diabetes in yovtu
in tue }nited States. ‰A`A 2007; 297; 2716…2724.
9. \adi‚i VA, ˆeddy `ˆ, `ar•ov‚ AA. Incidence of insvlin-dependent diabe-
tes FIDD`G and non-insvlindependent diabetes FNIDD`G F0…34 years at onsetG in
Bengua•i, ]ibya. Diabetes ˆes Xlin Pract 1996; 32; 165…173.
10. Xuan ‰X, Xuevng X\, Swa|inatuan ˆ, Nicuolls `[, Xoc‚ra| XS. Vbesity
albv|invria, and uypertension a|ong Uong \ong Xuinese witu non-insvlin depen-
dent diabetes |ellitvs FNIDD`G. Postgrad `ed ‰ 1993; 69; 204…210.
11. xei ‰N, Svng ZX, ]i Xh et al. ]ow birtu weigut and uigu birtu weigut in infants
are botu an increased ris‚ to ua~e type 2 diabetes a|ong scuoolcuildren in Yaiwan.
Diabetes Xare 2003; 26; 343…348.
12. ˆa|acuandran A, Sneualatua X, Satya~ani \, Si~asan‚ari S, j˜ ay j. Yype 2
diabetes in Asian- Indian vrban cuildren. Diabetes Xare 2003; 2003; 1022…1023.
13. Sayee
d `A, Uvnsain `‡, Banv A, `a‚ ˆ, A•ad \uan A\. Pre~alence of
diabetes in a svbvrban popvlation of Bangladesu. Diabetes ˆes Xlin Pract 1997; 34;
149…155.
14. Bravn B, ‡i||er|an `B, \retcu|er N, Spargo ˆ`, S|itu ˆ`, [racey `.
ˆis‚ factors for diabetes and cardio~ascvlar disease in yovng Avstralian aborigines; a
5-year follow-vp stvdy. Diabetes Xare 1996; 19; 472…479.
15. `c[ratu N`, Par‚er [N, Dawson P. ^arly presensation of type 2 diabetes
|ellitvs in yovng New ‡ealand `aori. Diabetes ˆes Xlin Pract 1999; 43; 205…209.
16. ^ppens `X, Xraig `^, ‰ones Yx et al. Yype 2 diabetes in yovtu fro| tue
xestern Paci”
c region; glyce|ic control, diabetes care and co|plications. Xvrr `ed
ˆes Vpin 2006; 22; 1013…1020.
17. Svgiuara S, Sasa‚i N, \ouno U et al. Svr~ey of cvrrent |edical treat|ents for
cuilduood-onset type 2 diabetes |ellitvs in ‰apan. Xlin Pediatr ^ndocrinol 2005; 14;
65…75.
  \b\t\b
101
18. ˆosenbloo| A], Sil~erstein ‰U, A|e|iya S, ‡eitler P, \lingens|itu [‰. Yype
2 diabetes in cuildren and adolescents. Pediatr Diabetes 2009; 10 FSvppl 12G; 17…32.
19. Drvet X, Yvbiana-ˆv” N, Xue~enne D, ˆigal V, Pola‚ `, ]e~y-`arcual X.
Xuaracteri•ation of insvlin secretion and resistance in type 2 diabetes of adolescents.
‰ Xlin ^ndocrinol `etab 2006; 91; 401…404.
20. `iller ‰, Sil~erstein ‰U, ˆosenbloo| A]. Yype 2 diabetes in tue cuild and ado-
lescent. In; ]ifsuit• Z FedG Pediartric ^ndocrinology; ”
ftu edition, ~olv|e 1. New hor‚,
`arcel De‚‚er 2007; pp 169…188.
21. }nited \ingdo| Prospecti~e Diabetes Stvdy [rovp. Intensi~e blood-glvcose
control witu svlpuonylvreas or insvlin co|pared witu con~entional treat|ent and ris‚ of
co|plications in patients witu type 2 diabetes F}\PDS 33G. ]ancet 1998; 352; 837…853.
22. YVDAh Stvdy [rovp, ‡eitler P, Uirst \ et al. A clinical trial to|aintain glyce-
|ic control in yovtu witu type 2 diabetes. N ^ngl ‰ `ed 2012; 366; 2247…2256.
23. YVDAh Stvdy [rovp. ˆapid rise in uypertension and nepuropatuy in yovtu
witu type 2 diabetes; tue YVDAh clinical trial. Diabetes Xare 2013; 36; 1735…1741.
24. Plovrde [. I|pact of obesity on glvcose and lipid pro”
les in adolescents at dif-
ferent age grovps in relation to advltuood. B`X Za| Pract 2002; 3; 18.
25. A|erican Diabetes Association. Standards of |edical care in diabetes … 2014.
Diabetes Xare 2014; 37 FSvppl 1G; S14…S80.
26. ]ib|an I`, Barinas-`icuell ^, Bartvcci A, ˆobertson ˆ, Arslanian S.
ˆeprodvcibility of tue oral glvcose tolerance test in o~erweigut cuildren. ‰ Xlin
^ndocrinol `etab 2008; 93; 4231…4237.
27. \apadia Xˆ. Are tue ADA ue|oglobin A1c criteria rele~ant for tue diagnosis of
type 2 diabetes in yovtu— Xvrr Diab ˆep 2013; 13; 51…55.
28. }|paicuitra j, Baner–i `A, Xastells S. Avtoantibodies in cuildren witu type 2
diabetes |ellitvs. ‰ Pediatr ^ndocrinol `etab 2002; 15; 525…530.
29. ˆeinuard Y, Scuober ^, xeigand S, Yuon A, Uoll ˆ, [rovp obotD-xS. W-cell
avtoantibodies in cuildren witu type 2 diabetes |ellitvs; svbgrovp or |isclassi”
cation—
Arcu Dis Xuild 2006; 91; 473…477.
30. ]andin-Vlsson `. ]atent avtoi||vne diabetes in advlts. Ann N h Acad Sci
2002; 958; 112…116.
31. xinter x^, `aclaren N\, ˆiley x‰, Xlar‚e Dx, \appy `S, Spillar ˆP.
`atvrity onset diabetes of yovtu in blac‚ A|ericans. N ^ngl ‰ `ed 1987; 316; 112…116.
32. \lingens|itu [‰, ]aŠ
el ], Pyle ] et al. Yue presence of [AD and IA-2 anti-
bodies in yovtu witu a type 2 diabetes puenotype. Diabetes Xare 2010; 33; 1970…1975.
33. Yvrner ˆ, Stratton I, Uorton j et al. }\PDS 25; avtoantibodies to islet cell
cytoplas| and glvta|ic acid decarboylase for pre-diction of insvlin revire|ent in
type 2 diabetes. ]ancet 1997; 350; 1288…1293.
34. ]aŠ
el ], Xuang N, [rey ` et al. `etfor|in |onotuerapy in yovtu witu
recent onset type 2 diabetes; eperience fro| tue prerando|i•ation rvn-in puase of tue
YVDAh stvdy. Pediatr Diabetes 2012; 13; 369…375.
35. Xopeland \X, ‡eitler P, [eŠ
ner ` etal. Xuaracteristics of adolescents
and yovtu witu recentonset type 2 diabetes; tue YVDAh couort at baseline. ‰ Xlin
^ndocrinol `etab 2011; 96; 159…167.
102
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
36. Yue ^pide|iology of Diabetes Inter~entions and Xo|plications Stvdy [rovp.
Svstained eŠ
ect of intensi~e treat|ent of type 1 diabetes |ellitvs on de~elop|ent and
progression of diabetic nepuropatuy; tue ^pide|iology of Diabetes Inter~entions and
Xo|plications F^DIXG stvdy. ‰A`A 2003; 290; 2159…2167.
37. }ra‚a|i Y, \vwabara ˆ, Uabv ` et al. Xlinical cuaracteristics of non-obese
cuildren witu type 2 diabetes |ellitvs wituovt in~ol~e|ent of W-cell avtoi||vnity.
Diabetes ˆes Xlin Pract 2013; 99; 105…111.
38. ˆosenbloo| A]. Vbesity, insvlin resistance, beta cell avtoi||vnity, and tue cuang-
ing clinical epide|iology of cuilduood diabetes. Diabetes Xare 2003; 26; 2954…2956.
39. ‡eitler P, Ua A, ˆosenbloo| A, [laser N, ]awson xil‚ins Pediatric
^ndocrine Society. Uyperglyce|ic uyperos|olar syndro|e in cuildren; patuopuysio-
logical considerations and svggested gvidelines for treat|ent. ‰ Pediatr 2011; 158; 9…14.
40. Nadeav \‰, ˆegensteiner ‰[, Baver YA et al. Insvlin resistance in adolescents
witu type 1 diabetes and its relationsuip to cardio~ascvlar fvnction. ‰ Xlin ^ndocrinol
`etab 2010; 95; 513…521.
41. Nadeav \‰, ‡eitler PS, Baver YA et al. Insvlin resistance in adolescents witu
type 2 diabetes is associated witu i|paired eercise capacity. ‰ Xlin ^ndocrinol `etab
2009; 94; 3682…3685.
42. Xali A`X, Bonadonna ˆX, Yro|betta `, xeiss ˆ, Xaprio S. `etabolic abnor-
|alities vnderlying tue diŠ
erent prediabetic puenotypes in obese adolescents. ‰ Xlin
^ndocrinol `etab 2008; 93; 1767…1773.
43. xeiss ˆ, Ya‚sali S^, Ya|borlane xj, Bvrgert YS, Sa~oye `, Xaprio S.
Predictors of cuanges in glvcose tolerance statvs in obese yovtu. Diabetes Xare 2005;
28; 902…909.
44. [rovp YS. ˆetinopatuy in yovtu witu type 2 diabetes participating in tue
YVDAh clinical trial. Diabetes Xare 2013; 36; 1772…1774.
45. [rovp YS. ]ipid and in›
a||atory cardio~ascvlar ris‚ worsens o~er 3 years in
yovtu witu type 2 diabetes. Diabetes Xare 2013; 36; 1758…1764.
46. Aslander-~an jliet ^, S|art X, xaldron S. Nvtritional |anage|ent in cuild-
uood and adolescent diabetes. Pediatr Diabetes 2007; 8; 323…339.
47. Xopeland \X, Sil~erstein ‰, `oore \ˆ et al. `anage|ent of newly diagnosed
type 2 Diabetes `ellitvs FY2D`G in cuildren and adolescents. Pediatrics 2013; 131;
e648…e664.
48. Scuellenberg ^S, Dryden D`, jander|eer B, Ua X, \orowny‚ X. ]ifestyle
inter~entions for patients witu and at ris‚ for type 2 diabetes; a syste|atic re~iew and
|eta-analysis. Ann Intern `ed 2013; 159; 543…551.
49. hoon }, \wo‚ ]], `ag‚idis A. ^ž
cacy of lifestyle inter~entions in redvcing
diabetes incidence in patients witu i|paired glvcose tolerance; a syste|atic re~iew of
rando|i•ed controlled trials. `etabolis| 2013; 62; 303…314.
50. ]ee S, \i| h. ^Š ects of eercise alone on insvlin sensiti~ity and glvcose toler-
ance in obese yovtu. Diabetes `etab ‰ 2013; 37; 225…232.
51. Barlow S^, Xo||ittee ^. ^pert co||ittee reco||endations regarding tue
pre~ention, assess|ent, and treat|ent of cuild and adolescent o~erweigut and obesity;
sv||ary report. Pediatrics 2007; 120 FSvppl 4G; S164…S192.
  \b\t\b
103
52. Zitcu X, \ei| \S, Acade|y of Nvtrition and Di
104
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
69. Singu ˆ\, Perros P, Zrier B`. Uospital |anage|ent of diabetic ‚etoacidosis;
are clinical gvidelines i|ple|ented eŠ ecti~ely— Diabet `ed 1997; 14; 482…486.
70. Xuiasson ‰, ‰osse ˆ, Uvnt ‰ et al. Yue ež
cacy of acarbose in tue treat|ent of
patients witu non-insvlindependent diabetes |ellitvs. A |vlticenter controlled clinical
trial. Ann Intern `ed 1994; 121; 928…935.
71. Inge YU, ‡eller`,[arcia jZ, Daniels Sˆ. Svrgical approacu to adolescent obe-
sity. Adolesc `ed Xlin 2004; 15; 429…453.
72. `icuals‚y `P, Inge YU, Yeicu S et al. Adolescent bariatric svrgery progra|
cuaracteristics; Yue Yeen ]ongitvdinal Assess|ent of Bariatric Svrgery FYeen- ]ABSG
stvdy eperience. Se|in Pediatr Svrg 2014; 23; 5…10.
73. ˆea~en [. Yue |etabolic syndro|e or tue insvlin resistance syndro|e—
erent na|es, diŠ erent concepts, diŠ erent goals. ^ndocrinol `etab Xlin Nortu A|
2004; 33; 283…303.
74. Baner–ee S, ˆagua~an S, xasser|an ^‰, ]in-Der B], Saenger P, Di|artino-Nardi
‰. Uor|onal ”
ndings in African A|erican and Xaribbean Uispanic girls witu pre|atvre
adrenarcue; i|plications for polycystic o~arian syndro|e. Pediatrics 1998; 102; ^35.
75. Ibane• ], Potav N, `arcos `j, De•eguer Z. ^aggerated adrenarcue and
uyperinsvlinis| in adolescent girls born s|all for gestational age. ‰ Xlin ^ndocrinol
`etab 1999; 84; 4739…4741.
76. Dabelea D, Xrv|e Y. `aternal en~iron|ent and tue transgenerational cycle of
obesity and diabetes. Diabetes 2011; 60; 1849…1855.
77. ^pert Panel onDetection, ^~alvation, and Yreat|ent of Uigu Blood Xuolesterol
in Advlts. ^ecvti~e Sv||ary of tue Yuird ˆeport of tue National Xuolesterol
^dvcation Progra| FNX^PG ^pert Panel on Detection, ^~alvation, and Yreat|ent
of Uigu Blood Xuolesterol in Advlts FAdvlt Yreat|ent Panel IIIG. ‰A`A 2001; 285;
2486…2497.
78. Zord ^S, ]i X. De”
ning tue |etabolic syndro|e in cuildren and adolescents;
will tue real de”
nition please stand vp— ‰ Pediatr 2008; 152; 160…164.
79. ‡i||et P, Alberti [, \avf|an Z et al. Yue|etabolic syndro|e in cuildren and
adolescents. ]ancet 2007; 369; 2059…2061.
80. ]avrson \ˆ, xel‚ [‰, ^isen|ann ‰X. Diagnostic perfor|ance of B`I percen-
tiles to identify adolescents witu |etabolic syndro|e. Pediatrics 2014; 133; e330…e338.
81. \irpicuni‚o~ D, Sowers ‰ˆ. Diabetes |ellitvs and diabetes-associated ~ascvlar
disease. Yrends ^ndocrinol `etab 2001; 12; 225…230.
82. ]aa‚so `. ]ipids in type 2 diabetes. Se|in jasc`ed 2002; 2; 59…66.
83. [oldberg Ÿ
. Diabetic dyslipide|ia; cavses and consevences. ‰ Xlin ^ndocrinol
`etab 2001; 86; 965…971.
84. Donaguve \X, Zrancesco X, Yrotta D, Allgro~e ‰, Daul-‰orgensen \.
`icro~ascvlar and |acro~ascvlar co|plications. Pediatr Diabetes 2007; 8; 163…170.
85. xabitscu `, Uavner U, Uertra|pf ` etal. Yype II diabetes and i|paired glv-
cose regvlation in Xavcasian cuildren and adolescents witu obesity li~ing in [er|any.
Int ‰ Vbes 2004; 28; 307…313.
86. xiegand S, ˆaile \, ˆeineur Y et al. Daily insvlin revire|ent of cuildren and
adolescents witu type 1 diabetes; eŠ ect of age, gender, body |ass inde and |ode of
tuerapy. ^vr ‰ ^ndocrinol 2008; 158; 543…549.
  \b\t\b
105
87. Sualitin S, Abraua|i `, ]ilos P, Puillip `. Insvlin resistance and i|paired
glvcose tolerance in obese cuildren and adolescents referred to a tertiary care center in
Israel. Int ‰ Vbes 2005; 29; 571…578.
88. SYVPP-Y2D Stvdy [rovp. Presence of diabetes ris‚ factors in a large }S
eigutu-grade couort. Diabetes Xare 2006; 29; 212…217.
89. [oran `I, Berg|an ˆN, A~ila Ž et al. I|paired glvcose tolerance and redvced
W-cell fvnction in o~erweigut ]atino cuildren witu a positi~e fa|ily uistory for type
2 diabetes. ‰ Xlin ^ndocrinol `etab 2004; 89; 207…212.
90. ]ee S, Bacua Z, [vngor N, Arslanian SA. xaist circv|ference is an independent
predictor of insvlin resistance in blac‚ and wuite yovtus. ‰ Pediatr 2006; 148; 188…194.
91. Zreed|an DS, \uan ]\, Diet• xU, Srini-jasan Sˆ, Berenson [S. ˆelationsuip
of cuilduood obesity to coronary ueart disease ris‚ factors in advlt-uood; tue Bogalvsa
ueart stvdy. Pediatrics 2001; 108; 712…718.
92. Berenson [S, Srini-jasa Sˆ. Xardio~ascvlar ris‚ factors in yovtu witu i|plica-
tions for aging; tue Bogalvsa Ueart Stvdy. Nevrobiol Aging 2005; 26; 303…307.
93. ‰vonala `, ‰ar~isalo `‰, `a‚i-Yor‚‚o N, \auonen `, jii‚ari ‰S, ˆaita‚ari
VY. ˆis‚ factors identi” ed in cuilduood and decreased carotid artery elasticity in advlt-
uood; tue Xardio~ascvlar ˆis‚ in hovtu Zinns Stvdy. Xircvlation 2005; 112; 1486…1493.
94. jisser `, Bovter ]`, `cŽvillan [`, xener `U, Uarris YB. ]ow-grade
syste|ic in›
a||ation in o~erweigut cuildren. Pediatrics 2001; 107; e13.
95. `arcvs `D, Zoster [D, ^l [uor|li ] et al. Suifts in B`I category and associ-
ated cardio|etabolic ris‚; prospecti~e resvlts fro| U^A]YUh stvdy. Pediatrics 2012;
129; e983…e991.
96. xillia|s X], Uay|an ]], Daniels Sˆ et al. Xardio~ascvlar uealtu in cuild-
uood; A state|ent for uealtu professionals fro| tue Xo||ittee on Atuerosclerosis,
Uypertension, and Vbesity in tue hovng FAUVhG of tue Xovncil on Xardio~ascvlar
Disease in tue hovng, A|erican Ueart Association. Xircvlation 2002; 106; 143…160.
97. }\PDS Stvdy [rovp. Yigut blood pressvre control and ris‚ of |acro~ascvlar
and |icro~ascvlar co|plications in type 2 diabetes; }\PDS. B`‰ 1998; 317; 703…713.
98. ^ppens `X, Xraig `^, Xvsv|ano ‰ et al. Pre~alence of diabetes co|plications in
adolescents witu type 2 co|pared witu type 1 diabetes. Diabetes Xare 2006; 29; 1300…1306.
99. xest NA, Ua||an ˆZ, `ayer-Da~is ^‰ et al. Xardio~ascvlar ris‚ factors
a|ong yovtus witu and wituovt type 2 diabetes; diŠ erences and possible |ecuanis|s.
Diabetes Xare 2009; 32; 175…180.
100. `ayer-Da~is ^‰, `a B, ]awson A et al. Xardio~ascvlar disease ris‚ factors
in yovtu witu type 1 and type 2 diabetes; i|plications of a factor analysis of clvstering.
`etab Syndr ˆelat Disord 2009; 7; 89…95.
101. xier•bic‚i AS, Ni||o ], Zeuer`D,Xo A, Zoton ‰, ]ant AZ. Association
of angiotensin-con~erting en•y|e DD genotype witu uypertension in diabetes. ‰ Uv|
Uypertens 1995; 9; 671…673.
102. Batis‚y D]. xuat is tue opti|al ”
rst-line agent in cuildren reviring antiuy-
pertensi~e |edication— Xvrr Uypertens ˆep 2012; 14; 603…607.
103. National Uigu Blood Pressvre ^dvcation xor‚ing [rovp on Uigu Blood
Pressvre in Xuildren and Adolescents. Yue fovrtu report on tue diagnosis, e~alvation,
106
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
and treat|ent of uigu blood pressvre in cuildren and adolescents. Pediatrics 2004; 114
F2 Svppl 4tu ˆeportG; 555…576.
104. Blowey D]. }pdate on tue puar|acologic treat|ent of uypertension in pedi-
atrics. ‰ Xlin Uypertens 2012; 14; 383…387.
105. ]vrbe ^, Xif‚o~a ˆ, Xrvic‚suan‚ ‰\ et al. `anage|ent of uigu blood
pressvre in cuildren and adolescents; reco||endations of tue ^vropean Society of
Uypertension. ‰ Uypertens 2009; 27; 1719…1742.
106. ^ttinger ]`, Zree|an \, Di`artino-Nardi ‰ˆ, Zlynn ‰Y. `icroalbv|invria
and abnor|al a|bvlatory blood pressvre in adolescents witu type 2 diabetes |ellitvs.
‰ Pediatr 2005; 147; 67…73.
107. Zagot-Xa|pagna A, \nowler xX, Pettit D‰. Yype 2 diabetes in Pi|a Indian
cuildren; cardio~ascvlar ris‚ factors at diagnosis and 10 years later. Diabetes 1998; 47
FSvppl 1G; A155.
108. Sellers ^, hovng [, Dean U. Dyslipide|ia and otuer cardio~ascvlar ris‚ fac-
tors in a Xanadian Zirst Nation pediatric popvlation witu type 2 diabetes |ellitvs.
Pediatr Diabetes 2007; 8; 384…390.
109. Dart AB, Sellers ^A, `artens P‰, Brownell `D, Dean U‰.Uigu bvrden of
‚idney disease in yovtu-onset type 2 diabetes. Diabetes Xare 2012; 35; 1265…1271.
110. ho‚oua|a U, V‚vdaira `, Vtani Y etal. Uigu incidence of diabetic nepuropa-
tuy in early-onset ‰apanese NIDD` patients. Diabetes Xare 1998; 21; 1080…1085.
111. ho‚oua|a U, V‚vdaira `, Vtani Y et al. Uiguer incidence of diabetic
nepuropatuy in type 2 tuan in type 1 diabetes in early-onset diabetes in ‰apan. \idney
Int 2000; 58; 302…311.
112. ˆodrigve• B], Zv–i|oto xh, `ayer-Da~is ^‰ et al. Pre~alence of cardio~as-
cvlar disease ris‚ factors in}.S. cuildren and adolescents witu diabetes; tue S^AˆXU
for diabetes in yovtu stvdy. Diabetes Xare 2006; 29; 1891…1896. 113. Springer SX,
Sil~erstein ‰, Xopeland \ etal. `anage|ent of type 2 diabetes |ellitvs in cuildren and
adolescents. Pediatrics 2013; 131; e648…e664.
114. \a~ey ˆ^, Allada j, Daniels Sˆ et al. Xardio~ascvlar ris‚ redvction in uigu-ris‚
pediatric patients; a scienti”
c state|ent fro| tue A|erican Ueart Association ^pert Panel
on Popvlation and Pre~ention Sciencez tue Xovncils on Xardio~ascvlar Disease in tue
hovng, ^pide|iology and Pre~ention, Nvtrition, Puysical Acti~ity and `etabolis|, Uigu
Blood Pressvre ˆesearcu, Xardio~ascvlar Nvrsing, and tue \idney in Ueart Diseasez and
tue Interdisciplinary xor‚ing [rovp on Žvality of Xare and Vvtco|es ˆesearcu; endorsed
by tue A|erican Acade|y of Pediatrics. Xircvlation 2006; 114; 2710…2738.
115. ^pert panel on integrated gvidelines for cardio~ascvlar uealtu and ris‚ redvc-
tion in cuildren and adolescents, National Ueart ]vng and Blood Institvte. ^pert
panel on integrated gvidelines for cardio~ascvlar uealtu and ris‚ redvction in cuildren
and adolescents; sv||ary report. Pediatrics 2011; 128 FSvppl 5G; S213…S256.
116. Zlint A, Arslanian S. Yreat|ent of type 2 diabetes in yovtu. Diabetes Xare 2011;
34 FSvppl 2G; S177…S183.
117. xadwa ˆP, }rbina ^`, Anderson A` et al. `easvres of arterial stiŠ
ness
in yovtu witu type 1 and type 2 diabetes; tue S^AˆXU for diabetes in yovtu stvdy.
Diabetes Xare 2010; 33; 881…886.
  \b\t\b
107
118. Nor|an ˆ‰, Dewailly D, ]egro ˆS, Uic‚ey Y^. Polycystic o~ary syndro|e.
]ancet 2007; 370; 685…697.
119. A|ini `, Uorri N, Zar|ani ` et al. Pre~alence of polycystic o~ary syndro|e in
reprodvcti~e-aged wo|en witu type 2 diabetes.[ynecol ^ndocrinol 2008; 24; 423…427.
120. Sua” ee `N, \uan [, Ariž n ˆ et al. Pre~enting endo|etrial cancer ris‚ in
polycystic o~arian syndro|e FPXVSGwo|en; covld|etfor|in uelp—[ynecolVncol
2014; 132; 248…253.
121. ]egro ˆS, Arslanian SA, ^ur|ann DA et al. Diagnosis and treat|ent of
polycystic o~ary syndro|e; an ^ndocrine Society clinical practice gvideline. ‰ Xlin
^ndocrinol `etab 2013; 98; 4565…4592.
122. Dean U, Sellers ^. Steatouepatitis in cuildren witu type 2 diabetes |ellitvs.
Diabetes 2001; 50 FSvppl 2G; A378.
123. New” eld ˆ, Scuwi||er ‰. Non alcouolic steatouepatitis in cuildren and ado-
lescents witu type 2 diabetes |ellitvs. Diabetes 2003; 52 FSvppl 1G; A4041754.
124. Nadeav \‰, \lingens|itu Z, ‡eitler P. Yype 2 diabetes in cuildren is frevently
associated witu ele~ated alanine a|inotransferase. ‰ Pediatr [astroenterol Nvtr 2005;
41; 94…98.
125. ˆoberts ^A. Non-alcouolic fatty li~er disease FNAZ]DG in cuildren. Zront
Biosci 2005; 10; 2306…2318.
126. Uvdson VD, Nvne• `, Suaibi [Ž. ^tunicity and ele~ated li~er transa|inases
a|ong newly diagnosed cuildren witu type 2 diabetes. B`X Pediatr 2012; 12; 174.
127. Svndara| SS, ‡eitler P, Nadeav \. Yue |etabolic syndro|e and nonalcouolic
fatty li~er disease in cuildren. Xvrr Vpin Pediatr 2009; 21; 529…535.
128. [aggini `, `orelli `, Bv••igoli ^, DeZron•o ˆA, Bvgianesi ^, [astaldelli A.
Non-alcouolic fatty li~er disease FNAZ]DG and its connection witu insvlin resistance,
dyslipide|ia, atuerosclerosis and coronary ueart disease. Nvtrients 2013; 5; 1544…1560.
129. Angvlo P, \eacu ‰X, Batts \P, ]indor \D. Independent predictors of li~er
brosis in patients witu nonalcouolic steatouepatitis. Uepatology 1999; 30; 1356…1362.
130. Sinua S\, Suaueen `, ˆa–a~asuistu YB, Pan D, Norris \X, Nicuolas SB.
Association of raceetunicity, in›
a||ation, and albv|invria in patients witu diabetes
and early curonic ‚idney disease. Diabetes Xare 2014; 37; 1060…1068.
131. \astelan S, Yo|ic `, [~ero~ic Antvnica A, Salope‚ ˆabatic ‰, ]–vbic S.
a||ation and puar|acological treat|ent in diabetic retinopatuy. `ediators
a|| 2013; 2013.
132. ~an [r
ee~enbro
e‚ ``, Scual‚w˜ ‚ X[, Steuovwer XD. Vbesity-associated
low-grade in›
a||ation in type 2 diabetes |ellitvs; cavses and consevences. Netu ‰
`ed 2013; 71; 174…187.
133. `ontane ‰, Xada~e• ], No~ials A. Stress and tue in›
a||atory process; a
|a–or cavse of pancreatic cell deatu in type 2 diabetes. Diabetes `etab Syndr Vbes
2014; 7; 25…34.
134. jendrell ‰, Xuacon `ˆ. Yx^A\; a new player in obesity and diabetes. Zront
I||vnol 2013; 4; 488.
135. ‡uong ‰, ˆao _, Bravnstein ‡ et al. Y cell costi|vlation protects obesity-
indvced adipose in›
a||ation and insvlin resistance. Diabetes 2013; 63; 1289…1302.
108
!\t\t 3. \t\t\b\f\r \t  2- \t    \r  \b
136. ]ee ‰. Adipose tissve |acropuages in tue de~elop|ent of obesity-indvced
a||ation, insvlin resistance and type 2 diabetes. Arcu Puar| ˆes 2013; 36;
137. ˆice YB, Zoster [D, Sanders `U et al. Yue relationsuip between obstrvcti~e
sleep apnea and selfreported stro‚e or coronary ueart disease in o~erweigut and obese
advlts witu type 2 diabetes |ellitvs. Sleep 2012; 35; 1293…1298.
138. Zoster [D, Sanders `U, `ill|an ˆ, [rovp SAˆ. Vbstrvcti~e sleep apnea
a|ong obese patients witu type 2 diabetes. Diabetes Xare 2009; 326; 1017…
1019.
139. Suaw ‰^, Pvn–abi N`, xilding ‰P, Alberti \[, ‡i||et P‡, Pre~ention
IDZYo^a. Sleep-disordered breatuing and type 2 diabetes; a report fro| tue International
Diabetes Zederation Yas‚force on ^pide|iology and Pre~ention. Diabetes ˆes Xlin
Pract 2008; 8; 2…12.
140. xalders-Abra|son N. Depression and vality of life in yovtu-onset type 2
diabetes |ellitvs. Xvrr Diab ˆep 2014; 14; 449.
141. ‡enlea IS, `ednic‚ ], ˆein ‰, Žvinn `, xolfsdorf ‰, ˆuodes ^Y. ˆovtine
beua~ioral and |ental uealtu screening in yovng cuildren witu type 1 diabetes |ellitvs.
Pediatr Diabetes 2013; No~ 26 ^pvb auead of print.
142. Per~anidov P, Xurovsos [P. `etabolic consevences of stress dvring cuild-
uood and adolescence. `etabolis| 2012; 61; 611…619.
143. Anderson B‰, ^delstein S, Abra|son Nx et al. Depressi~e sy|pto|s and
vality of life in adolescents witu type 2 diabetes; baseline data fro| tue YVDAh stvdy.
Diabetes Xare 2011; 34; 2205…2207.
144. ]awrence ‰`, Standiford DA, ]oots B et al. Pre~alence and correlates of
depressed |ood a|ong yovtu witu diabetes; tue S^AˆXU for diabetes in yovtu stvdy.
Pediatrics 2006; 117; 1348…1358.
145. Diet• xU, [ross x], \ir‚patric‚ ‰A. Blovnt disease Ftibia ~araG; anotuer
s‚eletal disorder associated witu cuilduood obesity. ‰ Pediatr 1982; 101; 735…737.
146. ]oder ˆY, Aronson DD, [reen”
eld `]. Yue epide|iology of bilateral slipped
capital fe|oral epipuysis. A stvdy of cuildren in `icuigan. ‰ Bone ‰oint Svrg A| 1993;
75; 1141…1147.
147. Xonstantino `I, `olyneav ], ]i|acuer-[isler Z et al.]ong-ter| co|plica-
tions and |ortality in yovngonset diabetes; type 2 diabetes is |ore ua•ardovs and letual
tuan type 1 diabetes. Diabetes Xare 2013; 36; 3863…3869.
148. ˆuodes ^Y, Prosser ]A, Uoerger Y‰, ]vdwig DS, ]aŠ
el ]`. ^sti|ated |or-
bidity and |ortality in adolescents and yovng advlts diagnosed witu type 2 diabetes
|ellitvs. Diabet `ed 2012; 29; 453…463.
149. Sac‚ett D], Uolland xx. Xontro~ersy in detection of disease. ]ancet 1965;
ii; 357…359.
1 \t\t
5\t\b\n\t\f \t \b\t 7\b\b\b
\n\r\b 5\t  5 \t 5\r\n\f
Craig M.E.
110 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\b\b:\t8 \t \r\f7\b5:\t\t



&\t\r-"#\t \f#"# \n '\t" \t"@, 
 #' $#" "@ "$#\t  #/ , #  \t'# 
%"# #/ C #"@ ## \f'# @##,  
"@\t 'C. #"# "C '\t" #"@ #\r$#J 
\f\r#/ \r\t"/ \r\t#\t/ :'#, \r#\r, : %'\r#

…\n\t #"\r#\t \n  \f #' \r\f#" # \f #'
…\n:\rC\t, ":#@\t,  \r\r#\rJE\t #\r-


  \f


\r\t"@ :@  $##"   \f#:" ## 


5\b\t
###  # ##'## \n  C#/,
112 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\f\t\b\t\n\f8 \b\t7\nL 5\t\b\n\t\f\t 7\b\b\b
\n\r\b 5\t
\f7 \b5\t7 7\f8\r\b \n\t\r\b\t
\t\r-"# ""#\r#   "#"@"@J #
$##"@J. *"# ""#\r# \f\t \f" 
\f \t \f\t* \t\f \f \f\f \t\t\b\f \t \t
113
 \f\f\t \n8 \n5 \r5 M\tL,  5\t\b
\n\r\b 5\t 1B \t   \r\b\f \b\r\bT
 \f\f\t \n8 \n5 \r5 M\tL,  5\t\b
\n\r\b 5\t 2B \t   \r\b\f \b\r\bT
114 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\t\b\r \r:\t8 \rL \b\t\n\f \n\t\r\b\t8
\n :\t9\t\n\f\t 5\t  7\b\b\b \n\r\b 5\t
\t \t \b\t
\b\bL\b \n\r\b 5\t, 5\t\b\n\t\r\b\b
 \r U…12 7\n M\t\b\t
##\t #"$#\t "# \n1 \r \r\f
 #   \f \f\f \t\t\b\f \t \t     \f
115
G m34q. :@! #"  ?\n
\r\b\t\r\b \b\bL\b \n\r\b 5\t \n5\n\t
\b7\t \t7 \r\t\b\t\b UW24
116 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
 4.1
7%%%@ *!*@ %%()% ! #(%/" !- O#�!!3!%%@ %%@ !' [RX]Q
%$"\b"(%!
5$! (!%!/"! ;!"!!\t"/%!!
9q5JT\t\t \f (-
9p55.2S\r\r
2Gq25.2S\r\r
26p25.5S\r\r
26p25.5S\r\r
28q52.G3\t
9q55.2S\r\r
GATA6
2q22.2-q22.53\t
GATA4
p5G.23\t
 #   \f \f\f \t\t\b\f \t \t     \f
117
%$"\b"(%!
5$! (!%!/"! ;!"!!\t"/%!!
Kp5J.G-p5GS\r\r
26q52.GS\r\r
5qG5S\r\r
PAX6
22p2GS\r\r
8eG9.GS\r\r
56p22.55S\r\r
KCNJ11
�22p2.2'\t   \b-
�22p2.2'\t, \b\t-
��22p2.S\r\r
�8p2-p2GS\r\r
Gq59.2-q59.GS\r\r
 \t \t\n, \b\r$ ^2G_SLC19A22q5G.GS\r\r
\n\n\r \r . 4.1
118 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
%$"\b"(%!
5$! (!%!/"! ;!"!!\t"/%!!
��22p2.'\t   \b-
5p22.5S\r\r
2q52.5S\r\r
FOXP3
Zp22.5G-p2G.GZ-\r , \r-
Jp29.2S\r\r
 #   \f \f\f \t\t\b\f \t \t     \f
119
�# ! ' \r#""J"   / $#".
120 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\b\bL\b \n\r\b 5\t \n5\n\t 7:\t
9B\n\tL\b \f\t \f\b
# "\r/ \r#\rJE#/ S}ˆ1-:H\f##$, \f#\r/ #
 #   \f \f\f \t\t\b\f \t \t     \f
121
#\f#\t \t#@, " \r# \f\r: ""#\r## /
\r#\r 90k $#"  "##\rJE## "$#\t# 
122 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\b\bL\b \n\r\b 5\t, \b\b 7:\t87\t
 \b
INS
 #   \f \f\f \t\t\b\f \t \t     \f
123
\n\t\b5\r7 \f…\r\t\n\b
\r$# #\f\r, /\r"\r#'JE#\t \r# \f:J" \n,
\r# """## $#@ : \r'#"# \fC\f
\b\bL\b 5\t, \n8\b\b \n 7:\t87\t
\rCJ \f"J \r\r#\rJEJ #\r##J
124 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
B\n: \b\b \n\t\b5\r7 \t77\b\b 5\t\n\r8:\t\t,
\t6\b5\f\r\t\b \t\t \t 6\b\r \t\t
5\r\t \r\t\t\b \b\bL\b \n\r\b 5\t
\f-\f\t\f\f\t \f\t  \f\f\t \t\b\t= \f\f\t  \b ...
125
\n7\bB57\t\b\b\b8 \b\n5\n\b\b8
\n\rM\b\b8 \t \r\t\f7\t8 \t\t \n\r\b 5\t
O5\t \r \t   75Q
\n\rM\b\b8 \t \r\t\f7\t8 \b\f  \n8\t
\n 7:\t87\t \b =\f\f\t\b O
GCK-
YZD\, YZD\2Q
#/ #", #\f"@""  ", "  :\fE  #/, 'C,
126 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
m95, 96q.
 \f" # \f\r" :\r"" '\r" """# C#\r#\t
\„\r\r\r\f\f:"  \f",   ### "# "#"\t "@J. = \r"#C"@ \f\r# \f"# \f#:" \r# [X\-`VDh \r$#\t ## \r#\r"\t \f",  \r @ : #/ '#,   '\f\r/ \f". = \r'@""  #/  \rC-\f#\t \r#""" \r\r#\rJE\t :\rC\t #\r#-#\t m97q. \r@ UbA1c  !,  : #C 7,5k m98q. "\r\t  J #\r##J "E, \r# \r\f## *?? : "@ :@! !# \r\t * F‘60 \f, ## ‘3,5 @G m99q, /"\t %"" \r#"\r# @'\t #""@ :J"- #'-' \r#:@"# *??. @ \r@ #\r### \f"" # \f\t ", ": '"@ "## #"-, ':#  :@!#"  :\rC#"\t , &#xG m9; q, ;&#x/" %;&#x"" #;&#x"# @;&#x' #";&#x"@ :;&#xJ"-T;&#xj 0.;ᘇ&#x Tw ;&#xT* ;&#x#'-';&#x #:@;&#x"# *;&#x??. ;&#[email protected] @ ;&#x####;&#x Tj ;�.07; Tw;&#x T* ;&#x"" #;&#x ",;&#x ": ;&#x'"@ ;&#x"## ;&#x#"-T;&#xj 0.;㍳&#x Tw ;&#xT* ,;&#x ':#;&#x :@;&#x!#" ;&#x :C#;&#x" , ;&#xTj 0;&#x.142; Tw;&#x T* ;&#x# #';&#x## ;&#x* ;&#x. 00;\r# #'\r## \r\t *  \f\r \f. @ " \f#'  \r\f#"\t :E  \t\t"\t ## !#: \r\f\t"\t  \n2  \f:J"  \f '\r". \r# \f'\r##  "$#J  J-#' C #'\r\t"@ \r@ J' "E   #JE#/ #" \r\f#".@ \r@ * E"  /\f!"\t  "# \r-#, %"" \f"# &*\n \r\f \t'  /\r### #\r- ##  4.2
\r"*"%%%@ *!*@ !- '( !* $ #(@; ! "+'%%@
" %!#! (!%!/"! *+(%!+
%$"\f(!%!/"! *+(%!+
*!+\t"/%!
D\t\r  \t\t \f\t
 ,  \r\b
�8p2-p2GR\t \r\r\t  -
\n\t\b\t^2_HNF1A25q5J.5%\t  \n
28q25C\t+ \t\n , \t\t-
Q\r ^2K6_
\f-\f\t\f\f\t \f\t  \f\f\t \t\b\t= \f\f\t  \b ...
127
\\n\t\t\t @\t/  [X\-`VDh  "" \r\f"/ :\r ## "\r "$## de novo.\b\n5\n\b\b \n\r\b 5\t, \n8\b\b \n
HNF1
BYZD\
OYZD\RQ \t
HNF4
BYZD\ OYZD\1Q
:"@ \r@  '#"@ !# \r\t * F80 \f,
\r"\r"@ #\r\f#"/ C# F\r"#"##,
128 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b



:"J" !#J ## "\r\t,  ##,
" \f'G \f\t \r\f"\rE#\t ####. $#" "
! \f   \f\b, \t\b\t\f\f  \t\t\b\f \t 
129
\b\t\n\f\t \n\t\b5\r7, \n\n:\t\t\r\b\b \n \n\r\b7
5\t7
»; uttp;www.ncbi.nl|.niu.go~entre•very.fcgi. *"#
\n\t\b5\r7 \b\n\r\b 5\t, \n\r\b 5\t, \r9\t\t
\r\tL\b \b\r \t \n\t O\n\t\b5\r7 L9\r7Q
$#$#\t \f#:"  \r\r#\rJE "\r# '\r#"@
\r@ "\t" \f#' \n1z \fJE\t "\r\t '\r#\t,
130 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\b \f\t\n \t \n\t\b5\r7 \n\r\b 5\t O
HNF1B-
YZD\,
\t\t YZD\^Q
! \f   \f\b, \t\b\t\f\f  \t\t\b\f \t 
131
7\t\b5\r\tL\b \n\r\b 5\t
�\n"\t :#", \f \r#\r  20k $#"  #-"#\r" "\r "\t# "@ \f  m142q. "\r\t  " " : \f:J" \f#:" \r#/\f#"  '\r '\r", "@ \f   \t/  \f\r"  # \r "\r'## m143, 144q. \f'\r#  #"/\f\r#@ \n '#" \r# ###  $#" \n # \r\r "/"#, \f  ### "\r#. ("\r, " " C "$#\t |.3243A�[ #" " # \r# #\f\r `^]AS F#"/\f\r#@\t #"#\t, %$"#\t, -"$#\f' # #@"\f: %#'\fG m145q.&#"/\f\r#@ \f#:" C"  /\r! \r#\r"@  \f#" ## \r# \r\r@/ ####/ \r\f",  \r' @ \t$ ## " $#" " "\r:"\t ##"\r#\t. '"@ "\r#  \r\f"\t, @  #\t"  #"-/\f\r#@J $#J # C" '"@ %#'\f "$#\f' m146q.\r"\r"@ \n  #" "$## '##" " '\r",   70 \f  \r!" 85k m142q. (JE# \n C#  \r\fJ" ':# # \f"\t. OE#, :\r", \r\fJ" "$#J  # \f"\t, /"\t  "\r/ #' #/ ':#  \r'@"\t m6q. #:"  \r# \f:J" F\fC  \f"G C" \r'#"@\t  "@  \r'@"" "$## |.3243A�[,  #  \r'@-"" \f\r#/,  \r\r"\r/ #"/\f\r#@/ \r!#, "#/  #\f\r \r…\n\r m147q # #\r m148q.\n\r\b 5\t, \b\t\f=\t \n5\n\t 7\b\b\b
\b\r\b\t 6\f\f\r\t\b\b 9\b\f:\t\t 5M5\b M
132 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
/ ':#, #\tJE#/    %'\r#J
7\b\b\b \n\t\b5\r7 \t\b\n\t\b\r\t\n\b\b\n\t
�# :"\t# #\f\r ##\r'#"""#
\r\t\b 59\f \n\t\bL\b  \t\b\n\t\b, \n8\b\b
\n 7:\t87\t \b \r: \r \t\b\n\t\b
)\f \f\f \f\b \f\f\b  \f\f
133
 4.3
\f�(""!!3!+ "!%# +F(& "*%! !%"$(!%'!"%%"! O*!% * !"/%!$ [1^4]Q
% O%"(%!Q*!%!*%!%
S
%&C\t \f
„T\r \r (
AGPAT2
%&%&=& \t \b\r \b (\r
PPARG
T\t\t \f„
PPARG
\r$, \r \n\r\r\f
\t\b…\b # BBS1 \b BBS18 ( \r S)„„„
„„„
134 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
7\b\b\b \t 5\t\n\r9\t\t
\r$# \r!#, /\r"\r#'JE\t \r"## 
)\f \f\f \f\b \f\f\b  \f\f
135
\t\b\n\t\b\r\t\n\b\b\nL \t 5\t, \n8\b\b \n :\t\t \t
136 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
\f=\b\t
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. Za–ans SS, Bell [I. `VDh; uistory, genetics, patuopuysiology, and clinical deci-
sion |a‚ing. Diabetes Xare 2011; 34; 1878…1884.
2. Yattersall ˆ. `atvrity-onset diabetes of tue yovng; a clinical uistory. Diabet `ed
1998; 15; 11…14. 3. Yattersall ˆB, Za–ans SS. A diŠ
erence between tue inueritance of
  \b\t\b
137
classical –v~enile-onset and |atvrityonset type diabetes of yovng people. Diabetes 1975;
24; 44…53.
4. Yattersall ˆB.`ild fa|ilial diabetes witu do|inant inueritance. Ž ‰ `ed 1974;
43; 339…357.
5. Za–ans SS, Bell [I, Polons‚y \S. `olecvlar |ecuanis|s and clinical patuo-
puysiology of |atvrityonset diabetes of tue yovng. N ^ngl ‰ `ed 2001; 345; 971…980.
6. `vrpuy ˆ, ^llard S, Uattersley AY. Xlinical i|plications of a |olecvlar genetic
classi”
cation of |onogenic beta-cell diabetes. Nat Xlin Pract ^ndocrinol `etab 2008;
4; 200…213.
7. [loyn A], Pearson ^ˆ, AntcliŠ
‰Z et al. Acti~ating |vtations in tue gene encod-
ing tue AYP-sensiti~e potassiv|-cuannel svbvnit \ir6.2 and per|anent neonatal
diabetes.N ^ngl ‰ `ed 2004; 350; 1838…1849.
8. Bellanné-Xuantelot X, Xlavin S, Xuav~eav D et al. ]arge geno|ic rearrange-
|ents in tue uepatocyte nvclear factor-1beta FYXZ2G gene are tue |ost frevent cavse
of |atvrity-onset diabetes of tue yovng type 5. Diabetes 2005; 54; 3126…3132.
9. Støy ‰, ^dguill ^], Zlanagan S^ et al. Insvlin gene |vtations as a cavse of per-
|anent neonatal diabetes. Proc Natl Acad Sci } S A 2007; 104; 15040…15044.
10. `øller A`, Dalgaard ]Y, Pociot Z, Nervp ‰, Uansen Y, Pedersen V. `vtations
in tue uepatocyte nvclear factor-1alpua gene in Xavcasian fa|ilies originally classi”
as ua~ing type I diabetes. Diabetologia 1998; 41; 1528…1531.
11. ]a|bert AP, ^llard S, Allen ]I et al. Identifying uepatic nvclear factor 1alpua
|vtations in cuildren and yovng advlts witu a clinical diagnosis of type 1 diabetes.
Diabetes Xare 2003; 26; 333…337.
12. ˆvbio-Xabe•as V, ^dguill ^], Argente ‰, Uattersley AY. Yesting for |onogenic
diabetes a|ong cuildren and adolescents witu antibodynegati~e clinically de”
ned Yype
1 diabetes. Diabet `ed 2009; 26; 1070…1074.
13. Awa x], Scuober ^, xiegand S et al. ˆeclassi”
cation of diabetes type in pediatric
patients initially classi”
ed as type 2 diabetes |ellitvs; 15 years followvp vsing rovtine data
fro| tue [er|anAvstrian DPj database. Diabetes ˆes Xlin Pract 2011; 94; 463…467.
14. Zendler x, Borowiec `, Baranows‚a-‰a•wiec‚a A et al. Pre~alence of |ono-
genic diabetes a|ongst Polisu cuildren after a nationwide genetic screening ca|paign.
Diabetologia 2012; 55; 2631…2635.
15. Irgens U}, `olnes ‰, ‰ouansson BB et al. Pre~alence of |onogenic diabetes in
tue popvlationbased Norwegian Xuilduood Diabetes ˆegistry. Diabetologia 2013; 56;
1512…1519.
16. Piuo‚er X, [illia| ]\, ^llard S et al. Pre~alence, cuaracteristics and clinical
diagnosis of |atvrity onset diabetes of tue yovng dve to |vtations in UNZ1A, UNZ4A,
and glvco‚inase; resvlts fro| tue S^AˆXU for Diabetes in hovtu. ‰ Xlin ^ndocrinol
`etab 2013; 98; 4055…4062.
17. Bonnefond A, Puilippe ‰, Dvrand ^ et al. Uiguly sensiti~e diagnosis of 43
|onogenic for|s of diabetes or obesity turovgu one-step PXˆ-based enricu|ent in
co|bination witu net-generation sevencing. Diabetes Xare 2014; 37; 460…467.
18. ^llard S, ]ango Allen U, De Zranco ^ et al. I|pro~ed genetic testing for
|onogenic diabetes vsing targeted net-generation sevencing. Diabetologia 2013; 56;
1958…1963.
138 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
19. [ao ˆ, ]iv h, [–esing AP et al. ^~alvation of a target region captvre sevencing
platfor| vsing |onogenic diabetes as a stvdy-|odel. B`X [enet 2014; 15; 13.
20. ‰ouansson S, Irgens U, Xuvdasa|a \\ et al. ^o|e sevencing and genetic
testing for `VDh. P]oS Vne 2012; 7; e38050.
21. [reeley SA, ‰oun P`, xinn AN et al. Yue costeŠ
ecti~eness of personali•ed
genetic |edicine; tue case of genetic testing in neonatal diabetes. Diabetes Xare 2011;
34; 622…627.
22. Naylor ˆN, ‰oun P`, xinn AN et al. XosteŠ ecti~eness of `VDh genetic
testing; translating geno|ic ad~ances into practical uealtu applications. Diabetes Xare
2014; 37; 202…209.
23. Iafvsco D, Sta•i `A, Xoticuini ˆ et al. Per|anent diabetes |ellitvs in tue ”
rst
year of life. Diabetologia 2002; 45; 798…804.
24. ˆvbio-Xabe•as V. Diagnosing |onogenic diabetes; co||on |isinterpreta-
tions of genetic ”
ndings. Pediatr Diabetes 2009; 10; 497…499.
25. ^llard S, Bellanne-Xuantelot X, Uattersley AY. ^vropean `olecvlar [enetics
Žvality Networ‚ `g. Best practice gvidelines for tue |olecvlar genetic diagnosis of
|atvrity-onset diabetes of tue yovng. Diabetologia 2008; 51; 546…553.
26. A|erican Diabetes Association. Diagnosis and classi”
cation of diabetes |el-
litvs. Diabetes Xare 2014; 37 FSvppl. 1G; S81…S90.
27. ^dguill ^], Di ˆ‰, Zlanagan S^ et al. U]A genotyping svpports a nonavtoi|-
|vne etiology in patients diagnosed witu diabetes vnder tue age of 6 |ontus. Diabetes
2006; 55; 1895…1898.
28. ˆvbio-Xabe•as V, `inton ‰A, Xaswell ˆ et al. Xlinical ueterogeneity in patients
witu ZV_P3 |vtations presenting witu per|anent neonatal diabetes. Diabetes Xare
2009; 32; 111…116.
29. ˆvbio-Xabe•as V, Zlanagan S^, Da|uvis A, Uattersley AY, ^llard S. \AYP
cuannel |vtations in infants witu per|anent diabetes diagnosed after 6 |ontus of life.
Pediatr Diabetes 2012; 13; 322…325.
30. `oua|adi A, Xlar‚ ]`, ]ip‚in PU, `auone ^`, xod‚a ^], Plotnic‚
]P.`edical and de~elop|ental i|pact of transition fro| svbcvtaneovs insvlin to
oral glybvride in a 15-yr-old boy witu neonatal diabetes |ellitvs and inter|ediat-
eD^NDsyndro|e; etending tue age of \XN‰11 |vtation testing in neonatal D`.
Pediatr Diabetes 2010; 11; 203…207.
31. [icvel X, ]e Bovc h. Uor|onal regvlation of fetal growtu. Uor| ˆes 2006;
32. Ye|ple I\, [ardner ˆ‰, `ac‚ay D‰, Barber ‰X, ˆobinson DV, Suield ‰P.
Yransient neonatal diabetes; widening tue vnderstanding of tue etiopatuogenesis of
diabetes. Diabetes 2000; 49; 1359…1366. 33. [ardner ˆ‰, `ac‚ay D‰, `vngall A‰ et
al. An i|printed locvs associated witu transient neonatal diabetes |ellitvs. Uv| `ol
[enet 2000; 9; 589…596.
34. Zlanagan S^, Patcu A`, `ac‚ay D‰ et al. `vtations in AYP-sensiti~e \š
cuannel genes cavse transient neonatal diabetes and per|anent diabetes in cuilduood
or advltuood. Diabetes 2007; 56; 1930…1937.
35. horifv–i Y, \vro‚awa \,`a|ada`et al. Neonatal diabetes |ellitvs and neona-
tal polycystic, dysplastic ‚idneys; puenotypically discordant recvrrence of a |vtation in
  \b\t\b
139
tue uepatocyte nvclear factor-1beta gene dve to ger|line |osaicis|. ‰ Xlin ^ndocrinol
`etab 2004; 89; 2905…2908.
36. [arin I, ^dguill ^], A‚er|an I et al. ˆecessi~e |vtations in tue INS gene resvlt
in neonatal diabetes turovgu redvced insvlin biosyntuesis. Proc Natl Acad Sci } S A
2010; 107; 3105…3110.
37. ˆvbio-Xabe•as V, ^llard S. Diabetes |ellitvs in neonates and infants; genetic
ueterogeneity, clinical approacu to diagnosis, and tuerapevtic options. Uor| ˆes
Paediatr 2013; 80; 137…146.
38. ˆvsso ], Iafvsco D, Brescianini S et al. Per|anent diabetes dvring tue ”
rst year
of life; |vltiple gene screening in 54 patients. Diabetologia 2011; 54; 1693…1701.
39. `ac‚ay D, Bens S, Pere• de Nanclares [, Siebert ˆ, Ye|ple I\. Xlinical vtil-
ity gene card for; transient neonatal diabetes |ellitvs, 624-related. ^vr ‰ Uv| [enet
2014; Zeb 26. doi; 10.1038e–ug.2014.27.
40. `a D, Suield ‰P, Dean x et al. I|paired glvcose uo|eostasis in transgenic
|ice epressing tue uv|an transient neonatal diabetes |ellitvs locvs, YND`. ‰ Xlin
In~est 2004; 114; 339…348.
41. Ye|ple I\, Suield ‰P. Yransient neonatal diabetes, a disorder of i|printing.
‰`ed[enet 2002; 39; 872…875.
42. `ac‚ay D‰, Boonen S^, Xlayton-S|itu ‰ et al. A |aternal uypo|etuylation syn-
dro|e presenting as transient neonatal diabetes |ellitvs. Uv| [enet 2006; 120; 262…269.
43. `ac‚ay D‰, Xallaway ‰], `ar‚s S` et al. Uypo|etuylation of |vltiple
i|printed loci in
indi~idvals witu transient neonatal diabetes is associated witu |vtations in ‡ZP57.
Nat [enet 2008; 40; 949…951.
44. Docuerty ]^, \abwa|a S, ]eu|ann A et al. Xlinical presentation of 624 tran-
sient neonatal diabetes |ellitvs F624 YND`G and genotype-puenotype correlation in
an international couort of patients. Diabetologia 2013; 56; 758…762.
45. Suield ‰P, Ye|ple I\, Sabin ` et al. An assess|ent of pancreatic endocrine
fvnction and insvlin sensiti~ity in patients witu transient neonatal diabetes in re|ission.
Arcu Dis Xuild Zetal Neonatal ^d 2004;
89; Z341…Z343. 46. `cYaggart ‰S, Xlar‚ ˆU, Asucroft Z`. Yue role of tue \AYP
cuannel in glvcose uo|eostasis in uealtu and disease; |ore tuan |eets tue islet.
‰ Puysiol 2010; 588 FPt 17G; 3201…3209.
47. Asucroft Z`. AYP-sensiti~e potassiv| cuannelopatuies; focvs on insvlin secre-
tion. ‰ Xlin In~est 2005; 115; 2047…2058.
48. Baben‚o AP, Pola‚ `, Xa~é U et al. Acti~ating |vtations in tue ABXX8 gene
in neonatal diabetes |ellitvs. N ^ngl ‰ `ed 2006; 355; 456…466.
49. ^llard S, Zlanagan S^, [irard XA et al. Per|anent neonatal diabetes cavsed by
do|inant, recessi~e, or co|povnd uetero•ygovs S}ˆ1 |vtations witu opposite fvnc-
tional eŠ ects. A| ‰ Uv| [enet 2007; 81; 375…382.
50. Zlanagan S^, ^dguill ^], [loyn A], ^llard S, Uattersley AY. `vtations in
\XN‰11, wuicu encodes \ir6.2, are a co||on cavse of diabetes diagnosed in tue ”
rst
6 |ontus of life, witu tue puenotype deter|ined by genotype. Diabetologia 2006; 49;
1190…1197.
140 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
51. jaillaire `, Popvlaire X, Bvsiau \ et al. \ir6.2 |vtations are a co||on cavse
of per|anent neonatal diabetes in a large couort of Zrencu patients. Diabetes 2004; 53;
2719…2722.
52. Pro‚s P, Arnold A], Brvining ‰ et al. A uetero•ygovs acti~ating |vtation in tue
svlpuonylvrea receptor S}ˆ1 FABXX8G cavses neonatal diabetes. Uv| `ol [enet
2006; 15; 1793…1800.
53. ^dguill ^], Zlanagan S^, Patcu A` et al. Insvlin |vtation screening in 1,044
patients witu diabetes; |vtations in tue INS gene are a co||on cavse of neonatal dia-
betes bvt a rare cavse of diabetes diagnosed in cuilduood or advltuood. Diabetes 2008;
57; 1034…1042.
54. Uattersley AY, Asucroft Z`. Acti~ating |vtations in \ir6.2 and neonatal dia-
betes; new clinical syndro|es, new scienti”
c insiguts, and new tuerapy. Diabetes 2005;
54; 2503…2513.
55. [loyn A], DiatloŠ
-‡ito X, ^dguill ^] et al. \XN‰11 acti~ating |vtations are
associated witu de~elop|ental delay, epilepsy and neonatal diabetes syndro|e and
otuer nevrological featvres. ^vr ‰ Uv| [enet 2006; 14; 824…830.
56. Xlar‚ ˆU, `cYaggart ‰S, xebster ˆ et al. `vscle dysfvnction cavsed by a
\AYP cuannel |vtation in neonatal diabetes is nevronal in origin. Science 2010; 329;
458…461.
57. Bvsiau \, Drvnat S, jai~re-Dovret ] et al. Nevropsycuological dysfvnction and
de~elop|ental defects associated witu genetic cuanges in infants witu neonatal diabetes
|ellitvs; a prospecti~e couort stvdy. ]ancet Diabetes ^ndocrinol 2013; 1; 199…207.
58. Pearson ^ˆ, Zlecutner I, N–olstad Pˆ et al. Switcuing fro| insvlin to oral svlfonyl-
vreas in patients witu diabetes dve to \ir6.2 |vtations. N ^ngl ‰ `ed 2006; 355; 467…477.
59. ˆa”  `, Zlanagan S^, Patcu A` et al. ^Š
ecti~e treat|ent witu oral svlfo-
nylvreas in patients witu diabetes dve to svlfonylvrea receptor 1 FS}ˆ1G |vtations.
Diabetes Xare 2008; 31; 204…209.
60. Sagen ‰j, ˆaeder U, Uatuovt ^ et al. Per|anent neonatal diabetes dve to
|vtations in \XN‰11 encoding \ir6.2; patient cuaracteristics and initial response to
svlfonylvrea tuerapy. Diabetes 2004; 53; 2713…2718.
61. [reeley SA, Yvc‚er
S^, Naylor ˆN, Bell [I, Puilipson ]U. Neonatal diabe-
tes |ellitvs; a |odel for personali•ed |edicine. Yrends ^ndocrinol `etab 2010; 21;
464…472.
62. \lvpa Y, S‚vpien ‰, `ir‚iewic•-Sierad•‚a B et al. ^ž
cacy and safety of svlfo-
nylvrea vse in per|anent neonatal diabetes dve to \XN‰11 gene |vtations; 34-|on-
tu|edian follow-vp. Diabetes Yecunol Yuer 2010;12; 387…391.
63. Xodner ^, Zlanagan S, ^llard S, [arcía U, Uattersley AY. Uigu-dose gliben-
cla|ide can replace insvlin tuerapy despite trans
itory diarruea in ea
  \b\t\b
141
66. Zendler x, Pietr•a‚ I, Brereton `Z et al. Switcuing to svlpuonylvreas in cuil-
dren witu iD^ND syndro|e cavsed by \XN‰11 |vtations resvlts in i|pro~ed cerebel-
lar perfvsion. Diabetes Xare 2013; 36; 2311…2316.
67. Battaglia D, ]in hx, Brogna X et al. [lybvride a|eliorates |otor coordination
and glvcose uo|eostasis in a cuild witu diabetes associated witu tue \XN‰11S225Y,
del226-232 |vtation. Pediatr Diabetes 2012; 13; 656…660.
68. [vrgel ]X, Xrispi| Z, NoŠ s `U, Bel•vnces ^, ˆaual `A, `oises ˆS.
Svlfonylrea treat|ent in per|anent neonatal diabetes dve to [53D |vtationin tue
\XN‰11 gene; i|pro~e|ent in glyce|ic control and nevrological fvnction. Diabetes
Xare 2007; 30; e108.
69. \oster ‰X, Xadario Z, Perv••i X, Xolo|bo X, Nicuols X[, Barbetti Z. Yue
[53D |vtation in \ir6.2 F\XN‰11G is associated witu neonatal diabetes and |otor
dysfvnction in advltuood tuat is i|pro~ed witu svlfonylvrea tuerapy. ‰ Xlin ^ndocrinol
`etab 2008; 93; 1054…1061.
70. Slingerland AS, Nvboer ˆ, Uadders-Algra `, Uattersley AY, Brvining [‰.
I|pro~ed |otor de~elop|ent and good long-ter| glycae|ic control witu svlfonylvrea
treat|ent in a patient witu tue syndro|e of int
er|ediate de~elop|ental delay, earlyon-
set generalised epilepsy and neonatal diabetes associated witu tue j59` |vtation in tue
\XN‰11 gene. Diabetologia 2006; 49; 2559…2563.
71. ^dguill ^], [loyn A], [oriely A et al. Vrigin of de no~o \XN‰11 |vtations
and ris‚ of neonatal diabetes for svbsevent siblings. ‰ Xlin ^ndocrinol `etab 2007;
92; 1773…1777.
72. Xolo|bo X, Por•io V, ]iv ` et al. Se~en |vtations in tue uv|an insvlin gene
lin‚ed to per|anent neonatalinfancy-onset diabetes |ellitvs. ‰ Xlin In~est 2008; 118;
2148…2156.
73. Pola‚ `, Decuav|e A, Xa~e U et al. Uetero•ygovs |issense |vtations in tue
insvlin gene are lin‚ed to per|anent diabetes appearing in tue neonatal period or in
early infancy; a report fro| tue Zrencu ND FNeonatal DiabetesG Stvdy [rovp. Diabetes
2008; 57; 1115…1119.
74. ^i•iri‚ D], Xardo•o A\, Xnop `. Yue role for endoplas|ic reticvlv| stress in
diabetes |ellitvs. ^ndocr ˆe~ 2008; 29; 42…61.
75. Bonfanti ˆ, Xolo|bo X, Nocerino j et al. Insvlin gene |vtations as cavse of
diabetes in cuildren negati~e for ”
~e type 1 diabetes avtoantibodies. Diabetes Xare 2009;
32; 123…125.
76. `ol~en A, ˆingdal `, Nordbo A` et al. `vtations in tue insvlin gene can
cavse `VDh and avtoantibody-negati~e type 1 diabetes. Diabetes 2008; 57; 1131…1135.
77. Delépine `, Nicolino `, Barrett Y, [ola|avlly `, ]aturop [`, ‰vlier X.
^IZ2A\3, encoding translation initiation factor 2-alpua ‚inase 3, is |vtated in patients
witu xolcott-ˆallison syndro|e. Nat [enet 2000; 25; 406…409.
78. Senée j, jatte| \`, Delépine ` et al. xolcott- ˆallison syndro|e; clinical,
genetic, and fvnctional stvdy of ^IZ2A\3 |vtations and svggestion of genetic uetero-
geneity. Diabetes 2004; 53; 1876…1883.
79. Uabeb A`, Zlanagan S^, Deeb A et al. Per|anent neonatal diabetes; diŠ
erent
aetiology in Arabs co|pared to ^vropeans. Arcu Dis Xuild 2012; 97; 721…723.
142 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
80. ˆvbio-Xabe•as V, Patcu A`, `inton ‰A et al. xolcott-ˆallison syndro|e is
tue |ost co||on genetic cavse of per|anent neonatal diabetes in consangvineovs
fa|ilies. ‰ Xlin ^ndocrinol `etab 2009; 94; 4162…4170.
81. `atscuins‚y Z`. [lvco‚inase, glvcose uo|eostasis, and diabetes|ellitvs.
XvrrDiabˆep 2005; 5; 171…176.
82. N–olstad Pˆ, Sagen ‰j, B–or‚uavg ] et al. Per|anent neonatal diabetes cavsed
by glvco‚inase de”
ciency; inborn error of tue glvcose-insvlin signalingpatuway.
Diabetes 2003; 52; 2854…2860.
83. N–ølstad Pˆ, Sø~i‚ V, Xvesta-`vño• A et al. Neonatal diabetes |ellitvs dve to
co|plete glvco‚inase de”
ciency. N ^ngl ‰ `ed 2001; 344; 1588…1592.
84. Bennett X], Xuristie ‰, ˆa|sdell Z et al. Yue i||vne dysregvlation, polyendo-
crinopatuy, enteropatuy, _-lin‚ed syndro|e FIP^_G is cavsed by |vtations of ZV_P3.
Nat [enet 2001; 27; 20…21.
85. jerbs‚y ‰x, Xuatila YA. I||vne dysregvlation, polyendocrinopatuy, enteropa-
tuy, _-lin‚ed FIP^_G and IP^_-related disorders; an e~ol~ing web of ueritable avtoi|-
|vne diseases. Xvrr Vpin Pediatr 2013; 25; 708…714.
86. Bindl ], Yorgerson Y, Perroni ] et al. Svccessfvl vse of tue new i||vne-svp-
pressor siroli|vs in IP^_ Fi||vne dysregvlation, polyendocrinopatuy, enteropatuy,
_-lin‚ed syndro|eG. ‰ Pediatr 2005; 147; 256…259.
87. hong P], ˆvsso P, Svlli~an \^. }se of siroli|vs in IP^_ and IP^_-li‚e cuil-
dren. ‰ Xlin I||vnol 2008; 28; 581…587.
88. ˆao A, \a|ani N, Zilipo~icu A et al. Svccessfvl bone |arrow transplanta-
tion for IP^_ syndro|e after redvced-intensity conditioning. Blood 2007; 109;
89. xeedon `N, Xebola I, Patcu A` et al. ˆecessi~e |vtations in a distal PYZ1A
enuancer cavse isolated pancreatic agenesis. Nat [enet 2014; 46; 61…64.
90. ]ango Allen U, Zlanagan S^, Suaw-S|itu X et al. [AYA6 uaploinsvž
ciency
cavses pancreatic agenesis in uv|ans. Nat [enet 2012; 44; 20…22.
91. Suields B`, Uic‚s S, Suepuerd `U, Xolclovgu \, Uattersley AY, ^llard S.
`atvrity-onset diabetes of tue yovng F`VDhG; uow |any cases are we |issing—
Diabetologia 2010; 53; 2504…2508.
92. Stani‚ ‰, Dvsat‚o~a P, Xine‚ V et al. De no~o |vtations of [X\, UNZ1A and
UNZ4A |ay be |ore frevent in `VDh tuan pre~iovsly assv|ed. Diabetologia 2014;
57; 480…484.
93. ˆaeder U, ‰ouansson S, Uol| PI et al. `vtations in tue X^] jNYˆ cavse a
syndro|e of diabetes and pancreatic eocrine dysfvnction. Nat [enet 2006; 38; 54…62.
94. ]orini ˆ, Alibrandi A, jitali ] et al. ˆis‚ of type 1 diabetes de~elop|ent in
cuildren witu incidental uyperglyce|ia; a |vlticenter Italian stvdy. Diabetes Xare 2001;
24; 1210…1216.
95. Zeigerlo~a ^, Prvuo~a S, Ditterto~a ] et al.Aetiological ueterogeneity of asy|p-
to|atic uyperglycae|ia in cuildren and adolescents. ^vr ‰ Pediatr 2006; 165; 446…452.
96. ]orini ˆ, \lersy X, dAnnvn•io [ et al. `atvrityonset diabetes of tue yovng
in cuildren witu incidental uyperglyce|ia; a |vlticenter Italian stvdy of 172 fa|ilies.
Diabetes Xare 2009; 32; 1864…1866.
  \b\t\b
143
97. Prisco Z, Iafvsco D, Zran•ese A, Svlli N, Barbetti Z. `VDh 2 presenting as
neonatal uyperglycae|ia; a need to resuape tue de”
nition of   neonatal diabetes—
Diabetologia 2000; 43; 1331…1332.
98. Steele A`, xensley \‰, ^llard S et al. }se of UbA1c in tue identi”
cation of
patients witu uyperglycae|ia cavsed by a glvco‚inase |vtation; obser~ational case
control stvdies. P]oS Vne 2013; 8; e65326.
99. Stride A, jaillaire `, Yvo|i Y et al. Yue genetic abnor|ality in tue beta cell
deter|ines tue response to an oral glvcose load. Diabetologia 2002; 45; 427…435.
100. Steele A`, Suields B`, xensley \‰, Xolclovgu \, ^llard S, Uattersley AY.
Pre~alence of ~ascvlar co|plications a|ong patients witu glvco‚inase |vtations and
prolonged, |ild uyperglyce|ia. ‰A`A 2014; 311; 279…286.
101. jeluo [, Blancué U, jaillaire ` et al. Identi” cation of 14 new glvco‚inase
|vtations and description of tue clinical pro”
le of 42 `VDh-2 fa|ilies. Diabetologia
1997; 40; 217…224.
102. Stride A, Suields B, [ill-Xarey V et al. Xrosssectional and longitvdinal stvdies
svggest puar|acological treat|ent vsed in patients witu glvco‚inase |vtations does not
alter glycae|ia. Diabetologia 2014; 57; 54…56.
103. Zendler x, `alacuows‚a B, Baranows‚a-‰a•wiec‚a A et al. Popvlation-based
esti|ates for dovble diabetes a|ongst people witu glvco‚inase |onogenic diabetes,
[X\-`VDh. Diabet `ed 2014; 31; 881…883.
104. Pearson ^ˆ, Prvuo~a S, Yac‚ X‰ et al. `olecvlar genetics and puenotypic
cuaracteristics of `VDh cavsed by uepatocyte nvclear factor 4alpua |vtations in a
large ^vropean collection. Diabetologia 2005; 48; 878…885.
105. Vstoft SU, Bagger ‰I, Uansen Y et al. Incretin eŠ ect and glvcagon responses to
oral and intra~enovs glvcose in patients witu |atvrity onset diabetes of tue yovng - type
2 and type 3. Diabetes 2014; `ar 27. m^pvb auead of printq.
106. Iso|aa B, Uenricsson `, ]euto ` et al. Xuronic diabetic co|plications in
patients witu `VDh3 diabetes. Diabetologia 1998; 41; 467…473.
107. Steele A`, Suields B`, Suepuerd `, ^llard S, Uattersley AY, Pearson ^ˆ.
Increased all-cavse and cardio~ascvlar |ortality in |onogenic diabetes as a resvlt of
|vtations in tue UNZ1A gene. Diabet `ed 2010; 27; 157…161.
108. Bellanne-Xuantelot X, Xarette X, ˆi~eline ‰P et al. Yue type and tue position
of UNZ1A |vtation |odvlate age at diagnosis of diabetes in patients witu |atvrity-
onset diabetes of tue yovng F`VDhG-3. Diabetes 2008; 57; 503…508.
109. Uarries ]x, ^llard S, Stride A, `organ N[, Uattersley AY. Iso|ers of tue
YXZ1 gene encoding uepatocyte nvclear factor-1 alpua suow diŠ erential epression in
tue pancreas and de”
ne tue relationsuip between |vtation position and clinical pueno-
type in |onogenic diabetes. Uv| `ol [enet 2006; 15; 2216…2224.
110. Stride A, ^llard S, Xlar‚ P et al. Beta-cell dysfvnction, insvlin sensiti~ity, and
glycosvria precede diabetes in uepatocyte nvclear factor-1alpua |vtation carriers.
Diabetes Xare 2005; 28; 1751…1756.
111. Ua|ilton A‰, Bingua| X, `cDonald Y‰ et al. Yue UNZ4A ˆ76x |vtation
cavses atypical do|inant Zanconi syndro|e in addition to a beta cell puenotype. ‰ `ed
[enet 2014; 51; 165…169.
144 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
112. Pearson ^ˆ, Bo– SZ, Steele A` et al. `acroso|ia and uyperinsvlinae|ic
uypoglycae|ia in patients witu uetero•ygovs |vtations in tue UNZ4A gene. P]oS
`ed 2007; 4; e118.
113. Zlanagan S^, \apoor ˆˆ, `ali [ et al. Dia•oideresponsi~e uyperinsvlin-
e|ic uypoglyce|ia cavsed by UNZ4A gene |vtations. ^vr ‰ ^ndocrinol 2010; 162;
114. \apoor ˆˆ, ]oc‚e ‰, Xolclovgu \ et al. Persistent uyperinsvline|ic uypogly-
ce|ia and |atvrity-onset diabetes of tue yovng dve to uetero•ygovs UNZ4A |vta-
tions. Diabetes 2008; 57; 1659…1663.
115. Stanescv D^, Uvgues N, \aplan B, Stanley XA, De ]eon DD. No~el presen-
tations of congenital uyperinsvlinis| dve to |vtations in tue`VDh genes; UNZ1A
and UNZ4A. ‰ Xlin ^ndocrinol `etab 2012; 97; ^2026…^2030.
116. Pearson ^ˆ, Star‚ey B‰, Powell ˆ‰, [ribble Z`, Xlar‚ P`, Uattersley AY.
[enetic cavse of uyperglycae|ia and response to treat|ent in diabetes. ]ancet 2003;
362; 1275…1281.
117. Byrne ``, Stvris ‰, `en•el S et al. Altered insvlin secretory responses to glv-
cose in diabetic and nondiabetic svb–ects witu |vtations in tue diabetes svsceptibility
gene `VDh3 on curo|oso|e 12. Diabetes 1996; 45; 1503…1510.
118. Za–ans SS, Brown `B. Ad|inistration of svlfonylvreas can increase glvcose-
indvced insvlin secretion for decades in patients witu |atvrity-onset diabetes of tue
yovng. Diabetes Xare 1993; 16; 1254…1261.
119. Suepuerd `, Suields B, ^llard S, ˆvbio-Xabe•as V, Uattersley AY. A genetic
diagnosis of UNZ1A diabetes alters treat|ent and i|pro~es glycae|ic control in tue
|a–ority of insvlin-treated patients. Diabet `ed 2009; 26; 437…441.
120. Be
c‚er `,
[aller A, ˆaile \. `eglitinide analogves in adolescent patients witu
UNZ1A-`VDh F`VDh 3G. Pediatrics 2014; 133; e775…e779.
121. Yvo|i Y, Uon‚anen ^U, Iso|aa B, Sarelin ], [roop ]X. I|pro~ed prandial
glvcose control witu lower ris‚ of uypoglyce|ia witu nateglinide tuan witu gliben-
cla|ide in patients witu |atvrity-onset diabetes of tue yovng type 3. Diabetes Xare
2006; 29; 189…194.
122. Vstoft SU, Bagger ‰I, Uansen Y et al. [lvcoselowering eŠ ects and low ris‚ of
uypoglyce|ia in patients witu |atvrity-onset diabetes of tue yovng wuen treated witu a
[]P-1 receptor agonis
ndo|i•ed, crosso~er
trial.DiabetesXare 2014;
37; 1797…1805.
123. Scu|idt Z, \apellen Y`, xiegand S et al. Diabetes |ellitvs in cuildren and
adolescents witu genetic syndro|es. ^p Xlin ^ndocrinol Diabetes 2012; 120; 579…585.
124. Zar|er A, Ay|e S, de Ueredia `] et al. ^}ˆVxABB; an ^} rare diseases
registry for xolfra| syndro|e, Alstro|
syndro|e and Bardet-Biedl syndro|e. B`X
Pediatr 2013; 13; 130.
125. Do|enecu ^, [o|e•-‡aera `, Nvnes j. xolfra|DID`VAD syndro|e,
a ueterogenic and |olecvlarly co|ple nevrodegenerati~e disease. Pediatr ^ndocrinol
ˆe~ 2006; 3; 249…257.
126. Barrett Y[, Bvndey S^, `acleod AZ. Nevrodegeneration and diabetes; }\
nationwide stvdy of xolfra| FDID`VADG syndro|e. ]ancet 1995; 346; 1458…1463.
  \b\t\b
145
127. `arsuall S], ^didin D, Suar|a j, Vgle [, Arena jX, Vrcuard Y. Xvrrent
clinical statvs, glvcose control, and co|plication rates of cuildren and yovtu witu type
1 diabetes inˆwanda. PediatrDiabetes 2013; 14; 217…226.
128. de Ueredia `], Xleries ˆ, Nvnes j. [enotypic classi”
cation of patients witu
xolfra| syndro|e; insiguts into tue natvral uistory of tue disease and correlation witu
puenotype. [enet `ed 2013; 15; 497…506.
129. ‡|yslows‚a A, Borowiec `, Zicuna P et al. Delayed recognition of xolfra|
syndro|e frevently |isdiagnosed as type 1 diabetes witu early curonic co|plications.
^p Xlin ^ndocrinol Diabetes 2014; 122; 35…38.
130. I
U, Yani•awa h, xasson ‰ et
al. A gene encoding a trans|e|brane
protein is |vtated in patients witu diabetes |ellitvs and optic atropuy Fxolfra| syn-
dro|eG. Nat [enet 1998; 20; 143…148.
131. \uani| Z, \ir‚ ‰, ]atif Z, Barrett Y[. xZS1wolfra|in |vtations, xolfra|
syndro|e, and associated diseases. Uv| `vtat 2001; 17; 357…367.
132. A|r S, Ueisey X, ‡uang ` et al. A uo|o•ygovs |vtation in a no~el •inc-
nger protein, ^ˆIS, is responsible forxolfra| syndro|e 2.A|‰Uv|[enet 2007; 81;
673…683.
133. Bingua| X, Uattersley AY. ˆenal cysts and diabetes syndro|e resvlting fro|
|vtations in uepatocyte nvclear factor-1beta. Nepurol Dial Yransplant 2004; 19;
2703…2708.
134. }lins‚i Y, ]escvre S, Beav”
ls S et al. ˆenal puenotypes related to uepatocyte
nvclear factor-1beta FYXZ2G |vtations in a pediatric couort. ‰ A| Soc Nepurol 2006;
17; 497…503.
135. ^dguill ^], Bingua| X, ^llard S, Uattersley AY. `vtations in uepatocyte
nvclear factor-1beta and tueir related puenotypes. ‰ `ed [enet 2006; 43; 84…90.
136. ˆaile \, \lopoc‚i ^, Uolder ` et al. ^panded clinical spectrv| in uepato-
cyte nvclear factor 1b|atvrity-onset diabetes of tue yovng. ‰ Xlin ^ndocrinol `etab
2009; 94; 2658…2664.
137. ^dguill ^], Bingua| X, Slingerland AS et al. Uepatocyte nvclear factor-1 beta
|vtations cavse neonatal diabetes and intravterine growtu retardation; svpport for a
critical role of UNZ-1beta in uv|an pancreatic de~elop|ent. Diabet `ed 2006; 23;
1301…1306.
138. Bellanné-Xuantelot X, Xuav~eav D, [avtier ‰Z et al. Xlinical spectrv|
associated witu uepatocyte nvclear factor-1beta |vtations. Ann Intern `ed 2004; 140;
510…517.
139. Pearson ^ˆ, Bad|an `\, ]oc‚wood Xˆ et al. Xontrasting diabetes pueno-
types associated witu uepatocyte nvclear factor-1alpua and -1beta |vtations. Diabetes
Xare 2004; 27; 1102…1107.
140. Y–ora ^, xatule [, ^rcuinger Z et al. ^ocrine pancreatic fvnction in uepato-
cyte nvclear factor 1beta-|atvrity-onset diabetes of tue yovng FUNZ1B`VDhG is only
|oderately redvced; co|pensatory uypersecretion fro| a uypoplastic pancreas. Diabet
`ed 2013; 30; 946…955.
141. Ualdorsen IS, jesteruvs `, ˆaederUet al.]ac‚ of pancreatic body and tail in
UNZ1B |vtation carriers. Diabet `ed 2008; 25; 782…787.
146 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
142. `aassen ‰A, Y Uart ]`, jan ^ssen ^ et al. `itocuondrial diabetes; |olecvlar
|ecuanis|s and clinical presentation. Diabetes 2004; 53 FSvppl. 1G; S103…S109.
143. [villavsseav P‰, Dvbois-]aforgve D, `assin P et al. Ueterogeneity of diabetes
puenotype in patients witu 3243 bp |vtation of |itocuondrial DNA F|aternally inuer-
ited diabetes and deafness or `IDDG. Diabetes `etab 2004; 30; 181…186.
144. ]aloi-`icuelin `, `eas Y, A|bon~ille X et al. Yue clinical ~ariability of
|aternally inuerited diabetes and deafness is associated witu tue degree of ueteroplas|y
in blood lev‚ocytes. ‰ Xlin ^ndocrinol `etab 2009; 94; 3025…3030.
145. [oto h, Nona‚a I, Uorai S. A |vtation in tue tˆNAF]evGF}}ˆG gene associ-
ated witu tue `^]AS svbgrovp of |itocuondrial encepualo|yopatuies. Natvre 1990;
348; 651…653.
146. ]alav ‰D. ]actic acidosis indvced by |etfor|in; incidence, |anage|ent and
pre~ention. Drvg Saf 2010; 33; 727…740.
147. ]aloi-`icuelin `, jirally `, ‰ardel X et al. \earns Sayre syndro|e; an
vnvsval for| of |itocuondrial diabetes. Diabetes `etab 2006; 32; 182…186.
148. Svperti-Zvrga A, Scuoenle ^, Yvcuscu|id P et al. Pearson bone|arrow-
pancreas syndro|e witu insvlindependent diabetes, progressi~e renal tvbvlopatuy,
organic acidvria and ele~ated fetal uae|oglobin cavsed by deletion and dvplication of
|itocuondrial DNA. ^vr ‰ Pediatr 1993; 152; 44…50.
149. ˆaeder U, Ualdorsen IS, ^rsland ] et al. Pancreatic lipo|atosis is a strvctvral
|ar‚er in nondiabetic cuildren witu |vtations in carboyl-ester lipase. Diabetes 2007;
56; 444…449.
150. ˆaeder U, `cAllister Z^, Y–ora ^ et al. Xarboylester lipase |atvrity-onset
diabetes of tue yovng is associated witu de~elop|ent of pancreatic cysts and vpregvlat-
ed `AP\ signaling in secretin-sti|vlated dvodenal ›
vid. Diabetes 2014; 63; 259…269.
151. `o
ran A, Pillay \, Be
c‚er D, Acer
ini X]. `anage|ent of cystic ”
brosis
related diabetes in cuildren and adolescents. Pediatr Diabetes 2014; 15; 65…76.
152. ˆebovrs j, Bovtron-ˆvavlt `X, Scunee ` et al. Yue natvral uistory of
uereditary pancreatitis; a national series. [vt 2009; 58; 97…103.
153. Se|ple ˆ\, Sa~age DB, Xocuran ^\, [orden P, Vˆauilly S. [enetic syn-
dro|es of se~ere insvlin resistance. ^ndocr ˆe~ 2011; 32; 498…514.
154. Par‚er j^, Se|ple ˆ\. [enetics in endocrinology; genetic for|s of se~ere
insvlin resistance; wuat endocrinologists suovld ‚now. ^vr ‰ ^ndocrinol 2013; 169;
ˆ71…ˆ80.
155. `vsso X, Xocuran ^, `oran SA et al. Xlinical covrse of genetic diseases of tue
insvlin receptor Ftype A and ˆabson-`endenuall syndro|esG; a 30-year prospecti~e.
`edicine FBalti|oreG 2004; 83; 209…222.
156. ˆegan Z`, xillia|s ˆ`, `cDonald A et al. Yreat|ent witu reco|bi-
nant uv|an insvlin-li‚e growtu factor FruI[ZG-IruI[Z binding protein-3 co|ple
i|pro~es |etabolic control in svb–ects witu se~ere insvlin resistance. ‰ Xlin ^ndocrinol
`etab 2010; 95; 2113…2122.
157. [arg A. Acvired and inuerited lipodystropuies. N ^ngl ‰ `ed 2004; 350;
1220…1234. 158. Agarwal A\, Si|ua j, Vral ^A et al. Puenotypic and genetic uet-
erogeneity in congenital generali•ed lipodystropuy. ‰ Xlin ^ndocrinol `etab 2003; 88;
4840…4847.
  \b\t\b
147
159. xeedon `N, ^llard S, Prindle `‰ et al. An infra|e deletion at tue poly|erase
acti~e site of PV]D1 cavses a |vltisyste| disorder witu lipodystropuy. Nat [enet 2013;
45; 947…950.
160. Xuvdasa|a \\, xinnay ‰, ‰ouansson S et al. SUVˆY syndro|e witu partial
lipodystropuy dve to i|paired puospuatidylinositol 3 ‚inase signaling. A| ‰ Uv|
[enet 2013; 93; 150…157.
161. Vwen \ˆ, Donouoe `, ^llard S, Uattersley AY. ˆesponse to treat|ent witu
rosiglita•one in fa|ilial partial lipodystropuy dve to a |vtation in tue ]`NA gene.
Diabet `ed 2003; 20; 823…827.
162. Beltrand ‰, Beregs•as•i `, Xue~enne D et al. `etabolic correction indvced
by leptin replace|ent treat|ent in yovng cuildren witu Berardinelli-Seip congenital
lipoatropuy. Pediatrics 2007; 120; e291…e296.
163. Si|ua j, Svbra|anya| ], S•c•epania‚]et al. Xo|parison of ež
cacy and
safety of leptin replace|ent tuerapy in |oderately and se~erely uypoleptine|ic patients
witu fa|ilial partial lipodystropuy of tue Dvnnigan ~ariety. ‰ Xlin ^ndocrinol `etab
2012; 97; 785…792.
164. Alstro| XU, Uallgren B, Nilsson ]B, Asander U. ˆetinal degeneration co|-
bined witu obesity, diabetes |ellitvs and nevrogenovs deafness; a speci”
c syndro|e
Fnot uituerto describedG distinct fro| tue ]avrence-`oon-Bardet-Biedl syndro|e;
a clinical, endocrinological and genetic ea|ination based ona large pedigree. Acta
Psycuiatr Nevrol Scand Svppl 1959; 129; 1…35.
165. Uearn Y, ˆenfortu [], Spallvto X et al. `vtation of A]`S1, a large gene
witu a tande| repeat encoding 47 a|ino acids, cavses Alstro| syndro|e. Nat [enet
2002; 31; 79…83.
166. `o‚asui A, Xv||ings ^A. Presentation and covrse of diabetes in cuildren
and adolescents witu Alstro| syndro|e. Pediatr Diabetes 2011; 12 F3 Pt 2G; 270…275.
167. Paisey ˆB, [eberuiwot Y, xaterson ` et al. `odi” cation of se~ere insvlin
resistant diabetes in response to lifestyle cuanges in Alstro| syndro|e. ^vr ‰ `ed
[enet 2014; 57; 71…75.
168. Yobin ‰], Beales P]. Bardet-Biedl syndro|e; beyond tue ciliv|. Pediatr
Nepurol 2007; 22; 926…936.
169. Scueide
c‚er S, ^t
ard X, Pierce Nx et al. ^o|e sevencing of Bardet-Biedl
syndro|e patient identi”
es a nvll |vtation in tue BBSo|e svbvnit BBIP1 FBBS18G.
‰ `ed [enet 2014; 51; 132…136.
170. [vo DZ, ˆau|ovni \. `olecvlar basis of tue obesity associated witu Bardet-
Biedl syndro|e. Yrends ^ndocrinol `etab 2011; 22; 286…293.
171. Abv-Sa” eu ], Al-Ana•i S, Al-Abdi ] et al. In searcu of triallelis| in Bardet-
Biedl syndro|e. ^vr ‰ Uv| [enet 2012; 20; 420…427.
172. \atsanis N, Ansley S‰, Badano ‰] et al. Yriallelic inueritance in Bardet-Biedl
syndro|e, a `endelian recessi~e disorder. Science 2001; 293; 2256…2259.
173. StoŠ
ers DA, ‡in‚in NY, Stano–e~ic j, Xlar‚e x], Uabener ‰Z. Pancreatic
agenesis attribvtable to a single nvcleotide deletion in tue uv|an IPZ1 gene coding
sevence. Nat [enet 1997; 15; 106…110.
174. Sellic‚ [S, Bar‚er \Y, Stolte-D˜ ‚stra I et al. `vtations in PYZ1A cavse pan-
creatic and cerebellar agenesis. Nat [enet 2004; 36; 1301…1305.
148 !\t\t 4. $\t\f\t    \f \f \f\f \t\t\b\f \t \t    \r  \b
175. S|itu SB, Žv UŽ, Yaleb N et al. ˆf6 directs islet for|ation and insvlin pro-
dvction in |ice and uv|ans. Natvre 2010; 463; 775…780.
176. DA|ato ^, [iacopelli Z, [iannattasio A et al. [enetic in~estigation in an
Italian cuild witu an vnvsval association of atrial septal defect, attribvtable to a new
fa|ilial [AYA4 gene |vtation, and neonatal diabetes dve to pancreatic agenesis.
Diabet `ed 2010; 27; 1195…1200.
177. Senee j, Xuelala X, Dvcuatelet S et al. `vtations in []IS3 are responsible for
a rare syndro|e witu neonatal diabetes |ellitvs and congenital uypotuyroidis|. Nat
[enet 2006; 38; 682…687.
178. ˆvbio-Xabe•as V, ‰ensen ‰N, Uodgson `I et al. Per|anent neonatal diabetes
and enteric anendo crinosis associated witu biallelic |vtations in N^}ˆV[3. Diabetes
2011; 60; 1349…1353.
179. ˆvbio-Xabe•as V, `inton ‰A, \antor I, xillia|s D, ^llard S, Uattersley AY.
Uo|o•ygovs |vtations in N^}ˆVD1 are responsible for a no~el syndro|e of per|a-
nent neonatal diabetes and nevrological abnor|alities. Diabetes 2010; 59; 2326…2331.
180. Solo|on BD, Pineda-Al~are• D^, Balog ‰‡ et al. Xo|povnd uetero•ygosity
for |vtations in PA_6 in a patient witu co|ple brain ano|aly, neonatal diabetes |el-
litvs, and |icrooputual|ia. A| ‰ `ed [enet A 2009; 149A; 2543…2546.
181.
Bonnefond A, jaillant ^, Puilippe ‰ et al. Yranscription factor gene `N_1
is a no~el cavse of per|anent neonatal diabetes in a consangvineovs fa|ily. Diabetes
`etab 2013; 39; 276…280.
182. Zlanagan S^, De Zranco ^, ]ango Allen U et al. Analysis of transcription fac-
tors ‚ey for |ovse pancreatic de~elop|ent establisues N\_2-2 and `N_1 |vtations
as cavses of neonatal diabetes in |an. Xell `etab 2014; 19; 146…154.
183. hoo Ux, Suin h], Seo ^‰, \i| [U. Identi”
cation of a no~el |vtation in
tue []}Y2 gene in a patient witu Zanconi-Bi
c‚el syndro|e
presenting witu neonatal
diabetes |ellitvs and galactosae|ia. ^vr ‰ Pediatr 2002; 161; 351…353.
184. `andel U, Berant `, Ua•ani A, Na~eu h. Yuia|ine-dependent beriberi in tue
  tuia|ineresponsi~e ane|ia syndro|e. N ^ngl ‰ `ed 1984; 311; 836…838.
185. Abdel-Sala| [`, ScuaŠ
er A^, ‡a‚i `S et al. A uo|o•ygovs I^ˆ3IP1 |vta-
tion cavses |icrocepualy witu si|pli”
ed gyral pattern, epilepsy, and per|anent neona-
tal diabetes syndro|e F`^DSG. A| ‰ `ed [enet A 2012; 158A; 2788…2796.
186. xildin ˆS, ˆa|sdell Z, Pea‚e ‰ et al. _-lin‚ed neonatal diabetes |ellitvs,
enteropatuy and endocrinopatuy syndro|e is tue uv|an evi~alent of |ovse scvrfy.
Nat [enet 2001; 27; 18…20.
187. ha|agata \, Zvrvta U, Vda N et al. `vtations in tue uepatocyte nvclear
factor-4alpua gene in |atvrityonset diabetes of tue yovng F`VDh1G. Natvre 1996;
384; 458…460.
188. jionnet N, StoŠ
el `, Ya‚eda ‰ et al. Nonsense |vtation in tue glvco‚inase gene
cavses early-onset non-insvlin-dependent diabetes |ellitvs. Natvre 1992; 356; 721…722.
189. ha|agata \, Vda N, \aisa‚i P‰ et al. `vtations in tue uepatocyte nvclear
factor-1alpua gene in |atvrityonset diabetes of tue yovng F`VDh3G. Natvre 1996;
384; 455…458.
190. Uori‚awa h, Iwasa‚i N, Uara ` et al. `vtation in uepatocyte nvclear factor-1
beta gene FYXZ2G associated witu `VDh.Nat [enet 1997; 17; 384…385.
1 \t�\t
\b\t \n\r\b 5\t, \n\b\b
7\f\t\n:\t57 O\f\t\n\b7 9\t\r7Q,
 5 \t 5\r\n\f
150
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
\b\b:\t8 \t \r\f7\b5:\t\t











#' &M\n C" :"@ " $#"  &= 
\f\f\t  \b  \f\t
151











$#"  &M\n \fC "\r#"@\t  \f"#C#J $ \r\t
J'  ', """JE#/ \r\f$#\t ADA \f\t /
" " :"@ " : # ## : #'# $# #



152
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...



 2500 C#\rC\f/ \f"  #\r \r#/\f#"\t 1  &=.
 5.1
\n%!()%@ ;!"!! '%@;� # !-
S\t\r\r\t\r\f6,[email protected]
# \r[\r\r[\r\r
% \n\t\r \b\t3,  \b&\fT\n\r 2…5J \b\t
# \t\rC\t \f#&# \t \f \t\r\r
\t  3\t
C
C
3$ \r \t%  \t\r,
$\t\f  \b \b \t \t\t\b\f \t \t...
153
'\t\b\t Q\r 3\t, \t \f-
%\t \r'\b-
5\t\b\n\t\n\f\t \f\r\t\r\t\t 7\f\t\n:\t5\t\n\t7
\n\r\b 5\t \t \b7L\b \r\b\b\n\t
\f =\f
 \r\r '\t##, \f " ADA # )\f
154
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
\f!+%) (_'@
C\t \f\t\8,6\8,T\r   \n \22,2
\8,%& -
C\t+\t (C=1)\8,6
(\t# \t \t\t\b\f \t \t
155
7\nL \t \r\n \r\n\r\b\b\b\nL
&M\n C" "@\t  J: '\r", J\t \f#.
�\f  \r\r"\r"@ ##"\t  '\r" $#".
"" m10q. = /\f \r"# #\f#\t, \r\f
 (\r\f##,  # '"# \r\r"\r"#;
\r@\t "\r""@  J' „ 69k, \r!\t "\r""@
 J' „ 14k # &M\n „ 17k  '\r" \r 10…19 " m11q.
= ## &M\n \r'#\t  50k $#"  '\r" 30 " m12q. = \f
#' \f#$##/ $"\r  \n \n : :\rC   5k \f" 
9\t\t\t8 7\f\t\n:\t5\t\n\t7 \n\r\b
5\t
156
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
F10 10…1G 20…2G
30…3GN40
\r!". ^.1.
S\t\r\r\t\r\f \r\b\n\n\t\r \r\t\t \b\t\t  \t\n
\n\t\r \t     � 66 \t  \b\t 7\r\t +\t\t
D\r\t ^K_
\t8 5M5\b M
 \rC\f# %'\r# "\tJE \fC\f C' 
\r\r#\rJE# #:\r' # C#\r ##@"\r$#. +" \r#\f#"
\r#/ W-, ’- # #"#\f/ " \fC\f C' m13…15q.
 :@!#" $#"  &=, '## " ##\t ## """#\t
\n, "\r : # "\r . '\r!# W-"
"\r"@  #/ \f#:"##/ ""#" # "# 
$#"\r "# FU]AG, \t'/  \n1, /\f  " 
\rL \t\b\n\t\b \b5\n\b\n\t
(\t# \t \t\t\b\f \t \t
157
\rL \t\b\n\t\b\r\t\n\b\b\n\t
 ':#J ":#@, \f ##\r'#"""@
\b\t\f 7\f\t\n:\t5\t\n\t7 \n\r\b 5\t
158
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
\f\t\b\t\n\f8 \r\f\r\t\n\t\f 7\f\t\n:\t5\t\n\t7
\n\r\b 5\t
&M\n \r'#"\t :#". \n#" &M\n \r#\f 
":. 5.3. =C ""#"@, " #\f/ #"  :@!#"
$#" ".  "\r"\t \r\f, \r#E" \f"#
/\r %\f \r$## ## ## \f"# ", "
$#\t/ !#\t ##\r'#"""#, "#/  "\r 
 #"##   \r\tG. \n " "\r"\t \r# "\r"$##
#/, \f \r\f "\r"$# $#" /\f#"\t  \r#"#
", \r#\r, "\r#\f ## ##:#"\r @$#\r# m39, 42q.
 5.3
\n!#*#@ #$!"3!''!"!# ";% !-
#\r\r \t   \n&\r\f \b\b&\t \t\r\r  \t, \r \t \r-
=\t *  \b\f
159
M\t7\nL \t \r\b
\t\b\t \n7\r\b\n\t \r\t 7\f\t\n:\t5\t\n\t77
\n\r\b7 5\t
7\t\f\rB \t 7\f\r\b\t \t\n\f\t \nM\b\b\t8
160
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
/  \r""# " \r#"##/ C# \r# &=
". +" C, @ \r# \r#"##/ ':#
\t\t"\t \r\f\tJE# \r# "## \r\f$#  #J #
\t"\t  &= # \fC " '"@\t \r\f#. \r@ /"\r# \r#
&= : #'#,  \r\f "\r"\t #'#\r !#
\r\t "\r##$\r#\f m59…63q. ! \r@ ##\f C"
E "\r"@\t  "\r"$## #/ #  $#" "\r!
\t \t\f7\t8
\r\f# :@/ &= '## " ##\t ## """#\t  #/ \n.
*###\t "E : :\rC  14k #' 129 \f" # '\r/ 
 $##, : "# #"#'$#\t#G m28q. = " C \r"
$#" \r"#\t ###\t : \t  15k  
"#\t ###\t  *?? : "  6,3k $#" m64q.
#. "\r\t  " "  :@/ &= #C \r$#\t J,
 #/ ""\t \r@ "# " ' ##
####, ", \r\t", \t'  /\r"@J "/#
\r$## m23q. ? C  # \f\t / $#"  ##"\r##,
###\t \r\f"\t" : \r#, "\r $#" # #/ :#'#
\t\b\t 7\n\t  \r55\t\t\n\f7 \n\n8\b\t\t
\b\f\f \f\t \t\r \t\t\b\f\r \t 
161
\n\f\r\t\b\t\b \b 7\f\t\n:\t5\t\n\t7 \n\r\b 5\t
\r\rL\b =\f\r\b\b \n
162
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
7\t\b A1c \f\f 5\t\b\n\t\n\f\t \t\b\n\r7\b
\r\bL =\f \b\f \r\t \n\b7  \r5\b\t\t
\t \r\t \n7\n8L\b7 7\b\t\r\t\b =\f  \f\r\t
 5\t\b\n\t\f 7\f\t\n:\t5\t\n\t7 \n\r\b 5\t
 \f \t \t\t\b\f \t \t
163
\n8\b\b 7\b\t\r\t\b =\f
\b\t 7\f\t\n:\t5\t\n\t7 \n\r\b 5\t
75\t:\t\b\n\f8 5\t\r \t8
\f$##  #"#J \f\t :@/ &M\n "#J"\t "
\t\b\n\t\b\r \t8
164
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
 5.4
5!!/"! #%3!! *! #$!"3!''!"!## ";%# !-
G,G   \t \t \t\b& \f% \n\t \t\t,  \t
[ �2…[email protected]   \r\t
�# 2666 \b 266 4\r%+\t \r\f, \t-
 \f \t \t\t\b\f \t \t
165
 5.5
!%3!*@ !%"$(!%*!! *! #$!"3!''!"!## ";%# !-
# �%\t\t \r D`'3  \r 6,…6, /3 \r \t \t
166
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
\r\rL\b \n\r\n\b\tM=\t \r \r
\r\r@ /\r#CJE# \r\r"  "\tE \r\t 
\r\f \r# &M\n. = \f /\r :'\r :
G m84q,
 "\r/ "#\t"\r \r$## \r##\f  ' ":#@
##\t  "  :@/  &M\n :' #\r### "E
m72q. &\r\t", " \r\f", #CJE# ##\r'#"""@,
"@  \t\t"\t E" %"### "\r. \b ",
"@ \r: #  \f"#  \f\t!# \f@ #:##'"\r#
\t$## &=, "  " '"@ \r\f# \r : \f"# 
'#\f#\f#G.  : #@'## #"# #\r"#, "#/
 #" *-1 ## ##:#"\r \f#"#\f#"#\f'-4, \r# &=
"""J",  \r\t", " # \f!# : \f\t #@'#\t 
\b\t\n \f \r . 5.5
/  \f\t
167
5\b\t :\t\b \n 7\f\t\n:\t5\t\n\t77
\n\r\b7 5\t7  \n:\t\b\r\b \n\t8
\b\t :\t\b \n 7\f\t\n:\t5\t\n\t77 \n\r\b7
5\t7 \r\t \b7L\b \r\b\b\n\t \f =\f
\r\f7\b5:\t\t
168
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...

…J'  ' "E ‹126 \f F7,0 @Gz ##
…J'  '  \r'@"" \f/ *?? ‹200 \f
…UbA1c ‹48 @@ F6,5kG FUbA1c #C %" \r\t 
…J' \r#  \r\f## ‹200 \f F11,1 @G



/  \f\t
169
\n\f\r\t\b\t\b









$#"  &=,  ### \f#:"  "\r/ #  #'",
\r\f J: "\r"$# \fC \r"# \r## "\f
*??, # #  \r/\f## \r##  &M\n ' \f#
6 . :/\f# #"@ \f#"@ ' \r J' 
'  "# \r#\f \r#\r"# #"# "\r## #
\f ## #' :@#$. \f$##  \r## $#",
 """JE#/ \f#"## \r#"\r#\t &M\n  "
##, "# C,  # \f\t / "@/ $#"  &= F^,
170
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
5\b\t 7\f\t\n:\t5\t\n\t7 \n\r\b 5\t







…\t :@!#" $#"  &M\n $ \r@ \fC
"\t"@  7k F53 @@G \f\t #C#\t \r#


\nM\b\b\t8

  \b\t\b
171

## \f#:"  """##  \r\f$#\t# ADA.

\f"\t C\f #"\r# #\r#"##/

$#"  &M\n,  "\r/ :\rC #\r"'#\t ##

' ## #\t #\r# "\r## 
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. `oran A, Brvn•ell X, Xouen ˆX et al. Xlinical care gvidelines for XZˆD; rec-
o||endations fro| tue cystic ”
brosis fovndation, tue A|erican diabetes association
and tue pediatric endocrine society. Diabetes Xare 2010; 33; 2697…2708.
2. Vˆiordan S`, Uind|arsu P, Uill Nˆ et al. jalidation of continvovs glvcose
|onitoring in cuildren and adolescents witu cystic ”
brosis; a prospecti~e couort stvdy.
Diabetes Xare 2009; 32; 1020…1022.
3. `oreav Z, xeiller `A, ˆosner j et al. Xontinvovs glvcose |onitoring in XZ
patients according to tue glvcose tolerance. Uor|`etab ˆes 2008; 40; 502…506.
172
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
4. Zrounert B, Vde \], `oran A et al. I|paired fasting glvcose in cystic ”
brosis.
Diabetes Xare 2010; 33; 2660…2664.
5. Scueving N, Uoll ˆx, Doc‚ter [ et al. Diabetes in cystic ”
brosis; `vlticenter
screening resvlts based on cvrrent gvidelines. P]oS Vne 2013; 8; e81545 doi;10.1371
–ovrnal.pone.0081545
6. Uardin DS, ˆice ‰, Xouen ˆX, ^llis \‰, Nic‚ ‰A. Yue |etabolic eŠ
ects of preg-
nancy in cystic ”
brosis. Vbstet [ynecol 2005; 106; 367…375.
7. `artin-Zrias `, ]a|as Zerreiro A, ^nes ˆo|ero P, Xano [vtierre• B, Barrio
Xastellanos ˆ. Abnor|al glvcose tolerance in prepvbertal patients witu cystic ”
brosis.
An Pediatr FBarcG 2012; 77; 339…343.
8. ]anng S, Uansen A, Yuorsteinsson B, Nervp ‰, \ocu X. [lvcose tolerance in
cystic ”
brosis; a ”
~e year prospecti~e stvdy. B`‰ 1995; 311; 655…659.
9. `oran A, Dvnit• ‰, Natuan B, Saeed A, Uol|e B, Yuo|as x. Xystic ”
brosis
related diabetes; cvrrent trends in pre~alence, incidence and |ortality. Diabetes Xare
2009; 32; 1626…1631.
10. \ocu D, ˆainisio `, `adessani } et al. Presence of cystic ”
brosis-related dia-
betes |ellitvs is tigutly li‚ed to poor lvng fvnction in patients witu cystic ”
brosis; data
fro| tue ^vropean epide|iologic registry of cystic ” brosis. Pediatr Pvl|onol 2001; 32;
343…350.
11. Vˆiordan S`, Uoey U, Xostigan X. De|ograpuics and pre~alence of glvcose
intolerance and cystic ”
brosis related diabetes in 167 cystic ”
brosis cuildren. Diabetes
2006; 55; A224.
12. ]anng S. [lvcose intolerance in cystic ”
brosis patients. Paediatr ˆespir ˆe~
1991; 2; 253…259.
13. Iannvcci A, `v‚ai \, ‰ounson D, Bvr‚e B. ^ndocrine pancreas in cystic ”
sis; an i||vnouistocue|ical stvdy. Uv| Patuol 1984; 15; 278…284.
14. ]our `, [oertcue| P, Ni••e U et al. XZ associated islet cuanges |ay pro~ide
a basis for diabetes. jircuows Arcu A Patuol Anat 1989; 414; 179…185.
15. Xovce `, VBrien YD, `oran A, ˆocue PX, Bvtler PX. Diabetes |ellitvs in
XZ is cuaracteri•ed by islet a|yloidosis. ‰ Xlin ^ndocrinol`etab 1996; 81; 1267…1272.
16. [ottlieb PA, hv ], Babv S et al. No relation between cystic-”
brosis related dia-
betes and type 1 diabetes avtoi||vnity. Diabetes Xare 2012; 35; e1.
17. Bis|vtu ^, ]aborde \, Yavpin P et al. [lvcose tolerance and insvlin secretion,
|orbidity and deatu in patients witu XZ. ‰ Pediatr 2008; 152; 540…545.
18. Uoll ˆx, xolf A, Yuon A et al. Insvlin resistance witu altered secretory ‚inetics
and redvced proinsvlin in XZ patients. ‰ Pediatr [astroenterol Nvtr 1997; 25; 188…193.
19. ]anng S, Yuorsteinsson B, ˆoder `^ et al. Pancreas and gvt uor|one respons-
es to oral glvcose and intra~enovs glvcagon in cystic ”
brosis patients witu nor|al,
i|paired, and diabetic glvcose tolerance. Acta ^ndocrinol 1993; 128; 207…214.
20. DeScuepper ‰, Dab I, Derde `P, ]oeb U. Vral glvcose tolerance testing in
cystic ”
brosis; correlations witu clinical para|eters and glycosylated ue|oglobin deter-
|inations. ^vr ‰ Pediatr 1991; 150; 403…406.
21. Ua|di I, Payne S, Barton D et al. [enotype analysis in XZ in relation to tue
occvrrence of diabetes |ellitvs. Xlin [enet 1993; 43; 186…189.
  \b\t\b
173
22. hvng B, Noor|oua|ed ZU, \e|p `, Uooper ‰, ]ant AZ, Uodson `^.
XZˆD; tue role of peripueral insvlin resistance and beta-cell dysfvnction. Diabet `ed
2002; 19; 221…226.
23. `oran A, Die| P, \lein D‰, ]e~itt `D, ˆobertson ˆP. Pancreatic endocrine
fvnction in cystic ”
brosis. ‰ Pediatr 1991; 118; 715…723.
24. Xvcinotta D, De ]vca Z, [igante A et al. No cuanges of insvlin sensiti~ity in
cystic ”
brosis patients witu diŠ
erent degrees of glvcose tolerance; an epide|iological
and longitvdinal stvdy. ^vr ‰ ^ndocrinol 1994; 130; 253…258.
25. ]anng S, Yuorsteinsson B, ˆoder `^, Nervp ‰, \ocu X. Insvlin sensiti~ity
and insvlin clearance in XZ patients witu nor|al and diabetic glvcose tolerance. Xlin
^ndocrinol 1994; 41; 217…223.
26. Uardin DS, ]eBlance A, Para ], Seiluei|er D\. Uepatic insvlin resistance and
defects in svbstrate vtili•ation in cystic ”
brosis. Diabetes 1999; 48; 1082…1087.
27. `oran A, Py•drows‚i \, xeinreb `D et al. Insvlin sensiti~ity in cystic ”
brosis.
Diabetes 1994; 43; 1020…1026.
28. Batte•atti A, `ari A, ‡a••erson ] et al. Identi”
cation of insvlin secretory
defects and insvlin resistance dvring oral glvcose tolerance test in a couort of cystic
brosis patients. ^vr ‰ ^ndocrinol 2011; 165; 69…76.
29. ^dlvnd A, Uvun `, Zlodstro|-Yvllberg `, ^liasson ]. Acti~e XZYˆ cuannels
are i|portant for insvlin and glvcagon secretion. Acta Puysiologica 2010; 198 FSvppl.
677P-`VN-66G.
30. Boo| A, ]ybaert P, Pollet ‰Z et al. ^pression and locali•ation of XZYˆ in tue
rat endocrine pancreas. ^ndocr Pract 2008; 32; 197…205.
31. Vli~ier A\, hi h, Svn _ et al. Abnor|al endocrine pancreas fvnction at birtu in
cystic ”
brosis ferrets. ‰ Xlin In~est 2012; 122; 3755…3768.
32. Bellin `D, ]agvna Y, ]escuysuyn ‰ et al. Proofof-concept pilot; insvlin secre-
tion i|pro~es in cystic ”
brosis following i~acaftor correction of XZYˆ. Pediatr Diabetes
2013; 14; 417…421.
33. Blac‚|an S`, Usv S, janscoy ]] et al. [enetic |odi” ers play a svbstan-
tial role in diabetes co|plicating cystic ”
brosis. ‰ Xlin ^ndocrinol `etab 2009; 94;
1302…1309.
34. Blac‚|an S`, Usv S, ˆitter S^ et al. A svsceptibility gene for type 2 diabetes
confers svbstantial ris‚ for diabetes co|plicating cystic ”
brosis.Diabetologia 2009; 52;
1858…1865.
35. Blac‚|an S`, Xo||ander Xx, xatson X et al. [enetic |odi”
ers of cystic
brosis-related diabetes. Diabetes 2013; 62; 3627…3635.
36. ]anng S, Yuorsteinsson B, Pociot Z et al. Diabetes |ellitvs in cystic ”
brosis;
genetic and i||vnological |ar‚ers. Acta Paediatr 1993; 82; 150…154.
37. ‰ensen P, ‰ouansen U\, Xar|i P, Uoiby N, Xouen Iˆ. Avtoantibodies to
pancreatic usp60 precede tue de~elop|ent of g‚vcose intolerance in patients witu XZ.
‰ Avtoi||vn 2001; 17; 165…172.
38. Derbel S, Dov|agvet X, Uvbert D et al. Xalpain 10 and de~elop|ent of dia-
betes |ellitvs in cystic ”
brosis. ‰ Xyst Zibros 2006; 5; 47…51. 39. Bravn AY, `erlo XA.
Xystic ”
brosis and lvng transplantation. Xvrr Vpin Pvl| `ed 2011; 17; 467…472.
174
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
40. Uad–iliadis D, `adill ‰, Xuaparro X et al. Incidence and pre~alence of diabetes
|ellitvs in patients witu cystic ”
brosis vndergoing lvng transplantation before and after
lvng transplantation. Xlin Yransplant 2005; 19; 773…778.
41. Bradbvry ˆA, Suir‚ued‚ar D, [lan~eill Aˆ, Xa|pbell ]j. Prior diabetes |el-
litvs is associated witu increased |orbidity in XZ patients vndergoing bilateral lvng
transplantation; an   orpuan area—Aretrospecti~e case-control stvdy. Intern `ed ‰
2009; 39; 384…388.
42. ~an `eer‚er‚ [, ~an de [raŠ
^A, \wa‚‚el~an ^rp ‰` et al. Diabetes before
and after lvng transplantation in patients witu cystic ” brosis and otuer lvng diseases.
Diabet `ed 2012; 29; e159…e162.
43. `arsuall BX, Bvtler S`, Stoddard `, `oran A`, ]iov Y[, `organ x‰.
^pide|iology of cystic ”
brosis-related diabetes. ‰ Pediatr 2005; 146; 681…687.
44. Zin‚elstein S`, xielins‚i X], ^lliott [ˆ et al. Diabetes |ellitvs associated
witu cystic ”
brosis. ‰ Pediatr 1988; 112; 373…377.
45. ˆosene
c‚er ‰, Uo›
er ˆ, Stein‚a|p [ et al. Diabetes |ellitvs in patients witu
cystic ”
brosis; tue i|pact of diabetes |ellitvs on pvl|onary fvnction and clinical ovt-
co|e. ^vr ‰ `ed ˆes 2001; 6; 345…350.
46. `illa X^, Billings ‰, `oran A. Diabetes is associated witu dra|atically
decreased svr~i~al in fe|ale bvt not |ale svb–ects witu cystic ”
brosis. Diabetes Xare
2005; 28; 2141…2144.
47. Si|s ^‰, [reen `x, `euta A. Decreased lvng fvnction in fe|ale bvt not
|ale svb–ectswitu establisued cystic ”
brosis-related diabetes. Diabetes Xare 2005; 28;
1581…1587.
48. Xua|nan P, Suine BSZ,UawortuX, Bilton D, Adler AI. Diabetes as a deter|i-
nant of |ortality in cystic ”
brosis. Diabetes Xare 2010; 33; 311…316.
49. \ien X], ‡ipf xB, Uorswill XA, Denne SX, `cXoy \S, VDorsio Y`. ^Š
of feeding on protein tvrno~er in uealtuy cuildren and in cuildren witu cystic ”
brosis.
A| ‰ Xlin Nvtr 1996; 64; 608…614.
50. Uardin DS, ]eblanc A, ]v‚enbavgu S, Para ], Seiluei|er D\. Proteolysis
associated witu insvlin resistance in cystic ” brosis. Pediatrics 1998; 101; 433…437.
51. `oran A, `illa X, DvXret ˆ, Nair \S. Protein |etabolis| in clinically stable
advlt XZ patients witu abnor|al glvcose tolerance. Diabetes 2001; 50; 1336…1343.
52. `oran A, Basv ˆ, `illa X, ‰ensen `. Insvlin regvlation of free fatty acid ‚inet-
ics in advlt cystic ”
brosis patients witu i|paired glvcose tolerance. `etabolis| 2004;
53; 1467…1472.
53. Brennan A], [yi \`, xood D` et al. Airway glvcose concentrations and
ect on growtu of respiratory patuogens in XZ. ‰ Xyst Zibros 2007; 6; 101…109.
54. Nti|bane Y, \risuna|oortuy P, Uvot X et al. Vidati~e stress and cystic
brosis-related diabetes; a pilot stvdy in cuildren. ‰ Xyst Zibros 2008; 7; 373…384.
55. Svratwala D, Xuan ‰SU, \elly A et al. Noctvrnal uypoe|ia and glvcose toler-
ance in cuildren witu cystic ”
brosis. Yuora 2011; 66; 574…578.
56. Uvnt xˆ, ‡vguaier S`, [ventert D^ et al. Uyperglyce|ia i|pedes lvng bac-
terial clearance in a |vrine |odel of cystic-”
brosis-related diabetes. A| ‰ Puysiol ]vng
Xell `ol Puysiol 2014; 306; ]43…]49.
  \b\t\b
175
57. Andersen U}, ]anng S, Yressler Y, ]avgesen XS, `atuiesen ^ˆ. Xystic ”
sis-related diabetes; tue presence of |icro~ascvlar diabetes co|plications. Diabetes
Xare 2006; 29; 2660…2663.
cuwar•enberg S‰, Yuo|as x, Vlsen Yx et al. `icro~ascvlar co|plications in
cystic ”
brosis-related diabetes. Diabetes Xare 2007; 30; 1056…1061.
59. Zigveroa j, `illa X, Par‚s ^‰, S
cuwar•enberg S‰, `oran A. Abnor|al lipid
le~els in cystic ”
brosis. A| ‰ Xlin Nvtr 2002; 75; 1005…1011.
60. [eorgiopolov x, Den‚er A, Bisuop \] et al. `etabolic abnor|alities in advlts
witu XZ.ˆespirology 2010; 15; 823…829.
61. Isui|o `X, Belson ], ‡iai S et al. Uypertriglyceride|ia is associated witu insv-
lin le~els in advlt cystic ”
brosis patients. ‰ Xyst Zibros 2013; 12; 271…276.
62. Nasu ^Z, Stepuenson A, Uel| ^‰ et al. I|pact of lvng transplantation on serv|
lipids in advlts witu cystic ”
brosis. ‰ Ueart ]vng Yransplant 2011; 30; 188…193. 63.
ˆuodes B, Nasu ^Z, Yvllis ^ et al. Pre~alence of dyslipide|ia in advlts witu XZ. ‰ Xyst
Zibros 2010; 9; 24…28.
64. ˆadi‚e \, `ol• \, Uoll ˆx, Peoeter B, Uebestreit U, Ball|ann `. Prognostic
rele~ance of uypoglyce|ia following an oral glvcose cuallenge for cystic ”
brosisrelated
diabetes. Diabetes Xare 2011; 34; e43.
65. ]anng S, Yuorsteinsson B, Nervp ‰, \ocu X. In› vence of tue de~elop|ent of
diabetes |ellitvs on clinical statvs in patients witu cystic ”
brosis. ^vr ‰ Pediatr 1992;
151; 684…687.
66. `illa X^, xarwic‚ x‰, `oran A. Yrends in pvl|onary fvnction in cystic ”
sis patients correlate witu tue degree of glvcose intolerance at baseline. A| ‰ ˆespir Xrit
Xare `ed 2001; 162; 891…895.
67. Novsia-Ar~anita‚is S, [alli-Ysinopovlov A, \ara|ov•is `. Insvlin i|pro~es
clinical statvs of patients witu cystic ”
brosis-related diabetes |ellitvs. Acta Paediatr
2001; 90; 515…519.
68. ˆolon `A, Benali \, `vnc‚ A et al. XZˆD; clinical i|pact of prediabetes and
ects of insvlin tuerapy. Acta Paediatr 2001; 90; 860…867.
69. xuite U, `orton A`, Pec‚ua| D[, Xonway SP. Dietary inta‚es in advlt
patients witu cystic ”
brosis-do tuey acuie~e gvidelines— ‰ Xyst Zibros 2004; 3; 1…7.
70. Xuevng `S, Bridges NA, Prasad SA et al. [rowtu in cuildren witu cystic
brosis-related diabetes. Pediatr Pvl|onol 2009; 44; 1223…1225.
71. ˆipa P, ˆobertson I, Xowley D, Uarris `, `aster IB, Xotterill A`. Yue rela-
tionsuip between insvlin secretion, tue insvlin-li‚e growtu factor ais and growtu in
cuildren witu cystic ”
brosis. Xlin ^ndocrinol 2002; 56; 383…389.
72. `oran A, Pe‚ow P, [ro~er P et al. Insvlin tuerapy to i|pro~e B`I in cystic
brosis related diabetes wituovt fasting uyperglyce|ia; resvlts of tue cystic ”
brosis
related diabetes tuerapy trial. Diabetes Xare 2009; 32; 1783…1788.
73. Scu|id \, Zin‚ \, Uoll ˆx, Uebestreit U, Ball|ann `. Predictors for fvtvre
cystic ”
brosisrelated diabetes by oral glvcose tolerance test. ‰ Xyst Zibros 2014; 13;
74. [eocobbe ]^, Ngvyen ˆU, Agvilera `N et al. ^Š
ect of |aternal cystic ”
brosis
genotype on diabetes in pregnancy. Vbstet [ynecol 2012; 120; 1394…1399.
176
!\t\t 5.  \f \t\t\b\f \t \t,  \f\f ...
75. Ua|eed S, `orton ‰, ‰aŠ e A et al. ^arly glvcose abnor|alities in cystic ”
brosis
are preceded by poor weigut gain. Diabetes Xare 2010; 33; 221…226.
76. Brods‚y ‰, Dovguerty S, ˆa|‚risuna `, ˆvbenstein ˆX, \elly A. ^le~ation
of 1-uovr plas|a glvcose dvring oral glvcose tolerance testing is associated witu worse
pvl|onary fvnction in cystic ”
brosis. Diabetes Xare 2011; 34; 292…295.
77. `o••illo ^, ˆaia j, ˆaggorvsso j et al. [lvcose derange|ents in ~ery yovng
cuildren witu cystic ”
brosis and pancreatic insvž
ciency. Diabetes Xare 2012; 35; e78.
78. Vde \], Zrounert B, ]agvna Y et al. Vral glvcose tolerance testing in cuildren
witu cystic ”
brosis. Pediatr Diabetes 2010; 11; 487…492.
79. Dobson ], Sueldon XD, Uattersley AY. Xon~entional |easvres vnderesti|ate
glycae|ia inXZpatients. Diabet `ed 2004; 21; 691…696.
80. Scuiaž
ni ˆ, Brvfani X, ˆvsso B et al. Abnor|al glvcose tolerance in cuildren
witu cystic ”
brosis; tue predicti~e role of continvovs glvcose |onitoring syste|. ^vr
‰ ^ndocrinol 2010; 162; 705…710.
81. \olovs‚o~a S, ‡e|‚o~a D, Bartoso~a ‰ et al. ]owdose insvlin tuerapy in
patients witu cystic ”
brosis and early-stage insvlinopenia pre~ents deterioration of lvng
fvnction; a 30 year prospecti~e stvdy. ‰ Pediatr ^ndocrinol `etab 2011; 24; 499…454.
82. Svnni `, Bellin `D, `oran A. ^ogenovs insvlin revire|ents do not diŠ
er
between yovtu and advlts witu cystic ”
brosis related diabetes. Pediatr Diabetes 2013;
14; 295…298.
83. \onrad \, Yuon A, Zritscu ` et al. Xo|parison of XZˆDwitu Y1D based on
a[er|anAvstrian pediatric diabetes registry. Diabetes Xare 2012; 35; 1…8.
84. Vnady [`, Stol”
A. Insvlin and oral agents for |anaging cystic ”
brosis-related
diabetes. Xocurane Database Syst ˆe~ 2013; 7; XD004730. doi;10.100214651858.
XD004730.pvb3.
85. Ne•er N, Suoseyo~ D, \ere| ^, ‡angen DU. Patients witu cystic ”
brosis and
nor|oglyce|ia euibit diabetic glvcose tolerance dvring pvl|onary eacerbation.
‰ Xyst Zibros 2010; 9; 199…204.
86. ˆasovli N, Seggel‚e S, [ibbs ‰ et al. Xystic ”
brosisrelated diabetes in advlts;
i|patient |anage|ent of 121 patients drving 410 ad|issions. ‰ Diabetes Sci Yecunol
2012; 6; 1038…1044.
87. `o••illo ^, Zran•ese A, jalerio [ et al. Vne year glargine treat|ent can
i|pro~e tue covrse of lvng disease in cuildren and adolescents witu cystic ”
brosis and
early glvcose derange|ents. Pediatr Diabetes 2009; 10; 162…167.
88. Bi••arri X, ]vcidi j, Xia|palini P, Bella S, ˆvsso B, Xappa `. Xlinical eŠ
of early treat|ent witu insvlin glargine in patients witu cystic ”
brosis and i|paired
glvcose tolerance. ‰ ^ndocrinol In~est 2006; 29; ˆX1…ˆX4.
89. Ua|eed S, `orton ‰ˆ, Zield PI et al. Vnce daily insvlin dete|ir in cystic ”
sis witu insvlin de” ciency. ADX 2012; 97; 464…467.
90. UAPV Stvdy Xooperati~e ˆesearcu [rovp. Uyperglyce|ia and ad~erse preg-
nancy ovtco|es. N ^ngl ‰ `ed 2008; 358; 1991…2002.
1 \t\t 9
 \r\n \b\t8 \r\t \n\r\b7 5\t
 5 \t 5\r\n\f
178
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
\b\b:\t8 \t \r\f7\b5:\t\t
�:\r'"@ \f/\f, \r\f"\r#\r!# #:@!J





(@'J" #"#-:#/#\r@ "/##, E 
\f\f\t  \b  \f\t
179

180
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
?   #""## :'\r #/-:\r'"@/
# "\r@ " C#"@ \f \r\f m16…21q # @
:@!# „  #/## \r'@"" m22, 23q. +"# %" :
'"  \f",   '\r/ m22q. ##\t  :#J #:
E"\tJ"\t  "# \r\f#". \r ", "# #@'#
\r#$# \r!#\r#\t 'C", "/# %"# \r!#\t
\b\t\r\nL\b \r\t\b:\t 
 \b=\t\f  \b\t\f\t \b\t\t *\f \b\b\t
181
\n5\rM\b\t \t \r\b\t:\t8 \rL\b \r\r77
182
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
\r##\t \f\t \r\f#\t \r\f#'#\r/ "\r#\r/




 \b=\t\f  \b\t\f\t \b\t\t *\f \b\b\t
183
 6.1
!%3!*@ ! *! -$/%!+ &, *"
! !; !(&a*#`%!
 6.2
\f/"%%@ ;!"!!, @; F! _ "%
 -'%!! [Rb]
&\b\t.
184
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
\r\t\b \r\bL \b\t8 O\r\bL 1Q


(\b= \f  \f� \b \f* 2?
185
\r5M\b\t \b\t8 O\r\bL 2Q
186
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
 \f  \b\t\f \b
187
"# "\t"\t C "@J \r #"# #\t
\f#:". \b C \r \rC# "\r##  \r\f#
, "\t\t \fC\t #'#\t ## F((, ##
G,  "C !# \r#:\r "\t #'\r#\t \r\t
#"@ / "#/ !"@", "\r:"\t # \r@ :#\t #
##\t /#',  "C :@! \r#,  # \r\r
" "\f !"@"  !" ":## "\r@
 \f/\f \r\f" :HJE "\r"\r#\r :#\t
\r\t""@ \f"#@ / ! m2…8, 16, 24, 61, 62q,  :"# \r#
\b\t \t \r\n\b \r 
188
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
75\b: \t 5\t \r55\fL\b \r\n






*###\t "\r"\t E F.  12  ####G.
# \r#\f #\r### " \r##"@ \fC :@!#

5\t \fL\b \r\n

\r'#"# " :" \f"#" # "!# 
\r" ## m34, 55q.




 \f  \b\t\f \b
189


\n" \r\f#"\t  " \r'#"#J '##"#
5\r\n\f\t
( \t$ \r.   \t  \b\r \b\t)

\r#\t"#  \r# \r\fCJE\t "#\t \r\f#" 







" # "\r"\r#\r :#  \r \f#:" \fC
:"@ \f"  \f J\f\t, "\r\fJE# \n, # ", " ' ##
190
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
\f\b9\t\f \t\b\r\n
Sano“
Sano“
\t\t\r\n \t\n\f \t\r\r
1. ISPAD Xonsensvs [videlines for tue `anage|ent of Yype 1 Diabetes `ellitvs in
Xuildren and Adolescents. Swift P[Z, ed. ‡eist; `edforv|, Brvssels, 2000.
2. Uaas ], `aryniv‚ `, Bec‚ ‰ et al. Standardsˆe~ision Yas‚ Zorce. National
standards for diabetes self|anage|ent edvcation and svpport. Diabetes Xare 2012;
37 FSvppl. 1G; S144…S153.
3. Sil~erstein ‰, \lingens|itu [, Xopeland \ et al. A|erican Diabetes Association.
XAˆ^ of cuildren and adolescents witu type 1 diabetes; a state|ent of tue A|erican
Diabetes Association FADA State|entG. Diabetes Xare 2005; 28; 186…212.
4. Xanadian Diabetes Association Xlinical Practice [videlines ^pert Xo||ittee.
Xanadian Diabetes Association 2013 Xlinical Practice [videlines for tue Pre~ention
and `anage|ent of Diabetes in Xanada. Xan ‰ Diabetes 2013; 37 FSvppl. 1G; S1…S212.
5. Xraig `^, Ywigg S`, Donaguve \X et al. for tue Avstralian Yype Diabetes
[videlines ^pert Ad~isory [rovp. National ^~idence-based Xlinical Xare [videlines
for Yype 1 Diabetes in Xuildren, Adolescents and Advlts. Xanberra; Avstralian
[o~ern|ent Depart|ent of Uealtu and Ageing, 2011 Fa~ailable fro| uttp;www.dia-
betessociety. co|.avposition-state|ents.aspG.
6. National Institvte for Xlinical ^cellence }\ FNIX^G. Yype 1 diabetes; Diagnosis
and |anage|ent of type 1 diabetes in cuildren, yovng people and advlts. 2004. Fa~ail-
able fro| uttp;www.nice.org.v‚pdf X[015NIX^gvideline.pdfG.
7. DU Diabetes Policy Yea|. `a‚ing ^~ery hovng Person witu Diabetes `atter;
ˆeport of tue Xuildren and hovng People witu Diabetes xor‚ing [rovp. }\ Depart|ent
of Uealtu, ]ondon. 2007. Fa~ailable fro| uttp;www.du.go~.v‚prod™consv|™du
grovpsdu™digitalassets†du†endocv|entsdigitalassetdu™073 675.pdfG.
8. Uolteruvs P`, Beyer P, Bürger-Büsing ‰ et al. Diagnosti‚, Yuerapie vnd
jerlavfs‚ontrolle des Diabetes |ellitvs i| \indes- vnd ‰vgendalter. S3 ]eitlinie der
Devtscuen Diabetes [esellscuaft. mDiagnosis, Yuerapy and ]ong Yer| Xare of Diabetes
in Xuilduood and Adolescence … S3 [videlineq.`ain•; \ircuuei|, 2009; p1…p306.
9. \vl•er B, Albvs X, Uerpert• S, \rvse ‰, ]ange \, ]ederbogen Z, Petra‚ Z.
^~iden•basierte ]eitlinie - Psycuoso•iales vnd Diabetes |ellitvs S2-]eitlinie Psycuoso•iales
vnd Diabetes.Ueravsgeber; S.`attuaei, `. \ellerer. Diabetologie vnd StoŠ
wecusel F2013G
Yeil 1. F2013G 8; 198…242. mS2-[videlines; Diabetes and psycuosocial aspectsq
10. Diabetes }\ and Depart|ent of Uealtu. Strvctvred Patient ^dvcation in
Diabetes. ˆeport fro| tue Patient ^dvcation xor‚ing [rovp. Diabetes }\ and
Depart|ent of Uealtu. 2005. Fa~ailable fro| uttp;www.du.go~.v‚pvblicationsG.
  \b\t\b
191
11. IDZ Xonsvltati~e Section on Diabetes ^dvcation FD^XSG. International
Xvrricvlv| for Diabetes Uealtu Professional ^dvcation. 2 edn. Brvssels; International
Diabetes Zederation. 2008. Fa~ailable fro| uttp;www. idf.orgG.
12. `artin D, ]ange \, Si|a A et al. on beualf of tue Sx^^Y grovp.
ˆeco||endations for age-appropriate edvcation of cuildren and adolescents witu
diabetes and tueir parents in tue ^vropean }nion. Pediatr Diabetes 2012; 13 FSvppl.
16G; 20…28.
13. xaldron S, ˆvri‚ I, `adacsy ] et al. [ood practice reco||endations on pae-
diatric training progra||es for uealtu care professionals in tue ^}. PediatrDiabetes
2012; 13 FSvppl. 16G; 29…38.
14. ]ange \, \lot|ann S, Saß|ann U et al. Sx^^Y grovp. A pediatric diabetes
toolbo for creating centres of reference. Pediatr Diabetes 2012; 13 FSvppl. 16G; 49…61.
15. `vrpuy Uˆ, ˆay|ann [, S‚inner YX. Psycuoedvcational inter~entions for
cuildren and yovng people witu type 1 diabetes. Diabet `ed 2006; 23; 935…943.
16. ˆosenbaver ‰, Dost A, \arges B et al. I|pro~ed |etabolic control in cuildren
and adolescents witu type 1 diabetes; a trend analysis vsing prospecti~e |vlticenter data
fro| [er|any and Avstria. Diabetes Xare 2012; 35; 80…86.
17. Ua|pson S^, S‚inner YX, Uart ‰ et al. ^Š
ects of edvcational and psycuosocial
inter~entions for adolescents witu diabetes |ellitvs; a syste|atic re~iew. Uealtu Yecunol
Assess 2001; 5; 1…79.
18. Nortua| ^A, Yodd S, Xa|eron Z‰. Inter~entions to pro|ote opti|al uealtu
ovtco|es in cuildren witu type 1 diabetes … are tuey eŠ
ecti~e— Diabet `ed 2006; 23;
113…121.
19. Xovcu ˆ, ‰etua `, Dryden D`, et al. F2008G Diabetes edvcation for cuildren
witu type 1 diabetes |ellitvs and tueir fa|ilies. ˆoc‚~ille F`DG; Agency for Uealtucare
ˆesearcu and Žvality F}SGz F^~idence ˆeportsYecunology Assess|ents, No. 166G
20. [age U, Ua|pson S, S‚inner YX et al. ^dvcational and psycuosocial progra||es
for adolescents witu diabetes; approacues, ovtco|es and cost-eŠ
ecti~eness. Patient ^dvc
Xovns 2004; 53; 333…346. 21. [rey `, xuite|ore ˆ, ‰eon S, `vrpuy \, Zavl‚ner `S,
Dela|ater Az YeenXope Stvdy [rovp. Internet psycuo-edvcation progra|s i|pro~e
ovtco|es in yovtu witu type 1 diabetes. Diabetes Xare 2013; 36; 2475…2482.
22. xin‚ley \, Is|ail \, ]andav S, ^isler I. Psycuological inter~entions to i|pro~e
glyce|ic control in patients witu type 1 diabetes; syste|atic re~iew and |eta-analysis of
rando|i•ed controlled trials. B`‰ 2006; 333; 65.
23. Peyrot `, ˆvbin ˆˆ. Beua~ioral and psycuosocial inter~entions in diabetes; a
conceptval re~iew. Diabetes Xare 2007; 30; 2433…2440.
24. Xa|eron Z, de Beavfort X, Aanstoot U‰ et al. International Stvdy [rovp.
]essons fro| tue U~idoere International Stvdy [rovp on cuilduood diabetes; be dog-
|atic abovt ovtco|e and ›
eible in approacu. Pediatr Diabetes 2013; 14; 473…480.
25. Barlow ‰U, ^llard Dˆ. Psycuo-edvcational inter~entions for cuildren witu
curonic disease, parents and siblings; an o~er~iew of tue researcu e~idence-base. Xuild
Xare Uealtu De~ 2004; 30; 637…645.
26. Diabetes Xontrol and Xo|plications ˆesearcu [rovp. ^Š
ect of intensi~e dia-
betes treat|ent on tue de~elop|ent and progression of long-ter| co|plications in
adolescents witu insvlin-dependent diabetes |ellitvs. ‰ Pediatr 1994; 125; 177…188.
192
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
27. I|plications of tue Diabetes control and Xo|plications Yrial. ADA Position
State|ent. Diabetes Xare 2003; 26; S25…S27.
28. \yngas U, Uentinen `, Barlow ‰U. Adolescents perceptions of puysicians,
nvrses, parents and friends; uelp or uindrance in co|pliance witu diabetes self-care.
‰ Ad~ Nvrs 1998; 27; 760…769.
29. S‚inner YX. xuat does |a‚e tue diŠ erence— Diabet `ed 2006; 23; 933…934.
30. ‰acobson A`, Uavser SY, xillett ‰, xolfsdorf ‰I, Uer|an ]. Xonsevences of
irregvlar ~ersvs continvovs |edical follow-vp in cuildren and adolescents witu insvlin-
dependent diabetes|ellitvs. ‰ Pediatr 1997; 131; 727…733.
31. \avf|an Zˆ, Ual~orson `, Xarpenter S. Association between diabetes control
and ~isits to a |vltidisciplinary pediatric diabetes clinic. Pediatrics 1999; 103; 948…951.
32. Uoll ˆ, Swift P[Z, `ortensen UB et al. Insvlin in–ection regi|ens and |eta-
bolic control in an international svr~ey of adolescents witu type 1 diabetes o~er 3 years;
resvlts fro| tue U~idore Stvdy [rovp. ^vr ‰ Pediatr 2003; 162; 22…29.
33. Svlli~an-Bolyai S, Bo~a X, ]ee `, [rvppvso PA. `entoring fatuers of cuildren
newly diagnosed witu Y1D`. `XN A| ‰ `atern Xuild Nvrs 2011; 36; 224…231.
34. A|erican Diabetes Association, Xlar‚e x, Deeb ]X et al. Diabetes care in tue
scuool and day care setting. Diabetes Xare 2013; 36 FSvppl. 1G; S75…S79.
35. Douerty h, ‰a|es P, ˆoberts S. Stage of cuange covnselling. In; Snoe‚ Z‰, S‚inner
YX, eds. Xuapter 5 in Psycuology in Diabetes Xare. 2 edn. Xuicuester; ‰oun xiley, 2007.
36. Procuas‚a ‰V, Dicle|ente XX. Yowards a co|preuensi~e |odel of cuange. In;
`iller xˆ, Ueatuer N, eds. Yreating Addicti~e Beua~iors; Process of Xuange. New
hor‚; Plenv|, 1986; 1007…1030.
37. `üuluavser I, Brvc‚ner I, Berger ` et al. ^~alvation of an intensi”
ed insvlin
treat|ent and teacuing progra||e as rovtine |anage|ent of type 1 diabetes Finsvlin-
dependentG diabetes. Yue Bvcuarest-Düsseldorf Stvdy Diabetologia 1987; 30; 681…690.
38. DAZN^ Stvdy [rovp. Yraining in ›
eible, intensi~e insvlin |anage|ent to
enable dietary freedo| in people witu type 1 diabetes; dose ad–vst|ent for nor|al eat-
ing FDAZN^G rando|i•ed controlled trial. Br `ed ‰ 2002; 325; 746…749.
39. \nowles ‰A, xaller U, ^iser X et al. Yue de~elop|ent of an inno~ati~e edv-
cational cvrricvlv| for 11…16 yr old cuildren witu type 1 diabetes FY1D`G. Pediatr
Diabetes 2006; 7; 322…328.
40. ]ange \, Sass|ann U, ~on Scuüt• x, \ordonovri V, Danne Y. Prerevisites
for age-appropriate edvcation in type 1 diabetes; a |odel progra||e for paediatric
diabetes edvcation in [er|any. Pediatr Diabetes 2007; 8 FSvppl. 6G; 63…71.
41. \yriacov X. ^ssential Yeacuing S‚ills. 2 edn. Nelson Yuornes ]td, Xueltenua|,
1998.
42. ]ange \, \leine Y, Danne Y, on beualf of A[ Diabetesscuvlvng für ^ltern.
Initialscuvlvng für ^ltern ~on \indern |it Diabetes; Avfwand vnd ^Š e‚te bei \indern
vnd ^ltern mInitial edvcation for parents of cuildren witu diabetes; ependitvre and
ects in cuildren and parentsq. D`x 2011; 136; 1106…1110.
43. Zorsander [A, Svndelin ‰, Persson B. In›
vence of tue initial |anage|ent regi-
|en and fa|ily social sitvation on glyce|ic control and |edical care in cuildren witu
type 1 diabetes. Acta Paediatr 2000; 89; 1462…1468.
  \b\t\b
193
44. ‰asins‚i XZ, ˆodrigve•-`ongvio ˆ, Yonyvsu‚ina \, Allen U. Uealtucare cost
of type 1 diabetes |ellitvs in new-onset cuildren in a uospital co|pared to an ovtpatient
setting. B`X Pediatr 2013; 13; 55. doi;10.11861471-2431-13-55.
45. Yiberg I, \atarina SX, Xarlsson A, Uallströ| I. Xuildren diagnosed witu type
1 diabetes; a rando|i•ed controlled trial co|paring uospital ~ersvs uo|e-based care.
Acta Paediatr 2012; 101; 1069…1073.
46. Boren SA, Zit•ner \A, Panual‚ar PS, Spe
c‚er
‰^. Xosts and bene”
ts associ-
ated witu diabetes edvcation; a re~iew of tue literatvre. Diabetes ^dvc 2009; 35; 72…96.
47. Anderson ˆ`, Zvnnell `, Xarlson A, Saleustatin N, Xradoc‚ S, S‚inner YX.
Zacilitating self care turovgu e|power|ent. In; Snoe‚ Z‰, S‚inner YX, eds. Xuapter 4
in Psycuology in Diabetes Xare. 2 edn. Xuicuester; ‰oun xiley, 2007.
48. Anderson ˆ`, Zvnnell `, Bvtler P, Arnold `S, Zit•gerald ‰Y, Zeste X. Patient
e|power|ent; resvlts of a rando|i•ed control trial. Diabetes Xare 1995; 18; 943…949.
49. \err D. Poor nv|eracy; tue elepuant in tue diabetes tecunology roo|.
‰ Diabetes Sci Yecunol 2010; 4; 1284…1287.
50. ‰anisse UX, Naar-\ing S, ^llis D. Brief report; parents uealtu literacy a|ong
uigu-ris‚ adolescents witu insvlin dependent diabetes. ‰ Pediatr Psycuol 2010; 35;
436…440.
51. jon Sengbvscu S, `üller-[rodeŠ
roy ^, Uager S et al. `obile diabetes edvca-
tion and care; inter~ention for cuildren and yovng people witu type 1 diabetes in rvral
areas of nortuern [er|any. Diabet`ed 2005; 23; 122…127.
52. Zran‚lin j], xaller A, Pagliari X, [reene SA. A rando|i•ed controlled trial of
194
!\t\t 6. \b  \f \b \t\t\b\f \t     \r  \b
60. Boland ^A, [rey `, Vesterle A et al. Xontinvovs svbcvtaneovs insvlin infv-
sion. A new way to lower ris‚ of se~ere uypoglyce|ia, i|pro~e|etabolic control, and
enuance coping in adolescents witu type 1 diabetes. Diabetes Xare 1999; 22; 1779…1784.
61. Pán‚ows‚a ^, B¡a•i‚ `,X•erniaws‚a ^ et al. Žvality of treat|ent in cuildren
witu type 1 diabetes based on tue Polisu Prospecti~e Pv|p Progra||e. `ed xie‚v
ˆo•wo– 2012; 16; 15…22.
62. Dea‚in YA, Xade ‰^, xillia|s ˆ, [reenwood DX. Strvctvred patient edvcation;
tue diabetes _-P^ˆY Progra||e |a‚es a diŠ
erence. Diabet `ed 2006; 23; 944…954.
63. Zollansbee DS. Assv|ing responsibility for diabetes |anage|ent; wuat age—
xuat price— Diabet ^dvc 1989; 15; 347…352.
64. Powers Sx, Byars \X, `itcuell `‰, Patton Sˆ, Standiford DA, Dolan ]`.
Parent report of|ealti|e beua~iovr and parenting stress in yovng cuildren witu type
1 diabetes and in uealtuy control svb–ects. Diabetes Xare 2002; 25; 313…318.
65. Uatton D], Xana| X, Yuorne S, Uvgues A`. Parents perception of caring for
an infant or toddler witu diabetes. ‰ Ad~ Nvrs 1995; 22; 569…577.
66. Uorscu A, `c`anvs Z, \ennedy P, ^dge ‰. Aniety, depressi~e, and post-
trav|atic stress sy|pto|s in |otuers of cuildren witu type 1 diabetes. ‰ Yrav|a Stress
2007; 20; 881…891.
67. ]indströ| X, A|aan ‰, Norberg A]. Parental bvrnovt in relation to sociode|o-
grapuic, psycuosocial and personality factors as well as disease dvration and glycae|ic
control in cuildren witu type 1 diabetes |ellitvs. Acta Paediatr 2011; 100; 1011…1017.
68. ^iser X. Xuronic cuilduood disease; an introdvction to psycuological tueory and
researcu. New hor‚ Xa|bridge }ni~ersity Press, Xa|bridge, 1990.
69. Patton Sˆ, Dolan ]`, S|itu ]B, Yuo|as IU, Powers Sx. Pediatric parenting
stress and its relation to depressi~e sy|pto|s and fear of uypoglyce|ia in parents of yovng
cuildren witu type 1 diabetes |ellitvs. ‰ Xlin Psycuol `ed Settings 2011; 18; 345…352.
70. Barnard \, Yuo|as S, ˆoyle P, Noyes \, xavgu N. Zear of uypoglycae|ia
in parents of yovng cuildren witu type 1 diabetes; a syste|atic re~iew. B`X Pediatr
201015; 10;
50. doi;10.11861471-2431-10-50.
71. Sass|ann U, de Uair `, Danne Y, ]ange \. ˆedvcing stress and svpporting
positi~e relations in fa|ilies of yovng cuildren witu type 1 diabetes; a rando|i•ed con-
trolled stvdy for e~alvating tue eŠ
ects of tue D^]ZIN parenting progra|. B`X Pediatr
2012; 12; 152 doi; 10.11861471-2431-12-152.
72. ]aŠ el ]`, jangsness ], Xonnell A, [oebel-Zabbri A, Bvtler D, Anderson B‰.
I|pact of a|bvlatory, fa|ily-focvsed tea|wor‚ inter~ention on glyce|ic control in
yovtu witu type 1 diabetes. ‰ Pediatr 2003; 142; 409…416.
73. Nordfeldt S, ‰ouansson X, Xarlsson ^, Ua||ers–ö ‰A. Persistent eŠ ects of a
pedagogical de~ice targeted at pre~ention of se~ere uypoglycae|ia; a rando|i•ed, con-
trolled stvdy. Acta Paediatr 2005; 94; 1395…1401.
74. xysoc‚i Y, Uarris `A, Bvc‚lou ]` et al. ˆando|i•ed trial of beua~ioral fa|ily
syste|s tuerapy for diabetes; |aintenance of eŠ
ects on diabetes ovtco|es in adoles-
cents. Diabetes Xare 2007; 30; 555…560.
75. Vl|sted `P, Dane|an D, ˆydall AX, ]awson `], ˆodin [. Yue eŠ
ects of
psycuoedvcation on distvrbed eating attitvdes and beua~ior in yovng wo|en witu type
1 diabetes |ellitvs. Int ‰ ^at Disord 2002; 32; 230…239.
  \b\t\b
195
76. hovng j, ^iser X, ‰ounson B et al. ^ating proble|s in adolescents witu type
1 diabetes; a syste|atic re~iew witu |eta-analysis. Diabet `ed 2013; 30; 189…198.
77. [ayes ]A, Steele ˆ[. A |eta-analysis of |oti~ational inter~iewing inter~en-
tions for pediatric uealtu beua~ior cuange. ‰ Xonsvlt Xlin Psycuol 2014; 82; 521…535.
78. Peters A, ]aŠ
el ], A|erican Diabetes Association Yransitions xor‚ing[rovp.
Diabetes care for e|erging advlts; reco||endations for transition fro| pediat-
ric to advlt diabetes care syste|s; a position state|ent of tue A|erican Diabetes
Association, witu representation by tue A|erican Xollege of Vsteopatuic Za|ily
Puysicians, tue A|erican Acade|y of Pediatrics, tue A|erican Association of
Xlinical ^ndocrinologists, tue A|erican Vsteopatuic Association, tue Xenters for
Disease Xontrol and Pre~ention, Xuildren witu Diabetes, Yue ^ndocrine Society,
tue International Society for Pediatric and Adolescent Diabetes, ‰v~enile Diabetes
ˆesearcu Zovndation International, tue National Diabetes ^dvcation Progra|,
and tue Pediatric ^ndocrine Society Ffor|erly ]awson xil‚ins Pediatric ^ndocrine
SocietyG. Diabetes Xare 2011; 34; 2477…2485.
1 \t\t
\f\b\t 7\r\b 5\t\t\n\f 7\t
587 \t 5\r\n\f7 \n 5\t7
\f\f\t  \b  \f\t
197
\b\b:\t8 \t \r\f7\b5:\t\t
\n"\r\fJE# \f#:" \f"# # \f\r"#,  "C #/ @# \fC 
  ':#\t "@ [email protected] " @"#\f#$##\r
\r $##"  \f#:", #JE#/ \f" # %\r"#' 
J"\t \f"# # \f\r"# FLG. *\r "\r## /\r \f#:" F*?\nG
\fC $"#\r"@ ##  ", " @\t # \r: \t\tJ"\t
#\t.  #\t \fC #"\r#\r"@ \rJ "/#J,
"""JE#  \f" \r\r # #\f##\f@ "\r:"#
\r:@# FLG. ?\t @"#\f#$##\r\t \f \r\t\f # :\f"
# \f#:" "\r"\t \r\f. = "#/ \t/ /\f, \r , :\f"
:#"@\t " \f#"\r ## "\r" F \rG,








 # [email protected] \f"\t, /\f\tE#\t  " ' \r
\r#, \r#\r, \f"\t  /# ### "\r

198 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...



�:#  \r/\f  '\r \f# '#\t
E#, " '#" !#"@ \r'@"" # \r"#\r"@


\rL \f7 7\t
  \f
199
5\b\t
200 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
:#\t E#z \r$ E# #J",  #
\n\r\f\r 7\t
\b\b\t \n
201
"J".  \f", \r#\fCE#/  \r  :

\f#"\r, $##'#\rJE#\t  :"# \f#:"## ##




202 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...

…## # \f\f\rC #/##/ # $#@/ "\r:-
…%\r" \r"# \r\f" # "\r#\r .


\n \r ", JE#\t ##"\r##,
"/# #"\r# \r\t *, #"\r# $"\r$##
\r"#\t$#J #\f##\f@/ :#/###/ $ F$/

�:# $#" # \r#@/ \r \r




$##"#, :#JE## \r#J \f#$#J

(\b  \t\t\f \n

*J"\r, "#  @J"\r, \r \r\r
\r# „  %" " :#"@ '#\f"#  *?\n C\f

\r:\n\n \f\b\t8 7\t
\r\t 5=


204 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...

(@'# \r##/ :/ "\r# # \r"/
(\b  \t\t\f \n
205
\r!". X.1.
E\t \r \t  \b\t+ \r . 7\t \t\r  -
,   \t\n\f \r\f. %\b\r\t  \b
Archana Sarda,
, Q\b
\r U…12 7\n

206 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...


\n8\b\b8 7L \r\t 5\t




, \r!#/ " # \f\r#/ \rC#,  "C \r##/
$#, \r#\r "#"@"#  # \r##\t,
(\f\f\t \n* \b \t 
207
#:\r$##Gz :\f# C#,  :"#  "/ #H$#,
""\r#'$## # \f\r#/ "/ ""  \r#:\r# "\r\t
\f\t :\rC#\t \r#' ##\r"\r##, #"\r## ##
�#$##. 'JE\t [email protected] "\r \fC '"@ 







\n#", """JE# ""JE# ':#\t,
208 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...




"# C\f \r:\f\r" # @#, \r 

#\f##\f@ $ '"# UbA1cG # \r##

M#"\r :C\f#, \r  ##
(\f\f\t \n* \b \t 
209










210 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...





�:'\r / \r##/ \r"/ \r\f" # #E/



#\r@:#   # "@# :\f#.
(\f\f\t \n* \b \t 
211
:\b\f 57\b\t  \t\n :\t\b \r\t \n\b\t\t
5\t \t 7M5 \n\b\t87\t




212 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
(\n* \f\t "\t \b \f
213
\t\b\t
 \rM\b\b\t8
7L \b 6  \r\n\b\t8
214 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
\f J\f# \f"\r#\rJ" /\f!# "\tE#/\t  \f#:"
='\r" \r/\f  '\rJ ## \[email protected]#\r"  '##"# "
" # #" '\f\r/\r#\tz   #\tJ" " :# #
\r\r, \r\f"#\t $#" # , \f\r"\t #"#
\r/ C : : \r\f"@ "#@ '\r" \f\t \r/\f.
\f# #\f#\t  "# "\r!#  \n '#,
" ", " \r!#  #J E# \f\t '\r/ \r\f \f#
"\r#\rJ" /\f!# ### "\r@ \r' \f  #\t
"\r! !  \r#J  \f# J\[email protected]#, \r\fC!##
"@ \f#"\r#J [email protected] F #/ ### "\r@ 
/\f " \f#"\r# \f#$# :C##\t  '\r C"
) \f\t \n*    \r  \f\t\f\t*\f  \f*&\f...
215
\r\r5  \f\b\t\t 7\t
75\t:\t\b\n\f8 7L 58 5 \t \b:\t\bL\b
7\bL\t\b\n \t 5 \b5\b\t \t77\t\r\b
216 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...


:E#\t C" @  #$##, @"#\r##,
) \f\t \n*    \r  \f\t\f\t*\f  \f*&\f...
217

(\r$#\t  @"\r/ # \r##'/ \r\f"#\t/
@# C" :"@ \r#"# \r# \r\f"## E#.
\r#\r, "\r/ '\rC#\t, #\t "#"@ :/
#"@ "C ## :/\f# \f # \n
m33q. \n"#"#'$#\t C" \r#"#  ", " @\t #"
"@ \r \r# \r: #E# ## ##
##, :\r", C" C\f"@  #""@\t \r#@, "
"@ C" \r\t"""@ '#J \f" E#
 :/\f#"#, , \r#\r,   ####.
E\r#   ", ": # \f##@  #"$#,
 \r \r  @## C# J\[email protected]#, "## 
$##@ C \f\t #\t E#  :"\t"@"/
"\r :/\f#"#. \r ", \r"#"@\t \r:" 
!, \f /\f#" \r:, C" E" #'#"@ \r#
"#"#'$##. = "\r/ "/  \f#\r###\r
  \r#' C## " '"@\t \f# #
\f!#. +" C" '"\r\f#"@ \f\t #/ " \r#@

218 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
[email protected], '#\f"# \r# # \r \f\f\rC#
\b\t7\b\t \f \r7\b\n\t O\r5\t \t \r\b\fQ
\t 7\b\t= \n\tL
\f\n, \n\r\f\r, \r:\n\n 7\t \t  \rL
\t , \b\b\t, \b  \n  \b *\t
219
220 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
 7.1
'(! /", F_`! *3"" ! %/%@ !";@ (/%!+
";% !-, "-%% '%/!#@ (+ ";% !-
 *!!/"& *! O3!!$"+ * [41]Q
C\t \f \r3  \t \r \r ?G-   (\r\t 
\t , \b\b\t, \b  \n  \b *\t
221
'(! /"
Q\r\t \t-

3  \t \t  & \r \t.
D \f\b\r -
3  \t, \r\t+ \b \t   \r \b
#\t \f\t \r-
'\b \r  \b, \b   \f.
0\t\r &\n
222 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
�\r#'$#\t #\f# \f#:" \r\f# \fC# \n FS^AˆXUG
T1D
75\t:\t\b\n\f8 7L 587  5\r\t 7\n
5\t, L\b 5\t7,  \f
\r, \r\f" \t ", \f#$## :#" #

) \f\t \n*    \b  \t


\r"  C\t \n \f "/ \r,  #  "
\f"@ %" "\t"@. L# \r: @'"\t #'\r#"
J' "\t \f"#\t F&*G, !@ \r \fC
\r"# "\r# # #"@ \r" #"\r$##,  \r#\r"@

 \r:"## ! \fC "@ \r'"@ #"
224 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
@\t\b\t \f\t   \f  \t\f\t  "## \f
225







\r\r F#\r$# #"###, :\r\f#,


\r \b \b\t \t \b\t \t 699\f\t\b\n\t
226 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...



\f# \f \b 
227

\t \b\t \r, \n8\b\b \n \n\r\b7 5\t7
\f\b9\t\f \t\b\r\n
228 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
\n \t\n\f \t\r\r
1. Suobuana ˆ, ˆa|a ˆao P, ]a~anya A et al. Xosts incvrred by fa|ilies ua~ing type
1 diabetes in a de~eloping covntry … a stvdy fro| Sovtuern India. Diabetes ˆes Xlin
2. ^lrayau U, ^lto| `, Bedri A, Belal A, ˆosling U, Vstenson X[. ^cono|ic
bvrden on fa|ilies of cuilduood type 1 diabetes in vrban Svdan. Diabetes ˆes Xlin
Pract 2005; 70;159…165.
3. jir|ani A. Safe disposal of vsed suarp ob–ects. Indian Pediatr 2008; 46; 539…540.
4. [ar~ey \X, xolpert UA, ˆuodes ^Y et al. Uealtu care transition in patients witu
type 1 diabetes; yovng advlt eperiences and relationsuip to glyce|ic control. Diabetes
Xare 2012; 35; 1716…1722.
5. Xuannon S, S|itu j, Alcolado ‰, [regory ‰x. Xvrrent |etuods of transfer of
yovng people witu type 1 diabetes to advlt ser~ices. Diabet`ed 2003; 20; 1034.
6. Bryden \S, Dvnger DB, `ayov ˆA, Pe~eler ˆX, Neil UA. Poor prognosis of
yovng advlts witu type 1 diabetes; a longitvdinal stvdy. 2003; 26; 1052…1057.
7. `argeirsdottir UD, ]arsen ‰ˆ, \v||ernes S‰, Brvnborg X, Daul-‰orgensen \.
Yue establisu|ent of a new national networ‚ leads to vality i|pro~e|ent in cuilduood
diabetes; i|ple|entation of tue ISPAD [videlines. Pediatr Diabetes 2010; 11; 88…95.
8. Institvte of `edicine. Xrossing tue Žvality Xuas|; A New Uealtu Syste| for tue
21st Xentvry. xasuington, DX; Yue National Acade|ies Press, 2001.
9. A|erican Diabetes Association Xlinical Practice ˆeco||endations. Diabetes
Xare 2014; 37 FSvppl 1G; 50…59.
10. Yue DXXY ˆesearcu grovp. Diabetes Xontrol and Xo|plications Yrial
FDXXYG; resvlts of feasibility stvdy. Yue DXXY ˆesearcu [rovp. Diabetes Xare 1987;
10; 1…19.
11. jalen•vela ‰`, ]a [reca A`, Usin V, Yaylor X, Dela|ater A`. Prescribed
regi|en intensity in di~erse yovtu witu type 1 diabetes; role of fa|ily and pro~ider per-
ceptions. Pediatr Diabetes 2011; 12; 696…703.
12. Blac‚|an S`, ˆaguinarv D, Adi S et al. Insvlin pv|p vse in yovng cuildren in
tue Y1D ^cuange clinic registry is associated witu lower ue|oglobin A1c le~els tuan
in–ection tuerapy. Pediatr Diabetes 2014. doi; 10.1111pedi.12121, m^pvb auead of printq.
13. Piuo‚er X, Badarv A, Anderson A et al. Insvlin regi|ens and clinical ovtco|es
in a type 1 diabetes couort, tue S^AˆXU stvdy. Diabetes Xare 2013; 2013; 1.
14. Ic‚s A, ˆa•v| V, Bacule X et al. ]ower frevency of insvlin pv|p treat|ent
in cuildren of Yvr‚isu bac‚grovnd witu type 1 diabetes; analysis of 21497 patients in
[er|any. Diabetes Yecunol Yuer 2012; 14; 1105…1109.
15. Swift P[, S‚inner YX, de Beavfort X^ et al. Yarget setting in intensi~e insvlin
|anage|ent is associated witu |etabolic control; tue U~idore cuilduood diabetes stvdy
grovp centre diŠ
erences stvdy 2005. Pediatr Diabetes 2005; 11; 271…279.
16. de Beavfort X, ja•eov A, Sv|ni‚ ‡ et al. Uar|oni•e care to opti|i•e ovtco|e
in cuildren and adolescents witu diabetes |ellitvs; treat|ent reco||endations in
^vrope. Pediatr Diabetes 2012; 13 FSvppl 16G; 15…19.
  \b\t\b
17. Pins‚er ‰^, Ngvyen X, hovng S, Zrederic‚s [‰, Xuan D. A pilot pro–ect for
i|pro~ing diabetes ovtco|es vsing a website; tue Pediatric Diabetes edvcation Portal.
‰ Yele|ed Yelecare 2011; 17; 226…230.
18. I•vierdo ˆ, `orin PX, Bratt \, `oreav ‡ et al. Scuool-centered tele|edicine
for cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr 2009; 155; 374…379.
19. ji|ala~atuini ˆ, [itan–ali B. ^Š
ect of te|peratvre on tue potency and puar|a-
cological action of insvlin. Indian ‰ `ed ˆes 2009; 130; 166…169.
20. Al Suaibi \, Zalata x, Sayes N et al. Storing insvlin in a clay pot in tue desert
cavses no loss of acti~ity; a preli|inary report. Annals of Savdi |edicine 1999; 19;
547…549.
21. ^ng DS, ]ee ‰. Yue pro|ise and peril of |obile uealtu applications for diabetes
and endocrinology. Pediatr Diabetes 2013; 14; 231…238.
22. Zran‚ `. Zactors associated witu non-co|pliancewitu a |edical follow-vp
regi|en after discuarge fro| a pediatric diabetes clinic.Xan ‰Diabetes 1996; 20; 13…20.
23. Pacavd D, `cXonnell B, Uvot X, Aebi X, hale ‰. Yransition fro| pediatric care
to advlt care for insvlindependent diabetes patients. Xan ‰ Diabetes 1996; 20; 14…20.
24. Pacavd D, hale ‰Z, Stepuvre D, Dele-Da~ies U. Proble|s in transition fro|
pediatric care to advlt care for indi~idvals witu diabetes. Xan ‰ Diabetes 2005; 29; 13…18.
25. \ipps S, Bauv Y, Vng \ et al. Xvrrent |etuods of transfer of yovng people witu
type 1 diabetes to advlt ser~ices. Diabet `ed 2002; 19; 649…654.
26. Bvsse ZP, Uier|ann P, [aller A et al. ^~alvation of patients opinion and |eta-
bolic control after transfer of yovng advlts witu type 1 diabetes fro| a pediatric diabetes
clinic to advlt care. Uor| ˆes 2007; 67; 132…138.
27. jan xallegue| N, `acdonald XA, Dean U‰. ^~alvation of a syste|s na~igator
|odel for transition fro| pediatric to advlt care for yovng advlts witu type 1 diabetes.
Diabetes Xare 2008; 31; 1529…1530.
28. Na‚ula `, Dane|an D, Yo Y, Paradis [, [vtt|ann A. Yransition to advlt
care for yovtus witu diabetes |ellitvs; ”
ndings fro| a }ni~ersal Uealtu Xare Syste|.
Pediatrics 2009; 124; e1134…e1141. doi; 10.1542peds.2009-0041, m^pvb 2009 No~ 23q.
29. Sparvd-]vndin X, Vurn I, Danielson ^, Zorsander [. [lycae|ic control and
diabetes care vtili•ation in yovng advlts witu type 1 diabetes.Diabet`ed 2008; 25;
968…973.
30. Do~ey-Pearce [, Uvrrell ˆ, `ay X, xal‚er X, Douerty h. hovng advlts
F16…25 yearsG svggestions for pro~iding de~elop|entally appropriate diabetes ser~ices;
a valitati~e stvdy. Uealtu Soc Xare Xo||vnity 2005; 13; 409…419.
31. ]otstein DS, Seid `, \lingens|itu[et al.Yransition fro| pediatric to advlt
care for yovtu diagnosed witu type 1 diabetes in adolescence. Pediatrics 2013; 131;
e1062…e1070.
32. ‰acobson A`, Uavser SY, xillett ‰, xolfsdorf ‰I, Uer|an ]. Xonsevences of
irregvlar ~ersvs continvovs |edical follow-vp in cuildren and adolescents witu insvlin-
dependent diabetes|ellitvs. ‰ Pediatr 1997; 131; 727…733.
33. Bryden \S, Pe~eler ˆX, Stein A, Neil A, `ayov ˆA, Dvnger DB. Xlinical and
psycuological covrse of diabetes fro| adolescence to yovng advltuood; a longitvdinal
couort stvdy. Diabetes Xare 2001; 24; 1536…1540.
230 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
34. xills X‰, Scott A, Swift P[, Da~ies `‰, `ac‚ie AD, `ansell P. ˆetrospecti~e
re~iew of care and ovtco|es in yovng advlts witu type 1 diabetes. B`‰ 2003; 327;
260…261.
35. ]aing SP, ‰ones `^, Swerdlow A‰, Bvrden AX, [atling x. Psycuosocial and
socioecono|ic ris‚ factors for pre|atvre deatu in yovng people witu type 1 diabetes.
Diabetes Xare 2005; 28; 1618…1623.
36. Blv| ˆx, [arell D, Uodg|an XU et al. Yransition fro| cuild-centered to
advlt uealtu-care syste|s for adolescents witu curonic conditions.Aposition paper of
tue Society for Adolescent `edicine. ‰ Adolesc Uealtu 1993; 14; 570…576.
  \b\t\b
231
47. Xarson x. Adolescence to advltuood; uow to ‚eep adolescents in tue syste|.
‰ Diabetes Nvrs 2007; 7; 24…27.
48. Sa|velsson }. Data fro| tue Swedi
su National Paediatric Diabetes ˆegistry
FSx^DIAB\IDSG. 2012.
49. Uanberger ], Sa|velsson }, ]indblad B, ]vd~igsson ‰. A1X in cuildren
and adolescents witu diabetes in relation to certain clinical para|eters; tue Swedisu
Xuilduood Diabetes ˆegistry Sx^DIAB\IDS. Diabetes Xare 2008; 31; 927…929.
50. xood ‰ˆ, `iller \`, `aaus D` et al. `ost yovtu witu type 1 diabetes
in tue Y1D ^cuange Xlinic ˆegistry do not |eet A|erican Diabetes Association
or International Society for Pediatric and Adolescent Diabetes clinical gvidelines.
Diabetes Xare 2013; 36; 2035…2037.
51. Petitti DB, \lingens|itu [‰, BellˆAet al.[lyce|ic control in yovtu witu dia-
betes; tue S^AˆXU for diabetes in hovtu Stvdy. ‰ Pediatr 2009; 155; 668…672 e1-3.
52. [erstl ^`, ˆabl x, ˆosenbaver ‰ et al. `etabolic control as re›
ected by UbA1c
in cuildren, adolescents and yovng advlts witu type-1 diabetes |ellitvs; co|bined lon-
gitvdinal analysis inclvding 27,035 patients fro| 207 centers in [er|any and Avstria
dvring tue last decade. ^vr ‰ Pediatr 2008; 167; 447…453.
53. Xraig `^, Ywigg S`, Donaguve \X et al. Yecunical ˆeport; [videlines for
Yype 1 Diabetes. Avstralian [o~ern|ent Depart|ent of Uealtu and Ageing; Xanberra,
2011.
54. `ortensen UB, Uovgaard P. International perspecti~es in cuilduood and ado-
lescent diabetes; a re~iew. Yue U~idore Stvdy [rovp on Xuilduood Diabetes. ‰ Pediatr
^ndocrinol `etab 1997; 10; 261…264.
55. `ortensen UB, ˆobertson \‰, Aanstoot U‰ et al. Insvlin |anage|ent and
|etabolic control of type 1 diabetes |ellitvs in cuilduood and adolescence in 18 covn-
tries. U~idore Stvdy [rovp on Xuilduood Diabetes. Diabet `ed 1998; 15; 752…759.
56. Abdel [awwad ^S. Yeacuers and |anage|ent practices abovt diabetes care in
ˆiyadus scuools. ‰ ^gypt Pvblic Uealtu Assoc 2008; 83; 206…222.
57. `aslow [ˆ, ]obato D. Diabetes sv||er ca|ps; uistory, safety and ovtco|es.
Pediatr Diabetes 2009; 10; 278…288.
58. ji‚lvnd [^, ˆvdberg S, xi‚blad \Z. Yeenagers witu diabetes; self-|anage-
|ent edvcation and training on a big scuooner. Int ‰ Nvrs Pract 2007; 13; 385…392.
59. ]ee ‰`, ˆvedy \, Vgrady `‰ et al. Uealtu vtilities for cuildren and advlts witu
type 1 diabetes. `ed Xare 2011; 49; 924…931.
60. Pet‚o~a ^, Pet‚o~a j, \onstantino~a `, Petro~a [. ^cono|ic e~alvation of
continvovs svbcvtaneovs insvlin infvsion for cuildren witu diabetes … a pilot stvdy;
XSII application for cuildren … econo|ic e~alvation. B`X Pediatr 2013; 13.
61. Uvang ^S, V[rady `, Basv A et al. Yue costeŠ ecti~eness of continvovs glv-
cose |onitoring in type 1 diabetes. Diabetes Xare 2010; 33; 1269…1274.
62. Pic‚vp ‰X. Yue e~idence base for diabetes tecunology; appropriate and inappro-
priate|eta-analysis. ‰ Diabetes Sci Yecunol 2013; 7; 1567…1574.
63. Danne Y, \ordonovri V, Uolder`et al. Pre~ention of uypoglyce|ia by vsing
low glvcose svspend fvnction in sensor-avg|ented pv|p tuerapy. Diabetes Yecunol
Yuer 2011; 13; 1129…1134.
232 !\t\t 7. \t\t\f \t\t\b\f\r \t  \r \n    \b\t...
64. Puillip `, Danne Y, Sualitin S et al. }se of continvovs glvcose |onitoring in
cuildren and adolescents. Pediatr Diabetes 2012; 13; 215…228.
65. Puillip `, Battelino Y, Atlas ^ et al. Noctvrnal glvcose control witu an arti”
cial
pancreas at a diabetes ca|p. N ^ngl ‰ `ed 2013; 368; 824…833.
66. Ya|borlane xj. Xlosed-loop insvlin deli~ery; were   ~irtvally tuere. Diabetes
Yecunol Yuer 2012; 14; 203…204.
67. `avsetu ˆ, Uirscu IB, Bolly‚y ‰ et al. }se of a   fv••y logic controller in a
closed-loop arti” cial pancreas. Diabetes Yecunol Yuer 2013; 15; 628…633.
68. `inistry of Uealtu. Uealtu and Uealtu ˆelated Indicators. 2011. 12.
69. jir|ani A, }suabala P, ˆao Pj. Diabetes |ortality in a tertiary referral uospital
in India. ]ancet 1990; 2; 1341.
70. Bere‚et Z^[. Pre~alence of diabetic ‚etoacidosis in newly diagnosed diabetes
|ellitvs pediatrics patients in Yi‚vr Anbessa Speciali•ed Uospital. ^tuiop ‰ Pediatr
Xuild Uealtu 2008; 4; 5…8.
71. ^tuiopia De|ograpuy and Uealtu Svr~ey. ^dvcation Attain|ent. 26…30.
1 \t\t
:\b\f \t 7\b\t\r\t\b \f\b\r8 \t\f7\t\t  5
\t 5\r\n\f \n \n\r\b7 5\t7
234
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
\b\b:\t8 \t \r\f7\b5:\t\t




\r\f7\b5:\t\t

�# # \f\r"#  \f#:".  \fC :"@ \f" \f\t \f"

\n* \fC :"@ \r\f  #@'#J  "#@
\f\t "\r\t ' \f#:" "", : 4…6 \r'  \f@, " 



\n \b\f \f\b  
235

… \r\t :'#, : \rC\fJE\t :\t#  :-
…\r# "#/ \r\t/ * : 14 @ F250 \fG.


 #'\r# \fC \f\r"@\t " #' 




\f $ '# UbA1c \f\t / '\r"/


\t \r\t\b:\t  \f\b\r8 \t\f7\t\t
236
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
+" #"# "\r##  C#\t m8q C" :"@ \t'
"#  UbA1c. UbA1c #" # \r##\t  \r ##
\f## 7 \r'  "#G, \r 192 \f F10,7 @G,  $#" 
"\r\f#$# "\r##  \r#J  163 \f F9 @G  \r
#"# "\r## m6q. \n/\f \r'##\t C\f #'\r#\t# * #
UbA1c "#@  #\f##, \f \r#"# \r\f '#
  "\t F‹4 \f  \fJG m9q. \r\t\t@ E"\t
#\f##\f@\t \r#:@"@  \r\f## '#\t# $"\r$##
J'  \r " 128 \f 187 \f \r# UbA1c 6,9…7,1k. +"# \f
"\r$## J', \r#"  ## #'\r/ '#
\n \b\f \f\b  
237
J"  ", " 5…7 " / ## "\r\t, \fC 
\f\r" ## J! '\r", \r#\f\t"  !#J
E# 6…10 " m7, 10…13q. +"# \f \f\f\rC#J" \r\f$##,
#\f"@"JE#  ", " \f "\r"@\t \f"#@ #@
\r#:#C  \r \r\t UbA1c.  :'\r %"
##  \f" # \f\r"  /\r \f#:"». ("\r## #'#
\r# UbA1c $##\r#@  ## #" %#'\f
###  \fC#  %/  # \r"/ C\f
#H$# F&L(G #\f"@"J"  ", " %"" "\r  \t\t"\t
: "# '# "\r \r#,  %" : \r@! m14…17q.
"# #  \r\f#/ \t/ \r""#  \f/ J\f  \n1 m18…21q.
(\f# C#\f/ C#, \r\f ^}ˆVDIAB,
$# '#"!# C\f '#\t# UbA1c # \r""#
" / 'C/ \r##  \r "\r' 7 " \r\f# 2764
\r#/ $#"  \f#:" 1- "#  '\r" 15…60 ".
# \r""# ##\t \r# #'#/ # #/ '#\t/
UbA1c F\r## \f  }-:\r' \r#G. \n\r""@
" / "\r :   #' \r \r# '#\t/ UbA1c
7…8k F53,0 # 63,9 @G m22q.  "/ \r  \r## \r""#
\r\f# $#"  \f#:" 1- "#  \r@ \r UbA1c
 :\f" "@J \t", $ '#\t UbA1c  6,5k
"\r\tJE#\t %#'\f ####/ \f\r  @#/
238
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
 ' "#"\t : "#"@  \fJE#
)\f\b\f \f\b   „ c\t\f\b* \b\f '  \b
239
7\b\t\r\t\b \f\b\r8 \t\f7\t\t „ d7\f\b\rL \r\b8
=\f  \f\r\t





240
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
\r5\b\t
\nE""  "# \r\r/ #" #"\r# \f\t
\r78 \r5\b\t8 \n7\f\b\r8 \r\b8 =\f  \f\r\t










)\f\b\f \f\b   „ c\t\f\b* \b\f '  \b
241
:\t
 8.1
:(@ *'(! (!#!/" %(+. :(@ '%/%!+
*!#%@. 5(+ F -% (F%@ [email protected]) !%!!$()% *(%@
"! "-"%%@ 3(@ '%/%!+, #"!#()% *!-(!F%%@
 %#()%@# *'(+#. ! E# F% !'-)  +F(&
!*(!#!!,  ! /"& (& !(! "%@F%%& !*(!#!!
%(+
\t()%@&
O%!-!B
/"!&Q
*! #()B
%@&
\n$-*!#()B
%@& O#%B
$"+ #?B
()"Q
@"!& !"
O#?()"
-+'()%Q
\b\t\n\b \f\b\n
%+\t
10
C -
C \r-
% ,  -
C \n,
242
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
C\n\t 10C \n\t#\r\r
%\b \r�J,6…,9
C\t 1%�G,9…,9
�8,**�8,…K,6**
\b\t\n \f \r . 8.1
(\f\f\r \f\b\f \b\f '
243
\n8\b\b 7\b\t\r\t\b \r\b8 =\f
""@ \r\f#"\t ##  \r'@"" &*  \r@
\r# # \f\t \r\r$#\t, \r\f\r##\t \f\t ", ":
##   :\r \f/, "\r #'#\rJ"\t \f\r:"##
'\f m72q.  \f\t!# \f@ \r\f"\t \f\r\t"@ \f
&* "\f\r"# \f# \n* \f\t \r\r"#\r# \f'#\r#
##  \r@ \r#,  \r \r  @ "\f##
�#@'#\t &*. \f \r#\f# ## \f/ \f"
" #\r$## # \f"@ : :HJEJ \r\r"#\r.
"  ", " "\t %" \r# #E#, \r# #\t
## # #'# "#"#  \r@ J'. \r#\f#
##  $#@/ \r/ $#", \r#\r,  \r\f\f#:"
1- "# m73q, &*\n m74q ## &M\n m75, 76q. (\r$#\t, \t
 \r'@"" #'#\t \f/ &*, '# \r'\r:""@ !
\r\f$##  \r##J ## \f\t / J\f  \f#:"
244
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
"@\t $#@# # "# #"# "\r/#\t, #
# "\r/ :/\f# \f\t \f\f\rC#\t "#@,
@J"\r#'#\r/ \r#" F#"\t \fC\f\t
" \r@ ' \r J' m90q.
7\b\t\r\t\b \r\b \f\b  \f\r\t \t 7

)\f\b\f \b\f \r  \f  \b  
245
… :"# \r# ### :  :"# C#", \r", -
…\r# "#/ \r\t/ * : 14 @ F250 \fG.





\r5\b\t 58  \r5\b\t8 \r\b8 \f\b  7


\t\b\r \r:\t8 \rL \n\t\r\b\t8 \f\b  7
### \t\tJ"\t "\rC# ## \f"""# #
\r# ":# \f$##, \r#\f\tE  "$#\f'.
" ## '"\r\f \f/#  "##  #\r## #
# \r "   " :"@ \t'  #"
$#\f', %" "\t# :@ "\r:" \f@! $#.
(\f# "  ,  \r"#C"@ ""#\r#J
246
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
\r5\b\t 58  \r5\b\t8 \r\b8 \f\b  \f\r\t

L"@ \r" \f\t \r\f#\t \r\t BVUB, # # "

\t\b\r \r:\t8 \r\b8 \f\b  \f\r\t


\f#"@J \fCJ #H$#J :"\r\f"JE


B  \t\t  \r    \f\b
247
 \f \t\f7\t\n\f \f\b\r8


…\r# *z
…\f' ##z
…'"#  $#@/ :"#\t/, #\tJE#/  '"#
…"\r:# \f F \r"-#'\r#"\t/Gz
…# ####, ## #/ "\tC"#, "$#@
…%#'\f "\r##"##.



248
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
\t\f\t\r\b\b 7\t\b


UbA1c "\rC" '"# ###  \r\f!"!#
# :# \f\rJ 'C"@ :H"#/ #'\r#
:#,  \r\f &C\f\r\f #" \f##$
\t\r\r\f\r:#G  @@ \f##$ IZXXSI C "#  "; uttp;www.ngsp.orgcon~ert1.asp.\r5\b\t \t \r\t\n \n\b\t8

!\b\t\f\f\r  \f
249

\f##$/ IZXXSI. €


: \r\b\t 7\t\b A1c
250
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
!\b\t\f\f\r  \f
251





252
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
\r\t\r\t 5\r\r\b\b\t8
9\r\f7\t\b \t 5\r\t \t\f\t\r\b\b \r5\f
)\r"'# #'\r\t" ##\r# : \r"# \r#,
  \b\t\b
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. DXXY ˆesearcu [rovp FDiabetes Xontrol and Xo|plications Yrial ˆesearcu
[rovpG. Yue eŠ
ect of intensi~e treat|ent of diabetes on tue de~elop|ent and progres-
sion of long-ter| co|plications in insvlindependent diabetes |ellitvs. N ^ngl ‰ `ed
1993; 329; 977…986.
2. DXXY ˆesearcu [rovp FDiabetes Xontrol and Xo|plications Yrial ˆesearcu
[rovpG. ^Š
ect of intensi~e diabetes treat|ent on tue de~elop|ent and progression
of long-ter| co|plications in adolescents witu insvlin-dependent diabetes |ellitvs;
Diabetes Xontrol and Xo|plications Yrial. ‰ Pediatr 1994; 125; 177…188.
3. Arbelae• A`, Se|en‚o~icu \, Uersuey Y. [lyce|ic etre|es in yovtu witu
Y1D`; tue strvctvral and fvnctional integrity of tue de~eloping brain. Pediatr Diabetes
2013; 14; 541…553.
4. de Beavfort X^, Swift P[, S‚inner XY et al. Xontinving stability of center diŠ
er-
ences in pediatric diabetes care; do ad~ances in diabetes treat|ent i|pro~e ovtco|e—
Yue U~idoere Stvdy [rovp on cuilduood diabetes. Diabetes Xare 2007; 30; 2245…2250.
5. Natuan D`, ‡in|an B, Xleary PA et al. `odernday clinical covrse of type 1
diabetes |ellitvs after 30 years dvration; tue diabetes control and co|plications trial
epide|iology of diabetes inter~entions and co|plications and Pittsbvrgu epide|iology of
diabetes co|plications eperience F1983…2005G. Arcu Intern `ed 2009; 169; 1307…1316.
6. xuite NU, Xleary PA, Dau|s x, [oldstein D, `alone ‰, Ya|borlane xj.
Bene”
cial eŠ
ects of intensi~e tuerapy of diabetes dvring adolescence; ovtco|es after
tue conclvsion of tue Diabetes Xontrol and Xo|plications Yrial FDXXYG. ‰ Pediatr
2001; 139; 804…812.
7. `ousin Z, Xraig `^, Xvsv|ano ‰ et al. Discordant trends in |icro~ascvlar
co|plications in adolescents witu type 1 diabetes fro| 1990 to 2002. Diabetes Xare
2005; 28; 1974…1980.
254
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
8. ]acuin ‰`, [envtu S, Natuan D`, ‡in|an B, ˆvtledge BN. ^Š
ect of glyce|ic
eposvre on tue ris‚ of |icro~ascvlar co|plications in tueDiabetes control and co|-
plications trial-re~isited. Diabetes 2008; 57; 995…1001.
9. xilson D`, _ing D, Bec‚ ˆx et al. Ue|oglobin A1c and |ean glvcose in patients
witu type 1 diabetes analysis of data fro| tue ‰v~enile Diabetes ˆesearcu Zovndation
continvovs glvcose |onitoring rando|i•ed trial. Diabetes Xare 2011; 34; 540…544.
10. Di]iberti ‰U, ]oren• ˆA. ]ong-ter| trends in cuilduood diabetes |ortality;
1968…1998. Diabetes Xare 2001; 24; 1348…1352.
11. Donaguve \X, Zvng AY, Uing S et al. Yue eŠ ect of prepvbertal diabetes dvra-
tion on diabetes. `icro~ascvlar co|plications in early and late adolescence. Diabetes
Xare 1997; 20; 77…80.
12. xriting Yea| for tue DXXY^DIX ˆesearcu [rovp. Svstained eŠ
ect of inten-
si~e treat|ent of type 1 diabetes |ellitvs on de~elop|ent and progression of diabetic
nepuropatuy; tue ^pide|iology of Diabetes Inter~entions and Xo|plications F^DIXG
stvdy. ‰A`A 2003; 290; 2159…2167.
13. Vrcuard Y‰, Zorrest \h, \vller ]U, Ber
c‚er
D‰. ]ipid and blood pressvre treat-
|ent goals for type 1 diabetes; 10-year incidence data fro| tue Pittsbvrg ^pide|iology
of Diabetes Xo|plications Stvdy. Diabetes Xare 2001; 24; 1053…1059.
14. ]y YY, Nicuolas ‰A, ˆetteratu A, ]i| ^`, Da~is ^A, ‰ones Yx. ^Š
ect of
sensor-avg|ented pv|p tuerapy and avto|ated insvlin svspension ~s standard insvlin
pv|p tuerapy on uypoglyce|ia in patients witu type 1 diabetes; a rando|i•ed clinical
trial. ‰A`A 2013; 310; 1240…1247.
15. ‰ounson Sˆ, Xooper `N, ‰ones Yx, Da~is ^A. ]ong-ter| ovtco|e of insvlin
pv|p tuerapy in cuildren witu type 1 diabetes assessed in a large popvlation-based case-
control stvdy. Diabetologia 2013; 56; 2392…2400.
16. Downie ^, Xraig `^, Uing S, Xvsv|ano ‰, Xuan A\, Donaguve \X.
Xontinved redvction in tue pre~alence of retinopatuy in adolescents witu type 1 diabe-
tes; role of insvlin tuerapy and glyce|ic control. Diabetes Xare 2011; 34; 2368…2373.
17. Xooper `N, VXonnell S`, Da~is ^A, ‰ones Yx. A popvlation-based stvdy of
ris‚ factors for se~ere uypoglycae|ia in a conte|porary couort of cuilduood-onset type
1 diabetes. Diabetologia 2013; 56; 2164…2170.
18. Secrest A`, Be
c‚er
D‰, \elsey SZ, ]aPorte ˆ^, Vrcuard Y‰. Xuaracteri•ing
svdden deatu and deadin- bed syndro|e in type 1 diabetes; analysis fro| two cuild-
uood-onset type 1 diabetes registries. Diabet `ed 2011; 28; 293…300.
19. xeston P‰, [ill [j. Is vndetected avtono|ic dysfvnction responsible for svd-
den deatu in type 1 diabetes |ellitvs—Yue dead in bed syndro|e re~isited. Diabet `ed
1999; 16; 626…631.
20. So~i‚ V, Yuordarson U. Dead-in-bed syndro|e in yovng diabetic patients.
Diabetes Xare 1999; 22 FSvppl 2G; B40…B42.
21. Nisui|vra ˆ, ]aPorte ˆ^, Dor|an ‰S, Ya–i|a N, Be
c‚er D, Vrc
uard Y‰.
`ortality trends in type 1 diabetes. Yue Allegueny Xovnty FPennsyl~aniaG ˆegistry
1965…1999. Diabetes Xare 2001; 24; 823…827.
22. Scuoena‚er DA, Si|on D, Xuatvr~edi N, Zvller ‰U, Soeda|au-`vtuv SS.
[lyce|ic control and allcavse |ortality in type 1 diabetes patients; tue ^}ˆVDIAB
Prospecti~e Xo|plications Stvdy. ‰ Xlin ^ndocrinol `etab 2014; 99; 800…807.
  \b\t\b
23. Avstin ^‰, Deary Ÿ
ects of repeated uypoglyce|ia on cogniti~e fvnction; a
psycuo|etrically ~alidated reanalysis of tue Diabetes Xontrol and Xo|plications Yrial
data. Diabetes Xare 1999; 22; 1273…1277.
24. xysoc‚i Y, Uarris `A, `avras N et al. Absence of ad~erse eŠ ects of se~ere
uypoglyce|ia on cogniti~e fvnction in scuool-aged cuildren witu diabetes o~er 18
|ontus. Diabetes Xare 2003; 26; 1100…1105.
25. Da~is ^A, ‰ones Yx. Uypoglyce|ia in cuildren witu diabetes; incidence, covn-
terregvlation and cogniti~e dysfvnction. ‰ Pediatr ^ndocrinol `etab 1998; 11 FSvppl
1G; 177…182.
26. Strvdwic‚ S\, Xarne X, [ardiner ‰, Zoster ‰\, Da~is ^A, ‰ones Yx. Xogniti~e
fvnctioning in cuildren witu early onset type 1 diabetes and se~ere uypoglyce|ia.
‰ Pediatr 2005; 147; 680…685.
27. Soltes• [, Acsadi [. Association between diabetes, se~ere uypoglycae|ia, and
electroencepualograpuic abnor|alities. Arcu Dis Xuild 1989; 64; 992…996.
28. Sculac‚ U, Pal| D, ‰ocu|vs I. In›
vence of recvrrent uypoglyce|ia on tue
^^[ of tue diabetic cuild. `onatsscur \inderueil‚d 1969; 117; 251…253.
29. ˆyan X`, xillia|s Y`, Zinegold DN, Vrcuard Y‰. Xogniti~e disfvnction
in advlts witu type 1 Finsvlin-dependentG diabetes |ellitvs of long dvration; eŠ
of recvrrent uypoglyce|ia and otuer curonic co|plications. Diabetologia 1993; 36;
329…334.
30. [iluavs \U, Dawe‚e U, ]vlsdorf U[, Sacusse ˆ, Sacusse B. ^^[ cuanges in
diabetic cuildren. Dtscu `ed xocuenscur 1973; 98; 1449…1454.
31. ‰acobson A`, `vsen [, ˆyan X` et al. ]ongter| eŠ ect of diabetes and its
treat|ent on cogniti~e fvnction.New ^ngland ‰ovrnal of`edicine 2007; 356; 1842…
1852.
32. `vsen [, ‰acobson A`, ˆyan X` et al. I|pact of diabetes and its treat|ent
on cogniti~e fvnction a|ong adolescents wuo participated in tue Diabetes Xontrol and
Xo|plications Yrial. Diabetes Xare 2008; 31; 1933…1938.
33. \ent S, Xuen ˆ, \v|ar A, Uol|es X. Indi~idval growtu cvr~e |odeling of spe-
ci”
c ris‚ factors and |e|ory in yovtu witu type 1 diabetes; an accelerated longitvdinal
design. Xuild Nevropsycuol 2009; 16; 169…
34. Antenor-Dorsey ‰A, `eyer ^, ˆvtlin ‰ et al. xuite |atter |icrostrvctvral
integrity in yovtu witu type 1 diabetes. Diabetes 2013; 62; 581…589.
35. Yvpola S, ˆa–antie ‰, A‚erblo| U\. ^perience of se~ere uypoglycae|ia |ay
vence botu patients and puysicians svbsevent treat|ent policy of insvlindepen-
dent diabetes |ellitvs. ^vr ‰ Pediatr 1998; 157; 625…627.
36. Scuoenle ^‰, Scuoenle D, `olinari ], ]argo ˆU. I|paired intellectval de~el-
op|ent in cuildren witu type I diabetes; association witu UbAF1cG, age at diagnosis and
se. Diabetologia 2002; 45; 108…114.
37. Xo D‰, \o~atcue~ BP, [onder-Zrederic‚ ]A et al. ˆelationsuips between
uyperglyce|ia and cogniti~e perfor|ance a|ong advlts witu type 1 and type 2 diabetes.
Diabetes Xare 2005; 28; 71…77.
38. Da~is ^A, Soong SA, Byrne [X, ‰ones Yx. Acvte uyperglycae|ia i|pairs cog-
niti~e fvnction in cuildren witu IDD`. ‰ Pediatr ^ndocrinol `etab 1996; 9; 455…461.
256
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
39. `artin DD, Da~is ^A, ‰ones Yx. Acvte eŠ ects of uyperglyce|ia in cuildren-
witu type 1 diabetes |ellitvs; tue patients perspecti~e. ‰ Pediatr ^ndocrinol `etab
2006; 19; 927…936.
40. Perantie DX, xv ‰, \oller ‰` et al. ˆegional brain ~olv|e diŠ
erences associat-
ed witu uyperglyce|ia and se~ere uypoglyce|ia in yovtu witu type 1 diabetes. Diabetes
Xare 2007; 30; 2331…2337.
41. Barnea-[oraly N, ˆa|an `, `a•ai‚a P et al. Alterations in wuite |atter strvc-
tvre in yovng cuildren witu type 1 diabetes. Diabetes Xare 2014; 37; 332…340.
42. [avdieri PA, Xuen ˆ, [reer YZ, Uol|es XS. Xogniti~e fvnction in cuildren
witu type 1 diabetes; a |eta-analysis. Diabetes Xare 2008; 31; 1892…1897.
43. `vsen [, ]yoo I\, Spar‚s Xˆ et al. ^Š
ects of type 1 diabetes on gray |atter
density as |easvred by ~oelbased |orpuo|etry. Diabetes 2006; 55; 326…333.
44. ˆyan X`. xuy is cogniti~e dysfvnction associated witu tue de~elop|ent of
diabetes early in life— Yue diatuesis uypotuesis. Pediatr Diabetes 2006; 7; 289…297.
45. `ar•elli `‰, `a•ai‚a P\, Barnea-[oraly N et al. Nevroanato|ical correlates
of dysglyce|ia in yovng cuildren witu type 1 diabetes.Diabetes 2014; 63; 343…353.
46. \ircuuoŠ BA, ]vgar U`, S|itu S^ et al. Uypoglycae|ia-indvced cuanges in
regional brain ~olv|e and |e|ory fvnction. Diabet `ed 2013; 30; e151…e156.
47. ScuiŠ rin A, Bel|onte `. `vltiple daily self-glvcose |onitoring; its essential
role in long-ter| glvcose control in insvlin-dependent diabetic patients treated witu
pv|p and |vltiple svbcvtaneovs in–ections. Diabetes Xare 1982; 5; 479…484.
48. ˆvsso jX, Uiggins S, xetuer [A, Xa|eron Z‰. ^Š
ects of ›
vctvating glvcose
le~els on nevronal cells in ~itro. Nevrocue| ˆes 2012; 37; 1768…1782.
49. S~oren B`, jol‚ening ]\, Bvtler DA, `oreland ^X, Anderson B‰, ]aŠ
el
]`. Ye|poral trends in tue treat|ent of pediatric type 1 diabetes and i|pact on acvte
ovtco|es. ‰ Pediatr 2007; 144; 660…661.
50. Natuan D`, ]acuin ‰, Xleary P et al. Intensi~e diabetes tuerapy and carotid
inti|a-|edia tuic‚ness in type 1 diabetes |ellitvs. N ^ngl ‰ `ed 2003; 348; 2294…2303.
51. Ualler `‰, Stal~ey `S, Sil~erstein ‰U. Predictors of control of diabetes; |oni-
toring |ay be tue ‚ey. ‰ Pediatr 2004; 144; 660…661.
52. ]e~ine BS, Anderson B‰, Bvtler DA, Antisdel ‰^, Brac‚ett ‰, ]aŠ
el ]`.
Predictors of glyce|ic control and suort-ter| ad~erse ovtco|es in yovtu witu type 1
diabetes. ‰ Pediatr 2001; 139; 197…203.
53. Plotnic‚ ]P, Xlar‚ ]`, Brancati Z], ^rlinger Y. Safety and eŠ
ecti~eness of
insvlin pv|p tuerapy in cuildren and adolescents witu type 1 diabetes. Diabetes Xare
2003; 26; 1142…1146.
54. Scuneider S, Iannotti ˆ‰, Nansel Yˆ et al. Identi”
cation of distinct self-|an-
age|ent styles of adolescents witu type 1 diabetes. Diabetes Xare 2007; 30; 1107…1112.
55. xein•i|er SA, Auern ‰U, Doyle^Aet al.Persistence of bene” ts of continvovs
svbcvtaneovs insvlin infvsion in ~ery yovng cuildren witu type 1 diabetes; a follow-vp
report. Pediatrics 2004; 114; 1601…1605.
56. Ysali‚ian ^, \oll|an X, Ya|borlane xB et al. Pre~ention of uypoglyce|ia
dvring eercise in cuildren witu type 1 diabetes by svspending basal insvlin. Diabetes
Xare 2006; 29; 2200…2204.
  \b\t\b
257
57. ‰vnguei| \, \oscuins‚y Y. [lvcose |onitoring at tue ar|; ris‚y delays of
uypoglyce|ia and uyperglyce|ia detection. Diabetes Xare 2002; 25; 956…960.
58. ]vcidar|e N, Alberti X, ‡accaria I, Xlavde ^, Yvbiana-ˆv”
N. Alternate-site
testing is reliable in cuildren and adolescents witu type 1 diabetes, ecept at tue forear|
for uypoglyce|ia detection. Diabetes Xare 2005; 28; 710…711.
59. Bergenstal ˆ, Pearson ‰, Xe|brows‚i [S, Bina D, Da~idson ‰, ]ist S.
Identifying ~ariables associated witu inaccvrate self-|onitoring of blood glvcose; pro-
posed gvidelines to i|pro~e accvracy. Diabetes ^dvc 2000; 26; 981…989.
60. Ysali‚ian ^, `avras N, Bec‚ ˆx et al. I|pact of eercise on o~ernigut glyce|ic
control in cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr 2005; 147; 528…534.
61. Yansey `‰, Ysali‚ian ^, Bec‚ ˆx et al. Yue eŠ
ects of aerobic eercise on glv-
cose and covnterregvlatory uor|one concentrations in cuildren witu type 1 diabetes.
Diabetes Xare 2006; 29; 20…25.
62. Uer|ansson [, ]vd~igsson ‰, ]arsson h. Uo|e blood glvcose |onitoring in
diabetic cuildren and adolescents. A 3-year feasibility stvdy. Acta Paediatr Scand 1986;
75; 98…105.
63. Bergenstal ˆ`, \lonoŠ
DX, [arg S\ et al. Yuresuold-based insvlin-pv|p
interrvption for redvction of uypoglyce|ia. N ^ngl ‰ `ed 2013; 369; 224…232.
64. `aaus D`, Xaluovn P, Bvc‚ingua| BA et al. A rando|i•ed trial of a uo|e
syste| to redvce noctvrnal uypoglyce|ia in type 1 diabetes. Diabetes Xare 2014; 37;
1885…1891.
65. ]eelaratuna ], ]ittle SA, xal‚insuaw ^ et al. ˆestoration of self-awareness of
uypoglyce|ia in advlts witu long-standing type 1 diabetes; uyperinsvline|ic-uypogly-
ce|ic cla|p svbstvdy resvlts fro| tue UypoXV`PaSS trial. Diabetes Xare 2013; 36;
4063…4070.
66. Uo~or‚a ˆ. Xlosed-loop insvlin deli~ery; fro| bencu to clinical practi~e. Nat
ˆe~ ^ndocrinol 2011; 7; 385…395.
67. Xuovduary P, ˆa|asa|y S, [reen ] et al. ˆealti|e continvovs glvcose |oni-
toring signi”
cantly redvces se~ere uypoglyce|ia in uypoglyce|iavnaware patients witu
type 1 diabetes. Diabetes Xare 2013; 36; 4160…4162.
68. Bvc‚ingua| B, Xuase UP, Dassav ^ et al. Pre~ention of noctvrnal uypogly-
ce|ia vsing predicti~e alar| algoritu|s and insvlin pv|p svspension. Diabetes Xare
2010; 33; 1013…1017.
69. Sparacino [, ‡anderigo Z, Xora••a S, `aran A, Zaccuinetti A, Xobelli X.
[lvcose concentration can be predicted auead in ti|e fro| continvovs glvcose |oni-
toring sensor ti|e-series. I^^^ Yrans Bio|ed ^ng 2007; 54; 931…937.
70. `astrototaro ‰‰, Xooper \x, Sovndarara–an [, Sanders ‰B, Suau ˆj. Xlinical
eperience witu an integrated continvovs glvcose sensorinsvlin pv|p platfor|; a fea-
sibility stvdy. Ad~ Yuer 2006; 23; 725…732.
71. Xuase UP, \i| ]`, Vwen S] et al. Xontinvovs svbcvtaneovs glvcose |onitor-
ing in cuildren witu type 1 diabetes. Pediatrics 2001; 107; 222…226.
72. [arg S, ‡isser U, Scuwart• S et
al. I|pro~e|ent in glyce|ic ecvrsions witu
a transcvtaneovs, real-ti|e continvovs glvcose sensor; a rando|i•ed controlled trial.
Diabetes Xare 2006; 29; 44…50.
258
 8. \b\t\n \f\r\t \r \t \n\r\t\r  \n\b\f  \b\b...
73. Steck AK, Dong F, Taki I, Ho man M, Klingensmith GJ, Rewers MJ. Early
hyperglycemia detected by continuous glucose monitoring in children at risk for type 1
diabetes. Diabetes Care 2014: 36: 4063…4070.
74. Borowiec M, Mysliwiec M, Fendler W et al. Phenotype variability and neonatal
diabetes in a large family with heterozygous mutation of the glucokinase gene. Acta
Diabetol 2011: 48: 203…208.
75. Je eries C, Solomon M, Perlman K, S
weezey N,
Daneman D. Continuous
glucose monitoring in children and adolescents with cystic “
brosis. J Pediatr 2005: 147:
76. ORiordan SM, Hindmarsh P, Hill NR et al. Validation of continuous glucose
monitoring in children and adolescents with cystic “
brosis: a prospective cohort study.
Diabetes Care 2009: 32: 1020…1022.
77. Deiss D, Bolinder J, Riveline JP et al. Improved glycemic control in poorly
controlled patients with type 1 diabetes using real-time continuous glucose monitoring.
Diabetes Care 2006: 29: 2730…2732.
78. Iscoe KE, Campbell JE, Jamnik V, Perkins BA, Riddell MC. E
cacy of
continuous real-time blood glucose monitoring during and after prolonged highinten-
sity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes
Technol Ther 2006: 8: 627…635.
79. Maia FF, Araujo LR. Accuracy, utility and complications of continuous glucose
monitoring system (CGMS) in pediatric patients with type 1 diabetes. J Pediatr (Rio J)
2005: 81: 293…297.
80. Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L. Safety of various methods
of intense insulin therapy in hospital condition assessed by hypoglycemic episodes detected
with the use of continuous glucose monitoring system. Adv Med Sci 2006: 51: 133…136.
81. Bergenstal RM, Tamborlane WV, Ahmann A et al. E ectiveness of sensor-
augmented insulin-pump therapy in type 1 diabetes. New England Journal of Medicine
2010: 363: 311…320.
82. Beck RW, Buckingham B, Miller K et al. Factors predictive of use and of ben-
t from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009: 32:
1947…1953.
83. Weinzimer S, Xing D, TanseyM et al. Prolonged use of continuous glucose
monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion
or intensive multiple-daily injection therapy. Pediatr Diabetes 2009: 10: 91…96.
84. JDRFCGMStudy Group (Juvenile Diabetes Research Foundation Continuous
Glucose Monitoring Study Group), Tamborlane WV, Beck RW et al. Continuous glu-
cosemonitoring and intensive treatment of type 1 diabetes. New England Journal of
Medicine 2008: 359: 1464…1476.
85. Cemeroglu AP, Stone R, Kleis L, Racine MS, Pstellon DC, Wood MA. Use
of a real-time continuous glucose monitoring system in children and young adults on
insulin pump therapy: patients and caregivers perception of bene“
t. Pediatr Diabetes
2010: 11: 182…187.
86. Battelino T, Krzisnik C. Incidence of type 1 diabetes mellitus in children in
Slovenia during the years 1988…1995. Acta Diabetol 1998: 35: 112…114.
  \b\t\b
87. Puillip `, Battelino Y, Atlas ^ et al. Noctvrnal glvcose control witu an arti”
cial
pancreas at a diabetes ca|p. N ^ngl ‰ `ed 2013; 368; 824…833.
88. V[rady `‰, ˆetteratu A‰, \eenan DB et al. Yue vse of an avto|ated, por-
table, glvcose control syste| for o~ernigut glvcose control in adolescents and yovng
advlts witu type 1 diabetes. Diabetes Xare 2012; 35; 2182…2187.
89. Uo~or‚a ˆ, ^lleri D, Yuabit U et al. V~ernigut closed-loop insvlin deli~ery in
yovng people witu type 1 diabetes; a free-li~ing, rando|i•ed clinical trial. Diabetes
Xare 2014; 37; 1204…2011.
90. Xefalv xY, Ya|borlane xj. Yue arti” cial pancreas; are we tuere yet— Diabetes
Xare 2014; 37; 1182…1183.
91. ]aŠ el ]`B, xent•ell \, ]ovgulin X, Yo~ar A, `olt• \, Brin‚ S. Sic‚ day
|anage|ent vsing blood 3-uydroybvtyrate F3-VUBG co|pared witu vrine ‚etone
|onitoring redvces uospital ~isits in yovng people witu Y1D`; a rando|i•ed clinical
trial. Diabet `ed 2006; 23; 278…284.
92. ˆewers A, `cZann \, Xuase UP. Bedside |onitoring of blood beta-uydroy-
bvtyrate le~els in tue |anage|ent of diabetic ‚etoacidosis in cuildren. Diabetes
Yecunol Yuer 2006; 8; 671…676.
c‚er AA, Pue
lan U, Ywigg S`, Xraig `^. Blood W-uydroybvtyrate ~s.
vrine acetoacetate testing for tue pre~ention and |anage|ent of ‚etoacidosis in type 1
diabetes; a syste|atic re~iew. Diabet `ed 2013; 30; 818…824.
94. ˆewers A, Xuase UP, `a
c‚en•ie Y et al. Predictors of acvte co|plications in
cuildren witu type 1 diabetes. ‰A`A 2002; 287; 2511…2518.
95. Yabovlet P, Deconinc‚ N, Yuvrel A et al. Xorrelation between vrine ‚etones
FacetoacetateG and capillary blood ‚etones F3-beta-uydroybvtyrateG in uyperglycae|ic
patients. Diabetes `etab 2007; 33; 135…139.
96. Yauara h, Sui|a \. \inetics of UbA1c, glycated albv|in, and frvctosa|ine
and analysis of tueir weigut fvnctions against preceding plas|a glvcose le~el. Diabetes
Xare 1995; 18; 440…447.
97. Natuan D`, \venen ‰, Borg ˆ, ‡ueng U, Scuoenfeld D, Ueine ˆ‰. Yranslating
tue A1X assay into esti|ated a~erage glvcose ~alves. Diabetes Xare 2008; 31;
1473…1478.
98. `osca A, [oodall I, Uosuino Y et al. [lobal standardi•ation of glycated ue|o-
globin |easvre|ent; tue position of tue IZXX xor‚ing [rovp. Xlin Xue| ]ab `ed
2007; 45; 1077…1080.
99. ˆeport of tue ADA^ASIDZ xor‚ing [rovp of tue UbA1c Assay, ]ondon,
}\. Diabetologia 2014; 47; ˆ53…ˆ54.
100. Uoel•el x, `eide|a \. De~elop|ent of a reference syste| for tue interna-
tional standardi•ation of UbA1cglycoue|oglobin deter|inates. ‰ Int Zed Xlin Xue|
1996; 8; 62…67.
101. \obold },
‰eppss
er Y, Zin‚e A, Uoel•elx, `eide|a \. Xandidate
reference|etuods for ue|oglobin A1c based on peptide |apping. Xlin Xue| 1997; 43;
1944…1951.
102. Uoel•el x, xey‚a|p X,
‰eppsson
‰V et al. IZXX reference syste| for |easvre-
|ent of ue|oglobin A1c in uv|an blood and tue national standardi•ation scue|es in
tue }nited States, ‰apan, and Sweden; a |etuod-co|parison stvdy. Xlin Xue| 2004; 50;
166…174.
260
!\t\t 8.  \f\t  \f\b\f \f\b      \r...
103. xey‚a|p X. UbA1c; a re~iew of analytical and clinical aspects. Ann ]ab `ed
2013; 33; 393…400.
104. A|erican Diabetes Association, ^vropean Association for tue Stvdy of
Diabetes, International Zederation of Xlinical Xue|istry and ]aboratory `edicine,
International Diabetes Zederation. Xonsensvs state|ent on tue worldwide standardi•a-
tion of tue ue|oglobin A1X |easvre|ent. Diabetes Xare 2007; 30; 2399…2400.
105. Ya|borlane xj, \oll|an X, SteŠ es `x et al. Xo|parison of ”
ngerstic‚
ue|oglobin A1c le~els assayed by DXA 2000 witu tue DXXY^DIX central laboratory
assay; resvlts of a Diabetes ˆesearcu in Xuildren Networ‚ FDirecNetG Stvdy. Pediatr
Diabetes 2005; 6; 13…16.
106. Xuiang ‰], \ir‚|an `S, ]aŠ el ]`B, Peters A], on beualf of tue Yype 1
Diabetes Sovrceboo‚ Avtuors. Yype 1 diabetes turovgu tue life span; a position state-
|ent of tue A|erican Diabetes Association. Diabetes Xare 2014; 37; 2034…2054.
107. xood ‰ˆ, `iller \`, `aaus D` et al.`ost yovtu witu type 1 diabetes
in tue Y1D ^cuange Xlinic ˆegistry do not |eet A|erican Diabetes Association
or International Society for Pediatric and Adolescent Diabetes clinical gvidelines.
Diabetes Xare 2013; 36; 2035…2037.
108. Sa|valsson }, Uanberger ], Pvnd•vite-]yc‚å A, Å‚esson ^lf~in \, Ört~ist
^, Särnblad S, `iftara– `. hearly report. Sx^DAID\IDS. National vality register for
cuildren and adolescents witu diabetes. ˆegister Xenter jästra [ötaland, [otuenbvrg,
Sweden 2013 Fa~ailable fro| uttps;swediab‚ids.ndr.nvG
109. [vbitosi-\lvg ˆA. Yue diabetes control and co|plications trialepide|iol-
ogy of diabetes inter~entions and co|plications stvdy at 30 years; sv||ary and fvtvre
directions. Diabetes Xare 2014; 37; 44…49.
110. Xuase UP, ]oc‚speiser Y, Peery B et al. Yue i|pact of tue diabetes control and
co|plications trial and uv|alog insvlin on glycoue|oglobin le~els and se~ere uypogly-
ce|ia in type 1 diabetes. Diabetes Xare 2001; 24; 430…434.
111. Da~is ^A, \eating B, Byrne [X, ˆvssell `, ‰ones Yx. I|pact of i|pro~ed
glycae|ic control on rates of uypoglycae|ia in insvlin dependent diabetes |ellitvs.
Arcu Dis Xuild 1998; 78; 111…115.
112. Nordfeldt S, ]vd~igsson ‰. Ad~erse e~ents in intensi~ely treated cuildren and
adolescents witu type 1 diabetes. Acta Paediatr 1999; 88; 1184…1193.
113. `itra‚ov A, ˆyan X, jene|an Y et al. Uierarcuy of glyce|ic turesuolds
for covnterregvlatory uor|one secretion, sy|pto|s, and cerebral dysfvnction. A|
‰ Puysiol 1991; 260 F1 Pt 1G; ^67…^74.
114. Zanelli X, Pa|panelli S, ^pifano ] et al. ˆelati~e roles of insvlin and uypogly-
cae|ia on indvction of nevroendocrine responses to, sy|pto|s of, and deterioration
of cogniti~e fvnction in uypoglycae|ia in |ale and fe|ale uv|ans. Diabetologia 1994;
37; 797…807.
115. Da~is SN, Sua~ers X, `osveda-[arcia ˆ, Xosta Z. ^Š
ects of diŠ ering ante-
cedent uypoglyce|ia on svbsevent covnterregvlation in nor|al uv|ans. Diabetes
1997; 46; 1328…1335.
116. Xryer P^. Uypoglyce|ia; tue li|iting factor in glycae|ic |anage|ent of type
I and type II diabetes. Diabetologia 2002; 45; 937…948.
  \b\t\b
261
117. Ueller Sˆ, Xryer P^. ˆedvced nevroendocrine and sy|pto|atic responses
to svbsevent uypoglyce|ia after 1 episode of uypoglyce|ia in nondiabetic uv|ans.
Diabetes 1991; 40; 223…226.
118. ‰ones Yx, Borg xP, Borg `A et al. ˆesistance to nevroglycopenia; an adapti~e
response dvring intensi~e insvlin treat|ent of diabetes. ‰ Xlin ^ndocrinol `etab 1997;
82; 1713…1718.
119. Si|onson DX, Ya|borlane xj, DeZron•o ˆA, Suerwin ˆS. Intensi~e insvlin
tuerapy redvces covnterregvlatory uor|one responses to uypoglyce|ia in patients witu
type 1 diabetes. Ann Intern `ed 1985; 103; 184…190.
120. Xranston I, ]o|as ‰, `aran A, `acdonald I, A|iel SA. ˆestoration of uypo-
glycae|ia awareness in patients witu long-dvration insvlin-dependent diabetes. ]ancet
1994; 344; 283…287.
121. Xryer P^, Zisuer ‰N, Sua|oon U. Uypoglyce|ia. Diabetes Xare 1994; 17;
734…755.
122. Bober ^, Bvyv‚gebi• A. Uypoglyce|ia and its eŠ
ects on tue brain in cuildren
witu type 1 diabetes |ellitvs. Pediatr ^ndocrinol ˆe~ 2005; 2; 378…382.
123. Desrocuer `, ˆo~et ‰. Nevrocogniti~e correlates of type 1 diabetes |ellitvs in
cuiluood. Xuild Nevropsycuol 2004; 10; 36…52.
124. `aaus D`, Uer|ann ‰`, DvBose SN et al. Xontrasting tue clinical care and
ovtco|es of 2,622 cuildren witu type 1 diabetes less tuan 6 years of age intue }nited
States Y1D ecuange and[er|anAvstrian DPj registries. Diabetologia 2014.
125. Natuan D`, `c[ee P, SteŠ
es `x, ]acuin ‰`, DXXY^DIX ˆesearcu
[rovp. ˆelationsuip of glycated albv|in to blood glvcose and UbA1c ~alves and to
retinopatuy, nepuropatuy, and cardio~ascvlar ovtco|es in tue DXXY^DIX stvdy.
Diabetes 2014; 63; 282…290.
126. Sel~in ^, ˆawlings A`, [ra|s ` et al. Zrvctosa|ine and glycated albv|in
for ris‚ strati”
cation and prediction of incident diabetes and |icro~ascvlar co|plica-
tions; a prospecti~e couort analysis of tue Atuerosclerosis ˆis‚ in Xo||vnities FAˆIXG
stvdy. ]ancet Diabetes ^ndocrinol 2014; 2; 279…288.
1 \t\t
\t\b\n\t\b\r \t8 \r\t \n\r\b7 5\t
 5 \t 5\r\n\f
\b\t   \f  \b  \f\t
263
\f\r\f 5\b\t \t \r\f7\b5:\t\t


 'C"# #"# \rC# ## F# ##





!#\t  ## "\r,  :"#  "/

264
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b






5\b\t
  \f
265
266
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
  \f
267
## \f#"@ \f"#\t m42…52q. \b # #C#
268
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
\fC :"@ \r## \f\t  #\r \f#:"#
 &*  \r# #@'## , " # \r# &L( F'\r"
"  "\tC ####z \r# %" #C# UbA1c :
# m62q,  \t\tJE#\t \r'@"" \f#/ #\f# #"
5\n \b\nL \t\b\n\t\b


$\f* \f\f\t
269
9\r7 \t \r\b\t5\b\n\t \t\b\n\t\b



# \f" # "#  #@'J"\t #\f  #\r. \r#'\f"
 9.1
!"! ** !%"$(!% ! **(#@� *!(! &"!+,
"("% *!"%!_ *!'!(&
!* !%"$(!%\b/( &"!+,
��6,2…6,G2…G�G…
�6,…2,65…J�…
2…5J…26…29
C%E5…JJ…2525…5J
Q"' \t G…J�9…22…5J
\t\n\t \f\t\t \b  \f\b\rQ\r   \t5…JC3 5J*
Q\r  \b2…5C3 5J*
Q\r  \b \b**��6,…2,C
270
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
!* !%"$(!%\b/( &"!+,
=\t  \f\t J…25…5J56…G6
\b \t\b\n\t\b \f\r\f 5\n\t8

##  ### \r\f \r\fC#"@"# \f"#\t \r#

\b\t \t\b\n\t\b L\r\f\r\f 5\n\t8

\b\t\n \f \r . 9.1
E \t\f* \t\f\t \f\f\t
271




\b\t L\r\f\r\f\t \b\t
 \n\b\nL \b \t\b\n\t\b
272
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
\r#", "  E"" #'" /#', \r\f"
\b\r\t\b\b 5\b\t \t\b\n\t\b


\t\b\n\t\b \n\r5\b \r5M\tL\b\n\t 5\n\t8
\r## \f"#\t %"#/ #'-## Q \fJ" #/ \f:#
/ \rC#/. @ # \r\f"\tJ" : '#J, :/\f#
\r#@ \r\f#"@ !## \r\f #/ \f#.   J: 
# \t'  :@! #"\r- # #"\r#\f##\f@ \r#:@"@J
L\b \b\t \t\b\n\t\b
 #/ : \r\f' ## %"  @!
C\f\f \t\b\f
273
\t\b\n\t\b \r\t\b
## m80q. \f#'#\r "\r@ %\r#" 
 \r#\r \r' 20   #H$##  #" #C"@\t
 ## \r# "@  \f""\t \t$#\t
274
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
\t\b\n\t\b 57\t\r
\t\b\n\t\b 5\tL\b 5\n\t8
\t\b\n\t\b 55\f
(# \f\f \t\t"\t !#  @"\r\f#"@
.  \fC
$##\rJ", " \r#\f#"  \f # ":#@ :C\f#J
\r ## \f\f  \r". = \t'# %"#  \f"#
'"  ", " \f\r %" ## \f\f /\r\t"\t
#  %" '\r" \r m87q. @"\r\f#"@ \r#@ \f"#\t
## \f\f '\t" #"@  C"# \r \r#
\f#\t :'@ C\f ##, " C" \r#\f#"@\t \f\t
$#"  \r\t\f :\r' C#'#, \r#\r, \f\r".
/ \r # ":#@ \r#"## # \r\f###.
\t\t\r\b\b \t \r O
PEGYLATED LISPRO
!   \f\f \b \t\b\t
275
L\r\b
 \n7\n\t \t\b\n\t\b \r \r
*" ## # F ##\r "!#



*" ## # \f/\f\t" \f\t #@'#\t 

276
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
\t\b\t\r7 \t\b\n\t\b
\f\b:\b\r:\t\t \t\b\n\t\b
\r\b\b\t \t\b\n\t\b
) \t \fF \r
277







/ !\r#$-\r " :"@  "##,  \f\t .
7\n \t\be\f:\t



278
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b

\r7 \n \r5\b\t7 \t\be\f:\t
\t\tJ"\t " \r:  \f".
\b \f\f\t
279
\n\r:\t8 \t\b\n\t\b










280
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
# \f:  ##, #: :\f# \f \f "#
 \r" \f#\t ## F\r\f\r\tJE \f#G
m118q. \r\f "  \r\f"@ %"" "\f \f\t \f#"\r#
"#", C :\f#"@\t   \f\r %"#"# #
(\b \f \f \f\f\t
281
282
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
\r# #@'## 4…6-##"\r/ # #H$## C \f"@
 F \r \r, 8  \fC \t, "\r " C#J"\t
\r# \r\f#\t\r #H$##G m123q.  /\f/ @#, \f,
: "#  \fC C#\r, :  :"# :\f\r m123,
124q. L# \r\f#"@ #H$#J  \t\f#$, " "  \fC C#\r
: \f"" "E#, \f\t " ": \r\f#"@ #H$#J :'
. ?# ""\r F\r#\r,
(\b \f \f \f\f\t
283
'#"# %"  "\r@ ### # #### 
284
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
(\b \f \f \f\f\t
285
(' "\r/ #@'/ \f\t @"\r\r"#/ ##  \f/ #'
\r#"@/ \f/,  : ## #'#. \b !#\r
\f#\t# ((, "\r '# : # \r# J'##
#'#  \r#J  \f\t \f\r## @"\r\r"## # m153q.
= " $## \f\t ! ":# "\r\t \r# ((
\f :J  #" : # m57q. = \f\r /
286
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
\b\t\f \t\be\f:\t
(\b \f \f \f\f\t
287
\rM\t7 \t\b\n\t\b\r \t\t
=:\r \rC# ##"\r## '##" " #/ "\r,

288
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b


# \r" ## @"\r\r" \f"#\t # ## \r\f
\f"#\t ## :'@  ## \f#"@ \f"#\t,
"@ \f"\r#"@ '"# ":# "\r\t
## ## \r\f \r\fC#"@"# ## \f#"@
\r\t\b:\t  \t\b\n\t\b\r \t\t
\n \t\n L7 \rM\t7
'!"%@& -(_"%@& F!#





/  \b\t\f'
289
#*+ !%"$(!%*!+ *"+%%& *F�%& !%$'!& !%"$(!%

\n%"%@ *!!

7% !%%"!%@ F!#@


\n\b8 5 \t\b\n\t\b










\r\f5\n  5\t\r\b\t=
290
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b



\r\n \r5\b\t 5 \t\b\n\t\b
/ \b\t  \f\f\t
291
\r\t\r\f 5 \t\b\n\t\b
\n\f\r \n \n\b\f\t 5\t\b



5L\b8 \f\r\r\f\t\r\f 5 \t\b\n\t\b



292
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
 5L \r\t \n8\b\b \f\b\b\t8 \r\b8
=\f  \f\r\t  : \b\b\t






:  \t* \b \f\f \f \f \b\f '  \b...
293








9\b7\b «\r\b\b \r\t» O
DAWN PHENOMENON
\r# * #J" "\f$#J  !#J  "\r# 
294
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b


\f\b9\t\f \t\b\r\n
Sano“
# Roche. P‰-X  " ' $## " Eli Lilly, Novo Nordisk, Sano“
Sano“
Sano“
Sano“
2014
  \b\t\b
295
\n \t\n\f \t\r\r
1. Bangstad U‰, Danne Y, Deeb ], ‰aros•-Xuobot P, }ra‚a|i Y, Uanas ˆ. Insvlin
treat|ent in cuildren and adolescents witu diabetes. Pediatr Diabetes 2009; 10 FSvppl.
12G; 82…99.
2. ‰ounsson S. ˆetinopatuy and nepuropatuy in diabetes |ellitvs; co|parison of
tue eŠ
ects of two for|s of treat|ent. Diabetes 1960; 9; 1…8.
3. Siebenuofer A, Plan‚ ‰, Berguold A et al. Suort acting insvlin analogves ~ersvs
regvlar uv|an insvlin in patients witu diabetes |ellitvs. Xocurane Database Syst ˆe~
2006; XD003287.
4. Brvnner [A, Uirscuberger S, Sendluofer [ et al. Postprandial ad|inistration of
tue insvlin analogve insvlin aspart in patients witu type 1 diabetes |ellitvs. Diabet `ed
2000; 17; 371…375.
5. Danne Y, Deiss D, Uopfen|vller x, ~on Scuvt• x, \ordonovri V. ^perience
witu insvlin analogves in cuildren. Uor| ˆes 2002; 57 FSvppl. 1G; 46…53.
6. `ortensen UB, ]induol| A, Vlsen BS, Uylleberg B. ˆapid appearance and
onset of action of insvlin aspart in paediatric svb–ects witu type 1 diabetes. ^vr ‰ Pediatr
2000; 159; 483…488.
7. Danne Y, Be
c‚er
ˆU, Ueise Y, Bittner X, Zric‚ AD, ˆa~e \. Puar|aco‚inetics,
prandial glvcose control, and safety of insvlin glvlisine in cuildren and adolescents witu
type 1 diabetes. Diabetes Xare 2005; 28; 2100…2105.Acerini X], Xueetua| YD, ^dge
‰A, Dvnger DB. Botu insvlin sensiti~ity and insvlin clearance in cuildren and yovng
advlts witu type I Finsvlin-dependentG diabetes ~ary witu growtu uor|one concentra-
tions and witu age. Diabetologia 2000; 43; 61…68.
8. A|iel SA, Suerwin ˆS, Si|onson DX, ]avritano AA, Ya|borlane xj.
I|paired insvlin action in pvberty. A contribvting factor to poor glyce|ic control in
adolescents witu diabetes. N ^ngl ‰ `ed 1986; 315; 215…219.
9. Plan‚ ‰, xvtte A, Brvnner [ et al. A direct co|parison of insvlin aspart and
insvlin lispro in patients witu type 1 diabetes. Diabetes Xare 2002; 25; 2053…2057.
10. Xe|eroglv AP, \leis ], xood A, Par‚es X, xood `A, Da~is AY. Xo|parison
of tue eŠ ect of insvlin glvlisine to insvlin aspart on brea‚fast postprandial blood glvcose
le~els in cuildren witu type 1 D` on |vltiple daily in–ections. ^ndocr Pract 2013; 2013z
19;614…619.
11. Ueise Y, Nose‚ ], Spit•er U et al. Insvlin glvlisine; a faster onset of action co|-
pared witu insvlin lispro. Diabetes Vbes `etab 2007; 9; 746…753.
12. Zord-Ada|s `^, `vrpuy NP, `oore ^‰ et al. Insvlin lispro; a potential role
in pre~enting noctvrnal uypoglycae|ia in yovng cuildren witu diabetes |ellitvs.Diabet
`ed 2003; 20; 656…660.
13. Deeb ]X, Uolco|be ‰U, Brvnelle ˆ et al. Insvlin lispro lowers postprandial
glvcose in prepvbertal cuildren witu diabetes. Pediatrics 2001; 108; 1175…1179.
14. Yvbiana-ˆv”
N,Xovtant ˆ, Blocu ‰ et al.Special |anage|ent of insvlin lispro
in continvovs svbcvtaneovs insvlin infvsion in yovng diabetic cuildren; a rando|i•ed
cross-o~er stvdy. Uor| ˆes 2004; 62; 265…271.
15. Yvpola S, \o|vlainen ‰, ‰aas‚elainen ‰, Sipila I. Postprandial insvlin lispro ~s.
uv|an regvlar insvlin in prepvbertal cuildren witu type 1 diabetes |ellitvs. Diabet `ed
2001; 18; 654…658.
296
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
16. Uolco|be ‰U, ‡alani S, Arora j\, `ast X‰. Xo|parison of insvlin lispro witu
regvlar uv|an insvlin for tue treat|ent of type 1 diabetes in adolescents. Xlin Yuer
17. ˆenner ˆ, Pfvt•ner A, Yravt|ann `, Uar•er V, Savter \, ]andgraf ˆ. }se
of insvlin lispro in continvovs svbcvtaneovs insvlin infvsion treat|ent. ˆesvlts of
a |vlticenter trial. [er|an Uv|alog-XSII Stvdy [rovp. Diabetes Xare 1999; 22;
784…788.
18. ˆvtledge \S, Xuase UP, \lingens|itu [‰, xalra~ens PA, Slo~er ˆU, [arg
ecti~eness of postprandial Uv|alog in toddlers witu diabetes. Pediatrics 1997;
100; 968…972.
19. Ueller Sˆ, Xolagivri S, jaaler S et al. Uypoglycae|ia witu insvlin aspart; a
dovble-blind, rando|ised, cross o~er trial in svb–ects witu type1diabetes. Diabet `ed
2004; 21; 769…775.
20. Uo|e PD, ]induol| A, ˆiis A, ^vropean Insvlin Aspart Stvdy [rovp. Insvlin
aspart ~s. uv|an insvlin in tue |anage|ent of long-ter| blood glvcose control in type
1 diabetes |ellitvs; a rando|i•ed controlled trial. Diabet `ed 2000; 17; 762…770.
21. Ueise Y, Nose‚ ], ˆonn BB et al. ]ower wituinsvb–ect ~ariability of insvlin
dete|ir in co|parison to NPU insvlin and insvlin glargine in people witu type 1 diabe-
tes. Diabetes 2004; 53; 1614…1620.
22. Danne Y, Dat• N, ^ndaul ] et al. Insvlin dete|ir is cuaracteri•ed by a |ore
reprodvcible puar|aco‚inetic pro”
le tuan insvlin glargine in cuildren and adolescents
witu type 1 diabetes; resvlts fr
o| a rando
|i•ed,
bleblind, controlled trial. Pediatr
Diabetes 2008; 9; 554…560.
23. Uer|ansen \, Zontaine P, \v‚ol–a \\, Peter‚o~a j, ]etu [, [all `A. Insvlin
analogves Finsvlin dete|ir and insvlin aspartG ~ersvs traditional uv|an insvlins FNPU
insvlin and regvlar uv|an insvlinG in basal-bolvs tuerapy for patients witu type 1 dia-
betes. Diabetologia 2004; 47; 622…629.
24. Scuober ^, Scuoenle ^, jan Dy‚ ‰, xernic‚e-Panten \. Xo|parati~e trial
between insvlin glargine and
NPU insvlin in cuildren and adolescents witu type 1 diabetes. Diabetes Xare 2001;
24; 2005…2006.
25. Debrau \, Suerwin ˆS, `vrpuy ‰, \err D. ^Š ect of caŠ eine on recognition of
and puysiological responses to uypoglycae|ia in insvlin-dependent diabetes. ]ancet
1996; 347; 19…24.
26. Porcellati Z, ˆossetti P, Pa|panelli S et al. Better longter| glycae|ic control
witu tue basal insvlin glargine as co|pared witu NPU in patients witu type 1 diabetes
|ellitvs gi~en |eal-ti|e lispro insvlin. Diabet `ed 2004; 21; 1213…1220.
27. NIX^. FNational Institvte of Xlinical ^cellenceG. [vidance on tue }se of
]ong-Acting Insvlin Analogves for tue Yreat|ent of Diabetes-Insvlin [largine.
Yecunology Appraisal [vidance No 53 2002 Fa~ailable fro| uttp;gvidance.nice.org.
v‚YA53 gvidancepdf^nglisuG.
28. Xuase UP, Dion B, Pearson ‰ et al. ˆedvced uypoglyce|ic episodes and
i|pro~ed glyce|ic control in cuildren witu type 1 diabetes vsing insvlin glargine and
nevtral prota|ine Uagedorn insvlin. ‰ Pediatr 2003; 143; 737…740.
  \b\t\b
297
29. Uatuovt ^U, Zv–isuige ], [eacu ‰, Iscuandar `, `arvo S, `ace ‰x. ^Š
of tuerapy witu insvlin glargine FlantvsG on glyce|ic control in toddlers, cuildren, and
adolescents witu diabetes. Diabetes Yecunol Yuer 2003; 5; 801…806.
30. Ale|•adeu ˆ, Berue Y, xyatt DY. Zleible insvlin tuerapy witu glargine insvlin
i|pro~ed glyce|ic control and redvced se~ere uypoglyce|ia a|ong prescuool-aged
cuildren witu type 1 diabetes |ellitvs. Pediatrics 2005; 115; 1320…1324.
31. `oun A, Strang S, xernic‚e-Panten \, ]ang A`, ^dge ‰A, Dvnger DB.
Noctvrnal glvcose control and free insvlin le~els in cuildren witu type 1 diabetes by vse
of tue longacting insvlin UV^ 901 as part of a turee-in–ection regi|en. Diabetes Xare
2000; 23; 557…559.
32. ˆobertson \‰, Scuoenle ^, [vce~ ‡, `orduorst ], [all `A, ]vd~igsson ‰.
Insvlin dete|ir co|pared witu NPU insvlin in cuildren and adolescents witu type 1
diabetes. Diabet `ed 2007; 24; 27…34.
33. Danne Y, ]vp‚e \, xalte \, jon Scuvet• x, [all `A. Insvlin dete|ir is
cuaracteri•ed by a consistent puar|aco‚inetic pro”
le across age-grovps in cuildren,
adolescents, and advlts witu type 1 diabetes. Diabetes Xare 2003; 26; 3087…3092.
34. jagve P, Sela| ‰], S‚eie S et al. Insvlin dete|ir is associated witu |ore predict-
able glyce|ic control and redvced ris‚ of uypoglyce|ia tuan NPU insvlin in patients
witu type 1 diabetes on a basal-bolvs regi|en witu pre|eal insvlin aspart. Diabetes
Xare 2003; 26; 590…596.
35. de Beavfort X^, Uovt•agers X`, Brvining [‰ et al. Xontinvovs svbcvtane-
ovs insvlin infvsion FXSIIG ~ersvs con~entional in–ection tuerapy in newly diagnosed
diabetic cuildren; two-year follow- vp of a rando|i•ed, prospecti~e trial. Diabet `ed
1989; 6; 766…771.
36. DXXY. ^Š
ect of intensi~e diabetes treat|ent on tue de~elop|ent and progres-
sion of long-ter| co|plications in adolescents witu insvlin-dependent diabetes |el-
litvs; Diabetes Xontrol and Xo|plications Yrial. Diabetes Xontrol and Xo|plications
Yrial ˆesearcu [rovp. ‰ Pediatr 1994; 125; 177…188.
37. ‰acobson A`, `vsen [, ˆyan X` et al. ]ongter| eŠ ect of diabetes and its
treat|ent on cogniti~e fvnction. N ^ngl ‰ `ed 2007; 356; 1842…1852.
38. `vsen [, ‰acobson A`, ˆyan X` et al. I|pact of diabetes and its treat|ent
on cogniti~e fvnction a|ong adolescents wuo participated in tue Diabetes Xontrol and
Xo|plications Yrial. Diabetes Xare 2008; 31; 1933…1938.
39. `ortensen UB, ˆobertson \‰, Aanstoot U‰ et al. Insvlin |anage|ent and
|etabolic control of type 1 diabetes |ellitvs in cuilduood and adolescence in 18 covn-
tries. U~idore Stvdy [rovp on Xuilduood Diabetes. Diabet `ed 1998; 15; 752…759.
40. Downie ^, Xraig `^, Uing S, Xvsv|ano ‰, Xuan A\, Donaguve \X.
Xontinved redvction in tue pre~alence of retinopatuy in adolescents witu type 1 diabe-
tes; role of insvlin tuerapy and glyce|ic control. Diabetes Xare 2011; 34; 2368…2373.
41. Di`eglio ]A, PottorŠ
Y`, Boyd Sˆ, Zrance ], Zineberg N, ^vgster ^A.
A rando|i•ed, controlled stvdy of insvlin pv|p tuerapy in diabetic prescuoolers.
‰ Pediatr 2004; 145; 380…384.
42. Pic‚vp ‰, `attoc‚ `, \erry S. [lycae|ic control witu continvovs svbcvtane-
ovs insvlin infvsion co|pared witu intensi~e insvlin in–ections in patients witu type 1
diabetes; |eta-analysis of rando|ised controlled trials. B`‰ 2002; 324; 705.
298
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
43. xilli S`, Planton ‰, ^gede ], S
cuwar• S. Bene” ts of continvovs svbcvtaneovs
insvlin infvsion in cuildren witu type 1 diabetes. ‰ Pediatr 2003; 143; 796…801.
44. \avf|an Zˆ. Intensi~e |anage|ent of type 1 diabetes in yovng cuildren.
]ancet 2005; 365; 737…738.
45. Uanas ˆ, Adolfsson P. Insvlin pv|ps in pediatric rovtine care i|pro~e long-
ter| |etabolic control wituovt increasing tue ris‚ of uypoglyce|ia. Pediatr Diabetes
2006; 7; 25…31.
46. Boland ^A, [rey `, Vesterle A, Zredric‚son ], Ya|borlane xj. Xontinvovs
svbcvtaneovs insvlin infvsion. A new way to lower ris‚ of se~ere uypoglyce|ia, i|pro~e
|etabolic control, and enuance coping in adolescents witu type 1 diabetes. Diabetes
Xare 1999; 22; 1779…1784.
47. ]itton ‰, ˆice A, Zried|an N, Vden ‰, ]ee ``, Zree|ar‚ `. Insvlin pv|p
tuerapy in toddlers and prescuool cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr 2002;
141; 490…495.
48. Auern ‰AU, Boland ^A, Doane ˆ et al. Insvlin pv|p tuerapy in pediatrics;
a tuerapevtic alternati~e to safely lower UbA1c le~els across all age grovps. Pediatr
Diabetes 2002; 3; 10…15.
49. Plotnic‚ ]P, Xlar‚ ]`, Brancati Z], ^rlinger Y. Safety and eŠ
ecti~eness of
insvlin pv|p tuerapy in cuildren and adolescents witu type 1 diabetes. Diabetes Xare
2003; 26; 1142…1146.
50. Saua `^, Uvvppone Y, `i‚ael \, ‰vvti `,\o|vlainen ‰. Xontinvovs svbcv-
taneovs insvlin infvsion in tue treat|ent of cuildren and adolescents witu type 1 diabe-
tes |ellitvs. ‰ Pediatr ^ndocrinol `etab 2002; 15; 1005…
1010.
51. Svlli N, Suasua– B. Xontinvovs svbcvtaneovs insvlin infvsion in cuildren and
adolescents witu diabetes |ellitvs; decreased UbA1c witu low ris‚ of uypoglyce|ia.
‰ Pediatr ^ndocrinol `etab 2003; 16; 393…399.
52. S‚ogsberg ], Zors U, Uanas ˆ, Xuaplin ‰^, ]ind|an ^, S‚ogsberg ‰. I|pro~ed
treat|ent satisfaction bvt no diŠ
erence in |etabolic control wuen vsing continvovs
svbcvtaneovs insvlin infvsion ~s. |vltiple daily in–ections in cuildren at onset of type
1 diabetes |ellitvs. Pediatr Diabetes 2008; 9; 472…479.
53. Bolli [B, \err D, Yuo|as ˆ et al. Xo|parison of a |vltiple daily insvlin in–ec-
tion regi|en Fbasal oncedaily glargine plvs |ealti|e lisproG and continvovs svbcvtane-
ovs insvlin infvsion FlisproG in type 1 diabetes;a rando|i•ed open parallel |vlticenter
stvdy. Diabetes Xare 2009; 32; 1170…1176.
54. Xolvitt ‰, ˆoyle P ,xavgu N. Are analogve insvlins better tuan solvble in con-
tinvovs svbcvtaneovs insvlin infvsion— ˆesvlts of a |eta-analysis. Diabet `ed 2003;
55. Svl|ont j, Sovcuon PZ, [ovillard-Darnavd X et al. `etabolic control in
cuildren witu diabetes |ellitvs wuo are yovnger tuan 6 years at diagnosis; continvovs
svbcvtaneovs insvlin infvsion as a ”
rst line treat|ent— ‰ Pediatr 2010; 157; 103…107.
56. Danne Y, Battelino Y, ‰aros•-Xuobot P et al. ^stablisuing glycae|ic control
witu continvovs svbcvtaneovs insvlin infvsion in cuildren and adolescents witu type
1 diabetes; eperience of tue PedPv|p Stvdy in 17 covntries. Diabetologia 2008; 51;
1594…1601.
  \b\t\b
299
57. Puillip `, Battelino Y, ˆodrigve• U, Danne Y, \avf|an Z. }se of insvlin pv|p
tuerapy in tue pediatric age-grovp; consensvs state|ent fro| tue ^vropean Society for
Paediatric ^ndocrinology, tue ]awson xil‚ins Pediatric ^ndocrine Society, and tue
International Society for Pediatric and Adolescent Diabetes, endorsed by tue A|erican
Diabetes Association and tue ^vropean Association for tue Stvdy of Diabetes. Diabetes
Xare 2007; 30; 1653…1662.
58. Pan‚ows‚a ^, Bla•i‚ `, D•iecuciar• P, S•ypows‚a A, S•a–ews‚a U. Xontinvovs
svbcvtaneovs insvlin infvsion ~s. |vltiple daily in–ections in cuildren witu type 1 diabe-
tes; a syste|atic re~iew and |eta analysis of rando|i•ed control trials. Pediatr Diabetes
2009; 10; 52…58.
59. DXXY. Yue eŠ
ect of intensi~e treat|ent of diabetes on tue de~elop|ent and
progression of long-ter| co|plications in insvlin-dependent diabetes |ellitvs. N ^ngl
‰ `ed 1993; 329; 977…986.
60. xuite NU, Xleary PA, Dau|s x, [oldstein D, `alone ‰, Ya|borlane xj.
Bene”
cial eŠ
ects of intensi~e tuerapy of diabetes dvring adolescence; ovtco|es after
tue conclvsion of tue Diabetes Xontrol and Xo|plications Yrial FDXXYG. ‰ Pediatr
2001; 139; 804…812.
61. Battelino Y, Xonget I, Vlsen B et al. Yue vse and ež
cacy of continvovs glvcose
|onitoring in type 1 diabetes treated witu insvlin pv|p tuerapy; a rando|i•ed con-
trolled trial. Diabetologia 2012; 55; 3155…3162.
62. ^lleri D, Allen‰`, \v|areswaran\ et al. Xlosed loop basal insvlin deli~ery
o~er 36 uovrs in adolescents witutype1diabetes;rando|i•ed clinical trial.Diabetes Xare
2013; 36; 838…844.
63. Puillip `, Battelino Y, Atlas ^ et al. Noctvrnal glvcose control witu an arti”
cial
pancreas at a diabetes ca|p. N ^ngl ‰ `ed 2013; 368; 824…833.
64. xein•i|er SA, Steil [`, Swan \], D•ivra ‰, \vrt• N, Ya|borlane xj. Zvlly
avto|ated closed loop insvlin deli~ery ~ersvs se|iavto|ated uybrid control in pediatric
patients witu type 1 diabetes vsing anarti”
cialpancreas.DiabetesXare2008;31;934…939.
66. ]avrit•en Y. Puar|aco‚inetic and clinical aspects of intensi”
ed svbcvtaneovs insv-
lin tuerapy. Dan `ed Bvll 1985; 32; 104…118.
67. Bec‚er ˆ, Zric‚ A, Ueine
|ann ], Nose‚ ], ˆa~e \. Dose response relation of
insvlin glvlisine F[]}G in svb–ects witu type 1 diabetes FY1D`G. Diabetes 2005; 54
FSvppl. 1G; Abstract 1367-P.
68. xoodwortu‰, UoweyD, Bowsuerˆ,]vt•S,Sanat P, Brady P. ]ysFB28G, ProFB29G
uv|an insvlin F\G; dose ranging ~s. uv|vlin ˆ FUG. Diabetologia 1993; 42 FSvppl. 1G; 54A.
69. Nose‚ ], Ueine|ann ], \aiser `, Arnolds S, Ueise Y. No increase in tue dvration
of action witu rising doses of insvlin aspart. Diabetes 2003; 52 FSvppl. 1G; Abstract 551-P.
70. Puilotueov A, Arslanian S, Blatnic•‚y ], Peter‚o~a j, Sovua|i ^, Danne Y.
Xo|parable ež
cacy and safety of insvlin glvlisine and insvlin lispro wuen gi~en as
part of a Basal-bolvs insvlin regi|en in a 26-wee‚ trial in pediatric patients witu type 1
diabetes. Diabetes Yecunol Yuer 2011; 13; 327…334.
71. Danne Y, A|an ‰, Scuober ^ et al. A co|parison of postprandial and prepran-
dial ad|inistration of insvlin aspart in cuildren and adolescents witu type 1 diabetes.
Diabetes Xare 2003; 26; 2359…2364.
300
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
72. \rasner A, Poul ˆ, Si||s P, Picuotta P, Uavser ˆ, De Sov•a ^. A re~iew of a
fa|ily of vltra-rapidacting insvlins; for|vlation de~elop|ent. ‰ Diabetes Sci Yecunol
2012; 6; 786…796.
73. \vrt•uals P, ScuaŠ
er ], Sorensen A et al. Xorrelations of receptor binding and
|etabolic and |itogenic potencies of insvlin analogs designed for clinical vse. Diabetes
2000; 49; 999…1005.
74. ^vropean `edicines Agency F^`AG State|ent 2013 Fa~ailable fro| uttp;
www.e|a.evropa.evdocs n™[Bdocv|ent™library`edicine™ŽA201305
xX500143823.pdfG.
75. Stiller ˆ, \otuny Y, [vdat } et al. Intra~enovs ad|inistration of insvlin lispro
~ersvs regvlar insvlin in patients witu type 1 diabetes. Diabetes 1999; 48 FSvppl. 1G;
Abstract 0497.
76. ]epore `, Pa|panelli S, Zanelli X et al. Puar|aco‚inetics and puar|acody-
na|ics of svbcvtaneovs in–ection of longacting uv|an insvlin analog glargine, NPU
insvlin, and vltralente uv|an insvlin and continvovs svbcvtaneovs infvsion of insvlin
lispro. Diabetes 2000; 49; 2142…2148.
77. Ueller S, \oenen X, Bode B. Xo|parison of insvlin dete|ir and insvlin glargine
in a basal-bolvs regi|en, witu insvlin aspart as tue |ealti|e insvlin, in patients witu
type 1 diabetes; a 52-wee‚, |vltinational, rando|i•ed, openlabel, parallel-grovp,treat-
to-target non inferiority trial. Xlin Yuer 2009; 31; 2086…2097.
78. Dion B, Peter Xuase U, Bvrdic‚ ‰ et al. }se of insvlin glargine in cuildren
vnder age 6 witu type 1 diabetes. Pediatr Diabetes 2005; 6; 150…154.
79. Yuisted U, ‰ounsen SP, ˆvngby ‰. An vpdate on tue longacting insvlin analogve
glargine. Basic Xlin Puar|acol Yoicol 2006; 99; 1…11.
80. Pai~¨ arinta¨ `, Yapanainen P, je˜ ola ˆ. Basal insvlin switcu fro| NPU to
glargine in cuildren and adolescentswitutype1diabetes.PediatrDiabetes2008; 9; 83…90.
81. Danne Y, Puilotueov A, [old|an D et al. A rando|i•ed trial co|paring tue
rate of uypoglyce|ia … assessed vsing continvovs glvcose |onitoring … in 125 pre-
scuool cuildren witu type 1 diabetes treated witu insvlin glargine or NPU insvlin Ftue
Pˆ^SXUVV] stvdyG. Pediatr Diabetes 2013; 14; 593…601.
82. Ua|ann A, `attuaei S, ˆosa‚ X, Sil~estre ]. A rando|i•ed clinical trial co|-
paring brea‚fast, dinner, orbedti|e ad|inistration of insvlin glargine in patients witu
type 1 diabetes. Diabetes Xare 2003; 26; 1738…1744.
83. Ueise Y, Bott S, ˆa~e \, Dressler A, ˆoss‚a|p ˆ, Ueine|ann ]. No e~idence
for accv|vlation of insvlin glargine F]ANY}SG; a |vltiple in–ection stvdy in patients
witu Yype 1 diabetes. Diabet `ed 2002; 19; 490…495.
84. ˆatner ˆ^, Uirscu IB, Nei”
ng ‰], [arg S\, `ecca Y^, xilson XA. ]ess
uypoglyce|ia witu insvlin glargine in intensi~e insvlin tuerapy for type 1 diabetes. }.S.
Stvdy [rovp of Insvlin [largine in Yype 1 Diabetes. Diabetes Xare 2000; 23; 639…643.
85. Plan‚ ‰, Bodenlen• `, Sinner Z et
|i•ed, dose-
response stvdy in~estigating tue puar|acodyna|ic and puar|aco‚inetic properties of
tue long-acting insvlin analog dete|ir. Diabetes Xare 2005; 28; 1107…1112.
86. Xarlsson A, Zorsander [, ]vd~igsson ‰, ]arsen S, Vrt~ist ^, [rovp SP-hS.
A |vlticenter obser~ational safety stvdy in Swedisu cuildren and adolescents vsing
insvlin dete|ir for tue treat|ent of type 1 diabetes. Pediatr Diabetes 2013; 14; 358…365.
  \b\t\b
301
87. Biester Y, Blaesig S, ˆe|vs \ et al.Insvlin deglvdecs vltralong puar|aco‚i-
netic properties obser~ed in advlts are retained in cuildren and adolescents witu type 1
diabetes. Pediatr Diabetes 2014; 15; 27…33.
88. ˆosenstoc‚ ‰, Bergenstal ˆ`, Ble~ins YX et al. Better glyce|ic control and
weigut loss witu tue no~el longacting basal insvlin ]h2605541 co|pared witu insvlin
glargine in type 1 diabetes; a rando|i•ed, crosso~er stvdy. Diabetes Xare 2013; 36;
89. `ortensen U, \oco~a `, Yeng ]h, \eiding ‰, Brvc‚ner I, Puilotueov A.
Bipuasic insvlin aspart ~s. uv|an insvlin in adolescents witu type 1 diabetes on |vltiple
daily insvlin in–ections. Pediatr Diabetes 2006; 7; 4…10.
90. Stic‚el|eyer `P,
[raf X‰, Zran‚ BU, Ballard ˆ], Stor|s S`. Stability of
}-10 and }-50 dilvtions of insvlin lispro.Diabetes Yecunol Yuer 2000;2;61…66.
91. ‰orgensen D, Solbec‚ U. Dilvtion of insvlin aspart witu NPU |ediv| for s|all
dose vse in continvovs svbcvtaneovs insvlin infvsion does not aŠ
ect in ~itro stability.
Diabetes 2005; 54 FSvppl. 1G; Abstract A102.
92. Dat• N, xestergaard ], Nestoris X et al. Increase of insvlin revire|ents after
cuanging fro| }40 to }100 insvlin in cuildren and adolescents witu type 1 diabetes
wituovt eŠ
ect on tue |etabolic statvs. Pediatr Diabetes 2008; 9; Abstract 59.
93. [ra–ower ``, Zraser X[, Uolco|be ‰U et al. Uow long suovld insvlin be vsed
once a ~ial is started— Diabetes Xare 2003; 26; 2665…2666 discvssion 266-9.
94. ˆangawala S, Suau P, Uvssain S, [oen‚a S, Pillai \. Insvlin stored in |at‚a
Feartuen pitcuerG witu water for 60 days does not redvce in bio-acti~ity. ‰ Pediatr
^ndocrinol `etab 1997; 10 FSvppl. 2G; Abstract 347.
95. `cXartuy ‰A, Xo~arrvbias B, Sin‚ P. Is tue traditional alcouol wipe necessary
before an insvlin in–ection— Dog|a dispvted. Diabetes Xare 1993; 16; 402.
96. ]oeb ‰A, Uerold \X, Barton \P, ˆobinson ]^, ‰aspan ‰B. Syste|atic approacu
to diagnosis and |anage|ent of bipuasic insvlin allergy witu local anti in›
a||atory
agents. Diabetes Xare 1989; 12; 421…423.
97. \ordonovri V, ]avterborn ˆ, Deiss D. ]ipouypertropuy in yovng patients witu
type 1 diabetes. Diabetes Xare 2002; 25; 634.
98. Uolstein A, Stege U, \o~acs P. ]ipoatropuy associated witu tue vse of insvlin
analogves; a new case associated witu tue vse of insvlin glargine and re~iew of tue lit-
eratvre. ^pert Vpin Drvg Saf 2010; 9; 225…231.
99. Zorsander [A, `al|odin VX, \ordonvri V, ]vd~igsson ‰, \lingens|itu [,
Beavfort XD. An ISPAD svr~ey insvlin-indvced lipoatropuy. Pediatr Diabetes 2013; 14; 1.
100. Scunell \, Biester Y, Ysioli X, Dat• N, Danne Y, \ordonvri V. ]ipoatropuy in
a large pediatric diabetes ovtpatient ser~ice. Pediatr Diabetes 2013; 14; 20.
101. Xuantelav ^, ]ee D`, Ue||ann D`, ‡ipfel }, ^cuteruoŠ
S. xuat |a‚es
insvlin in–ections painfvl— B`‰ 1991; 303; 26…27.
102. Uanas ˆ, Adolfsson P, ^lf~in-A‚esson \ et al. Indwelling catueters vsed fro|
tue onset of diabetes decrease in–ection pain and pre-in–ection aniety. ‰ Pediatr 2002;
140; 315…320.
103. Arendt-Nielsen ], ^ge‚~ist U, B–erring P. Pain following controlled cvtaneovs
insertion of needles witu diŠ
erent dia|eters. So|atosens `ot ˆes 2006; 23; 37…43.
302
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
104. [insberg BU, Par‚es ‰], Sparacino X. Yue ‚inetics of insvlin ad|inistration
by insvlin pens. Uor| `etab ˆes 1994; 26; 584…587.
105. Sindel‚a [, Ueine|ann ], Berger `, Zrenc‚ x, Xuantelav ^. ^Š
ect of insvlin
concentration, svbcvtaneovs fat tuic‚ness and s‚in te|peratvre on svbcvtaneovs insv-
lin absorption in uealtuy svb–ects. Diabetologia 1994; 37; 377…380.
106. hovng ˆ‰, Uannan x‰, Zrier B`, Steel ‰`, Dvncan ]‰. Diabetic lipouyper-
tropuy delays insvlin absorption. Diabetes Xare 1984; 7; 479…480.
107. ‰ouansson }B, A|sberg S, Uanner• ] et al. I|paired absorption of insvlin
aspart fro| lipouypertropuic in–ection sites. Diabetes Xare 2005; 28; 2025…2027.
108. Bantle ‰P, Neal ], Zran‚a|p ]`. ^Š
ects of tue anato|ical region vsed for
insvlin in–ections on glyce|ia in type I diabetes svb–ects. Diabetes Xare 1993; 16;
1592…1597.
109. Zrid A, [vnnarsson ˆ, [vntner P, ]inde B. ^Š ects of accidental intra|vscv-
lar in–ection on insvlin absorption in IDD`. Diabetes Xare 1988; 11; 41…45.
110. Zrid A, Vst|an ‰, ]inde B. Uypoglyce|ia ris‚ dvring eercise after intra|vs-
cvlar in–ection of insvlin in tuigu inIDD`. Diabetes Xare 1990; 13; 473…477.
111. Zrid A. In–ection and absorption of insvlin. PuDYuesis; Zacvlty of `edicine,
\arolins‚a Institvte, Stoc‚uol|, Swedenz 1992.
112. `vdaliar Sˆ, ]indberg ZA, ‰oyce ` et al. Insvlin aspart FB28 asp-insvlinG; a fast-
acting analog of uv|an insvlin; absorption ‚inetics and action pro”
le co|pared witu reg-
vlar uv|an insvlin in uealtuy nondiabetic svb–ects. Diabetes Xare 1999; 22; 1501…1506.
113. ter Braa‚ ^x, xoodwortu ‰ˆ, Biancui ˆ et al. In–ection site eŠ ects on tue
puar|aco‚inetics and glvcodyna|ics of insvlin lispro and regvlar insvlin. Diabetes
Xare 1996; 19; 1437…1440.
114. ˆa~e \, Ueise Y, xeyer X et al. Intra|vscvlar ~ersvs svbcvtaneovs in–ection of
solvble and lispro insvlin; co|parison of |etabolic eŠ
ects in uealtuy svb–ects. Diabet
`ed 1998; 15; 747…751.
115. Vwens Dˆ, Xoates PA, ]v•io SD, Yinbergen ‰P, \vr•ualsˆ. Puar|aco‚inetics
of 125 I-labeled insvlin glargine FUV^ 901G in uealtuy |en; co|parison witu NPU
insvlin and tue in› vence of diŠ erent svbcvtaneovs in–ection sites. Diabetes Xare 2000;
23; 813…819.
116. Peter ˆ, ]v•io SD, Dvnseatu [ et al. ^Š ects of eercise on tue absorption of
insvlin glargine in patients witu type 1 diabetes. Diabetes Xare 2005; 28; 560…565.
117. \arges B, Boeu| BV, \arges x. ^arly uypoglycae|ia after accidental intra-
|vscvlar in–ection of insvlin glargine. Diabet `ed 2005; 22; 1444…1445.
118. `orrow ], `vcu|ore DB, Uo|pescu `, ]vdington ^A, javgun D^.
Xo|parati~e puar|aco‚inetics and insvlin action for turee rapid-acting insvlin analogs
in–ected svbcvtaneovsly witu and wituovt uyalvronidase. Diabetes Xare 2013; 36; 273…275.
119. Xengi• ^,xein•i|er SA,Suerr ‰] et al. Zasterin and faster ovt; accelerating
insvlin absorption and action by insvlin infvsion site war|ing. Diabetes Yecunol Yuer
2014; 16; 20…25.
120. Scuvler [, Pel• \, \erp ]. Is tue revse of needles for insvlin in–ection syste|s
associated witu a uiguer ris‚ of cvtaneovs co|plications— Diabetes ˆes Xlin Pract 1992;
16; 209…212.
  \b\t\b
303
121. Zrid A, Uirscu ], [aspar ˆ et al. New in–ection reco||endations for patients
witu diabetes. Diabetes `etab 2010; 36 FSvppl. 2G; S3…S18.
122. Uof|an P], ]awton SA, Peart ‰` et al. An angled insertion tecunive vsing
6-|| needles |ar‚edly redvces tue ris‚ of intra|vscvlar in–ections in cuildren and
adolescents. Diabet `ed 2007; 24; 1400…1405.
123. Bir‚ebae‚ NU, ‰ouansen A, Sol~ig ‰. Xvtissvbcvtis tuic‚ness at insvlin in–ection
sites and locali•ation of si|vlated insvlin bolvses in cuildren witu type 1 diabetes |ellitvs;
need for indi~idvali•ation of in–ection tecunive— Diabet `ed 1998; 15; 965…971.
124. S|itu XP, Sargent `A, xilson BP, Price DA. Svbcvtaneovs or intra|vscvlar
insvlin in–ections.Arcu Dis Xuild 1991; 66; 879…882.
125. Uanas Sˆ, ]vd~igsson ‰. `etabolic control is not altered wuen vsing indwell-
ing catueters for insvlin in–ections. Diabetes Xare 1994; 17; 716…718.
126. Bvrdic‚ P, Xooper S, Uorner B, Xobry ^, `cZann \, Xuase UP. }se of a svb-
cvtaneovs in–ection port to i|pro~e glyce|ic control in cuildren witu type 1 diabetes.
Pediatr Diabetes 2009; 10; 116…119.
127. Uanas Sˆ, Xarlsson S, Zrid A, ]vd~igsson ‰. }ncuanged insvlin absorption
after 4 days vse of svbcvtaneovs indwelling catueters for insvlin in–ections. Diabetes
Xare 1997; 20; 487…490.
128. Uanas ˆ, ]vd~igsson ‰. Side eŠ ects and indwelling ti|es of svbcvtaneovs catu-
eters for insvlin in–ections; a new de~ice for in–ecting insvlin witu a |ini|v| of pain
in tue treat|ent of insvlin-dependent diabetes |ellitvs. Diabetes ˆes Xlin Pract 1990;
10; 73…83. 129. Diglas ‰, Zeinboc‚ X, xin‚ler Z et al. ˆedvced pain perception witu an
avto|atic in–ection de~ice for vse witu an insvlin pen. Uor| ˆes 1998; 50; Abstract A30.
130. Xuiasson ‰], Dvcros Z, Polivin-Ua|et `, ]ope• D, ]eca~alier ], Ua|et P.
Xontinvovs svbcvtaneovs insvlin infvsion F`ill-Uill InfvserG ~ersvs |vltiple in–ections
F`edi-‰ectorG in tue treat|ent of insvlin dependent diabetes |ellitvs and tue eŠ
ect of
|etabolic control on |icroangiopatuy. Diabetes Xare 1984; 7; 331…337.
131. Uovt•agers X`, jisser AP, Bernt•en PA, Ueine ˆ‰, ~an der jeen ^A. Yue
`edi-‰ector II; ež
cacy and acceptability in insvlin-dependent diabetic patients witu
and wituovt needle puobia. Diabet `ed 1988; 5; 135…138.
132. ^ngwerda ^^, Abbin‚ ^‰, Yac‚ X‰, de [alan B^. I|pro~ed puar|aco‚inetic
and puar|acodyna|ic pro”
le of rapid-acting insvlin vsing needle-free –et in–ection
tecunology. Diabetes Xare 2011; 34; 1804…1808.
133. Berguaevser `A, \apellen Y, Ueidt|ann B, Uaberland U, \lin‚ert X, Uoll
ˆx. Xontinvovs svbcvtaneovs insvlin infvsion in toddlers starting at diagnosis of type
1 diabetes |ellitvs. A |vlticenter analysis of 104 patients fro| 63 centres in [er|any
and Avstria. Pediatr Diabetes 2008; 9; 590…595.
134. xilson D`, Bvc‚ingua| BA, \vnsel|an ^], Svlli~an ``, Pagvntalan
U}, [itel|an S^. A two-center rando|i•ed controlled feasibility trial of insvlin pv|p
tuerapy in yovng cuildren witu diabetes. Diabetes Xare 2005; 28; 15…19.
135. Blac‚ett Pˆ. Insvlin pv|p treat|ent for recvrrent ‚etoacidosis in adolescence
mletterq. Diabetes Xare 1995; 18; 881…882.
136. Steindel BS, ˆoe Yˆ, Xostin [, Xarlson `, \avf|an Zˆ. Xontinvovs svb-
cvtaneovs insvlin infvsion FXSIIG in cuildren and adolescents witu curonic poorly con-
trolled type 1 diabetes |ellitvs. Diabetes ˆes Xlin Pract 1995; 27; 199…204.
304
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
137. \apellen Y`, Ueidt|ann B, Bacu|ann ‰, ‡iegler ˆ, [rabert `, Uoll ˆx.
Indications for insvlin pv|p tuerapy in diŠ
erent age grovps; an analysis of 1,567 cuil-
dren and adolescents. Diabet `ed 2007; 24; 836…842.
138. NIX^ FNational Institvte of Xlinical ^cellenceG. Xlinical and Xost
ecti~eness of Xontinvovs Svbcvtaneovs Insvlin Infvsion for Diabetes. Yecunology
Appraisal No 57 2003 Fa~ailable fro| uttp;www. nice.org.v‚gvidanceYA57G.
139. Nauata ]. Insvlin tuerapy in pediatric patients witu type I diabetes; continv-
ovs svbcvtaneovs insvlin infvsion ~ersvs |vltiple daily in–ections. Xlin Pediatr FPuilaG
2006; 45; 503…508.
140. S‚ogsberg ], ]ind|an ^, Zors U. Yo co|pare |etabolic control and vality of
life FŽo]G of XSII witu |vltiple daily in–ections F`DIG in cuildrenadolescents at onset
of Y1D`. Pediatr Diabetes 2006; 7; Abstract 65.
141. \ordonovri V, Pan‚ows‚a ^, ˆa|i B et al. Sensor avg|ented pv|p tuerapy
fro| tue diagnosis of cuilduood type 1 diabetes; resvlts of tue Paediatric Vnset Stvdy
FVNS^YG after 12|ontus of treat|ent. Diabetologia 2010; 53; 2487…2495.
142. ^nander ˆ, [vnde~all X, Stro|gren A, Xuaplin ‰, Uanas ˆ. Xarbouydrate covnt-
ing witu a bolvs calcvlator i|pro~es post-prandial blood glvcose le~els in cuildren and
adolescents witu type 1 diabetes vsing insvlin pv|ps. Pediatr Diabetes 2012; 13; 545…551.
143. ‡isser U, ˆobinson ], Be~ier x et al. Bolvs calcvlator; a re~iew of fovr ¤s|art¤
insvlin pv|ps. Diabetes Yecunol Yuer 2008; 10; 441…444.
144. Uanas ˆ, ]vnd~ist \, xindell ]. Blood glvcose and beta-uydroybvtyrate
responses wuen tue insvlin pv|p is stopped in cuildren and adolescents. Pediatr
Diabetes 2006; 7 FSvppl. 5G; Abstract 35.
145. ‡isser U. Žvantifying tue i|pact of a suort-inter~al interrvption of insvlin-
pv|p infvsion sets on glyce|ic ecvrsions. Diabetes Xare 2008; 31; 238…239.
146. Svlli N, Suasua– B. ]ong-ter| bene” ts of continvovs svbcvtaneovs insvlin
infvsion in cuildren witu type 1 diabetes; a 4-year follow-vp. Diabet `ed 2006; 23;
900…906.
147. ‰ounson Sˆ, Xooper `N, ‰ones Yx, Da~is ^A. ]ongter| ovtco|e of insvlin
pv|p tuerapy in cuildren witu type 1 diabetes assessed in a large popvlation-based
casecontrol stvdy. Diabetologia 2013; 56; 2392…2400.
148. Uanas ˆ, ]vd~igsson ‰. Uypoglyce|ia and ‚etoacidosis witu insvlin pv|p
tuerapy in cuildren and adolescents. Pediatr Diabetes 2006; 7 FSvppl. 4G; 32…38.
149. `argeirsdottir U, ]arsen ‰, Brvnborg X, Daul ‰orgensen \. Nationwide
i|pro~e|ent in UbA 1 cand co|plication screening in a bencu|ar‚ing pro–ect in
cuilduood diabetes. Pediatr Diabetes 2006; 7 FSvppl. 5G; Abstract 18.
150. Uanas ˆ, ]indgren Z, ]indblad B. A 2-yr national popvlation stvdy of pedi-
atric ‚etoacidosis in Sweden; predisposing conditions and insvlin pv|p vse. Pediatr
Diabetes 2009; 10; 33…37.
151.
]iv D, `oberg ^, xredling ˆ, ]ins P^, Ada|son }. Insvlin absorption is
faster wuen ‚eeping tue infvsion site in vse for turee days dvring continvovs svbcvtane-
ovs insvlin infvsion. Diabetes ˆes Xlin Pract 1991; 12; 19…24.
152. Bode B, xeinstein ˆ, Bell D et al. Xo|parison of insvlin aspart witu bvŠ
ered
regvlar insvlin and insvlin lispro in continvovs svbcvtaneovs insvlin infvsion; a ran-
do|i•ed stvdy in type 1 diabetes. Diabetes Xare 2002; 25; 439…444.
  \b\t\b
305
153. ~an Bon AX, Bode Bx, Sert-]angeron X, Dejries ‰U, Xuarpentier [. Insvlin
glvlisine co|pared to insvlin aspart and to insvlin lispro ad|inistered by continvovs
svbcvtaneovs insvlin infvsion in patients witu type 1 diabetes; a rando|i•ed controlled
trial. Diabetes Yecunol Yuer 2011; 13; 607…614.
154. xood ‰ˆ, `oreland ^X, jol‚ening ]\, S~oren B`, Bvtler DA, ]aŠ
el ]`.
Dvrability of insvlin pv|p vse in pediatric patients witu type 1 diabetes. Diabetes Xare
2006; 29; 2355…2360.
155. Ya|borlane xj, Bec‚ ˆx, Bode Bx et al. Xontinvovs glvcose |onitoring
and intensi~e treat|ent of type 1 diabetes. N ^ngl ‰ `ed 2008; 359; 1464…1476.
156. xein•i|er S, _ing D, Yansey ` et al. ZreeStyle na~igator continvovs glvcose
|onitoring syste| vse in cuildren witu type 1 diabetes vsing glargine-based |vltiple
daily dose regi|ens; resvlts of a pilot trial Diabetes ˆesearcu in Xuildren Networ‚
FDirecNetG Stvdy [rovp. Diabetes Xare 2008; 31; 525…527.
157. Uirscu IB, Abelsetu ‰, Bode Bx et al. Sensor avg|ented insvlin pv|p tuerapy;
resvlts of tue ”
rst rando|i•ed treatto-target stvdy. Diabetes Yecunol Yuer 2008; 10; 377…383.
158. Peyrot `, ˆvbin ˆˆ, [rovp SS. Yreat|ent satisfaction in tue sensor-avg|ented
pv|p tuerapy for A1X redvction 3 FSYAˆ 3G trial. Diabet `ed 2013; 30; 464…467.
159. Slo~er ˆU, xelsu ‰B, Xriego A et al. ^Š
ecti~eness of sensor-avg|ented pv|p
tuerapy in cuildren and adolescents witu type 1 diabetes in tue SYAˆ 3 stvdy. Pediatr
Diabetes 2012; 13; 6…11.
160. Bvse ‰B, \vd~a hX, Battelino Y, Da~is SN, Suin ‰, xelsu ‰B. ^Š
ects of sen-
sor-avg|ented pv|p tuerapy on glyce|ic ~ariability in well-controlled type 1 diabetes
in tue SYAˆ 3 stvdy. Diabetes Yecunol Yuer 2012; 14; 644…647.
161. Bvc‚ingua| B, Xobry ^, Xlinton P et al. Pre~enting uypoglyce|ia vsing predicti~e
alar| algoritu|s and insvlin pv|p svspension. Diabetes Yecunol Yuer 2009; 11; 93…97.
162. ^lleri D, Allen ‰`, Nodale ` et al. Avto|ated o~ernigut closed-loop glvcose
control in yovng cuildren witu type 1 diabetes. Diabetes Yecunol Yuer 2011; 13; 419…424.
163. Ni|ri ˆ, `vller I, Atlas ^ et al. Nigut glvcose control witu `D-]ogic arti”
cial pancreas in uo|e setting; a single blind, rando|i•ed crosso~er trial interi| analy-
sis. Pediatr Diabetes 2014; 15; 91…99.
164. Uo~or‚a ˆ, ^lleri D, Yuabit U et al. V~ernigut closed-loop insvlin deli~ery
in yovng people witu type 1 diabetes; a free-li~ing, rando|i•ed clinical trial. Diabetes
Xare 2014; 37; 1204…1211.
165. xysoc‚i Y, Uarris `A, `avras N et al. Absence of ad~erse eŠ ects of se~ere
uypoglyce|ia on cogniti~e fvnction in scuool-aged cuildren witu diabetes o~er
18|ontus. Diabetes Xare 2003; 26; 1100…1105.
166. ‰eule P`, `icueler X, ‰eule Dˆ, Breitig D, Boeu| BV. Inadevate svspen-
sion of nevtral prota|ine Uagendorn FNPUG insvlin in pens msee co||entsq. ]ancet
1999; 354; 1604…1607.
167. Ueine ˆ‰, Bilo U‰, Zon‚ Y, ~an der jeen ^A, ~an der `eer ‰. Absorption
‚inetics and action pro”
les of |itvres of suort- and inter|ediate-acting insvlins.
Diabetologia 1984; 27; 558…562.
168. Perriello [, Yorlone ^, Di Santo S et al. ^Š ect of storage te|peratvre of insvlin on
puar|aco‚inetics and puar|acodyna|ics of insvlin |itvres in–ected svbcvtaneovsly in
svb–ects witu type 1 FinsvlindependentG diabetes |ellitvs. Diabetologia 1988; 31; 811…815.
306
!\t\t 9. C\f\f \b\t \b \t\t\b\f \t     \r  \b
169. Ualberg I, ‰acobsen ], Daul }. A stvdy on self|iing insvlin aspart witu NPU
insvlin in tue syringe before in–ection. Diabetes 1999; 48 FSvppl. 1G; Abstract 448.
170. ‰osepu S^, \or•on-Bvra‚ows‚a A, xoodwortu ‰ˆ et al. Yue action pro”
le of
lispro is not blvnted by |iing in tue syringe witu NPU insvlin. Diabetes Xare 1998;
21; 2098…2102.
171. Bastyr ^‰ III, Uolco|be ‰U, Anderson ‰U, Xlore ‰N. `iing insvlin lispro and
vltralente insvlin. Diabetes Xare 1997; 20; 1047…1048.
172. \aplan x, ˆodrigve• ]`, S|itu V^, Uay|ond `x, Ueptvlla ˆA. ^Š
of |iing glargine and suort-acting insvlin analogs on glvcose control. Diabetes Xare
2004; 27; 2739…2740.
173. Ziallo-Scuarer ˆ, Uorner B, `cZann \, xalra~ens P, Xuase UP. `iing
rapid-acting insvlin analogves witu insvlin glargine in cuildren witu type 1 diabetes
|ellitvs. ‰ Pediatr 2006; 148; 481…484.
174. Pan‚ows‚a ^, Bla•i‚ `, [roele ]. Does tue fatprotein |eal increasepost-
prandial glvcosele~el in type 1 diabetes patients on insvlin pv|p; tue conclvsion of a
rando|i•ed stvdy. Diabetes Yecunol Yuer 2012; 14; 16…22.
175. Xobry ^, `cZann \, `esser ] et al. Yi|ing of |eal insvlin bolvses to acuie~e
opti|al postprandial glyce|ic control in patients witu type 1 diabetes. Diabetes
Yecunol Yuer 2010; 12; 173…177.
176. ]v˜ f h`, ~an Bon AX, Uoe‚stra ‰B, De~ries ‰U. Pre|eal in–ection of rapid-
acting insvlin redvces postprandial glyce|ic ecvrsions in type 1 diabetes. Diabetes
Xare 2010; 33; 2152…2155.
177. xein•i|er S, _ing D, Yansey ` et al. Prolonged vse of continvovs glvcose
|onitors in cuildren witu type 1 diabetes on continvovs svbcvtaneovs insvlin infvsion
or intensi~e |vltiple-daily in–ection tuerapy. Pediatr Diabetes 2009; 10; 91…96.
178. Yan Xh, xilson D`, Bvc‚ingua| B. Initiation of insvlin glargine in cuildren
and adolescents witu type 1 diabetes.Pediatr Diabetes 2004; 5; 80…86.
179. VXonnell `A, [ilbertson Uˆ, Donatu S`, Xa|eron Z‰. Vpti|i•ing post-
prandial glyce|ia in pediatric patients witu type 1 diabetes vsing insvlin pv|p tuerapy;
i|pact of glyce|ic inde and prandial bolvs type. Diabetes Xare 2008; 31; 1491…1495.
180. Da~idson PX, Uebblewuite Uˆ, Steed ˆD, Bode Bx. Analysis of gvidelines
for basal-bolvs insvlin dosing; basal insvlin, correction factor, and carbouydrate-to-
insvlin ratio. ^ndocr Pract 2008; 14; 1095…1101.
181.
XonradSX, `c[ratu `Y, [itel|an S^. Yransition fro| |vltiple daily in–ec-
tions to continvovs svbcvtaneovs insvlin infvsion in type 1 diabetes |ellitvs. ‰ Pediatr
2002; 140; 235…240.
182. Nicola–sen Y, Sa|velsson A, Uanas ˆ. Insvlin doses before and one year after
pv|p start; cuildren ua~e a re~ersed dawn pueno|enon. ‰ Diabetes Sci Yecunol 2012;
6; 589…594.
183. S•ypows‚a A, ]ip‚a `, Bla•i‚ `, [roele ],Pan‚ows‚a ^. Insvlin revire|ent
in prescuoolers treated witu insvlin pv|ps at tue onset of type 1 diabetes |ellitvs. Acta
Paediatr 2009; 98; 527…530.
184. ]vd~igsson ‰, Uanas ˆ. Xontinvovs svbcvtaneovs glvcose |onitoring
i|pro~ed |etabolic control in pediatric patients witu type 1 diabetes; a controlled
crosso~er stvdy. Pediatrics 2003; 111; 933…938.
1 \t\t 26
\r\b\t:\t8 \t\b\t8 5 \t 5\r\n\f
\n \n\r\b7 5\t7
\b\f\n «\f \b   ISPAD \r\f \b \f \r\b» 2014 . (ISPAD Clinical Practice
Consensus Guidelines 2014 Compendium): Carlo Acerini, Carine de Beaufort, Maria Craig, David Maahs,
Ragnar Hanas.
  „ \t ! «\f \b   ISPAD \r\f \b \f \r\b» 2014 . "\f\n \b 
«\f \b  ƒ» \f#\f \b \r\f   \b: www.ispad.org.  \b \f\t\b \f \f\t\b\f 
308
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
\b\b:\t8 \t \r\f7\b5:\t\t

""JE# :\r' \f:\r ##"\r# C"







\nE"" @ "\f \r" "\r:#\t \f
/ \f//:/ \f##$/. (\f#, "\fJE#/ \t

  \f






, "#  #':"\t  ", /" #'# \r'#

5\b\t
310
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
\f#"\r-\f#"  " \r:"  \f"@#  \n \fC :"@ "@J
\f#"\r# C\f#$##\r \f  #J \n, ":
"@  :##, #"\r# # \f\f\rC \r:, \r\f#"\t,
E#, \f\r#  @#, \f\r, !@ #"\t
# \t\t. \t\r"@ \r# #E# #  "\r\f#$##, \f \r:
#@ #E \r## # ! \f#"@ ' " \r##
/  "\f \b   \t\t\f, \b  \r "\f \b  \t \n 311
:\t 5\t\r \t\t


 :#J"  :/\f# #""@ %",







\r\f5\n  6\b\r\t\n\f7 \b\n, \r87
6\b\r\t\t \t \n\n \t\t
\b\n 6\b\r\t\t
312
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 






55\rM\b\t 7\n\n 


\r"\r"@ C#\r#\t \r\f# \f" "\r#"@ \r"" 
 #\r m18q. \r## %" \t\t"\t "# \r'\r
# \f' ##, "\r:# \f#"@ #E# F\rG #

\r\f"\rE# #':"  "C#\r#\t \t\t"\t

/  "\f \b   \t\t\f, \b  \r "\f \b  \t \n 313



E\r# C\f\f \r\f! #'#




\r\f7\b5:\t\t  \r\b\t= 6\b\r\t\t
�\f #C. \f "#@ \r\r\f# \r%" C"
\r'#"@\t " $#"  $#"  '##"# " #\f##\f@
$#. = $#@/ \r\f$#\t/ "\r## # \f '\r
�" # 45…60k %\r## m2, 6q. \f \r# @! #"
"\r:\t/ \f " "\r:\t C#\r "#"\t :
C. = /\f \f#"##/ #\f# \f"  \f#:" :
:\rC, "  @!# "\r:#\t \f \f"# \r\t\tJ"
7  \r\t\t\n (\b [email protected]   \r\t ) ^9_.
314
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
\f7 \b\b \t\t
5

\n\r


\f\f


\f \f \n
315
 10.1
\r#%$# *-(%! (/!  '!"!#"!  '"







M\t\r
316
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
�: \r#\t $@, JE\t\t C#\r, "\r:\t/ 

\b\n\b\b M\t\r \t \r\b\nM\t\r\b \f\t\n

/ #" \f"  \r\f$#\t# \f\t : #\t.
M " E/ C#\r # "\rC#\r/ #" \r\f"\t
"@  : 10k %\r## m36q. E C#\r \t\tJ"\t
'C#\r  \r\f$##, C#\r \t # "/ \r\f"/
#'$#\tG, \f\rC"\t  \r\r#, C#\r/ \f\t :C\r#, #\r

M\t" E C#\r  E, "\r:\t\t
7\b\b\b\n\b\b \t \t\b\b\n\b\b M\t\r\b \f\t\n



\f"\t "@  10k %\r## " O m36q.
\f \f \n
317



\t \r\t \t57\t8




\f\t




 %\r##, :  \r\f \f"\t  \n1, " 
318
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 



\r# \f#"@ /\r\tJE\t #\r@:#\r## ## \r#
\t7\t\b, 7\t\b\r \t \b\t\f\n\t5\b
\nL
\f \f \n
319





\fL





320
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 



\n :\tL\b \b\b\b 5\t\t\n\f\t \r5\f


\t\n\f\n\n\b\b \t \t\b\b\n\t\b 7\b\t\t \n\r



?# \r\f",  :'C#\r \r"  #"##



\b\t\n \f \b \r  \b, \t\t  \f\t \t  \f ... 321
\b\t\n \f \b \r  \b, \t\t 
\f\t \t  \f  \f 
\b\n\f\f\n\n\b\t\n\t \f\r\t\f\n\t \t\n, \r : €
\f\f\n\t \f \b\t\n\t \f\r\t \t \r\t, \n\b\t\t\t \t


2. $\f\n\t \b \n \b  \n \f\n\r\t
\t\b , \b\f\n  \n\t\t !" (&'!").
 \n \r\f\n\t\t  \b \r  \t\b \t \f\f \n \t\n.3. "\t \r\n\r\n \t\f\n \n \f\n \f\t,  \r\r \t\t-   \t\b\n  2…4 \f\n   \b \f \n \t\n \r  \r \b [11]. +\n\t \r\n\r\n \b\t \b \n, \n \n  \r\f \f\n \r, \b\t \t, \f\t\f\t \b\n\t\t,
322
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
\rL\b \t\b\n\r7\b \t 75




\r \n, :# \fC  :@! #""@  :J\f#\t.
\n @ "#" :C\f"@ \r, \t'  *( # \f'#\r

\rL\b \t\b\n\r7\b 58 5\r \t\b\t8
\b\t\t *\f \f\b \f   
323
C\n%
\n%D
C\n
$D
O\n
*\n !\t &  !\n
\r!". 10.1.
% \n\t «\t \t», 3\t\r  3&\r  ^(\r) 562G wtxyiz Fi{b|}|x
u|z}|r (~~~.txyiz.trl). T\r \t\t \r\t. %\t\t\r \r \t\n+_
:\b\f \f\t\n 5 \t 75

= #/ "\r/ \f" # :\r'"@
324
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
\f#'#\r  """##  "\r:"\t# \r: #  @#,
\r, " # \f\t : #:#/ ##/ \rC# :/\f#
5\n 5

!  \r \f     \t \f\t\b\t
325





\t\f7\t\n\f\t \t\b5\f\n \t \t\f7\t\n\f8 \b\r\f
326
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 


5\t\t\n\f\t \r\f7\b5:\t\t 58 \n :\t9\t\n\f\t
\t\b\n\t\b \rM\t7
\b8 \r \t8

(# \rC#  #H$#\t# ## \r" #

$   \b  \f\t   #  \f\f \b =
327


\rM\t7 7\b\f\r\b \t\b\n\t\b \t\be\f:\t 7D I
\t 7 8 \t\b\n\t\b\r \t8


328
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
(@'# @\t"\r :J ##  "##  &L(

 '" ### " "\r/ $"\r, ",


\n#" &* " :"@ '  \r\r"#\r ## 

/  \f\t  \b\t\f \b  \b\t
329
\r\f7\b5:\t\t 58 \r\t\b \r \t \r\n
#""@  /\r"\r#"## \r'#/ '\r"/ \r.
\r55\fL\b \r\n



330
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 


\f#"@ :"  ", " \r: ", \t\t"\t
"## "#"@ \f" %" '\r" \r. +"
5\t \fL\b \r\n




5\r\n\f\t
(\t\f \b \t\f #  \b\t=\f \f  \b
331




\t\b\t \r\t \b8\t8 9\t\t\n\f\t7\t  \rM\b\b\t87\t
\t \n \r7
332
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
\b \b8 \t \n \b\b\b8 9\t\t\n\f8 \f\t\b\nL



(\t\f \b \t\f #  \b\t=\f \f  \b
333
#,  :, #'# "#"# " 60 #  \f@.

\n\f"  'C"# #C"@ \f' ## @"\r\r"
\f"#\t \r\f \rC#\t#,   ##"@ "\r:# \f,
 ##"\r##, /"\t \r# / \rC#\t/ %" C
\b \t\t \n\r\bL\b \b8\t8 \n \r7
334
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 

" #. L# \f "\r:\tJ"  \r\t \rC#  "\r\f
#"@ "\r:# \f  \r\t \rC#



(\t\f   \r   ' \r  \t\t\b\f \t  2- \t
335
\t\b\t 5 \t 75 =5 \n \n\r\b7 5\t7
2B \t 



\r\f7\b5:\t\t  \b\t=


336
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 


\f #'# "#"# \f 60 # \t\t"\t C


\n#C#J  " # \f"#C#J $/ '# *



:\t\f\t8
T##\t E "\r"\t \r\f# \f"  \n1,   \t$##
 $. L \r\r"\r"@ \r\f# \f"  \f#:" "\t"
0,6…16,4k m122, 123q. "  "" :#" m124q, /"\t C"
%\t\b& \f \t\f  \t\t\b\f\r \t 
337
# m125q. L\f#" \r#' : #\t $###
\t\t"\t :'J"\t \f#" F\b*G. " \f"#  \n # $## 
\b\r\b\t8 \t\b\t8 \t \n\r\b 5\t
338
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
75 7L\n
\b\t\n  \f\r \n \b  \f  \f  ...
339
\b\t\n  \f\r \n \b   
    \t\f  
\n\r\r\n.!\r \r$\r\n \r  \n \n \n \n \b -\r\n  \n\r \r \n \n\r   \r\t   \r\t  [147, 148]. '\r \n  \n  %   \n  \t\r \r     !"  \n\f  \r \n\b \r  \n\t  \n\b   \f\r. (\n\r,   \b,     \n\r \r \r  , \n \t\r    !", , \n \n \t, $    - \r [149]. &\n\r  \r\r\t  , \r \r  \r  \r\r  \f\n   !" \n   -\r\r\r\b \n\r [150].!  \b   ,  - \n \t\r\b \n \t\n \n \t\r \n\r \t  \b   $\r    \f\t\r\b %     \r\r \r -  \n\r \r \b [151, 152]. & \n \r    \f\t\r \n\r \n\r \r,      \r \n\f\r, \r\n\r  \n\r 
340
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 

#"#-\f#"\r \fC /\f#"@\t  \r \r'@""

�:# \f# # #/##  C"
\t\n\n5\b\t8


### \r'@"", JE#\t ":#', "
\f=\b\t
\t #'\tJE##\t #'#### "\r:"\t#,  #
"\r\t   %", " #\f"@"", " \r# \r#"@
  \b\t\b
341
:" " $"\r$##  \f#"##/ '\f/  "!#J 
\rM\b\t \r\t\bL\b\n\t
342
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
9. Ø~erby N, `argeirsdottir U, Brvnborg X, Andersen ], Daul-‰ørgensen \. Yue
vence of dietary inta‚e and |eal pattern on blood glvcose control in cuildren and
adolescents vsing intensi~e insvlin treat|ent. Diabetologia 2007; 50; 2044…2051.
10. Delauanty ]`, Natuan D`, ]acuin ‰` et al. Association of diet witu glycated
ue|oglobin dvring intensi~e treat|ent of type 1 diabetes in tue Diabetes Xontrol and
Xo|plications Yrial. A| ‰ Xlin Nvtr 2009; 89; 518…524.
11. Zran• `‰, Powers `A, ]eontos X et al. Yue e~idence for |edical nvtrition
tuerapy for type 1 and type 2 diabetes in advlts. ‰ A| Diet Assoc 2010; 110; 1852…1889.
12. Zvnnell ``, Anderson ˆ`. ^|power|ent and self-|anage|ent of diabetes.
Xlin Diabetes 2004; 22; 123…127.
13. Douerty h, Do~ey-Pearce [. }nderstanding tue de~elop|ent and psycuologi-
cal needs of yovng people witu diabetes. Pract Diabetes Int 2005; 22; 59…64.
14. Xa|eron Z‰, de Beavfort X, Aanstoot U-‰ et al. ]essons fro| tue U~idoere
International Stvdy [rovp on cuilduood diabetes; be dog|atic abovt ovtco|e and
eible in approacu. Pediatr Diabetes 2013; 14; 473…480.
15. New” eld ˆS, Xouen D, Xapparelli ^j, Suragg P. ˆapid weigut gain in cuildren
soon after diagnosis of type 1 diabetes; is tuere roo| for concern— Pediatr Diabetes
2009; 10; 310…315.
16. Da~is N], Bvrsell ‰DU, ^~ans xD, xarner ‰Y, [regory ‰x. Body co|position
in cuildren witu type 1 diabetes in tue ”
rst year after diagnosis; relationsuip to glycae|ic
control and cardio~ascvlar ris‚. Arcu Dis Xuild 2012; 97; 312…315.
17. Sil~erstein ‰, \lingens|itu [, Xopeland \ et al. Xare of cuildren and adoles-
cents witu type 1 diabetes; a state|ent of tue A|erican Diabetes Association. Diabetes
Xare 2005; 28; 186…212.
18. Xole Y, Belli••i `, Zlegal \, Diet• x. ^stablisuing a standard de”
nition for cuild
o~erweigut and obesity worldwide; international svr~ey. B`‰ 2000; 320; 1240…1243.
19. `ortensen U, ˆobertson \‰, Aanstoot U et al. Insvlin |anage|ent and |eta-
bolic control of type 1 diabetes |ellitvs in cuilduood and adolescence in 18 covntries.
Diabet `ed 1998; 15; 752…759.
20. `aŠ eis X, `orandi A, jentvra ^ et al. Diet, puysical, and biocue|ical cuarac-
teristics of cuildren and adolescents witu type 1 diabetes; relationsuip between dietary
fat and glvcose control. Pediatr Diabetes 2012; 13; 137…146.
21. Sanduv N, xit|ans `B, ]e|ay ‰-Z, Xrawford S, ‰ada~–i N, Pacavd D.
Pre~alence of o~erweigut and obesity in cuildren and adolescents witu type 1 diabetes
|ellitvs. ‰ Pediatr ^ndocrinol `etab 2008; 21; 631…640.
22. xorld Uealtu Vrgani•ation FxUVG. Vbesity; pre~enting and |anaging tue
global epide|ic. xorld Uealtu Vrgan Yecu ˆep Ser 2000; 894.
23. xorld Uealtu Vrgani•ation FxUVG. [lobal ˆeco||endations for Puysical
Acti~ity and Uealtu 2010 Fa~ailable fro| uttp;wulibdocwuointpvblica-
tions20109789241599979™engpdf—va¦1G.
24. ˆic‚ard \A, Xle~eland ‰], ]ogu|ani ^S, Zineberg NS, Zreidenberg [ˆ.
Si|ilar glyce|ic responses to uigu ~ersvs |oderate svcrose-containing foods in test
|eals for adolescents witu type 1 diabetes and fasting evglyce|ia. ‰ A| Diet Assoc
2001; 101; 1202…1205.
  \b\t\b
343
25. ^bbeling XB, Zeld|an UA, Xuo|it• jˆ et al. A rando|i•ed trial of svgar-
344
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
43. Dewey \, Beaton [, Z–eld X, ]onnerdal B, ˆeeds P. Protein revire|ents of
infants and cuildren. ^vr ‰ Xlin Nvtr 1996; 50; S119…S150.
44. [rober }, Spit• ‰, ˆeicuratu ‰, \isters \, Uolic‚ `. jita|inD; }pdate 2013.
Zro| ric‚ets propuylais to general pre~enti~e uealtucare. Der|atoendocrinol 2013; 5;
e2-331…e2-347.
45. Yvrner BX, ‰en‚in ^, \err D, Suerwin ˆS, Xa~an DA. Yue eŠ ect of e~ening
alcouol consv|ption on net-|orning glvcose control in type 1 diabetes. Diabetes
Xare 2001; 24; 1888…1893.
46. ^~alvation of certain food additi~es and conta|inants FSe~enty-se~entu report
of tue ‰oint ZAVxUV ^pert Xo||ittee on Zood Additi~esG xUV Yecunical ˆeport
Series, No. 983, 2013.
47. \nowles ‰, xaller U, ^iser X et al. Yue de~elop|ent of an inno~ati~e edvca-
tion cvrricvlv| for 11-16 yr old cuildren witu type 1 diabetes |ellitvs. Pediatr Diabetes
2006; 7; 322…328.
48. }.S. Depart|ent of Agricvltvre and }.S. Depart|ent of Uealtu and Uv|an
Ser~ices. Dietary [videlines for A|ericans. 7tu edn. xasuington, DX; }.S. [o~ern|ent
Printing Vž
ce, 2010.
49. ˆabasa-]uoret ˆ, [aron ‰, ]angelier U, Poisson D, Xuiasson ‰]. ^Š
ects of |eal
carbouydrate content on insvlin revire|ents in type 1 diabetic patients treated intensi~ely
witu tue basal-bolvs FvltralenteregvlarG insvlin regi|en. Diabetes Xare 1999; 22; 667…673.
50. ]odefal‚ `, Å|an ‰, Bang P. ^Š
ects of fat svpple|entation on glycae|ic
response and gastric e|ptying in adolescents witu Yype 1 diabetes. Diabet `ed 2008;
25; 1030…1035.
51. Yuo|as D^, ^lliott ^‰. Yue vse of low-glycae|ic inde diets in diabetes control.
Br ‰ Nvtr 2010; 104; 797…802.
52. Panows‚a ^, Bla•i‚ `, [roele ]. Does tue fatprotein|eal increase postpran-
dial glvcose le~el in type 1 diabetes patients on insvlin pv|p; Yue conclvsion of a ran-
do|ised stvdy. Diabetes Yecunol Yuer 2011; 14; 1…8.
53. S|art X^, ^~ans `, VXonnell S et al. Botu dietary protein and fat increase
postprandial glvcose ecvrsions in cuildren witu type 1 diabetes, and tue eŠ ect is additi~e.
Diabetes Xare 2013; 36; 3897. 54. Sueard NZ, Xlar‚ N[, Brand-`iller ‰X, Zran• `‰ et al.
Dietary carbouydrate Fa|ovnt and typeG in tue pre~ention and |anage|ent of diabetes; a
state|ent by tue A|erican Diabetes Association. Diabetes Xare 2004; 27; 2266…2271.
55. xole~er Y`, Ua|ad S, Xuiasson ‰] et al. Day-today consistency in a|ovnt
and sovrce of carbouydrate associated witu i|pro~ed blood glvcose control in type 1
diabetes. ‰ A| Xoll Nvtr 1999; 18; 242…247.
56. \awa|vra Y. Yue i|portance of carbouydrate covnting in tue treat|ent of
cuildren witu diabetes. Pediatr Diabetes 2007; 8; 57…62.
57. ]avren•i A, Bolla A, Panigoni [ et al. ^Š
ects of carbouydrate covnting on
glvcose control and vality of life o~er 24wee‚s in advlt patients witu type 1 diabetes
on continvovs svbcvtaneovs insvlin infvsion. A rando|i•ed, prospecti~e clinical trial
F[IVXAˆG. Diabetes Xare 2011; 34; 823…827.
58. Sca~one [, `anto A, Pitocco D et al. ^Š
ect of carbouydrate covnting and-
|edical nvtritional tuerapy on glycae|ic control in type 1 diabetic svb–ects; a pilot
stvdy. Diabet `ed 2010; 27; 477…479.
  \b\t\b
345
59. ]owe ‰, ]in–awi S, `enscu `, ‰a|es \, Attia ‰. Zleible eating and ›
eible
insvlin dosing in patients witu diabetes; resvlts of an intensi~e self-|anage|ent covrse.
Diabetes ˆes Xlin Pract 2008; 80; 439…443.
60. DAZN^ Stvdy [rovp. Yraining in ›
eible, intensi~e insvlin |anage|ent to
enable dietary freedo| in people witu type 1 diabetes; Dose Ad–vst|ent for Nor|al
^ating FDAZN^G rando|ised controlled trial. Br `ed ‰ 2002; 325; 746…749.
61. Yrento `, Borgo ^, \vcicu X et al. Žvality of life, coping ability, and |etabolic
control in patients witu type 1 diabetes |anaged by grovp care and a carbouydrate
covnting progra|. Diabetes Xare 2009; 32; e134.
62. }lauannan Y, ˆoss x, Da~ies Z. Xarbouydrate covnting in type 1 diabetes; ti|e
to ˆ^AXXY. Pract Diabetes Int 2007; 24; 134…136.
63. `euta SN, Uaynie D], Uiggins ]A et al. ^|puasis on carbouydrates |ay
negati~ely in›
vence dietary patterns in yovtu witu type 1 diabetes. Diabetes Xare 2009;
32; 2174…2176.
64. [illespie S‰, \vl‚arni \D, Daly A^. }sing carbouydrate covnting in diabetes
clinical practice. ‰ A| Diet Assoc 1998; 98; 897…905.
65. Danne Y, `ortensen U, Uovgaard P, ]ynggaard U, for tue U~idore Stvdy
[rovp on Xuilduood Diabetes. Persistent diŠ
erences a|ong centers o~er 3 years in
glyce|ic control and uypoglyce|ia in a stvdy of 3,805 cuildren and adolescents witu
type 1 diabetes fro| tue U~idore Stvdy [rovp. Diabetes Xare 2001; 24; 1342…1347.
66. A|erican Diabetes Association. Standards of |edical care in diabetes-2014.
Diabetes Xare 2014; 37; S14…S80.
67. S|art X^, ˆoss \, ^dge ‰A, \ing Bˆ, `c^ldvŠ P, Xollins X^. Xan cuildren
witu type 1 diabetes and tueir caregi~ers esti|ate tue carbouydrate content of |eals and
snac‚s— Diabet `ed 2010; 27; 348…353.
68. Bra•eav AS, `ircescv U, Des–ardins \ et al. Xarbouydrate covnting accvracy
and blood glvcose ~ariability in advlts witu type 1 diabetes. Diabetes ˆes Xlin Pract
2013; 99; 19…23.
69. `euta S, Žvinn N, jol‚ening ], ]aŠ
el ]. I|pact of carbouydrate covnting on
glyce|ic control in cuildren witu type 1 diabetes. Diabetes Xare 2009; 32;
1014…1016.
70. S|art X^, \ing Bˆ, `c^ldvŠ P, Xollins X^. In cuildren vsing intensi~e insvlin
tuerapy, a 20-g ~ariation in carbouydrate a|ovnt signi”
cantly i|pacts on postprandial
glycae|ia. Diabet `ed 2012; 29; e21…e24.
71. Bisuop Z, `aaus D`, Spiegel [ et al. Yue carbouydrate covnting in adolescents
witu type 1 diabetes FXXAYG stvdy. Diabetes Spectr 2009; 22; 56…62.
72. Yuo|as D, ^lliott ^. ]ow glycae|ic inde, or low glycae|ic loads, diets for dia-
betes |ellitvs. Xocurane Database Syst ˆe~ 2009; XD006296. doi; 10.100214651858.
XD006296.pvb2.
73. Brand-`iller ‰, Uayne S, Petoc• P, Xolagivri S. ]ow-glyce|ic inde diets in
tue |anage|ent of diabetes; a |eta-analysis of rando|i•ed controlled trials. Diabetes
Xare 2003; 26; 2261.
74. Xraig `^, Ywigg S`, Donaguve \X et al.National ^~idence-Based Xlinical
Xare [videlines for Yype 1 Diabetes in Xuildren, Adolescents and Advlts. Xanberra;
Avstralian [o~ern|ent Depart|ent of Uealtu and Ageing, 2011.
346
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
75. [ilbertson Uˆ, Brand-`iller ‰X, Yuorbvrn Ax, ^~ans S, Xuondros P, xertuer
[A. Yue eŠ ect of ›
eible low glyce|ic inde dietary ad~ice ~ersvs |easvred carbouy-
drate ecuange diets on glyce|ic control in cuildren witu type 1 diabetes. Diabetes Xare
2001; 24; 1137…1143.
76. ˆyan ˆ, \ing Bˆ, Anderson D, Attia ‰, Xollins X^, S|art X^. In›
vence of and
opti|al insvlin tuerapy for a low-glyce|ic inde |eal in cuildren witu type 1 diabetes
recei~ing intensi~e insvlin tuerapy. Diabetes Xare 2008; 31; 1485…1490.
77. Zoster-Powell \, Uolt SU, Brand-`iller ‰. International table of glyce|ic inde
and glyce|ic load ~alves; 2002. A| ‰ Xlin Nvtr 2002; 76; 5…56.
78. Barclay Ax, Petoc• P, `c`illan-Price ‰ et al. [lyce|ic inde, glyce|ic load,
and curonic disease ris‚ … a |eta-analysis of obser~ational stvdies. A| ‰ Xlin Nvtr
2008; 87; 627…637.
79. Dorcuy U. Dietary |anage|ent for cuildren and adolescents witu diabetes
|ellitvs; personal eperience and reco||endations. ‰ Pediatr ^ndocrinol `etab 2003;
16; 131…148.
80. S|art X^, ˆoss \, ^dge ‰A, Xollins X^, Xoly~as \, \ing Bˆ.Xuildren and
adolescents on intensi~e insvlin tuerapy |aintain postprandial glycae|ic control witu-
ovt precise carbouydrate covnting. Diabet `ed 2009; 26; 279…285.
81. Price \, \nowles ‰, Zree|an ‰, xales ‰, \IX‚-VZZ Stvdy [rovp. I|pro~ing
ovtco|es for adolescents witu type 1 diabetes; resvlts fro| tue \ids in Xontrol VZ
Zood F\IX‚-VZZG trial. Pediatr Diabetes 2013; 14; 19…49.
82. ~on Sengbvscu S, `vller-[odeŠ
roy ^, Uager S, ˆeint–es ˆ, Uiort V, xagner
j. `obile diabetes edvcation and care; inter~ention for cuildren and yovng people witu
type 1 diabetes in rvral areas of nortuern [er|any. Diabet `ed 2006; 23; 122…127.
83. Anderson D[. `vltiple daily in–ections in yovng patients vsing tue e•y-BIXX
bolvs insvlin calcvlation card, co|pared to |ied insvlin and XSII. Pediatr Diabetes
2009; 10; 304…309.
84. Xa|pbell `S, Scuat• DA, Xuen j et al. A contrast between cuildren and ado-
lescents witu ecellent and poor control; tue Y1D ecuange clinic registry eperience.
Pediatr Diabetes 2014; 15; 110…117.
85. Uayes ˆ], [arnett SP, Xlar‚e S], Uar‚in N`, Xuan A\, A|bler [ˆ. A ›
e-
ible diet vsing an insvlin to carbouydrate ratio for adolescents witu type 1 diabetes … a
pilot stvdy. Xlin Nvtr 2012; 31; 705…709.
86. ^nander ˆ, [vnde~all X, Stro|gren A, Xuaplin ‰, Uanas ˆ. Xarbouydrate covnt-
ing witu a bolvs calcvlator i|pro~es post-prandial blood glvcose le~els in cuildren and
adolescents witu type 1 diabetes vsing insvlin pv|ps. Pediatr Diabetes 2012; 13; 545…551.
87. Barnard \, Par‚in X, hovng A, Asuraf `. }se of an avto|ated bolvs calcvlator
redvces fear of uypoglyce|ia and i|pro~es con”
dence in dosage accvracy in patients
witu type 1 diabetes |ellitvs treatedwitu|vltiple daily insvlin in–ections. ‰ Diabetes Sci
Yecunol 2012; 6; 144…149.
88. Deeb ]X, Uolco|be ‰U, Brvnelle ˆ et al. Insvlin lispro lowers postprandial
glvcose in prepvbertal cuildren witu diabetes. Pediatrics 2001; 108; 1175.
89. Bvrdic‚ ‰, Xuase UP, Slo~er ˆU et al.`issed insvlin |eal bolvses and ele~ated
ue|oglobin A1c le~els in cuildren recei~ing insvlin pv|p tuerapy. Pediatrics 2004; 113;
613…616.
  \b\t\b
347
90. jander xel B, `esser ], Uorton ] et al. `issed insvlin bolvses for snac‚s in
yovtu witu type 1 diabetes. Diabetes Xare 2010; 33; 507…508.
91. Danne Y, A|an ‰, Scuober ^ et al. A co|parison of postprandial and prepran-
dial insvlin aspart in cuildren and adolescents witu type 1 diabetes. Diabetes Xare 2003;
26; 2359…2364.
92. Xuase UP, Saib S‡, `ac\en•ie Y, Uansen ``, [arg S\. Post-prandial glv-
cose ecvrsions following fovr |etuods of bolvs insvlin ad|inistration in svb–ects witu
type 1 diabetes. Diabet `ed 2002; 19; 317…321.
93. ]ee Sx, Xao `, Sa–id S et al. Yue dval-wa~e bolvs featvre in continvovs svb-
cvtaneovs insvlin infvsion pv|ps controls post-prandial uyperglyce|ia better tuan
standard bolvs in type 1 diabetes. Diabetes Nvtr `etab 2004; 17; 211…216.
94. VXonnell `, [ilbertson U, Donatu S, Xa|eron Z. Vpti|i•ing postprandial
glyce|ia in pediatric patients witu type 1 diabetes vsing insvlin pv|p tuerapy; i|pact
of glyce|ic inde and prandial bolvs type. Diabetes Xare 2008; 31; 1491.
95. ‰ones S`, Žvarry ‰], Xaldwell-`X|illan `, `avger DY, [abbay ˆA.
Vpti|al insvlin pv|p dosing and postprandial glyce|ia following a pi••a |eal vsing
tue continvovs glvcose |onitoring syste|. Diabetes Yecunol Yuer 2005; 7; 233…240.
96. xolpert UA, Ata‚o~-Xastillo A, S|itu SA, Steil [`. Dietary fat acvtely
increases glvcose concentrations and insvlin revire|ents in patients witu type 1 dia-
betes; i|plications for carbouydratebased bolvs dose calcvlation and intensi~e diabetes
|anage|ent. Diabetes Xare 2013; 36; 810…816.
97. Pa‚ows‚a ^, S•ypows‚a A, ]ip‚a `, S•potas‚a `, Ba•i‚ `, [roele ].
Application of no~el dval wa~e |eal bolvs and its i|pact on glycated ue|oglobin A1c
le~el in cuildren witu type 1 diabetes. Pediatr Diabetes 2009; 10; 298…303.
98. \ordonovri V, Uart|ann ˆ, ˆe|vs \, Blasig S, Sadeguian ^, Danne Y.
Bene”
t of svpple|entary fat plvs protein covnting as co|pared witu con~entional car-
bouydrate covnting for insvlin bolvs calcvlation in cuildren witu pv|p tuerapy. Pediatr
Diabetes 2012; 13; 540…544.
99. Bao ‰, [ilbertson U, [ray ˆ et al. I|pro~ing tue esti|ation of |eal-ti|e insv-
lin dose in advlts witu type 1 diabetes. Diabetes Xare 2011; 34; 2146…2
151.
100. Puillip `, Battelino Y, ˆodrigve• U, Danne Y, \avf|an Z. }se of insvlin
pv|p tuerapy in tue pediatric age-grovp; consensvs state|ent fro| tue ^vropean
Society for Paediatric ^ndocrinology, tue ]awson xil‚ins Pediatric ^ndocrine Society,
and tue International Society for Pediatric and Adolescent Diabetes, endorsed by
tue A|erican Diabetes Association and tue ^vropean Association for tue Stvdy of
Diabetes. Diabetes Xare 2007; 30; 1653…1662.
101. `eyer Z, VXonnor U, SuirreŠ
s S`. Nvtrition for tue yovng atulete. ‰ Sports
Sci 2007; 25; S73…S82.
102. DirecNet Stvdy [rovp. I|pact of eercise on o~ernigut glyce|ic control in
cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr 2005; 147; 528…534.
103. `c`auon S\, Zerreira ]D, ˆatna| N et al. [lvcose revire|ents to |aintain
evglyce|ia after |oderate-intensity afternoon eercise in adolescents witu type 1 diabetes
are increased in a bipuasic|anner. ‰ Xlin ^ndocrinol `etab 2007; 92; 963…968.
104. [allen I. Yype 1DiabetesXlinical `anage|ent of tue Atulete. ]ondon;
Springer-jerlag ]ondon ]i|ited, 2012.
348
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
105. ]\ Pvrcell for tue Xanadian Paediatric Society. Sport nvtrition for yovng atu-
letes. Paediatric Sports and ^ercise `edicine Section 2013; 18; 200…202.
106. Uocu A‡, [oossen \, \retscu|er Y. Nvtritional revire|ents of tue cuild
and teenage atulete. Puys `ed ˆeuabil Xlin N A| 2008; 19; 373…398.
107. Perone X, ]aitano V, `eyer Z. ^Š
ect of carbouydrate ingestion on tue gly-
ce|ic response of type 1 diabetic adolescents dvring eercise. Diabetes Xare 2005; 28;
2537…2538.
108. ˆiddell `X, Iscoe \. Puysical acti~ity, sport and pediatric diabetes. Pediatr
Diabetes 2006; 7; 60…70.
109. [allen I. Uelping tue atulete witu type 1 diabetes. Br ‰ Diabetes jasc Dis 2004; 4;
87…92. 110. Xoyle ^Z. Zlvid and fvel inta‚e dvring eercise. ‰ Sports Sci 2004; 22; 39…55.
111. ˆowland Y. Zlvid replace|ent revire|ents for cuild atuletes. Sports `ed
2011; 41; 279…288.
112. Uernande• ‰`, `occia Y, Zlvc‚ey ‰D, }lbrecut ‰S, Zarrell PA. Zlvid snac‚s
to uelp persons witu type 1 diabetes a~oid late onset posteercise uypoglyce|ia. `ed
Sci Sports ^erc 2000; 32; 904…910.
113. YVDAh Stvdy [rovp. ]ipid and in› a||atory cardio~ascvlar ris‚ worsens
o~er 3 years in yovtu witu type 2 diabetes; tue YVDAh clinical trial. Diabetes Xare 2013;
36; 1758…1764.
114. Bloo|garden ‡Y. Yype 2 diabetes in tue yovng; tue e~ol~ing epide|ic.
Diabetes Xare 2004; 27; 998…
1010.
115. ˆosenbloo| A], Sil~erstein ‰U, A|e|iya S, ‡eitler P, \lingens|itu [‰. Yype
2 diabetes in cuildren and adolescents. Pediatr Diabetes 2009; 10; 17…32.
116. Uoelscuer D`, \ir‚ S, ˆitcuie ], Xvnningua|-Sabo ]. Position of tue
Acade|y of Nvtrition and Di
  \b\t\b
349
123. \ordonovri V, Uart|ann ˆ, Deiss D, xil|s `, [rvters-\ieslicu A. Natvral
covrse of avtoi||vne tuyroiditis in type 1 diabetes; association witu gender, age, dia-
betes dvration, and pvberty. Arcu Dis Xuild 2005; 90; 411…414.
124. Not Y, Yo||asini A, Yonini [ et al. }ndiagnosed celiac disease and ris‚ of avto-
i||vne disorders in svb–ects witu type 1 diabetes |ellitvs. Diabetologia 2001; 44; 151…155.
125. Xa|arca `, `o••illo ^, Nvgnes ˆ et al. Xeliac disease in type 1 diabetes |el-
litvs. Ital ‰ Pediatr 2012; 38; 1…7.
126. ]e§
er DA, ^dwards-[eorge ‰, Dennise ` et al. Zactors tuat in›
vence aduer-
ence to a glvten-free diet in advlts witu celiac disease. Dig Dis Sci 2008; 53; 1573…1581.
127. UoŠ
enberg ^‰, Uaas ‰, Drescuer A et al. A trial of oats in cuildren witu newly
diagnosed celiac disease. ‰ Pediatr 2000; 137; 361…366.
128. Uogberg ], ]avrin P, Zaitu-`agnvsson \ et al. Vats to cuildren witu newly
diagnosed celiac disease; a
rando|ise
ble-blind stvdy. [vt 2004; 53; 649…654.
129. ‰anatvinen ^\, \e|ppainen YA, ‰vl‚vnen ˆ‰ et al. No uar| fro| 5-year
ingestion of oats in celiac disease. [vt 2002; 50; 332…335.
130. `vrcu S, ‰en‚ins U, Avtu ` et al. ‰oint BSP[UAN and Xoeliac }\ gvidelines
for tue diagnosis and |anage|ent of coeliac disease in cuildren. Arcu Dis Xuild 2013;
98; 806…811.
131. ]vndin \^, Nilsen ^`, Scott U[ et al. Vats indvced ~illovs atropuy in celiac
disease. [vt 2003; 52; 1649…1652.
132. \av‚inen \, Xollin P, Uol| \ et al. xueat starcu containing glvten-free ›
ovr
prodvcts in tue treat|ent of celiac disease and der|atitis uerpetifor|is. A longter|
follow-vp stvdy. Scand ‰ [astroenterol 1999; 34; 164…169.
133. Yuo|pson Y, Dennis `, Uiggins ]A, ]ee Aˆ, Suarrett `\.[lvten- free diet
svr~ey; are A|ericans witu celiac disease consv|ing reco||ended a|ovnts of ”
iron, calciv| and grain foods— ‰ Uv| Nvtr Diet 2005; 18; 163…169.
134. Xriego A, Xrow S, [oebel-Zabbri A^, \endall D, Par‚in X. ^ating disorders
and diabetes; screening and detection. Diabetes Spectr 2009; 22; 143…146.
135. `ar‚owit• ‰, Bvtler D, jol‚ening ], Antisdel ‰, Anderson B, ]aŠ el ]. Brief
screening tool for disordered eating in diabetes; Internal consistency and eternal ~alid-
ity in a conte|porary sa|ple of pediatric patients witu type 1 diabetes. Diabetes Xare
2010; 33; 495…500.
136. d^|den U, Uolden ], `cDer|ott B et al. Xoncvrrent ~alidity of self-report
|easvres of eating disorders in adolescents witu type 1 diabetes. Acta Paediatr 2012;
101; 973…978.
137. ‰ones ‰, ]awson `, Dane|an D, Vl|sted `, ˆodin [. ^ating disorders in
adolescent fe|ales witu and wituovt type 1 diabetes; cross-sectional stvdy. Br `ed ‰
2000; 320; 1563…1566.
138. Pe~eler ˆX, Zairbvrn X[, Boller I, Dvnger D. ^ating disorders in adolescents
witu IDD`. A controlled stvdy. Diabetes Xare 1992; 15; 1356…1360.
139. Xolton P, Vl|sted `, Dane|an D, ˆydall ˆ, ˆodin [. Distvrbed eating
beua~ior and eating disord
ers in pr
350
!\t\t 10. \b\t\f\t \t\f   \r  \b  \t\t\b\f \t 
141. Xolton P, ˆodin [, Berenstal ˆ, Par‚in X. ^ating disorders and diabetes;
introdvction and o~er~iew. Diabetes Spectr 2009; 22; 138…142.
142. Zairbvrn X[, Pe~eler ˆX, Da~ies B, `ann ‰I, `ayov ˆA. ^ating disorders
in yovng advlts witu insvlin dependent diabetes |ellitvs; a controlled stvdy. B`‰ 1991;
303; 17…20.
143. Pe~eler ˆX, Bryden \S, Neil UA et al. Yue relationsuip of disordered eating
uabits and attitvdes to clinical ovtco|es in yovng advlt fe|ales witu type 1 diabetes.
Diabetes Xare 2005; 28; 84…88.
144. [oebel-Zabbri A, }plinger `, [er‚en S, `angua| D, Xriego A, Per‚in X.
Vvtpatient |anage|ent of eating disorders in type 1 diabetes. Diabetes Spectr 2009;
22; 147…152.
145. Vl|sted `P, Dane|an D, ˆydall AX, ]awson `], ˆodin [. Yue eŠ
ects of
psycuoedvcation on distvrbed eating attitvdes and beua~ior in yovng wo|en witu type
1 diabetes |ellitvs. Int ‰ ^at Disord 2002; 32; 230…239.
146. Anderson B, Brac‚et ‰. Diabetes dvring cuilduood. In; Psycuology inDiabetes
Xare. ]ondon;xiley, 2000.
147. Patton Sˆ, Dolan ]`, Powers Sx. `ealti|e interactions relate to dietary
aduerence and glyce|ic control inyovngcuildrenwitu type1diabetes.Diabetes Xare
2006; 29; 1002…1006.
148. ˆo~ner A‰, `euta SN, Uaynie D] et al. Percei~ed bene” ts, barriers, and
strategies of fa|ily |eals a|ong cuildren witu type 1 diabetes|ellitvs and tueir parents;
Zocvs-grovp ”
ndings. ‰ A| Diet Assoc 2010; 110; 1302…1306.
149. Nortua| ^A, `attuews ]\, Anderson P‰, Xa|eron Z‰, xertuer [A.
Psycuiatric |orbidity and uealtu ovtco|e in type 1 diabetesz perspecti~es fro| a pro-
specti~e longitvdinal stvdy. Diabet `ed 2005; 22; 152…157.
150. Suer|an A`, Bowen D‰, jitolins ` et al. Dietary aduerence; cuaracteristics
and inter~entions. Xontrol Xlin Yrials 2000; 21; S206…S211.
151. Nor
tua| ^A, Yodd S, Xa|eron Z‰. Inter~entions to pro|ote opti|al uealtu
ovtco|es in cuildren witu type 1 diabetes … are tuey eŠ
ecti~e— Diabet `ed 2006; 23;
113…121.
152. Ua|pson S^, S‚inner YX, Uart ‰ et al. Beua~ioral inter~entions for adoles-
cents witu type 1 diabetes; uow eŠ ecti~e are tuey— Diabetes Xare 2000; 23; 1416…1422.
153. `vrpuy Uˆ, ˆay|an [, S‚inner YX. Psycuoedvcational inter~entions for
cuildren and yovng people witu type 1 diabetes. Diabet `ed 2006; 23; 935…943.
154. `eetoo D. Xlinical s‚ills; e|powering people witu diabetes to |ini|ise co|-
plications. Br ‰ Nvrs 2004; 13; 644…651.
155. S‚inner YX, ‰oun N`, Ua|pson S^. Social svpport and personal |odels of
diabetes as predictors of self-care and wellbeingz a longitvdinal stvdy of adolescents witu
diabetes. ‰ Pediatr Psycuol 2001; 25; 257…267.
156. Price \‰, xales ‰, ^iser X et al. Does an intensi~e self-|anage|ent strvctvred
edvcation covrse i|pro~e ovtco|es for cuildren and yovng people witu type 1 diabe-
tes— Yue \ids In Xontrol VZ Zood F\IX‚-VZZG clvster-rando|ised controlled trial
protocol.B`‰ Vpen 2013; 3.
1 \t\t 22
5\t\t\n\f\t \f:\t5
\t \t \r\t\f7\t\n\f\t \t \r\n78\r\b \n\n
Barts Health NHS Trust,
Royal London Hospital, London, UK; CInstitute of Endocrinology and Diabetes, The Childrens Hospital at
Westmead; School of Womens and Childrens Health, University of New South Wales, Sydney, Australia;
352 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
«\f \b  ƒ» \f#\f \b \r\f   \b: www.ispad.org.  \b \f\t\b \f \f\t\b\f 
\f!\b \t \b  \b\b,  \r\f!\b\f $\b \f \b\f\f\b \f  \f%%\b.
\f\f = \f  \b  \f\t
353
\fC \t"@\t  :E#
\r\f$#\t \f\t $##'#\r \f#"\r#
\r#"# E# FPA]SG # J"@ '\f#"@
' " \r# #  #' \r#, $ "\tC"#
:'C##\t # \r@ '#\t FLG. C :"@ "
\r'@"" FLG. = " , # \r## \r##\t
""  #, ": \r# :/\f#"# \r\t "#
#'#\t, \t@  ###/ # :\r"\r/ \f/
; \r\r$#\t :'C##\t, \r\r$#\t $#\f'
# "\r# "', \f\t \r\r$#\t #\r\t\r"# #
"# \r\t J', :#'  \r, #"\r#
J\t :# \f "\r:"#  C#\f"#, "\r\t@
'EJEJ "\r#J #\t \f "/ \r,  
354 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
:\f" '\f"#\r \f#\r'. = \r"#  #J" 
\t\n \t\n/ *\n   \r \r\n\f  
\r'\f\rC#"@"@, !J #"@, \f\rC#G,
$### \r## \r#'# F"#  \r#
. \n\rC\f# %#'\f   \t\t"\t






$\t# @ #'# "\r## \t\tJ"\t
\r!#\r# "\r#- # \f#" :H, "#
 \r'#"\t \f"# \f"""# $#\r#\rJE
## # ##\t \r\t "\r\r\t"\r/ \r;
"/#, J, \r"#' # \r \r" m1, 2q.
:J"\t ##\t \f"""@ ""\t \r# \r
\f\f = \f  \b  \f\t
355
/#' "' # \f"  ":# \f$##,
F\r\f" ##' # J'G, \f\r 
\fJEJ \r\f$#J "\r/ \r, \r#\f\tEJ 
\r""@ "@\t \f#\f\r"$#\t # ":## $#\f'.
 /\r"\r#'"\t "\tC# \r!#\t# \f #
%"\r#" :  - # "\r#" C#\f"#.
 \r'@"" ! $"\r$## "/#  ',
 #\r\t\r"@, "\r\t !" \r"\r#@ \f#
\r:\rE#\t # \r\t\r #@"\r$##. \r# :H"#
356 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
\tA\r

\b\n,   \tA%&
!\n$ \t
\n\n\n% \n$%
\b
\b
\b
\b
\b
\b
\n\n
($A&
\n)
 Q\n
"\n\t\t
\f\t\n:\t
 !A
\t
%
\b
\t
!\n\t
\b
C\n% %
 !A\r
\n\t
#!\n$\n\r
!\n
C
\n;# 11.1.
%\t$\n  \b\t\r \t\b\n\t (\t\t \r \t\n+
\n: T \f$\r\b$  \b. ^5G5_)
\f\f = \f  \b  \f\t
357
 11.1
! F!"& ! E((! *! !-!/"# 3!'
! *-%"!  *F!_`& *!! $ %#()%@; &
C\t�9  \f (…2G)
0\t �  \f (G…9)
E \bJ  \f (G…K)
P\r$\t��6,…5,  \f
358 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
 \r5\b\t 5\t\t\n\f \f:\t5



$"\r$#J BVUB  \r#z \r@ : 3 @ \t\t"\t
:H\t#"@ \r'##\t#  /\r"\r#"#/ \t$##,  "C



, \r :'  #\r\t\r\t ""#\t ,
"\r"\t #  \f/ $#"  \n2 m26…28q,  J\f  \n 1 m29q #



\b\t \t\n \f\t\r \f\n\t\n
359



 11.2
\b\t\n \b\f\r \n  \n\n  \n \t
\n\t\t\n\n
!\t\t \t, "#\b\t \b\t,
/24 #/#
432553022
540565027
648579033
757092038
8640104043
9710116048
10780128053
11840139058
12890149062
13940159066
14990169070
151030178074
161070187078
171120197082
181150205085
191190214089
201230223093
2213002400100
2413602560107
2614302730114
2814902890120
3015603060128
8\t -\n  \f\r \t\f\n.
360 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
7"" (, \n$/%+ %#,
G52956G5562GJ
GJ296GG962J6
G928G6GJ962JJ
G28K6&#x-753;بK;-70;VG0;G62JK
J6�26G866�2J
�J2K6GK96-70;VGK;–-7;䉢’29
�65266J566�28
��5526JJ562J
965G56J9J62KG
�95J26J56562
86�566�66656
�8�5K6�26529
659K6-75;㙙&#xK6-7;ՠG655J
m6q. ?\r#J \f" """JE# :\r' \r\r"#\r"@ 
\r\n \r\n\r\b\b\b\nL 5\t\t\n\f \f:\t5
 5= \b\t8
\b\t\n \f \r . 11.2
 \f \t    \t\t
361
 5 \n \n\b\b\b7 5\t7








\b\t 5\t\t\n\f \f:\t5
\bM\b \n5\b\t
PA]S m50, 51q, : ## \f\tJ" \fJE# "  \f",

362 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
A A
9\nD
9!D
A !\n\t
 \n\t\tD
;/$A /\t\n\t\n
 \t
%  $AD
\b \t\n \f\r\n\r.
\r \r \r \n\b.
\f \r   
\t\r
 (C
"\n\t\t N5ID
+$\t\r\t \n\t\tD
'\t$\t
"%/\t\r% ! RM-
A
\f\tA  9 \tD
-\n\t!
'\tA\t& !\n\r  CD
0,GI & \n\t\nD
8 # !\n \t$\t\r%/ =-\t/D
\f A:
9\nC\t&  \t, \tA\t A\n
1…2 A ! C [0D05-1 \tM(
×
A \t
9A\t& \n\r %  \nD
 \f \t    \t\t
363
\n;# 11.2.
  \b \b\t\r \t\b\n\t (\t\b\t\t \n: Fzl|r |} {y. N{rl|r Wby. 2KKK ^5GG_). C1 „ \t\n-
\t\r\t \f; %0 „ \b&
/:
\f\nA
/:
@\n\r %  \n


!\t \n %  \n N5 $$\rM(
×
9\n\t \t
9A -C&D
\b$% \n\t!\n
-\n\t!
9\n/ \t  0,45I 
@A:
A /\n: \t$A,
!\n$\r !\n$\t C
\n\r
A !$D
\f  \t $\tT

\f\t\tA $\t\t 0,5…1 M 
9\n/ \t 9 
\f\tA 9 - \t,
\r\f\r \r\r \t\b
 \t   \r \f \b
#% , \t$ A\t%
\nA%/ \n\tB&,
!&, \n\t\n\tC\r\r,
!%:\t \r, \nC\t
$A), !A
\nA !\n\t
364 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
…('\r#"@ $"\r$#J BVUB  \r#  [email protected] \r""#-


…##\t $ "# \f#\f\r"$## „ " #
 \r\f "\f, # : # C\f \r\f\tE##
"#/ \r#'. ?\r# #: C/ ###/ \r#'
$# "# \f#\f\r"$##  @#/ \f" " 1  \f 5 ",
…\r# ' \r#'# $# "# \f#\f\r"$## J-
…&C \r\fC#"@

F!  *' „

…*J'  \r" ## ' \r#.
…+"\r#" FJ\t :#\r:"G.
…'"# #, \r"##.
…�\t\r"# \r#.
…=' pU, \r$#@ \f#\t # ' FpXV
…*:# # "\r#" ## \r'\r" ## -
 \f \t    \t\t
365
…\r @:#, @$#\t, \r, #\t F# 'CG.

"\t#\t # \f#\t \r"/ $#", @ \f"



 11.3
( #@ ('
3!+ ('
$/?+
-()%+
3!+
$/?!& -()%@&

O$ &, @
% '!_Q
$/?+ !()%+
O#%+Q 3!+
2. #\r\r
\t  \t\n
2. #\r\r
2. #\r\r -
2. #\r\r \b\t-
� : " 3 \f 15; 3 „ /\f!# : # 15 „ !# m63q. \f# #' "
{ \b\t'\t \r@, \r#'@ ## ""# \r"##\r\t \r@,  " "-
\t  :.
{{ &C" \f\rC#"@ ##, \f" \r#@ ""  \r,  \r#""-
J" "\r\t \f'\r#"$#\t # '!"@".
366 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
5 \b\tL\b 7\r

… 'C"# \f" #':"@ #":$##z ' \r"

…L# $#" "\r:# :@! #"  ## \f-



…\n"\r"@  "#"@ $"\r@ ' ""\r, ' #J-
…(# \r\f"#"@  \f"@  $"\r@ ""\r,

c \n!\t#\b \r\n\n\t\r\t\b
 \f \t    \t\t
367

""\r#'$##  '\r\t :  "\r:"\t, , #
\r: :' '#\t ##  C" \rC#"@  '\[email protected]
 "\r:"# F\r#\r,  \rC\f/ # @ :@/
5 \bM\b \r5\tL \b\t 5 \n 5\t\t\n\f\t7
\f:\t57T



\f"  :\r"\r C:, "\r C" :#"@
$##"@"" „ \f#"\r  $#@ :# #
"#  "\tC  F\f#"@ \r #""##,
\r!#\t# \r:\rE#\t ## \r! \r
\r@ #  \r#G \fC \r"\r#"@\t  "
\f#\f" \f\t "C #\t  "\f## #"#
" "C :J\f#\tG \f \r\f" "
368 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
\f\t\b\t\n\f\t \t \t\t7\t\n\f\t 7\b\t\r\t\b
## # :#/## "" \r$##  "\r#J 
\t\f\n \r  \t#
\f ###/ :J\f#, \r## "\r# #


…\t :@z
…:H\t# '\f# "" \r\f/ \rE#z
…"\r\t \r"z
…#'#\t \r# "" F:", ':\f#-
…!# \r\t z
…#C# \r\t E#\t #\r\fz
…:"\r !# $"\r$## "\r#\t, 'JE  '-



\f \r   \r \f\b\f
369


…\r""# F :\r"\rG ""#\r#  BVUB \t\t"-



…# \rC" ¦ Na FXl š UXV
\r#  # \rC" : "\t"
…\n\r\r"#\r "\r# ¦ #'\r Na š 2 FmJ'
…�+"#\t \t\r"@ ¦ FG ¦ 2 × FNa 'G š





M\t5\f\n\t \t \n\t
 $#"   #"\t \f#$#" :H "
C#\f"#, "\r : "\t" 5…10k m8, 9q.  
\f#### \r!#\t# \r\f "\r"\t \r#  
\f". ### $# \f#$#" :H :H"# # "
370 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
m59…61q,  %" \r## \r\f #""@, " \r# \r
\rC  \f#\f\r"$#\t "\t" 5…7k # \r# "\tC
 „ 7…10k. +"#\t \t\r"@ F. \r !G "
/\f#"\t  \r\f/ 300…350 @. !# \r\t #
 \r# # $"\r$## "\r#":#, ## @:#
 ', ## :E $"\r$## \r"# \r# \f'\r##
 #J m77q C" :"@ ' \r\r $# "#
\rC"# \f#$#" :H " C#\f"# m73, 78, 79q.
(/ \f" \r\t\r \r\f\t"@  \r\t \r#$## # #\t
C#\f"# m80q. \r@ "\r#\t  \r" \r# \r\f"\t"
: \f"\r "\f \r\f#\t "# @!#\t :H
" C#\f"#  \f \r##; 1G J',  :@!
"# \r#\t  " \r"\r", \r#\f#" 
"# \rE#J \f  " \r"\r",
\r#\f\t  #"\r### m81, 82q # 2G #' \f\rC#J
"\r#\t  ! ##\f \r$##  \r" \r# .
\f  \t\t"\t \r: \r# #@'## \r/
"\f \r\f#\t \r\t "\r#\t. ( %" C
\f#""@ \r\r"#\r \r@ "\r#\t F #@'#
!\r#\f \rG, "\rCJE# C#\fJ $"\r$#J
"\r#\t \r# """## #\r###, # #"\r#\r"@ %"#
#'#\t \r# "\r##.  \r #C#\t $"\r$## J' 
'  '#\t C#\f"# # ##, $"\r$#\t "\r#\t
 \r" \r# \fC ##"@\t. =C #"@, " %"
##  '" /\f!#\t #\r"# "". L#
\r@ #'\r "\r#\t  \r" \r#  ##"\t ##
\r\fC" #C"@\t \r# "\r##, " %" C #""@ 'C
\r#' \rCJE " ' m83…85q. \n#! :"\r
# \r\fC#"@ \r" $"\r$## "\r#\t  \r" C"
"C '"@ " '  \r'@"" "\r# :\f \f  



(\b\f \t  *\f\r  \b\t =  
371
\r\t\b:\t  7\n\tL\b \r \t\t M\t5\f\n87\t
\t \n87\t
" ',  "' ""\t  \f $ \t". "
\r'\r:"  :HJE :'\r #"\r"\r # :#
372 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
… $#"  :  \r#\r# \r:C#
…ME# \f#$#" \r' 4…6  \r\f\t" \r"\r#, "#-
…= \f#  :#J \f\f\rC#JE \f :H-
 C#\f"# \f" '"#"@ \r\f \f#$#"
…@ "\tC"@ \f#\f\r"$## C $#"@ # " 
…\f"\r#"@ \r'@"" :#  \r# #@'-
(\b\f \t  *\f\r  \b\t =  
373

= \f#  ### $ \f#\f\r"$## \f"



…�#\tJE# %" /\r#\f C" #\r"@ \r\rE#
…\r# \r'#"## #\r/\r##, :' \f#$#" C" :"@
…\t \r\f"\rE#\t %" !#: #"\r\r"$## #@-
'J" \r""# #'\r#\t \r\t BVUB. +" \r\t#"
…Q"\t # \rC" " \r\f#"@ \r\rE#
374 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
�: \r'#$ C\f $"\r$# "\r#\t # /\r 
\t\b\n\t\b\r \t8


…' 0,05…0,1 L   m\r#\r, \f# "\f 'J"\t 
…"@ \f#\t "\r#.
…="\r# :J  \fC #@'"@\t   "\r-

C\f\f \b\t
375



#/ \f' "\r#  "# \r\fC#"@ \r
…=\r\t "\r# ##\t ## #  \f' \fC


…&C" :"@ :/\f# #@'"@ 10 ## \fC 12,5k \f-

376 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...


…\r@\t \fC\t \f' 0,3 L  \f# \r'
…L# \r@ * #C"\t \f  14 @ F250 kG
7\n\tL\b8 \r \t8 \r \r7\t \f\t8
@\t  *\f\t  \b\t \b \t\b\t\t \t
377


#\t, "@ #  \r: #\r- ## ###\t m65, 66q.

@\t $"\r$#\t #\t  #'" \fC :"@
…L# # 'J"  \r# # :H,



&#@ \r\f\t \r"@ "\r# "\r##
378 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...

9\n9




!#\t \r"#"@ :"# #\r\f # \f/"@J

379



:\t5






380 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
\r5 \b \r\t7 M\t5\f\n \b\rL \t \b 5\fM\b
\t\be\f:\t\t \t\b\n\t\b

…"#\t "\r#\t F#'\r# "    [email protected]
…�"""# "\r##



J #H$#J ## \f" \f#"@ ' 15…30 # F\f\t


  \f \t
381
7\nL \t \n7\r\b\nL
\f# # ':"# F##\f#'$##G # \r""#

















\f \b 7
382 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
\r## "\r, $##\r  !







 \b\t\n \f\r


… €

\b  \t\n \f\r\n \r\f\b \r\r\r\r \n\r €




+  !\n !  \b \b \b!\b \t \n !\t 12 !
\b\n ! \t , \b \b\f  \b ! \t [85, 174,
204…207]  \t\b \t \n \b\b, !\t 24…48 ! \b\n !
\t [85, 198, 208]. $ \b   !\n  \t  \t .
/\b \n \n\t \b\b \b \t\b \n\t!\n \t \b\t
  \n  \n\b\b\n\b. 6\b   !\n\b  \b\n 
\b\n\b\n  \b% \t\b\b !\n\b\b \n\n  \b\n \b\b\b,
 \b\b  \f [209]. :   \b\n !\n  \t \t ,  \b\n\b
\t \t   \b  \b\n\b\b  \n\b\b \t \t  
!\n \b\n 92 !\n\b \b\f\b\b\b\f  \t\b 4.
&\t  , \b  \n \b ! ! , \b\f \t\n\n\t \n 






&\t\b\b\f\n   !\n\b \n\t! \n\b\t 

384 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...





\t# /\r \f#:", \r\t\tJE\t  #
###  ""JE# '" ##
$"\r$## "\r#\t  \r" \r#, "\rCJE# "\r"
\b\t \f \b 7




…\f 11-" \r"\r"# \r" #\f#



 \f  \b    \b\b\f \t\t
385

\t \r\t\f7\t\n\f\t \t \r\n78\r\b \n\n
 '\r/ "\r\t C#\f"# \r# **\n $#"\t  \r!JE\t
!# :H # "\r# %"\r#", #\r"#"@ \f\f\rC#"
"\r#\f#" :H, # \r#'# \f#\f\r"$## " :"@ 
'"#. = \r\t "\r## #C# \t\r"# \r"# \r#
F \r'@"" # J'\r## # E#\t J'  [email protected]
�", #C#J "\r#\f#" :H. "## \f#\r' C"
"#   C" :"@ '#"@. @ "\r#\f#"
:H :"\r #C"\t  \r\t #\t $#"  **\n, "\r:"\t
: \r# 'E# "\r#\f#" :H F \r#J
\b\t \t \r\t\f7\t\n\f
 \t \r\n78\r\b \n\n
386 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
8\n%

##\b
#!\n$\n%&
" 
; 0,G 
\n\t\n\t 20 D $M,
!\n\r 
\t
\n\tC
F5 $QM, \tA
\t$B
 !$B\r
40 $QM
\n\t/ $A
\t,  #
!\n !\n$
\r C&
 C\t
!\r\t
\t !
\tA\t\r \t
C
& K$
C !
!
\t  A
24…4S AV 0,45…0,75I
& \n\t\n
\t Q\n\t$,
\t\r$, $\t$
 \t$ \tC%
2…4 A

! 0,025…0,05 M(
×

! 0,05…0,1 M(
×
 \t$
 ! \t\t
\t  C
# ! 75…100 $M  A\t
'\n !\n\n&  \n\n\tBD
'\n& \r  \t Q\n
 C ! /$
\n;# 11.R.
R  \r \r  \r\t\r\t (\t\b\t\t
\n: "\t   \b. ^G5_)
M\t5\f\n\b8 \r \t8

C\f\f\t  \b\t
387




…Q"\t \f, 'JE#  "#@J \r"@ #C#\t
…\b :"\r #C# $"\r$## \r\t * "## \f\t
…= "## " #\t , \r\f"\t 'E"@ ", "
\t\b\n\t\b8 \r \t8
388 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...



…(# :J  \r\fJ"\t.
6\f\r\t
= $ \f#$#" #\t, " # #\t \r# **\n !,  \r#

…  ##"\r## " "\r:"@\t : -
…$"\r$#\t #\t  \r" \fC #'\r\t"@\t C\f
…L#  $#" :J\f"\t ###\t, C" "\r:-


G \b
…$"\r$#J "  \r" \f" #'\r\t"@ C\f

"""J" \f, \f"\rC\fJE# @' '"#"@
…ME# #\t C \r"\r"@  "\r/ $#",
\nM\b\b\t8

\r"## """J". K# \r# \f" '"@


390 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...

\n7\b\b 5\f \t \n
\r# ## \f" \r#\t"@  ## 'C C#\t
# , # **\n. \n\f" \r\f#"@ "E"@ #"\r# "@
 \f\t \r\f#\t \r#\t "\r##. \t \f\f\rC#\t \f"
#" : \r!" :  . \t \r'\r!#\t "'
# \r\f"\rE#\t "# J' "\r:"\t ##,
\f ## ## \f" "C#"@ \f "/ \r,  $#" 
:\f" \f \r :J C#\f"# #  ":##'#\r"\t $#\r\t$#\t.
\r5\r\b\t \r:\t5\t 5\t\t\n\f \f:\t5



\f# \f \b 
391
…�""\t \f#$#$#\t C\f "# # F"\r#\t #"\r-

…" #'#"@  "  \f-\f\r"  \r!#-
…" #':C"@ \r# # "\tC #"$## \f.
…##\t \f\r#\t ## \f\r\t \r## 'C"# \f\t



…\f#"# # \f"# \fC #"@\t \r'"@ # #"@ "'
…  $#" \fC :"@ \f"  24- "-
…\f '\r ""  ##"\r##, "" "\r-
\f\b9\t\f \t\b\r\n
392 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
\n \t\n\f \t\r\r
1. Zoster Dx, `c[arry ‰D. Yue |etabolic derange|ents and treat|ent of diabetic
‚etoacidosis. N ^ngl ‰ `ed 1983; 309; 159…169.
2. \itabcui A^, }|pierre• [^, `vrpuy `B, \reisberg ˆA. Uyperglyce|ic crises
in advlt patients witu diabetes; a consensvs state|ent fro| tue A|erican Diabetes
Association. Diabetes Xare 2006; 29; 2739…2748.
3. Uanas ˆ, ]indgren Z, ]indblad B. A2-year national popvlation stvdy of pediatric
‚etoacidosis in Sweden; predisposing conditions and insvlin pv|p vse. Pediatr
Diabetes 2009; 10; 33…37.
4. Xo \, Xoccui `N, Salciccioli ‰D, Xarney ^, Uowell `, Donnino `x.
Pre~alence and signi” cance of lactic acidosis in diabetic ‚etoacidosis. ‰ Xrit Xare 2012;
27; 132…137.
  \b\t\b
393
18. Suei‚u-Ali `, \aron BS, Basv A et al. Xan serv| beta-uydroybvtyrate be vsed
to diagnose diabetic ‚etoacidosis— Diabetes Xare 2008; 31; 643…647.
19. Bvrge `ˆ, Uardy \‰, Scuade DS. Suort-ter| fasting is a |ecuanis| for tue
de~elop|ent of evglyce|ic ‚etoacidosis dvring periods of insvlin de” ciency. ‰ Xlin
^ndocrinol `etab 1993; 76; 1192…1198.
20. Pin‚ey ‰U, Bingley P‰, Sawtell PA, Dvnger DB, [ale ^A. Presentation and
progress of cuilduood diabetes |ellitvs; a prospecti~e popvlation-based stvdy. Yue
Barts-Vford Stvdy [rovp. Diabetologia 1994; 37; 70…74.
21. Za•eli Zarsani S, ~an der Aa `P, ~an der jorst ``, \nibbe XA, de Boer
A. [lobal trends in tue incidence and pre~alence of type 2 diabetes in cuildren
and adolescents; a syste|atic re~iew and e~alvation of |etuodological approacues.
Diabetologia 2013; 56; 1471…1488.
22. A|erican Diabetes Association. Yype 2 diabetes in cuildren and adolescents.
FXonsensvs state|entG. Diabetes Xare 2000; 23; 381…389.
23. ˆewers A, \lingens|itu [, Da~is X et al. Presence of diabetic ‚etoacidosis
at diagnosis of diabetes |ellitvs in yovtu; tue Searcu for Diabetes in hovtu Stvdy.
Pediatrics 2008; 121; e1258…e1266.
24. [vngor N, Uannon Y, ]ib|an I, Bacua Z, Arslanian S. Yype 2 diabetes |ellitvs
in yovtu; tue co|plete pictvre to date. Pediatr Xlin Nortu A| 2005; 52; 1579…1609.
25. Xuase UP, [arg S\, ‰elley DU. Diabetic ‚etoacidosis in cuildren and tue role
of ovtpatient |anage|ent. Pediatr ˆe~ 1990; 11; 297…304.
26. `orales A^, ˆosenbloo| A]. Deatu cavsed by uyperglyce|ic uyperos|olar
state at tue onset of type 2 diabetes. ‰ Pediatr 2004; 144; 270…273.
27. Xanarie `Z, Bogve Xx, Banasia‚ \‰, xein•i|er SA, Ya|borlane xj.
Deco|pensated uyperglyce|ic uyperos|olarity wituovt signi”
cant ‚etoacidosis in tue
adolescent and yovng advlt popvlation. ‰ Pediatr ^ndocrinol `etab 2007; 20; 1115…1124.
28. ˆosenbloo| A]. Uyperglyce|ic uyperos|olar state; an e|erging pediatric
proble|. ‰ Pediatr 2010; 156; 180…184.
29. Bagdvre D, ˆewers A, Xa|pagna ^, Sills `ˆ. ^pide|iology of uyperglyce|ic
uyperos|olar
syndro|e in cuildren uospitali•ed in }SA. Pediatr Diabetes 2013; 14; 18…24.
30. Ye|ple I\, Suield ‰P. 624 transient neonatal diabetes. ˆe~ ^ndocr `etab
Disord 2010; 11; 199…204.
31. \itabcui A^, Nyenwe ^A. Uyperglyce|ic crises in diabetes |ellitvs; diabetic
‚etoacidosis and uyperglyce|ic uyperos|olar state. ^ndocrinol `etab Xlin Nortu A|
2006; 35; 725…751.
32. ‡eitler P, Ua A, ˆosenbloo| A, [laser N. Uyperglyce|ic uyperos|olar
syndro|e in cuildren; patuopuysiological considerations and svggested gvidelines for
treat|ent. ‰ Pediatr 2011; 158; 9…14 14 e11…12.
33. ]e~y-`arcual X, Papo• ], de Beavfort X et al. Xlinical and laboratory featvres
of type 1 diabetic cuildren at tue ti|e of diagnosis. Diabet `ed 1992; 9; 279…284.
34. \o|vlainen ‰, ]ovna|aa ˆ, \nip `, \aprio ^A, A‚erblo| U\. \etoacidosis at
tue diagnosis of type 1 Finsvlin dependentG diabetes |ellitvs is related to poor residval beta
cell fvnction. Xuilduood Diabetes Zinland Stvdy [rovp. Arcu Dis Xuild 1996; 75; 410…415.
394 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
35. ]e~y-`arcual X, Patterson XX, [reen A. [eograpuical ~ariation of presentation
at diagnosis of type I diabetes in cuildren; tue ^}ˆVDIAB stvdy. ^vropean and
Dibetes. Diabetologia 2001; 44 FSvppl 3G; B75…B80.
36. Uanas ˆ, ]indgren Z, ]indblad B. Diabetic ‚etoacidosis and cerebral oede|a in
Sweden, a 2-year paediatric popvlation stvdy. Diabet `ed 2007; 24; 1080…1085.
37. ˆodac‚i `, Pereira ‰ˆ, Nabvco de Vli~eira A` et al. ^tunicity and yovng age
vence tue frevency of diabetic ‚etoacidosis at tue onset of type 1 diabetes. Diabetes
ˆes Xlin Pract 2007; 78; 259…262.
38. }suer-S|itu ‰A, Yuo|pson `, ^rcole A, xalter Z`. jariation between
covntries in tue frevency of diabetic ‚etoacidosis at ”
rst presentation of type 1 diabetes
in cuildren; a syste|atic re~iew. Diabetologia 2012; 55; 2878…2894.
39. Žvinn `, Zleiscu|an A, ˆosner B, Nigrin D‰, xolfsdorf ‰I. Xuaracteristics at
diagnosis of type 1 diabetes in cuildren yovnger tuan 6 years. ‰ Pediatr 2006; 148; 366…371.
40. Bvi U, Yo Y, Stein ˆ, Zvng \, Dane|an D. Is diabetic ‚etoacidosis at disease
onset a resvlt of |issed diagnosis— ‰ Pediatr 2010; 156; 472…477.
41. S•ypows‚a A, S‚or‚a A. Yue ris‚ factors of ‚etoacidosis in cuildren witu newly
diagnosed type 1 diabetes |ellitvs. Pediatr Diabetes 2011; 12 F4 Pt 1G; 302…306.
42. \o|vlainen ‰, \vl|ala P, Sa~ola \ et al. Xlinical, avtoi||vne, and genetic
cuaracteristics of ~ery yovng cuildren witu type 1 diabetes. Xuilduood Diabetes in
Zinland FDi`eG Stvdy [rovp. Diabetes Xare 1999; 22; 1950…1955.
43. }suer-S|itu ‰A, Yuo|pson `‰, Suarp S‰, xalter Z`. Zactors associated witu
tue presence of diabetic ‚etoacidosis at diagnosis of diabetes in cuildren and yovng
advlts; a syste|atic re~iew. B`‰ 2011; 343; d4092.
44. ˆosilio `, Xotton ‰B, xielic•‚o `X et al. Zactors associated witu glyce|ic
control. A cross-sectional nationwide stvdy in 2,579 Zrencu cuildren witu type 1 diabetes.
Yue Zrencu Pediatric Diabetes [rovp msee co||entsq. Diabetes Xare 1998; 21; 1146…1153.
45. S|itu XP, Zirtu D, Bennett S, Uoward X, Xuisuol| P. \etoacidosis occvrring
in newly diagnosed and establisued diabetic cuildren. Acta Paediatr 1998; 87; 537…541.
46. `orris AD, Boyle DI, `c`auon AD, [reene SA, `acDonald Y`, Newton
ˆx. Aduerence to insvlin treat|ent, glycae|ic control, and ‚etoacidosis in insvlin-
dependent diabetes |ellitvs. Yue DAˆYS`^`V Xollaboration. Diabetes Avdit
and ˆesearcu in Yayside Scotland. `edicines `onitoring }nit. ]ancet 1997; 350;
1505…1510.
47. ˆewers A, Xuase UP, `a
c‚en•ie Y et al. Predictors of acvte co|plications in
cuildren witu type 1 diabetes. ‰A`A 2002; 287; 2511…2518.
48. Xengi• ^, _ing D, xong ‰X et al. Se~ere uypoglyce|ia and diabetic ‚etoacidosis
a|ong yovtu witu type 1 diabetes in tue Y1D ^cuange clinic registry. Pediatr Diabetes
2013; 14; 447…454.
49. Xope ‰}, `orrison A^, Sa|vels-ˆeid ‰. Adolescent vse of insvlin and patient-
controlled analgesia pv|p tecunology; a 10-year Zood and Drvg Ad|inistration
retrospecti~e stvdy of ad~erse e~ents. Pediatrics 2008; 121; e1133…e1138.
50. \lein|an `^, Xua|eides ], Scuenayder S` et al. Pediatric ad~anced
life svpport; 2010 A|erican Ueart Association [videlines for Xardiopvl|onary
ˆesvscitation and ^|ergency Xardio~ascvlar Xare. Pediatrics 2010; 126; e1361…e1399.
  \b\t\b
51. \lein|an `^, de Xaen Aˆ, Xua|eides ] et al. Pediatric basic and ad~anced
life svpport; 2010 International Xonsensvs on Xardiopvl|onary ˆesvscitation and
^|ergency Xardio~ascvlar Xare Science witu Yreat|ent ˆeco||endations. Pediatrics
2010; 126; e1261…e1318.
52. xigga| `I, V\ane `‰, Uarper ˆ et al. Yreat|ent of diabetic ‚etoacidosis
vsing nor|ali•ation of blood 3-uydroybvtyrate concentration as tue endpoint of
e|ergency |anage|ent. A rando|i•ed controlled stvdy. Diabetes Xare 1997; 20;
1347…1352.
53. janelli `, Xuiari [, Xapvano X, Io~ane B, Bernardini A, [iacalone Y. Yue
direct |easvre|ent of 3-beta-uydroy bvtyrate enuances tue |anage|ent of diabetic
‚etoacidosis in cuildren and redvces ti|e and costs of treat|ent. Diabetes Nvtr `etab
2003; 16 F5…6G; 312…316.
54. Ua| `ˆ, V‚ada P, xuite PX. Bedside ‚etone deter|ination in diabetic
cuildren witu uyperglyce|ia and ‚etosis in tue acvte care setting. Pediatr Diabetes 2004;
55. ˆewers A, `cZann \, Xuase UP. Bedside |onitoring of blood beta-
uydroybvtyrate le~els in tue |anage|ent of diabetic ‚etoacidosis in cuildren. Diabetes
Yecunol Yuer 2006; 8; 671…676.
56. Prisco Z, Picardi A, Iafvsco D et al. Blood ‚etone bodies in patients witu recent-
onset type 1 diabetes Fa |vlticenter stvdyG. Pediatr Diabetes 2006; 7; 223…228.
57. Noyes \‰, Xrofton P, Batu ]^ et al. Uydroybvtyrate near-patient testing to
e~alvate a new end-point for intra~enovs insvlin tuerapy in tue treat|ent of diabetic
‚etoacidosis in cuildren. Pediatr Diabetes 2007; 8; 150…156.
c‚er AA, Pue
lan U, Ywigg S`, Xraig `^. Blood beta-uydroybvtyrate ~s.
vrine acetoacetate testing for tue pre~ention and |anage|ent of ‚etoacidosis in Yype 1
diabetes; a syste|atic re~iew. Diabet `ed 2013; 30; 818…824.
59. \o~es IU, Nevt•e ‰, Donatu S et al. Yue accvracy of clinical assess|ent
of deuydration dvring diabetic ‚etoacidosis in cuilduood. Diabetes Xare 2004; 27;
2485…2487.
60. Sottosanti `, `orrison [X, Singu ˆN et al. Deuydration in cuildren witu
diabetic ‚etoacidosis; a prospecti~e stvdy. Arcu Dis Xuild 2012; 97; 96…100.
61. }gale ‰, `ata A, `eert \], Sarnai‚ AP.`easvred degree of deuydration in
cuildren and adolescents witu type 1 diabetic ‚etoacidosis. Pediatr Xrit Xare `ed 2012;
13; e103…e107.
62. Steiner `‰, Dexalt DA, Byerley ‰S. Is tuis cuild deuydrated— ‰A`A 2004; 291;
2746…2754.
63. Yeasdale [, ‰ennett B. Assess|ent of co|a and i|paired consciovsness.
A practical scale ]ancet 1974; 2; 81…84.
64. Zlood ˆ[, Xuiang jx. ˆate and prediction of infection in cuildren witu
diabetic ‚etoacidosis. A| ‰ ^|erg `ed 2001; 19; 270…273.
65. `alone ‰I, Brods‚y S‰. Yue ~alve of electrocardiogra| |onitoring in diabetic
‚etoacidosis. Diabetes Xare 1980; 3; 543…547.
66. Soler N[, Bennett `A, Zit•gerald `[, `alins ‰`. ^lectrocardiogra| as a
gvide to potassiv| replace|ent in diabetic ‚etoacidosis. Diabetes 1974; 23; 610…615.
396 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
67. Yas‚er ˆX, ]vt|an D, Peters `‰. Uyper~entilation in se~ere diabetic
‚etoacidosis. Pediatr Xrit Xare `ed 2005; 6; 405…411.
68. Da~ids `ˆ, ^dovte h, Stoc‚ S, Ualperin `]. Se~ere degree of uyperglycae|ia;
insiguts fro| integrati~e puysiology. Ž‰` 2002; 95; 113…124.
69. [vtierre• ‰A, Bagatell ˆ, Sa|son `P, Yueodorov AA, Berg ˆA. Ze|oral
central ~enovs catueterassociated deep ~enovs turo|bosis in cuildren witu diabetic
‚etoacidosis. Xrit Xare `ed 2003; 31; 80…83.
70. xorly ‰`, Zortenberry ‰D, Uansen I, Xua|bliss Xˆ, Stoc‚well ‰. Deep ~enovs
turo|bosis in cuildren witu diabetic ‚etoacidosis and fe|oral central ~enovs catueters.
Pediatrics 2004; 113 F1 Pt 1G; e57…e60.
71. `onroe \x, \ing x, Atcuison ‰A. }se of PˆIS` scores in triage of pediatric
patients witu diabetic ‚etoacidosis. A| ‰ `anag Xare 1997; 3; 253…258.
72. Bonadio xA, [vt•eit `Z, ]ose‚ ‰D, S|itu DS. Vvtpatient |anage|ent of
diabetic ‚etoacidosis. A| ‰ Dis Xuild 1988; 142; 448…450.
73. ]inares `h, Scuvn‚ ‰^, ]indsay ˆ. ]aboratory presentation in diabetic
‚etoacidosis and dvration of tuerapy. Pediatr ^|erg Xare 1996; 12; 347…351.
74. hv Uh, Agvs `, \ellogg `D. Xlinical vtility of Abbott Precision _ceed ProFˆG
‚etone |eter in diabetic patients. Pediatr Diabetes 2011; 12; 649…655.
75. ]vt”
ˆ, Uvang ‰, xong Uˆ. Plas|apueresis to treat uypertriglyceride|ia in a
cuild witu diabetic ‚etoacidosis and pancreatitis. Pediatrics 2012; 129; e195…e198.
76. Ualperin `], [oldstein `B. Zlvid, electrolyte, and acid…base puysiology. 3rd
edn. Puiladelpuia; Savnders, 1999.
77. ]o~e AU, Puillips ˆA. `easvre|ent of deuydration in cuolera. ‰ Infect Dis
1969; 119; 39…42.
78. Uarris [D, Ziordalisi I. Puysiologic |anage|ent of diabetic ‚etoacide|ia.
A 5-year prospecti~e pediatric eperience in 231 episodes. Arcu Pediatr Adolesc`ed
1994; 148; 1046…1052.
79. Napolo~a V, }rbacu S, Da~ids `ˆ, Ualperin `]. Assessing tue degree of
etracellvlar › vid ~olv|e contraction in a patient witu a se~ere degree of uyperglycae|ia.
Nepurol Dial Yransplant 2003; 18;
2674…2677.
80. Ualperin `], `accari X, \a|el \S, Xarlotti AP, Boun D. Strategies to
di|inisu tue danger of cerebral ede|a in a pediatric patient presenting witu diabetic
‚etoacidosis. Pediatr Diabetes 2006; 7; 191…195.
81. \at• `A. Uyperglyce|ia-indvced uyponatre|ia … calcvlation of epected
serv| sodiv| depression. N ^ngl ‰ `ed 1973; 289; 843…844.
82. Uillier YA, Abbott ˆD, Barrett ^‰.Uyponatre|ia; e~alvating tue correction
factor for uyperglyce|ia.A| ‰ `ed 1999; 106; 399…403.
83. Uarris [D, Ziordalisi I, Uarris x], `oso~icu ]], Zinberg ]. `ini|i•ing tue
ris‚ of brain uerniation dvring treat|ent of diabetic ‚etoacide|ia; a retrospecti~e and
prospecti~e stvdy. ‰ Pediatr 1990; 117; 22…31.
84. Uale P`, ˆe•~ani I, Bravnstein Ax, ]ip|an YU, `artine• N, [aribaldi ].
Zactors predicting cerebral ede|a in yovng cuildren witu diabetic ‚etoacidosis and new
onset type I diabetes. Acta Paediatr 1997; 86; 626…631.
  \b\t\b
397
85. [laser N, Barnett P, `cXaslin I et al. ˆis‚ factors for cerebral ede|a in cuildren
witu diabetic ‚etoacidosis. Yue Pediatric ^|ergency `edicine Xollaborati~e ˆesearcu
Xo||ittee of tue A|erican Acade|y of Pediatrics. N ^ngl ‰ `ed 2001; 344; 264…269.
86. Brown YB. Xerebral oede|a in cuilduood diabetic ‚etoacidosis; is treat|ent a
factor— ^|erg `ed ‰ 2004; 21; 141…144.
87. [laser NS, [uetti S, Xasper YX, Dean ‰`, \vpper|ann N. Pediatric diabetic
‚etoacidosis, ›
vid tuerapy, and cerebral in–vry; tue design of a factorial rando|i•ed
controlled trial. Pediatr Diabetes 2013; 14; 435…446.
88. ^dge ‰A, ‰a‚es ˆx, ˆoy h et al. Yue }\ case…control stvdy of cerebral oede|a
co|plicating diabetic ‚etoacidosis in cuildren. Diabetologia 2006; 49; 2002…2009.
89. Dvnger DB, Sperling `A, Acerini X] et al. ^vropean Society for Paediatric
^ndocrinology]awson xil‚ins Pediatric ^ndocrine Society consensvs state|ent on
diabetic ‚etoacidosis in cuildren and adolescents. Pediatrics 2004; 113; e133…e140.
90. Adrogve U‰, Barrero ‰, ^‚noyan [. Salvtary eŠ
ects of |odest ›
vid replace|ent
in tue treat|ent of advlts witu diabetic ‚etoacidosis. }se in patients wituovt etre|e
~olv|e de” cit. ‰A`A 1989; 262; 2108…2113.
91. `el ‰`, xertuer [A. Incidence and ovtco|e of diabetic cerebral oede|a in
cuilduood; are tuere predictors— ‰ Paediatr Xuild Uealtu 1995; 31; 17…20.
92. xagner A, ˆisse A, Brill U] et al. Yuerapy of se~ere diabetic ‚etoacidosis. ‡ero-
|ortality vnder ~ery-lowdose insvlin application. Diabetes Xare 1999; 22; 674…677.
93. Yoledo ‰D, `odesto j, Peinador ` et al. Sodiv| concentration in reuydration
vids for cuildren witu ‚etoacidotic diabetes; eŠ ect on serv| sodiv| concentration.
‰ Pediatr 2009; 154; 895…900.
94. ˆotuer \I, Scuwen‚ xZ 2nd. ^Š
ect of reuydration ›
vid witu 75 ||ol] of
sodiv| on serv| sodiv| concentration and serv| os|olality in yovng patients witu
diabetic ‚etoacidosis. `ayo Xlin Proc 1994; 69; 1149…1153.
95. Zelner ^I, xuite PX. I|pro~ing |anage|ent of diabetic ‚etoacidosis in
cuildren. Pediatrics 2001; 108; 735…740.
96. Basnet S, jenepalli P\, Andou ‰, jeruvlst S, \oirala ‰. ^Š
ect of nor|al
saline and ualf nor|al saline on serv| electrolytes dvring reco~ery puase of diabetic
‚etoacidosis. ‰ Intensi~e Xare `ed 2014; 29; 38…42.
97. Ziordalisi I, No~otny x^, Uolbert D, Zinberg ], Uarris [D. An 18-yr
prospecti~e stvdy of pediatric diabetic ‚etoacidosis; an approacu to |ini|i•ing tue ris‚
of brain uerniation dvring treat|ent. Pediatr Diabetes 2007; 8; 142…149.
98. xuite PX, Dic‚son BA. ]ow |orbidity and |ortality in cuildren witu diabetic
‚etoacidosis treated witu isotonic ›
vids. ‰ Pediatr 2013; 163; 761…766.
99. Uoorn ^‰, Xarlotti AP, Xosta ]A et al. Pre~enting a drop in eŠ
ecti~e
plas|a os|olality to |ini|i•e tue li‚eliuood of cerebral ede|a dvring treat|ent of
cuildrenwitu diabetic ‚etoacidosis. ‰ Pediatr 2007; 150; 467…473.
100. Dvc‚ SX, xyatt DY. Zactors associated witu brain uerniation in tue treat|ent
of diabetic ‚etoacidosis. ‰ Pediatr 1988; 113; 10…14.
101. Adrogve U‰, xilson U, Boyd A^ 3rd, Sv‚i xN, ^‚noyan [. Plas|a acid…
base patterns in diabetic ‚etoacidosis. N ^ngl ‰ `ed 1982; 307; 1603…1610.
398 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
102. Adrogve U‰, ^‚noyan [, Sv‚i x\. Diabetic ‚etoacidosis; role of tue ‚idney in
tue acid…base uo|eostasis re-e~alvated. \idney Int 1984; 25; 591…598.
103. Yaylor D, Dvrward A, Yibby S` et al. Yue in› vence of uyperculorae|ia on
acid base interpretation in diabetic ‚etoacidosis. Intensi~e Xare `ed 2006; 32; 295…301.
104. Dvrward A, S‚ellett S, `ayer A, Yaylor D, Yibby S`, `vrdocu IA. Yue
~alve of tue culoride; sodiv| ratio in diŠ
erentiating tue aetiology of |etabolic acidosis.
Intensi~e Xare `ed 2001; 27; 828…835.
105. Vu `S, Xarroll U‰, [oldstein DA, Zein IA. Uyperculore|ic acidosis dvring
tue reco~ery puase of diabetic ‚etosis. Ann Intern `ed 1978; 89; 925…927.
106. Vu `S, Baner–i `A, Xarroll U‰. Yue |ecuanis| of uyperculore|ic acidosis
dvring tue reco~ery puase of diabetic ‚etoacidosis. Diabetes 1981; 30; 310…313.
107. Vu `S, Xarroll U‰, }ribarri ‰. `ecuanis| of nor|oculore|ic and
uyperculore|ic acidosis in diabetic ‚etoacidosis. Nepuron 1990; 54; 1…6.
108. Xuva Uˆ, jen‚atesu B, Stacuows‚i ^ et al. Plas|a-]yte 148 ~s 0.9k saline for
vid resvscitation in diabetic ‚etoacidosis. ‰ Xrit Xare 2012; 27; 138…145.
109. xalduavsl x, \leinberger [, \orn A, Dvdc•a‚ ˆ, Bratvscu-`arrain P,
Nowotny P. Se~ere uyperglyce|ia; eŠ
ects of reuydration on endocrine derange|ents
and blood glvcose concentration. Diabetes 1979; 28; 577…584.
110. Vwen V^, ]icut ‰U, Sapir D[. ˆenal fvnction and eŠ
ects of partial
reuydration dvring diabetic ‚etoacidosis. Diabetes 1981; 30; 510…518.
111. ]v•i ], Barrett ^‰, [roop ]X, Zerrannini ^, DeZron•o ˆA. `etabolic eŠ
of low-dose insvlin tuerapy on glvcose |etabolis| in diabetic ‚etoacidosis. Diabetes
1988; 37; 1470…1477.
112. \itabcui A^. ]ow-dose insvlin tuerapy in diabetic ‚etoacidosis; fact or ”
ction—
Diabetes `etabˆe~ 1989; 5; 337…363.
113. `artin ``, `artin AA. Xontinvovs low-dose infvsion of insvlin in tue
treat|ent of diabetic ‚etoacidosis in cuildren. ‰ Pediatr 1976; 89; 560…564.
114. ^dwards [A, \ouavt ^X, xeuring B, Uill ]]. ^Š ecti~eness of low-
dose continvovs intra~enovs insvlin infvsion in diabetic ‚etoacidosis. A prospecti~e
co|parati~e stvdy. ‰ Pediatr 1977; 91; 701…705.
115. Drop S], Dv~al-Arnovld ‰`, [ober A^, Uersu ‰U, `c^nery PY, \nowles
UX. ]owdose intra~enovs insvlin infvsion ~ersvs svbcvtaneovs insvlin in–ection; a
controlled co|parati~e stvdy of diabetic ‚etoacidosis. Pediatrics 1977; 59; 733…738.
116. ]igutner ^S, \appy `S, ˆe~sin B. ]ow-dose intra~enovs insvlin infvsion in patients
witu diabetic ‚etoacidosis; biocue|ical eŠ ects in cuildren. Pediatrics 1977; 60; 681…688.
117. Per‚in ˆ`, `ar‚s ‰Z. ]ow-dose continvovs intra~enovs insvlin infvsion in
cuilduood diabetic ‚etoacidosis. Xlin Pediatr FPuilaG 1979; 18; 540, 545…540, 548.
118. \appy `S, ]igutner ^S. ]ow-dose intra~enovs insvlin in tue treat|ent of
diabetic ‚etoacidosis. A| ‰ Dis Xuild 1979; 133; 523…525.
119. Bvrguen [A, ^tteldorf ‰N, Zisuer ‰N, \itabcui AŽ. Xo|parison of uigu-dose
and low-dose insvlin by continvovs intra~enovs infvsion in tue treat|ent of diabetic
‚etoacidosis in cuildren. Diabetes Xare 1980; 3; 15…20.
120. \itabcui A^, }|pierre• [^, Zisuer ‰N, `vrpuy `B, Stent• ZB. Yuirty years
of personal eperience in uyperglyce|ic crises; diabetic ‚etoacidosis and uyperglyce|ic
uyperos|olar state. ‰ Xlin ^ndocrinol `etab 2008; 93; 1541…1552.
  \b\t\b
121. ]indsay ˆ, Bolte ˆ[. Yue vse of an insvlin bolvs in low-dose insvlin infvsion
for pediatric diabetic ‚etoacidosis. Pediatr ^|erg Xare 1989; 5; 77…79.
122. jan der `evlen ‰A, \lip A, [rinstein S. Possible |ecuanis| for cerebral
oede|a in diabetic ‚etoacidosis. ]ancet 1987; 2; 306…308.
123. Soler N[, Zit• [erald `[, xrigut AD, `alins ‰`. Xo|parati~e stvdy of diŠ
erent
insvlin regi|ens in |anage|ent of diabetic ‚etoacidosis. ]ancet 1975; 2; 1221…1224.
124. Pvttua ˆ, Xoo‚e D, Svbbarayan A et al. ]ow dose F0.05 vnits‚guG is
co|parable witu standard dose F0.1 vnits‚guG intra~enovs insvlin infvsion for
tue initial treat|ent of diabetic ‚etoacidosis in cuildren witu type 1 diabetes-an
obser~ational stvdy. Pediatr Diabetes 2010; 11; 12…17.
125. Al Uansui S, Suann Z. Insvlin infvsed at 0.05 ~ersvs 0.1 vnits‚gur in cuildren
ad|itted to intensi~e care witu diabetic ‚etoacidosis. Pediatr Xrit Xare`ed2011; 12;
137…140.
126. xang ‰, Barbry P, `aiyar AX et al. S[\ integrates insvlin and |ineralocorticoid
regvlation of epituelial sodiv| transport. A| ‰ Puysiol ˆenal Puysiol 2001; 280; Z303…Z313.
127. Yallini Nh, Stoner ]X. A|iloride-sensiti~e sodiv| cvrrent in e~erted
A|bysto|a initial collecting tvbvle; suort-ter| insvlin eŠ ects. A| ‰ Puysiol Xell
Puysiol 2002; 283; X1171…X1
128. `cXor|ic‚ ‰A, Bualla j, Pao AX, Pearce D. S[\1; a rapid aldosterone-
indvced regvlator of renal sodiv| reabsorption. Puysiology 2005; 20; 134…139.
129. Yiwari S, Nordvist ], Ualagappa j\, ^celbarger XA. Yraž
c‚ing of ^NaX
svbvnits in response to acvte insvlin in |ovse ‚idney. A| ‰ Puysiol ˆenal Puysiol 2007;
293; Z178…Z185.
130. Zrindt [, Pal|er ][. ^Š
ects of insvlin on Na and \ transporters in tue rat
XXD. A| ‰ Puysiol ˆenal Puysiol 2012; 302; Z1227…Z1233.
131. Xarlotti AP, St [eorge-Uyslop X, Boun D, Ualperin `]. Uypo‚ale|ia dvring
treat|ent of diabetic ‚etoacidosis; clinical e~idence for an aldosterone-li‚e action of
insvlin. ‰ Pediatr 2013; 163; 207…212 e201.
132. Zisuer ‰N, Suausuauani `N, \itabcui A^. Diabetic ‚etoacidosis; low-dose
insvlin tuerapy by ~ariovs rovtes. N ^ngl ‰ `ed 1977; 297; 238…241.
133. Sac‚s US, Suausuauani `, \itabcui A^, Zisuer ‰N, hovng ˆY. Si|ilar
responsi~eness of diabetic ‚etoacidosis to low-dose insvlin by intra|vscvlar in–ection
and albv|in-free infvsion. Ann Intern `ed 1979; 90; 36…42.
134. }|pierre• [^, ]atif \, Stoe~er ‰ et al. ^ž
cacy of svbcvtaneovs insvlin lispro
~ersvs continvovs intra~enovs regvlar insvlin for tue treat|ent of patients witu diabetic
‚etoacidosis. A| ‰ `ed 2004; 117; 291…296.
135. }|pierre• [^, Xver~o ˆ, \arabell A, ]atif \, Zreire A_, \itabcui A^.
Yreat|ent of diabetic ‚etoacidosis witu svbcvtaneovs insvlin aspart. Diabetes Xare
2004; 27; 1873…1878.
136. Della `anna Y, Stein|et• ], Xa|pos Pˆ et al. Svbcvtaneovs vse of a fast-
acting insvlin analog; an alternati~e treat|ent for pediatric patients witu diabetic
‚etoacidosis. Diabetes Xare 2005; 28; 1856…1861.
137. Adrogve U‰, ]ederer ^D, Sv‚i xN, ^‚noyan [. Deter|inants of plas|a
potassiv| le~els in diabetic ‚etoacidosis.`edicine FBalti|oreG 1986; 65; 163…172.
400 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
138. DeZron•o ˆA, Zelig P, Zerrannini ^, xauren ‰. ^Š
ect of graded doses of
insvlin on splancunic and peripueral potassiv| |etabolis| in|an. A| ‰ Puysiol 1980;
238; ^421…^427.
139. Yattersall ˆB. A paper wuicu cuanged clinical practice FslowlyG. ‰acob Uoller
on potassiv| de”
ciency in diabetic acidosis F1946G. Diabet `ed 1999; 16; 978…984.
140. Nabarro ‰D, Spencer A[, Stowers ‰`. Yreat|ent of diabetic ‚etosis. ]ancet
1952; 1; 983…989.
141. [vest [. Vrganic puospuates of tue blood and|ineral |etabolis| in diabetic
acidosis. A| ‰ Dis Xuild 1942; 64; 401…412.
142. [vest [, ˆapoport S. ^lectrolytes of blood plas|a and cells in diabetic
acidosis and dvring reco~ery. Proc A| Diabetes Assoc 1947; 7; 95…115.
143. ˆiley `S, Scuade DS, ^aton ˆP. ^Š
ects of insvlin infvsion on plas|a
puospuate in diabetic patients. `etabolis| 1979; 28; 191…194.
144. Alberti \[, ^|erson P`, Darley ‰U, Uoc‚aday YD. 2,3-Dipuospuoglycerate
and tissve oygenation in vncontrolled diabetes |ellitvs. ]ancet 1972; 2; 391…395.
145. \nocuel ‰P. Yue patuopuysiology and clinical cuaracteristics of se~ere
uypopuospuate|ia. Arcu Intern `ed 1977; 137; 203…220.
146. VXonnor ]ˆ, xueeler xS, Betuvne ‰^. ^Š
ect of uypopuospuate|ia on
|yocardial perfor|ance in |an. N ^ngl ‰ `ed 1977; 297; 901…903.
147. [ibby V`, jeale \^, Uayes Y`, ‰ones ‰[, xardrop XA. Vygen
a~ailability fro| tue blood and tue eŠ
ect of puospuate replace|ent on eryturocyte
2,3-dipuospuoglycerate and uae|oglobin-oygen až
nity in diabetic ‚etoacidosis.
Diabetologia 1978; 15; 381…385.
148. \eller }, Berger x. Pre~ention of uypopuospuate|ia by puospuate infvsion
dvring treat|ent of diabetic ‚etoacidosis and uyperos|olar co|a. Diabetes 1980; 29;
149. xilson U\, \ever SP, ]ea AS, Boyd A^ 3rd, ^‚noyan [. Puospuate tuerapy
in diabetic ‚etoacidosis. Arcu Intern `ed 1982; 142; 517…520.
150. Be
c‚er
D‰, Brown Dˆ, Steran‚a BU, Drasu A]. Puospuate replace|ent
dvring treat|ent of diabetic ‚etosis. ^Š
ects on calciv| and puospuorvs uo|eostasis.
A| ‰ Dis Xuild 1983; 137; 241…246.
151. Zisuer
‰N, \itabcui A^. A rando|i•ed stvdy of puospuate tuerapy in tue
treat|ent of diabetic ‚etoacidosis. ‰ Xlin ^ndocrinol `etab 1983; 57; 177…180.
152. Xlerbav Y, ˆeynaert `, xille|s ^, Zrans A. ^Š
ect of puospuate on oygen-
ue|oglobin až
nity, dipuospuoglycerate and blood gases dvring reco~ery fro| diabetic
‚etoacidosis. Intensi~e Xare `ed 1989; 15; 495…498.
153. xeisinger ‰ˆ, Bellorin-Zont ^. `agnesiv| and puospuorvs. ]ancet 1998;
352; 391…396.
154. Singual PX, \v|ar A, Desrocues ], [ibbons N, `attana ‰. Pre~alence and
predictors of ruabdo|yolysis in patients witu uypopuospuate|ia. A| ‰ `ed 1992; 92;
458…464.
155. \vtlv AV, \ara X, Xetin‚aya S. ˆuabdo|yolysis wituovt detectable
|yoglobvlinvria dve to se~ere uypopuospuate|ia in diabetic ‚etoacidosis. Pediatr
^|erg Xare 2011; 27; 537…538.
  \b\t\b
401
156. Bouannon N‰. ]arge puospuate suifts witu treat|ent for uyperglyce|ia. Arcu
Intern `ed 1989; 149; 1423…1425.
157. de Vli~eira Iglesias SB, Pons ]eite U, de Xar~aluo xB. Uypopuospuate|ia-
indvced sei•vre in a cuild witu diabetic ‚etoacidosis. Pediatr ^|erg Xare 2009; 25;
859…861.
158. ‡ipf xB, Bacon [^, Spencer `], \elcu ˆP, Uopwood N‰, Uaw‚er XD.
Uypocalce|ia, uypo|agnese|ia, and transient uypoparatuyroidis| dvring tuerapy
witu potassiv| puospuate in diabetic ‚etoacidosis. Diabetes Xare 1979; 2; 265…268.
159. xinter ˆ‰, Uarris X‰, Puillips ]S, [reen VX. Diabetic ‚etoacidosis. Indvction of
uypocalce|ia and uypo|agnese|ia by puospuate tuerapy. A| ‰ `ed 1979; 67; 897…900.
160. Uale P‰, Xrase ‰, Nattrass `. `etabolic eŠ
ects of bicarbonate in tue treat|ent
of diabetic ‚etoacidosis. Br `ed ‰ FXlin ˆes ^dG 1984; 289; 1035…1038.
161. `orris ]ˆ, `vrpuy `B, \itabcui A^. Bicarbonate tuerapy in se~ere diabetic
‚etoacidosis. Ann Intern `ed 1986; 105; 836…840.
162. V‚vda h, Adrogve U‰, Zield ‰B, Nouara U, ha|asuita \. Xovnterprodvcti~e
ects of sodiv| bicarbonate in diabetic ‚etoacidosis. ‰ Xlin ^ndocrinol `etab 1996;
81; 314…320.
163. [reen S`, ˆoturoc‚ S[, Uo ‰D et al. Zailvre of ad–vncti~e bicarbonate to
i|pro~e ovtco|e in se~ere pediatric diabetic ‚etoacidosis. Ann ^|erg`ed 1998; 31; 41…48.
164. Assal ‰P, Ao‚i YY, `an•ano Z`, \o•a‚ [P. `etabolic eŠ ects of sodiv|
bicarbonate in |anage|ent of diabetic ‚etoacidosis. Diabetes 1974; 23; 405…411.
165. Vu|an‰] ‰r, `arliss ^B, Ao‚i YY, `vnicuoodappa XS, \uanna jj, \o•a‚
[P. Yue cerebrospinal ›
vid in diabetic ‚etoacidosis. N ^ngl ‰ `ed 1971; 284; 283…290.
166. Soler N[, Bennett `A, Dion \, Zit• [erald `[, `alins ‰`. Potassiv|
balance dvring treat|ent of diabetic ‚etoacidosis witu special reference to tue vse of
bicarbonate. ]ancet 1972; 2; 665…667.
167. ]e~er ^, ‰aspan ‰B. Sodiv| bicarbonate tuerapy in se~ere diabetic ‚etoacidosis.
A| ‰ `ed 1983; 75; 263…268.
168. Narins ˆ[, Xouen ‰‰. Bicarbonate tuerapy for organic acidosis; tue case for its
continved vse. Ann Intern `ed 1987; 106; 615…618.
169. Xvrtis ‰ˆ, Yo Y, `viruead S, Xv||ings ^, Dane|an D. ˆecent trends in
uospitali•ation for diabetic ‚etoacidosis in Vntario cuildren. Diabetes Xare 2002; 25;
1591…1596.
170. ^dge ‰A, Zord-Ada|s `^, Dvnger DB. Xavses of deatu in cuildren witu
insvlin dependent diabetes 1990…96. Arcu Dis Xuild 1999; 81; 318…323.
171. Decovrcey DD, Steil [`, xyp˜ D, Agvs `S. Increasing vse of uypertonic
saline o~er|annitol in tue treat|ent of sy|pto|atic cerebral ede|a in pediatric
diabetic ‚etoacidosis; an 11-year retrospecti~e analysis of |ortality{. Pediatr Xrit Xare
`ed 2013; 14; 694…700.
172. Dane|an D. Diabetes-related |ortality. A pediatricians ~iew. Diabetes Xare
2001; 24; 801…802.
173. ^dge ‰A, Uaw‚ins ``, xinter D], Dvnger DB. Yue ris‚ and ovtco|e of
cerebral oede|a de~eloping dvring diabetic ‚etoacidosis. Arcu Dis Xuild 2001; 85;
16…22.
402 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
174. ]awrence S^, Xv||ings ^A, [abovry I, Dane|an D. Popvlation-based
stvdy of incidence and ris‚ factors for cerebral ede|a in pediatric diabetic ‚etoacidosis.
‰ Pediatr 2005; 146; 688…692.
175. [uetti S, ]ee ‰\, Si|s X^, De|aster D`, [laser NS. Diabetic ‚etoacidosis
and |e|ory dysfvnction in cuildren witu type 1 diabetes. ‰ Pediatr 2010; 156; 109…114.
176. Xooper `ˆ, Yvrner ˆA ‰r, UvtaŠ
], Pricuard ˆ. Diabetic ‚eto-acidosis
co|plicated by disse|inated intra~ascvlar coagvlation. Sovtu `ed ‰ 1973; 66; 653…657.
177. \eane S, [allaguer A, Ac‚royd S, `cSuane `A, ^dge ‰A. Xerebral ~enovs
turo|bosis dvring diabetic ‚etoacidosis. Arcu Dis Xuild 2002; 86; 204…205.
178. Uo ‰, `au ‰\, Uill `D, Pacavd D. Pediatric stro‚e associated witu new onset
type 1 diabetes|ellitvs; case reports and re~iew of tue literatvre. Pediatr Diabetes 2006;
7; 116…121.
179. `oye ‰, ˆosenbloo| A], Sil~erstein ‰. Xlinical predictors of |vcor|ycosis in
cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr ^ndocrinol `etab 2002; 15; 1001…1004.
180. xatson ‰P, Barnett AU. Pnev|o|ediastinv| in diabetic ‚etoacidosis. Diabet
`ed 1989; 6; 173…174.
181.
Uaddad N[, Xrož e ‰`, ^vgster ^A. Pancreatic en•y|e ele~ations in cuildren
witu diabetic ‚etoacidosis. ‰ Pediatr 2004; 145; 122…124.
182. [laser NS, xootton-[orges S], Bvonocore `U et al. Zrevency of svb-clinical
cerebral ede|a in cuildren witu diabetic ‚etoacidosis. Pediatr Diabetes 2006; 7; 75…80.
183. [laser NS, `arcin ‰P, xootton-[orges S] et al. Xorrelation of clinical and
biocue|ical ”
ndings witu diabetic ‚etoacidosis-related cerebral ede|a in cuildren vsing
|agnetic resonance diŠ
vsion-weiguted i|aging. ‰ Pediatr 2008; 153; 541…546.
184. \rane ^‰, ˆoc‚oŠ `A, xall|an ‰\, xolfsdorf ‰I. Svbclinical brain swelling
in cuildren dvring treat|ent of diabetic ‚etoacidosis.N^ngl ‰`ed 1985; 312; 1147…1
185. UoŠ |an xU, Steinuart X`, el [a||al Y, Steele S, Xvadrado Aˆ, `orse
P\. Xranial XY in cuildren and adolescents witu diabetic ‚etoacidosis. A‰Nˆ A| ‰
Nevroradiol 1988; 9; 733…739.
186. Sperling `A. Xerebral ede|a in diabetic ‚etoacidosis; an vnderesti|ated
co|plication— Pediatr Diabetes 2006; 7; 73…74.
187. ArieŠ
AI, \lee|an Xˆ. Stvdies on |ecuanis|s of cerebral ede|a in diabetic
co|as. ^Š ects of uyperglyce|ia and rapid lowering of plas|a glvcose in nor|al rabbits.
‰ Xlin In~est 1973; 52; 571…583.
188. ArieŠ
AI, \lee|an Xˆ. Xerebral ede|a in diabetic co|as. II. ^Š
ects of
uyperos|olality, uyperglyce|ia and insvlin in diabetic rabbits. ‰Xlin ^ndocrinol`etab
1974; 38; 1057…1067.
189. Proc‚op ]D. Uyperglyce|ia, polyol accv|vlation, and increased intracranial
pressvre. ArcuNevrol 1971; 25; 126…140.
190. Uarris [D, Ziordalisi I, Zinberg ]. Safe |anage|ent of diabetic ‚etoacide|ia.
‰ Pediatr 1988; 113; 65…67.
191. [laser NS, xootton-[orges S], `arcin ‰P et al. `ecuanis| of cerebral
ede|a in cuildren witu diabetic ‚etoacidosis. ‰ Pediatr 2004; 145; 164…171.
192. [laser N, hven N, Anderson S^, Yancredi D‰, VDonnell `^. Xerebral
|etabolic alterations in rats witu diabetic ‚etoacidosis; eŠ
ects of treat|ent witu insvlin
and intra~enovs › vids and eŠ ects of bv|etanide. Diabetes 2010; 59; 702…709.
  \b\t\b
403
193. hven N, Anderson S^, [laser N, Yancredi D‰, VDonnell `^. Xerebral
blood ›
ow and cerebral ede|a in rats witu diabetic ‚etoacidosis. Diabetes 2008; 57;
2588…2594.
194. ˆosenbloo| A], Scuat• DA, \riscuer ‰P et al. Yuerapevtic contro~ersy;
pre~ention and treat|ent of diabetes in cuildren. ‰ Xlin ^ndocrinol `etab 2000; 85;
494…522.
195. [laser N. Xerebral in–vry and cerebral ede|a in cuildren witu diabetic
‚etoacidosis; covld cerebral iscue|ia and reperfvsion in–vry be in~ol~ed— Pediatr
Diabetes 2009; 10; 534…541.
196. UoŠ
|an xU, Sta|ato~ic S`, And–el‚o~ic Aj. In›
a||atory |ediators and
blood brain barrier disrvption in fatal brain ede|a of diabetic ‚etoacidosis. Brain ˆes
2009; 1254; 138…148.
197. ja~ilala `S, ˆicuards Y], ˆoberts ‰S et al. Xuange in blood…brain barrier
per|eability dvring pediatric diabetic ‚etoacidosis treat|ent{. Pediatr Xrit Xare `ed
2010; 11; 332…338.
198. ˆosenbloo| A]. Intracerebral crises dvring treat|ent of diabetic ‚etoacidosis.
Diabetes Xare 1990; 13; 22…33.
199. Bello ZA, Sotos ‰Z. Xerebral oede|a in diabetic ‚etoacidosis in cuildren
mletterq. ]ancet 1990; 336; 64.
200. `auoney XP, jlce‚ Bx, DelAgvila `. ˆis‚ factors for de~eloping brain
uerniation dvring diabetic ‚etoacidosis. Pediatr Nevrol 1999; 21; 721…727.
201. Dvrr ‰A, UoŠ
|an xU, S‚lar AU, el [a||al Y, Steinuart X`. Xorrelates of
brain ede|a in vncontrolled IDD`. Diabetes 1992; 41; 627…632.
202. DvrwardA, Zergvson ]P, Yaylor D,`vrdocuIA, Yibby S`. Yue te|poral
relationsuip between glvcosecorrected serv| sodiv| and nevrological statvs in se~ere
diabetic ‚etoacidosis. Arcu Dis Xuild 2011; 96; 50…57.
203. Bvreav `A, Begin ˆ, Bertuiav|e h, Suapcott D, \uovry \, [agnon N. Xerebral
uypoia fro| bicarbonate infvsion in diabetic acidosis. ‰ Pediatr 1980; 96; 968…973.
204. Deeb ]. De~elop|ent of fatal cerebral ede|a dvring ovtpatient tuerapy for
diabetic ‚etoacidosis. Pract Diabetes 1989; 6; 212…213.
205. [lasgow A`.De~astating cerebral ede|a in diabetic ‚etoacidosis before
tuerapy mletterq. Diabetes Xare 1991; 14; 77…78.
206. Xovcu ˆ`, Acott PD, xong [x. ^arly onset fatal cerebral ede|a in diabetic
‚etoacidosis. Diabetes Xare 1991; 14; 78…79.
207. Ziordalisi I, Uarris [D, [illiland `[. Preuospital cardiac arrest in diabetic
‚etoacide|ia; wuy brain swelling|ay lead to deatu before treat|ent. ‰ Diabetes
Xo|plications 2002; 16; 214…219.
208. ^dge ‰A. Xerebral oede|a dvring treat|ent of diabetic ‚etoacidosis; are we
any nearer ” nding a cavse— Diabetes `etab ˆes ˆe~ 2000; 16; 316…324.
209. `vir AB, Žvisling ˆ[, hang `X, ˆosenbloo| A]. Xerebral ede|a in
cuilduood diabetic ‚etoacidosis; natvral uistory, radiograpuic ”
ndings, and early
identi”
cation. Diabetes Xare 2004; 27; 1541…1546. 210. Zran‚lin B, ]iv ‰, [insberg-
Zellner Z. Xerebral ede|a and oputual|oplegia re~ersed by |annitol in a new case of
insvlin-dependent diabetes |ellitvs. Pediatrics 1982; 69; 87…90.
404 !\t\t 11. $\t  \r  \t   \b  \r  \b\b\f\r...
211. Suabbir N, Vber”
eld S^, Xorrales ˆ, \aira| ˆ, ]e~ine ]S. ˆeco~ery fro|
sy|pto|atic brain swelling in diabetic ‚etoacidosis. Xlin Pediatr FPuilaG 1992; 31;
570…573.
212. ˆoberts `D, Slo~er ˆU, Xuase UP. Diabetic ‚etoacidosis witu intracerebral
co|plications. Pediatr Diabetes 2001; 2; 109…114.
213. Xvrtis ‰ˆ, Boun D, Dane|an D. }se of uypertonic saline in tue treat|ent
of cerebral ede|a in diabetic ‚etoacidosis FD\AG. Pediatr Diabetes 2001; 2; 191…194.
214. \a|at P, jats A, [ross `, Xueccuia PA. }se of uypertonic saline for tue
treat|ent of altered |ental statvs associated witu diabetic ‚etoacidosis. Pediatr Xrit
Xare `ed 2003; 4; 239…242.
215. \anter ˆ\, Vlipuant `, ‡i||er|an ‰‰, Stvart `‰. Arterial turo|bosis
cavsing cerebral ede|a in association witu diabetic ‚etoacidosis. Xrit Xare `ed 1987;
15; 175…176.
216. ˆoe YZ, Xrawford YV, UvŠ
\ˆ, Xostin [, \avf|an Zˆ, Nelson `D ‰r.
Brain infarction in cuildren witu diabetic ‚etoacidosis. ‰ Diabetes Xo|plications 1996;
10; 100…108.
217. ˆosenbloo| A]. Zatal cerebral infarctions in diabetic ‚etoacidosis in a cuild
witu pre~iovsly vn‚nown uetero•ygosity for factor j ]eiden de” ciency. ‰ Pediatr 2004;
145; 561…562.
218. Zovrtner SU, xein•i|er SA, ]e~itt \at• ]^. Uyperglyce|ic uyperos|olar
non-‚etotic syndro|e in cuildren witu type 2 diabetes. PediatrDiabetes 2005; 6;
129…135.
219. \ronan \, Nor|al `^. ˆenal and electrolyte e|ergencies. In; Zleisuer [ˆ,
]vdwig S, eds. Yetboo‚ of ^|ergency `edicine. 4tu edn. Puiladelpuia; ]ippincott
xillia|s and xil‚ins, 2000.
220. `at• ˆ. `anage|ent of tue uyperos|olar uyperglyce|ic syndro|e. A| Za|
Puysician 1999; 60; 1468…1476.
221. Delaney `Z, ‡is|an A, \ettyle x`. Diabetic ‚etoacidosis and uyperglyce|ic
uyperos|olar non‚etotic syndro|e. ^ndocrinol `etab Xlin Nortu A| 2000; 29;
683…705, j.
222. `anni ˆ, Yan `], xrigut ˆ, Bas‚in `. Acvte pediatric ruabdo|yolysis;
cavses and rates of renal failvre. Pediatrics 2006; 118; 2119…2125.
223. Uollander AS, Vlney ˆX, Blac‚ett Pˆ, `arsuall BA. Zatal |alignant
uypertuer|ia-li‚e syndro|e witu ruabdo|yolysis co|plicating tue presentation of
diabetes |ellitvs in adolescent |ales. Pediatrics 2003; 111 F6 Pt 1G; 1447…1452.
224. Xarcillo ‰A, Yas‚er ˆX. Zlvid resvscitation of uypo~ole|ic suoc‚; acvte
|edicines great triv|pu for cuildren. Intensi~e Xare `ed 2006; 32; 958…961.
225. \ilbane B‰, `euta S, Ba
c‚el–
avw PZ, Suanley YP, Xri||ins NA. Approacu to
|anage|ent of |alignant uypertuer|ia-li‚e syndro|e in pediatric diabetes |ellitvs.
Pediatr Xrit Xare `ed 2006; 7; 169…173.
226. ]aŠ el ]`, xent•ell \, ]ovgulin X, Yo~ar A, `olt• \, Brin‚ S. Sic‚ day
|anage|ent vsing blood 3-uydroybvtyrate F3-VUBG co|pared witu vrine ‚etone
|onitoring redvces uospital ~isits in yovng people witu Y1D`; a rando|i•ed clinical
trial. Diabet `ed 2006; 23; 278…284.
  \b\t\b
405
227. ]aŠ el ]. Sic‚-day |anage|ent in type 1 diabetes. ^ndocrinol `etab Xlin
Nortu A| 2000; 29; 707…723.
|an xU, VNeill P, \uovry X, Bernstein SS. Ser~ice and edvcation for
tue insvlin-dependent cuild. Diabetes Xare 1978; 1; 285…288.
229. Dro•da D‰, Dawson jA, ]ong D‰, Zreson ]S, Sperling `A. Assess|ent of
tue eŠ
ect of a co|preuensi~e diabetes |anage|ent progra| on uospital ad|ission
rates of cuildren witu diabetes |ellitvs. Diabetes ^dvc 1990; 16; 389…393.
230. [rey `, Boland ^A, Da~idson `, ]i ‰, Ya|borlane xj. Xoping s‚ills training
for yovtu witu diabetes |ellitvs uas long-lasting eŠ
ects on |etabolic control and vality
of life. ‰ Pediatr 2000; 137; 107…113.
231. [olden `P, Uerrold A‰, Vrr DP. An approacu to pre~ention of recvrrent
diabetic ‚etoacidosis in tue pediatric popvlation. ‰ Pediatr 1985; 107; 195…200.
232. xolfsdorf ‰, [laser N, Sperling `A. Diabetic ‚etoacidosis in infants, cuildren,
and adolescents; a consensvs state|ent fro| tue A|erican Diabetes Association.
Diabetes Xare 2006; 29; 1150…1159.
233. Dvnger D, `enon ˆ\, Sperling `A. \etoacidosis. In; Uocuberg ‡, ed.
Practical Algoritu|s in Pediatric ^ndocrinology. Basel; S. \arger A[, 1999; 104…105.
1 \t\t 25
:\b\f \t 5\b\t \t \t\f7\t\t  5
\t 5\r\n\f \n \n\r\b7 5\t7
Trang T Ly
, David M Maahs
\f\f = \f  \b  \f\t
407
\n\b\b M\b\t8 \t \r\f7\b5:\t\t



&#"\r# #### \t\t"\t J "






408 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 

\n#" #### # #'### \r@






 \f"  \n "\r"\t /\t "#"@"@  ####.
= %"  \r# "\tC #### '#"@ '\r"".
\f\f = \f  \b  \f\t
409
�\r\f# "#"@"#  #### \f" \f"@
" \r\t\r ## :\f#\t. !#

\r5\r\b\t \t \t\f7\t\t





" # \f\r#/ '\r/, \f\tE#/ ' $#"#, ": # '#,
 \r# \r\f\rC\fJE# \r#'# #### # 



\b\t \t \t\f7\t\t

410 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 


$#\t  \f", \f" "\r#"@ \r#,  # !.




5\b\t
\b   \f  \b\t\b\b\t\f \f\f*
411
J\t \f""@  ##,  "\r## #
\f\r# #" &*. Q"\t E"J" \f, "\rC\fJE#
 \r5\b\t \t \r\n \r\n\r\b\b\b\nL
 \r5\b\t
8M8 \t \t\f7\t8
412 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
\f8a7\r\b\b \rM\b\b8 \t \t\f7\t8
\r\n \r\n\r\b\b\b\nL
\n\r\f# \f\r", "!#/  DXXY, ':"@ #-
(\b\f\t  
413
= @#/ #\f#\t/  DXXY :# \r"\r
'"# \r\r"\r"# "\tC ####  \f".
= "\r/ #' #/ #@'# \r"# \f#' ##
:'#\r#@  \t$#/ \f/. M:"@ "\tC
= \f \r\t "@ \f, 'JE#  #C#
'" "\tC ####.  \f \r\r Y1D
%#'\f "\tC ####  ## \f\r ## "\r#
# ". m7q \f :## \f #' #: :!#\r/
UbA1  7k  # '# $#$##  !
\r\t\b\f\t \t \n\t7 7
" F\f\r\r#G "#$## ### \r#
# ! ""\f#. +"# #" \r\t\tJ"\t \r#
414 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
:J\f# #"#. =\fE# #" ####
\r##\t : /\r"\r  \r#J  "#
 12.1
!*(!#!+ !  "!#*#@
3&\t.
(\b\f\t  
415
\n\b\t&\r%\r\f\r%\t\r %\n\r  \b\t.1   .=+\t.7 \r\f9\t\t\t\n\f\t   5 \t 5\r\n\f
\f\r". DXXY \r\f"\r#\r : # \r@ %#'-
\b\t\n \f \r . 12.1
416 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
\r \t8
:L
8M8 \t \t\f7\t8
%" 100 G. \b"\r \f# ## \r'\r\t $"\r$#\t
"# J'  \r" "# """J". = \f
J' " :"@ \f"#, %" " #@'"\t
:J\f"\t \r". &C" \r#'"# "\r %#'\f ####.
=  \r$#\f# #### \r: "\r:J"\t \f#"@
 \r\f \f' 10k J' 2…5   #" F1,2…3,0 
\r \r$#\r# "\tC %#'\f, ":  :\fE \r\f"\r"#"@
+\t\b \b\t
417
"  #'""@, "  %#'\f "\tC ####
\r: '"\t \f :@!# \r# "\r#\t " %#'\f, 
\f8a7\r\b\b \rM\b\b8 \t \t\f7\t8
9\f\r \r\t\n\f
418 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
 \f\t\b  \f\r\f\b\t\t$#" # #/ @\t \fC :"@ :H\t "\r \r# \r'#"#\t ####, ": # '#,  \r\t # # #"-$## "\r:J" : " #"\r# \r\t * ## #'#\t \rC# #\t.\b@!#" \f"  \n1 \rC#J" \f## %#'\f #-###, \f "\r "\r\fJ" \r$#\f##\rJE ##-#. L# %" ", C #J#"@ E"# "# \r!#\t, "  ':#\t E#"#\f C', :'@
+  \b\t=\f \f
419
# ### " ##"@ ""JE\t $##\t,
9\t\t\n\f\t  \rM\b\b\t8
## \r#/\f#"\t #'#\t "#"@ m39…41q. #
C"#  \rC# \f#\t \f#:". \f# #\f#\t \r!# -
420 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
\b\b \t \t\f7\t\t
#\f#\t '# \r' J \r\r"\r"@
 #"\r# J' F‰DˆZ-X[`G '  "J, \r\f-
\b\t\n \f\r\f\f \f \f   \f\r\f \b \f\r\n \f \r\b
421
\b\b $   \f \b\b  \b\b \n\r\n\n   \b  \b\n-\n \b \b \n \r \n\b\t   [51, 52].%\n\b\n \f!\b \b \b \b  !\n\f  \b\b\t\n-  \b\b\t\b   \b\n [53]. &\b $ \b!  \t\f\n  \t\b\b! \b" \b \b \n\b \n\n \b\b \b \f   \n  \b\b\t\b \n.  \b\t\n  23   \b\b\b\t  \n \b\b\t\n \b  \b \b\t\n , \n\t \t\n"  \b-\b\n   \t   '(  \b\b\t" \n", \b \f\f \n \n\b(\b\t\n \n    \b\n" \b \t\b \b \b \b [54]. )\b ! \b\t\n  \b\b\t\n\b #*+, \b \b\b\b \t \b-  \n\b  \b\b! \b \b \b \b [54, 55].\b\t\n \f\r\f\f \f \f   \f\r\f \b
\f\r\n \f \r\b
422 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
%\t\b& \f  *\f   
423
####  DXXY \r# :\f\r"##  '\r/ :H" m73q.
"@"#  ####  \f" \f :\r"". = #\f##
424 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
\n\r7\b\b 7M\b\n\t \r \t\t
\n\t\n7 \n8\b\b 7\b\t\r\t\b =\f
# J "\r#J, #J \r \f\t #C#\t Ub1 3 FSYAˆ3G m77q,  '# #C#\t ####. "\r\t 
7 8 \r \t8, \n\t\b\b8 \n\b\n\r7, \r\t \b\t\f7 \r\b
=\f 58 \r\t\n\b\f\t
\b  \f\f =\f  \b\t
425
 \r\t\f ###/ #"# m81, 82q. +"# \r#" '\f
\f\t ", ": \r#"#"@ "# ## \f
#\f## 45 "# #@'# \r\f#"#J #"
7\f\b8 \n\t\n7 \n \b\t8 \t\b\n\t\b
""#'#\r "# ##  "\t
$#" \f" 'C"@ :"# '#"@ ###
###/ #\f#, $#!#/ \r""# '"/
= $ %"# #" #@'J" #\r$#J, "JEJ
" #" &*, ##J  \f\t \f# ## #
\r# #@'## '" #" F73kG  \r#J 
#@'#  "\r##, # \r F52kG, 
#", \f"\r#\rJE  "@ %"#"@,  "C
426 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
"""JE# \f# :'"#, "#  \r##
\r\t \r/ # ## \f\t \f\t"@"# '" #"
 12.3
3% ! %! !*(!#!/"!; E*!'
9@%!
  \b\t\b
9@%!
 \t \b\t & \t, \t\r  sU & \f \r\n\t \r \r&    .
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. A|erican Diabetes Association. Standards of |edical care in diabetes … 2008.
Diabetes Xare 2008; 31 FSvppl 1G; S12…S54.
2. Da~is ^A, \eating B, Byrne [X, ˆvssell `, ‰ones Yx. Uypoglyce|ia; incidence
and clinical predictors in a large popvlation-based sa|ple of cuildren and adolescents
witu IDD`. DiabetesXare 1997; 20; 22…25.
3. ‰v~enile Diabetes ˆesearcu Zovndation Xontinvovs [lvcose`onitoring Stvdy
[rovp. Prolonged noctvrnal uypoglyce|ia is co||on dvring 12 |ontus of continvovs
glvcose |onitoring in cuildren and advlts witu type 1 diabetes. Diabetes Xare 2010; 33;
1004…1008.
\b\t\n \f \r . 12.3
428 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
4. Da~is ^A, \eating B, Byrne [X, ˆvssell `, ‰ones Yx. I|pact of i|pro~ed
glycae|ic control on rates of uypoglycae|ia in insvlin dependent diabetes |ellitvs.
Arcu Dis Xuild 1998; 78; 111…115.
5. Bvc‚ingua| B, xilson D`, ]ecuer Y, Uanas ˆ, \aiser|an \, Xa|eron Z.
Dvration of noctvrnal uypoglyce|ia before sei•vres. Diabetes Xare 2008; 31; 2110…2112.
6. Yanenberg ˆ‰, Newton XA, Dra‚e A‰. Xon”
r|ation of uypoglyce|ia in
tue   dead-in-bed syndro|e, as captvred by a retrospecti~e continvovs glvcose
|onitoring syste|. ^ndocr Pract 2010; 16; 244…248.
7. VXonnell S`, Xooper `N,Bvlsara `\,Da~is ^A, ‰ones Yx. ˆedvcing rates of
se~ere uypoglyce|ia in a popvlation-based couort of cuildren and adolescents witu type
1 diabetes o~er tue decade 2000…2009. Diabetes Xare 2011; 34; 2379…2380.
8. Xooper `N, VXonnell S`, Da~is ^A, ‰ones Yx. A popvlation-based stvdy of
ris‚ factors for se~ere uypoglycae|ia in a conte|porary couort of cuilduoodonset type
1 diabetes.Diabetologia 2013; 56; 2164…2170.
9. Uoll ˆx, Swift P[, `ortensen UB et al. Insvlin in–ection regi|ens and
|etabolic control in an international svr~ey of adolescents witu type 1 diabetes o~er 3
years; resvlts fro| tue U~idore stvdy grovp. ^vr ‰ Pediatr 2003; 162; 22…29.
10. xood ‰ˆ, `iller \`, `aaus D` et al. `ost yovtu witu type 1 diabetes in tue
Y1D ecuange clinic registry do not |eet a|erican diabetes association or international
society for pediatric and adolescent diabetes clinical gvidelines. Diabetes Xare 2013; 36;
2035…2037.
11. ‰ones Yx, Bovlware SD, \rae|er DY, Xaprio S, Suerwin ˆS, Ya|borlane xj.
Independent eŠ
ects of yovtu and poor diabetes control on responses to uypoglyce|ia
in cuildren. Diabetes 1991; 40; 358…363.
12. Xryer P^. `ecuanis|s of uypoglyce|ia-associated avtono|ic failvre and its
co|ponent syndro|es in diabetes. Diabetes 2005; 54; 3592…3601.
13. Seavist ^ˆ, Anderson ‰, Xuilds B et al. Uypoglyce|ia and diabetes; a report
of a wor‚grovp of tue A|erican Diabetes Association and tue ^ndocrine Society.
Diabetes Xare 2013; 36; 1384…1395.
14. Xlar‚e x, ‰ones Y, ˆewers A, Dvnger D, \lingens|itu [‰. Assess|ent and
|anage|ent of uypoglyce|ia in cuildren and adolescents witu diabetes. Pediatr
Diabetes 2008; 9; 165…174.
15. Diabetes Xontrol and Xo|plications Yrial ˆesearcu [rovp. ^Š
ect of intensi~e
diabetes treat|ent on tue de~elop|ent and progression of long-ter| co|plications
in adolescents witu insvlin-dependent diabetes |ellitvs. Diabetes Xontrol and
Xo|plications Yrial. ‰ Pediatr 1994; 125; 177…188.
16. ˆewers A, Xuase UP, `a
c‚en•ie Y et al. Predictors of acvte co|plications in
cuildren witu type 1 diabetes. ‰A`A 2002; 287; 2511…2518.
17. Xengi• ^, _ing D, xong ‰X et al. Se~ere uypoglyce|ia and diabetic ‚etoacidosis
a|ong yovtu witu type 1 diabetes in tue Y1D ecuange clinic registry. Pediatr Diabetes
2013; 14; 447…454.
18. Bvlsara `\, Uol|an XD, Da~is ^A, ‰ones Yx. Yue i|pact of a decade of
cuanging treat|ent on rates of se~ere uypoglyce|ia in a popvlation-based couort of
cuildren witu type 1 diabetes. Diabetes Xare 2004; 27; 2293…2298.
  \b\t\b
429
19. Xryer P^. Sy|pto|s of uypoglyce|ia, turesuolds for tueir occvrrence, and
uypoglyce|ia vnawareness. ^ndocrinol `etab Xlin Nortu A| 1999; 28; 495…500 ~…~i.
20. ‰ones Yx, Borg xP, Borg `A et al. ˆesistance to nevroglycopenia; an adapti~e
response dvring intensi~e insvlin treat|ent of diabetes. ‰ Xlin ^ndocrinol `etab 1997;
82; 1713…1718.
21. `cXri||on ˆ‰, [old A^, Deary Ÿ , \elnar X‰, Zrier B`. Sy|pto|s of
uypoglyce|ia in cuildren witu IDD`. Diabetes Xare 1995; 18; 858…861.
22. Yvpola S, ˆa–antie ‰. Docv|ented sy|pto|atic uypoglycae|ia in cuildren
and adolescents vsing |vltiple daily insvlin in–ection tuerapy. Diabet `ed 1998; 15;
23. `orris AD, Boyle DI, `c`auon AD, [reene SA, `acDonald Y`, Newton
ˆx. Aduerence to insvlin treat|ent, glycae|ic control, and ‚etoacidosis in insvlin-
dependent diabetes |ellitvs. Yue DAˆYS`^`V Xollaboration. Diabetes Avdit
and ˆesearcu in Yayside Scotland. `edicines `onitoring }nit. ]ancet 1997; 350;
1505…1510.
24. A|iel SA, Suerwin ˆS, Si|onson DX, ]avritano AA, Ya|borlane xj.
I|paired insvlin action in pvberty. A contribvting factor to poor glyce|ic control in
adolescents witu diabetes. N ^ngl ‰ `ed 1986; 315; 215…219.
25. A|an ‰, xranne ]. Uypoglycae|ia in cuilduood diabetes. II. ^Š
ect of
svbcvtaneovs or intra|vscvlar in–ection of diŠ
erent doses of glvcagon. Acta Paediatr
Scand 1988; 77; 548…553.
26. [vnning ˆˆ, [arber A‰. Bioacti~ity of instant glvcose. Zailvre of absorption
turovgu oral |vcosa. ‰A`A 1978; 240; 1611…1612.
27. Brodows ˆ[, xillia|s X, A|atrvda ‰`. Yreat|ent of insvlin reactions in
diabetics. ‰A`A 1984; 252; 3378…3381.
28. [eorga‚opovlos \, \atsila|bros N, Zraga‚i ` et al.ˆeco~ery fro| insvlin-
indvced uypoglyce|ia after saccuarose or glvcose ad|inistration. Xlin Puysiol
Biocue| 1990; 8; 267…272.
29. xietuop Bj, Xryer P^. Alanine and terbvtaline in treat|ent of uypoglyce|ia in
IDD`. Diabetes Xare 1993; 16; 1131…1136.
30. Ysali‚ian ^, \oll|an X, Ya|borlane xB et al. Pre~ention of uypoglyce|ia
dvring eercise in cuildren witu type 1 diabetes by svspending basal insvlin. Diabetes
Xare 2006; 29; 2200…2204.
31. `aaus D`, Uer|ann ‰`, Dv Bose SN et al. Xontrasting tue clinical care and
ovtco|es of 2,622 cuildren witu type 1 diabetes less tuan 6 years of age in tue }nited
States and [er|anAvstrian DPj registries. Diabetologia 2014.
32. Boileav P, Abov|rad B, Bovgneres P. ˆecvrrent co|as dve to secret self-
ad|inistration of insvlin in adolescents witu type 1 diabetes. Diabetes Xare 2006; 29;
430…431.
33. hv ], Brewer \x, [ates S et al. DˆB1{04 and DŽalleles; epression of
21-uydroylase avtoantibodies and ris‚ of progression to Addisons disease. ‰ Xlin
^ndocrinol `etab 1999; 84; 328…335.
34. `cAvlay j, Zrier B`. Addisons disease in type 1 diabetes presenting witu
recvrrent uypoglycae|ia. Postgrad `ed ‰ 2000; 76; 230…232.
430 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
35. Puornpuvt‚vl X, Boney X`, [rvppvso PA. A no~el presentation of Addison
disease; uypoglyce|ia vnawareness in an adolescent witu insvlin-dependent diabetes
|ellitvs. ‰ Pediatr 1998; 132; 882…884.
36. Iafvsco D, ˆea Z, Prisco Z. Uypoglyce|ia and redvction of tue insvlin
revire|ent as a sign of celiac disease in cuildren witu IDD`. Diabetes Xare 1998; 21;
1379…1381.
37. `oun A, Xerrvto `, Iafvsco D et al. Xeliac disease in cuildren and adolescents
witu type I diabetes; i|portance of uypoglyce|ia. ‰ Pediatr [astroenterol Nvtr 2001;
32; 37…40.
38. `c`auon S\, Zerreira ]D, ˆatna| N et al. [lvcose revire|ents to |aintain
evglyce|ia after |oderateintensity afternoon eercise in adolescents witu type 1 diabetes
are increased in a bipuasic |anner. ‰ Xlin ^ndocrinol `etab 2007; 92; 963…968.
39. Yansey `‰, Ysali‚ian ^, Bec‚ ˆx et al. Yue eŠ
ects of aerobic eercise on
glvcose and covnterregvlatory uor|one concentrations in cuildren witu type 1 diabetes.
Diabetes Xare 2006; 29; 20…25.
40. [ri|| ‰‰, hbarra ‰, Berne X, `vcunic‚ S, [olay A. A new table for pre~ention
of uypoglycae|ia dvring puysical acti~ity in type 1 diabetic patients. Diabetes `etab
2004; 30; 465…470.
41. ˆiddell `X, Iscoe \^. Puysical acti~ity, sport, and pediatric diabetes. Pediatr
Diabetes 2006; 7; 60…70.
42. ˆobertson \, Adolfsson P, ˆiddell `X, Scueiner [, Uanas ˆ. ^ercise in
cuildren and adolescents witu diabetes. Pediatr Diabetes 2008; 9; 65…77.
43. `onaguan `X, Uilliard `^, Xogen Zˆ, Streisand ˆ. Nigutti|e caregi~ing
beua~iors a|ong parents of yovng cuildren witu type 1 diabetes; associations witu
illness cuaracteristics and parent fvnctioning. Za| Syst Uealtu 2009; 27; 28…38.
44. ‰ones Yx, Porter P, Suerwin ˆS et al. Decreased epinepurine responses to
uypoglyce|ia dvring sleep. N ^ngl ‰ `ed 1998; 338; 1657…1662.
45. `aty‚a \A, Xrowne ^X, Ua~el P‰, `acdonald IA, `attuews D, Dvnger DB.
Xovnterregvlation dvring spontaneovs noctvrnal uypoglyce|ia in prepvbertal cuildren
witu type 1 diabetes. Diabetes Xare 1999; 22; 1144…1150.
46. Beregs•as•i `, Yvbiana-ˆv”
N, Benali \, Noel `, Blocu ‰, X•ernicuow P.
Noctvrnal uypoglyce|ia in cuildren and adolescents witu insvlin-dependent diabetes
|ellitvs; pre~alence and ris‚ factors. ‰ Pediatr 1997; 131; 27…33.
47. `aty‚a \A, xigg ], Pra||ing S, Stores [, Dvnger DB. Xogniti~e fvnction
and |ood after profovnd noctvrnal uypoglycae|ia in prepvbertal cuildren witu
con~entional insvlin treat|ent for diabetes. Arcu Dis Xuild 1999; 81; 138…142.
48. \avf|an Zˆ, Avstin ‰, Neinstein A et al. Noctvrnal uypoglyce|ia detected
witu tue continvovs glvcose |onitoring syste| in pediatric patients witu type 1
diabetes. ‰ Pediatr 2002; 141; 625…630.
49. Porter PA, \eating B, Byrne [, ‰ones Yx. Incidence and predicti~e criteria of
noctvrnal uypoglyce|ia in yovng cuildrenwitu insvlin-dependent diabetes |ellitvs.
‰ Pediatr 1997; 130; 366…372.
50. \alergis `, ScuiŠ rin A, [ovgeon ˆ, ‰ones P‰, hale ‰Z. I|pact of bedti|e
snac‚ co|position on pre~ention of noctvrnal uypoglyce|ia in advlts witu type 1
  \b\t\b
431
diabetes vndergoing intensi~e insvlin |anage|ent vsing lispro insvlin before |eals; a
rando|i•ed, placebo-controlled, crosso~er trial. Diabetes Xare 2003; 26; 9…15.
51. jer~ers `Y, ˆovwe X, S|it [P. Xo|ple carbouydrates in tue pre~ention of
noctvrnal uypoglycae|ia in diabetic cuildren. ^vr ‰ Xlin Nvtr 1993; 47; 268…273.
52. \avf|an Zˆ, Ual~orson `, \avf|an ND. A rando|i•ed, blinded trial of
vncoo‚ed cornstarcu to di|inisu noctvrnal uypoglyce|ia at diabetes ca|p. Diabetes
ˆes Xlin Pract 1995; 30; 205…209.
53. xilli S`, Planton ‰, ^gede ], S
cuwar• S. Bene” ts of continvovs svbcvtaneovs
insvlin infvsion in cuildren witu type 1 diabetes. ‰ Pediatr 2003; 143; 796…801.
54. xeintrob N, Scuecuter A, Ben•aven U et al. [lyce|ic patterns detected
by continvovs svbcvtaneovs glvcose sensing in cuildren and adolescents witu type 1
diabetes |ellitvs treated by |vltiple daily in–ections ~s continvovs svbcvtaneovs insvlin
infvsion. Arcu Pediatr Adolesc `ed 2004; 158; 677…684.
55. ]vd~igsson ‰, Uanas ˆ. Xontinvovs svbcvtaneovs glvcose |onitoring i|pro~ed
|etabolic control in pediatric patients witu type 1 diabetes; a controlled crosso~er stvdy.
Pediatrics 2003; 111; 933…938.
56. ˆyan X, jega A, Drasu A. Xogniti~e de”
cits in adolescents wuo de~eloped
diabetes early in life. Pediatrics 1985; 75; 921…927.
57. xysoc‚i Y, Uarris `A, xil‚inson \, Sadler `, `avras N, xuite NU. Absence
of ad~erse eŠ
ects of se~ere uypoglyce|ia on cogniti~e fvnction in scuoolaged cuildren
witu diabetes o~er 18 |ontus. Diabetes Xare 2003; 26; 2043…2047.
58. Strvdwic‚ S\, Xarne X, [ardiner ‰, Zoster ‰\, Da~is ^A, ‰ones Yx. Xogniti~e
fvnctioning in cuildren witu early onset type 1 diabetes and se~ere uypoglyce|ia.
‰ Pediatr 2005; 147; 680…685.
59. ]y YY, Anderson `, `cNa|ara \A, Da~is ^A, ‰ones Yx. Nevrocogniti~e
ovtco|es in yovng advlts witu early-onset type 1 diabetes; a prospecti~e follow-vp
stvdy. Diabetes Xare 2011; 34; 2192…2197.
60. Uo `S, xeller N‰, I~es Z‰ et al. Pre~alence of strvctvral central ner~ovs syste|
abnor|alities in ea
432 !\t\t 12.  \f\t    \f      \r  \b  \t\t\b\f \t 
67. Arbelae• A`, Se|en‚o~icu \, Uersuey Y. [lyce|ic etre|es in yovtu witu
Y1D`; tue strvctvral and fvnctional integrity of tue de~eloping brain. Pediatr Diabetes
2013; 14; 541…553.
68. Xryer P^. Uypoglycae|ia; tue li|iting factor in tue glycae|ic |anage|ent of
type I and type II diabetes. Diabetologia 2002; 45; 937…948.
69. Sando~al DA, [vy D], ˆicuardson `A, ^rtl AX, Da~is SN. Acvte, sa|e-day
ects of antecedent eercise on covnterregvlatory responses to svbsevent uypoglyce|ia
in type 1 diabetes |ellitvs. A| ‰ Puysiol ^ndocrinol `etab 2006; 290; ^1331…^1338.
70. A|iel SA, Pottinger ˆX, Arcuibald Uˆ et al. ^Š
ect of antecedent glvcose
control on cerebral fvnction dvring uypoglyce|ia. Diabetes Xare 1991; 14; 109…118.
71. A|iel SA, [ale ^. Puysiological responses to uypoglyce|ia. Xovnterregvlation
and cogniti~e fvnction. Diabetes Xare 1993; 16 FSvppl 3G; 48…55.
72. A|iel SA, Si|onson DX, Suerwin ˆS, ]avritano AA, Ya|borlane xj.
^aggerated epinepurine responses to uypoglyce|ia in nor|al and insvlin-dependent
diabetic cuildren. ‰ Pediatr 1987; 110; 832…837.
73. Diabetes Xontrol and Xo|plications Yrial ˆesearcu [rovp. ^pide|iology
of se~ere uypoglyce|ia in tue diabetes control and co|plications trial. Yue DXXY
ˆesearcu [rovp. A| ‰ `ed 1991; 90; 450…459.
74. ]y YY, [allego PU, Da~is ^A, ‰ones Yx. I|paired awareness of uypoglyce|ia
in a popvlation-based sa|ple of cuildren and adolescents witu type 1 diabetes. Diabetes
Xare 2009; 32; 1802…1806.
75. Xranston I, ]o|as ‰, `aran A, `acdonald I, A|iel SA.ˆestoration of
uypoglycae|ia awareness in patients witu long-dvration insvlin-dependent diabetes.
]ancet 1994; 344; 283…287.
76. ]y YY, Uewitt ‰, Da~ey ˆ‰, ]i| ^`, Da~is ^A, ‰ones Yx. I|pro~ing
epinepurine responses in uypoglyce|ia vnawareness witu real-ti|e continvovs glvcose
|onitoring in adolescents witu type 1 diabetes. Diabetes Xare 2011; 34; 50…52.
77. Bergenstal ˆ`, Ya|borlane xj, Au|ann A et al. ^Š ecti~eness of sensor-
avg|ented insvlin-pv|p tuerapy in type 1 diabetes. N ^ngl ‰ `ed 2010; 363; 311…320.
78. Bvc‚ingua| B, Bloc‚ ‰, Bvrdic‚ ‰ et al. ˆesponse to noctvrnal alar|s vsing a
real-ti|e glvcose sensor. Diabetes Yecunol Yuer 2005; 7; 440…447.
79. ]y YY, ‰ones Yx, [riž tus A et al. Uypoglyce|ia does not cuange tue turesuold
for arovsal fro| sleep in adolescents witu type 1 diabetes. Diabetes Yecunol Yuer 2011;
14; 101…104.
80. ]y YY, Nicuolas ‰A, ˆetteratu A, ]i| ^`, Da~is ^A, ‰ones Yx. ^Š
ect of
sensor-avg|ented insvlin pv|p tuerapy and avto|ated insvlin svspension ~s standard
insvlin pv|p tuerapy on uypoglyce|ia in patients witu type 1 diabetes; a rando|i•ed
clinical trial. ‰A`A 2013; 310; 1240…1247.
81. Bvc‚ingua| B, Xuase UP, Dassav ^ et al. Pre~ention of noctvrnal uypoglyce|ia
vsing predicti~e alar| algoritu|s and insvlin pv|p svspension. Diabetes Xare 2010; 33;
1013…1017.
82. `aaus D`, Xaluovn P, Bvc‚ingua| BA et al. Arando|i•ed trial of a uo|e
syste| to redvce noctvrnal uypoglyce|ia in type 1 diabetes. Diabetes Xare 2014; 37;
1885…1891.
  \b\t\b
433
83. V[rady `‰, ˆetteratu Aˆ, \eenan DB et al. Yue vse of an avto|ated,
portable glvcose control syste| for o~ernigut glvcose control in adolescents and yovng
advlts witu type 1 diabetes. Diabetes Xare 2012; 35; 2182…2187.
84. xein•i|er SA, Steil [`, Swan \], D•ivra ‰, \vrt• N, Ya|borlane xj.
Zvlly avto|ated closed-loop insvlin deli~ery ~ersvs se|iavto|ated uybrid control in
pediatric patients witu type 1 diabetes vsing an arti”
cial pancreas. Diabetes Xare 2008;
31; 934…939.
85. Uo~or‚a ˆ, Allen ‰`, ^lleri D et al. `anval closedloop insvlin deli~ery in
cuildren and adolescents witu type 1 diabetes; a puase 2 rando|ised crosso~er trial.
]ancet 2010; 375; 743…751.
86. Puillip `, Battelino Y, Atlas ^ et al. Noctvrnal glvcose control witu an arti”
cial
pancreas at a diabetes ca|p. N ^ngl ‰ `ed 2013; 368; 824…833.
87. ]y YY, Breton `, \eitu-Uynes P et al. V~ernigut glvcose control witu an
avto|ated, vni”
ed safety syste| in cuildren and adolescents witu type 1 diabetes at
diabetes ca|p. Diabetes Xare 2014.
88. Ya|borlane xj. Xlosed-loop insvlin deli~ery; were   ~irtvally tuere. Diabetes
Yecunol Yuer 2012; 14; 203…204.
89. ^vgster ^A, Zrancis [. Position state|ent; continvovs svbcvtaneovs insvlin
infvsion in ~ery yovng cuildren witu type 1 diabetes. Pediatrics 2006; 118; e1244…e1249.
90. VXonnell `A, [ilbertson Uˆ, Donatu S`, Xa|eron Z‰. Vpti|i•ing
postprandial glyce|ia in pediatric patients witu type 1 diabetes vsing insvlin pv|p
tuerapy; i|pact of glyce|ic inde and prandial bolvs type. Diabetes Xare 2008; 31;
1491…1495.
91. S|art X^, ^~ans `, VXonnell S` et al. Botu dietary protein and fat increase
postprandial glvcose ecvrsions in cuildrenwitu type 1 diabetes, and tue eŠ
ect is
additi~e. Diabetes Xare 2013; 36; 3897…3902.
1 \t\t 2G
\n\b\b\n\t 5\b\t8 5 \t 5\r\n\f
\n \n\r\b7 5\t7
\r\t \n \n=\t \b\t8
 \r\f\f \f\t \n \b\f \r \f\r \t& !\f\b\t.
"\b\b  \b 2014: 15 (Suppl. 20): 193…202.
Stuart Brink
Phelan
a
\f\f = \f  \b  \f\t
435
\n\b\b M\b\t8 \t \r\f7\b5:\t\t

…"$#\f'z
…\f#\f\r"$##z
…"\r#\r ## #""# #\r###z
…####.



�: \f" #"@ \f' ##, \f :J\f"\t

:/\f# \f"@ 5…10k :E \f \f' ## Fª0,05…0,1
LG  \r ## \r" ## @"\r\r" \f"#\t
\fC ## "\r#! # "\r\t"@ \f' C\f 2…4  
�"""##  "" * # ### "\t#. :E\t


436
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...




…\f \r## "\t#\t $#"  \t # \r\fC"\t
…\f \r\fC"\t #C#  ", " #\f"@"" 
…\r" \r\fC"\t : 2  F:  @#/ \f"Gz
…* \r\fC" \r"#, "\r\t  \f#"@ \f#
…\r\f#"#  " :#"@ '"# * ! 3,5 @
…/\r\t"\t ## \r" F## $"G '/ \r# \f/-
…"\r#\t \rC # \r""/\r\t"\t ## " 
…\r: "#"\t #"E, '"\rC,   \r'-
…:J\fJ"\t #'#\t  \r# "", "
…\r: @ @# F‘2…5 "Gz
…"@ ':#\t, # \n, \r#\r, #\f\r , #-
/## ':#\t, %##\t, \t\r#\t, \r'#"##
 \r \t \t\f \f\t \t 
…$#"#/ \r\f"## " ##  \rJ" \r\f-
…\t' \r: C\tJ" :E#  @z
… "\r:#J $#" ## /C#JE ' # '\r





5\n\t \b\t8 \b 5\t
\f## : \t, " #C# $"\r$## Ig[ # #C#
438
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
':#\t. \r\f# "## #\r \r##JE\t
 \n 7\b\t\r\t\b
\r\bL =\f  \f\r\t

 \f
439

5\f \f \n\t:\t\t \b\t




\f\b
\t BVUB. \r# "\r "$#\f' "!# "  \r#'
FBVUBAcAcG '\r"" " \r 1;1 \f 10;1 ## : m10q. = "" 
##"\r#J \r# BVUB : #CJ"\t '\f \f #C-
440
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
AcAcG #  'C"# \r#  " F\f\t BVUBG C" @
\r#  " F \r\f# BVUBG :#" \f#"@-



�\r\f# $"\r$## BVUB  \r#  \f!#/ #\t/
�\r\f# \r BVUB  \r# C" :"@ : C
\r" # @"\r\r" \f"#\t. ## \r BVUB 

(\b \b\t\n \f \f\f \b\t  \b *\f \t\f
441


#@J #\r$#J  \f#J # C ""



\r\f\r\b\t \t\b\n\t\b\r \t\t \n7\rL\b  \n\b
442
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
\r8  \t




\n \b\t \t5\r:\t\t



 \t*\f  \f  
443

! \r# ", $##\rJE#\t  #'# \r
#\t #E# # C#\f", \f@! ##J \r ",

\n :\tL\b 75\t:\t\b\n\f\t \n

444
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...


… ':# #  : F".. "\r%"\r#", '\r\t'-
…#'# \r *z
…\f"""@J ##, \r#\f\tE   \rJ

L# " \f'\r#\t  #E "\r#, \r"\r#J"
\r  ## \r"  #@'# \f #H$## ##
\r"@ \r##\t \r"#\r"/ \r\r" F"#/
 \f"\r, '#"\r## «\r"'#»G, \f\t " ":
\r#\t"@ "\[email protected] \f, ' #J# #"$#, \f "@
�#\t  \f #/# "". \f  
 \r\t * # #':" \r\t " \r#\r#""
\fC "\f"@\t '#J \f#"@ #"
##,  "C \f"" #" / # \f/
\r"\r. = " #"$## \r" " \r\rE"\t \r#
\f## \f#"@ ## \f\t :\r" \r'#"#\t
 \r\r" \f\t \r# "\[email protected] \f\t :#\t #""## \r"
## \f#\r# " \f' %"#"#, #, \f"@, #/ \r#
:  \r\fJ". ?  , #  ### "@ \r#\f
## /\f \r\r" \r"# \f#\r#, \f\t :#\t #" "
5 \b\tL\b \t\b\n\t\b


 \t*\f  \f  
445





446
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
 13.1
5*(%!()%@& !%"$(!%  %! " "*$"$_`!# '-(%!# O*!% !'N [^, X…10]Q OGQ
\6,9#\t-
% \f
10   
6,9…6,K' \b  
2,6…2,JC \f+
 \t*\f  \f  
447
\f%@\f\f
�2,…5,K7
T\r 
  \b\t.
„„D& \t\f\r  \b  \n,
„%  10  -
\n\n\r \r . 13.1
448
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
\f%@\f\f
 \f \r#\f \r    \b\t. ' \b \f  -. %\f  10  . C\b \t\n\t- \b  \f  \r\t  \b  &\b\r#\f \r  -  \b\t. C\b \t\n\t- \b  \f-  \r\t  \b  &\b-\r. 3\t  �@  \b\n \r \t   �6,6 /34. %, \b\t \f 10 -\r\rC\b \t\n\t \b  \f  \r\t  -\b  &\b-\r. 3\t  [email protected]  \b\n \r \t   6,2 /343\t  26…[email protected]  \b\n \r \t   6,2 /34. % \b \b\n \n 5 , \r  -\f   \r\n\r„'\r  \r \t\n \t\b\n\t, \r  -
\b\t\n \f \r . 13.1
 \t*\f  \f  
449
 13.2
\r#%$#@ #!%!B'@ (_% OQi
7 7("
\r\f#\f/ #\r##. =# \r@ * # ! \r#
450
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...


\r@ "   " ""\t !  "#
#/  #'-' \r##  \r#' BVUB \r#  AcAc,
"\r C" \r\f\t"@\t   m5q. $" C" /\r#"@\t
 C#\r "# \r# "' # \f#"@  \r# BVUB
 AcAc C" #"@  \f  \r#"$#J \r\t ",
\f5 \b7M\b  \r5\b\t \r\b8 \f\b
"\t"@ \r\f"\t #'\r# \r\t " \r#
 \f#"@ ## \r# \r\f/ \r\t/ * F 
\f$#  \r" \f#"@ \f' ##  """##
 '\r" \r: # : :E \f' ## m8, 9q. \n\f"
\r\f#"@ \r\t\r :'\r # :# /"\t : \f# \r'  \f. L
\t\b9\f:\t\t, \n\n:\t\t\r7 \n \t \t\f7\t

 \t*\f  \f  
451



=#"@ $#" \f#\r' # \r\f#" #'\r# 
\f" \f\t \r\f#\t "\r:"#  C#\f"\t/. "\t
\f\f\rC#  " '" \f"J #\f\r"$#J #
'E# C#\f"\t#, "\f  "\t #C#  "



452
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
\n :\t9\t\n\f\t \n \b\n\tL\b 5\b\t8 5
\b 7  \t\b\n\t\b\r \t\t  5\b\t \n \n \n=\t7
\b\t7




\t \r\f#\t ##\r'#"""# :'@ \r@

 #    \f *\f   \f   \r \f\t \r...
453
 13.3
%! & % !%"$(!%& *#*  %!" "*$"$_`!# '-(%!#
! !*(!#!&
\t \f
/\r  \r\r   ,    -
T\b   \r \r
D \f   \r \t    
/&\t\r  \f 10,
! !%f3!! " !"*()'%!# ?*!3
% \t \r \t   -
#%!  ! *) -$ *#*@
/\r  \f 10 \r&\t\r \n
%\b &\t \b\f  \r \b\n \r \r \f-
`\t \r   , $\n \r\r-
  \t . 7\r\t \t\n\t \f \f \r
/\r  \f 10  \r&\t\r
%\b \t\r  10  -

% \t \r \f \r   -
/\r  \n 5    +, \t\r\f  -
  \r \t. /\r  \n 5 
454
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
\f\b9\t\f \t\b\r\n
B. V.; ad~isory boards for No~oNordis‚ and `edtronic spea‚ers fees,
. D.
‰.; fvnding fro| ^SP^. U. P. consvltant for Sano” . ]. ].; fvnding fro| Abbott
  \b\t\b
\n \t\n\f \t\r\r
1. `vller ]`, [orter \‰, Ua‚ ^, [ovd•waard x], Scuelle~is Z[, Uoepel|an I`.
Increased ris‚ of infection in patients witu diabetes |ellitvs type 1 or 2. Ned Y˜
dscur
[enees‚d 2006; 150; 549…553.
2. Bagdade ‰D, ˆoot ˆ\, Bvlger ˆ‰. I|paired lev‚ocyte fvnction in patients witu
poorly controlled diabetes. Diabetes 1974; 23; 9…15.
3. ]iberatore ˆˆ, Barbosa SZ, Al‚i|in `[, Bellinati-Pires ˆ, Zlorido `P,
Isaac ]. Is i||vnity in diabetic patients in› vencing tue svsceptibility to infections—
I||vnoglobvlins, co|ple|ent and puagocytic fvnction in cuildren and adolescents witu
type 1 diabetes |ellitvs. Pediatr Diabetes 2005; 6; 206…212.
4. ]aŠ el ]. Sic‚-day |anage|ent in type 1 diabetes. ^ndocrinol `etab Xlin Nortu
A| 2000; 29; 707…723.
5. Brin‚ S‰. Diabetic ‚etoacidosis; pre~ention, treat|ent and co|plications in
cuildren and adolescents.Diabetes Nvtr `etab 1999; 12; 122…135.
6. xal‚er `, `arsuall S`, Alberti \[. Xlinical aspects of diabetic ‚etoacidosis.
Diabetes `etab ˆe~ 1989; 5; 651…663.
7. Brin‚ S‰, ]ee xˆ, Pillay \, \leinebreil ]. Diabetes in Xuildren and Adolescents.
Basic Yraining `anval for Uealtu Xare Professionals in De~eloping Xovntries. Xuanging
Diabetes in Xuildren. Den|ar‚; No~oNordis‚, 2011.
8. Uanas ˆ. Yype 1 diabetes in cuildren, adolescents and yovng advlts. Uow to
beco|e an epert on yovr own diabetes. 3rd edn. ]ondon; Xlass Pvblisuing, 2007.
9. Xuase UP. }nderstanding Diabetes. 11tu edn. Den~er, XV; Xuildrens Diabetes
Zovndation, 2006.
10. ]aŠ el ]. \etone bodies; a re~iew of puysiology, patuopuysiology and application
of |onitoring to diabetes. Diabetes `etab ˆes ˆe~ 1999; 15; 412…426.
11. Sa|velsson }, ]vd~igsson ‰. xuen suovld deter|ination of ‚etone|ia be
reco||ended— Diabetes Yecunol Yuer 2002; 4; 645…650.
12. [verci B, Yvbiana-ˆv”
N, Bavdvceav B, Bresson ˆ, Xvperlier A, Delcroi X.
Ad~antages to vsing capillary blood beta-uydroybvtyrate deter|ination for tue detection
and treat|ent of diabetic ‚etosis.Diabetes `etab 2005; 31; 401…406.
13. [verci B, Benicuov `, Zloriot `, Bou|e P, Zovgnot S, Zranc‚ P. Accvracy
of an electrocue|ical sensor for |easvring capillary blood ‚etones by ”
ngerstic‚
sa|ples dvring |etabolic deterioration after continvovs svbcvtaneovs insvlin infvsion
interrvption in type 1 diabetic patients. Diabetes Xare 1995; 18; 137…138.
14. }|pierre• [^, xatts NB, Puillips ]S. Xlinical vtility of beta-uydroybvtyrate
deter|ined by re›
ectance |eter in tue |anage|ent of diabetic ‚etoacidosis. Diabetes
Xare 1995; 18; 137…138.
15. ]aŠ el ], ]ovgulin X, Yo~ar A, ‡veul‚e ‰, Brin‚ S. Sic‚ day |anage|ent vsing
blood beta uydroybvtyrate ~s vrine ‚etones signi”
cantly redvces uospital ~isits in yovtu
witu Y1D`; a rando|i•ed clinical trial. Diabetes 2002; 51 FSvppl 2G; A105.
16. ]aŠ el ]`, xent•ell \, ]ovgulin X, Yo~ar A, `olt• \, Brin‚ S. Sic‚ day
|anage|ent vsing blood 3 uydroybvtyrate co|pared witu vrine ‚etone |onitoring
redvces uospital ~isits in yovng people witu Y1D`; a rando|i•ed clinical trial. Diabet
`ed 2006; 23; 278…284.
456
!\t\t 13.  \f\f   \f   \r  \b  \t\t\b\f \t ...
17. \loc‚er AA, Pue
lan U, Ywigg S`, Xraig`^.Blood ß-uydroybvtyrate ~s vrine
acetoacetate testing for tue pre~ention and |anage|ent of ‚etoacidosis in Yype 1
diabetes; a syste|atic re~iew. Diabetes `ed 2013; 30; 818…824.
18. janelli `, Xuiari [, Xapvano X, Io~ane B, Bernardini A, [iacalone Y. Yue
direct |easvre|ent of 3-beta-uydroybvtyrate enuances tue |anage|ent of diabetic
‚etoacidosis in cuildren and redvces ti|e and costs of treat|ent. Diabetes Nvtr `etab
2003; 16; 312…316.
19. [olden `P, Uerrold A‰, Vrr DP. An approacu to pre~ention of recvrrent diabetic
‚etoacidosis in tue pediatric popvlation. ‰ Pediat 1985; 107; 195…200.
20. Aleander j, on beualf of DiabNet, Scotland }\. ˆedvcing D\A; a practical
approacu. ‰ Pediat ^ndocrinol `etab 2002; 15 FsvpplG; 22.
21. Zarrell \, Uol|es-xal‚er D‰. `obile puone svpport is associated witu redvced
‚etoacidosis in yovng advlts. Diabetes `ed 2011; 28; 1001…1004.
22. `orris AD, [reene SA, Boyle DIˆ. Direct e~idence of |issing insvlin as a cavse
of poor glyce|ic control and diabetic ‚etoacidosis. ‰ Pediat ^ndocrinol `etab 1997; 10;
345…351.
23. S‚inner YX. ˆecvrrent diabetic ‚etoacidosis; cavses, pre~ention and|anage|ent.
Uor|ˆes 2002; 57 FSvppl 1G; 78…80.
24. xuite \, \ol|an `], xeler P. }nstable diabetes and vnstable fa|ilies; a
psycuosocial e~alvation of diabetic cuildren witu recvrrent ‚etoacidosis. Pediatrics 1984;
73; 749…755.
25. Povderov P, Zried|an N, Suira•i P, ˆingelstein ‰[, \esua~ar•ian A. ^Š
ect of
carbonated water on gastric e|ptying and intragastric |eal distribvtion. Dig Dis Sci 1997;
42; 34…39.
26. Uay|ond `x, Scureiner B. `ini-dose glvcagon rescve for uypoglyce|ia in
cuildrenwitu type 1 diabetes. Diabetes Xare 2001; 24; 643…645.
27. Uartley `, Yuo|sett `‰, Xotterill A`.`ini-dose glvcagon rescve for |ild
uypoglycae|ia in cuildren witu type 1 diabetes; tue Brisbane eperience. ‰ Paediatr Xuild
Uealtu 2006; 42; 108…111.
28. xalsu ‰, ˆoberts ˆ. Pv|ping Insvlin; ^~erytuing hov Need for Svccess on a
S|art Insvlin Pv|p. 4tu edn. San Diego, XA; Yorrey Pines, 2006.
29. \avf|an Zˆ. Insvlin Pv|ps and Xontinvovs [lvcose `onitoring. 1st edn.
Aleandria jA; A|erican Diabetes Association, 2012.
1 \t\t 2J
9\t\t\n\f\t \b\r\f\t  5 \t 5\r\n\f
\n \n\r\b7 5\t7
\b \b\b\b \r\f\f \f\t \n \b\f."\b\b  \b 2014: 15 (Suppl. 20): 203…223.
458
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\n\b\b M\b\t8 \t \r\f7\b5:\t\t


…\f "#"@ #\r"\t  " # \f"#\t ##-
… \f" "J#"@ ## \r##"@ \r :'@
… \f#" ##  " ", "\r :\f" "# 







…('\[email protected]" * \r\f  # #'@" :'@  ##
\f\f = \f  \b  \f\t
459
…# #### C" :"@ #C \r# \f:## \r"-
…\t \r\f\rC\f#\t ####  \r"\r #'#-
…\r# !/ %\r:/ # %\r:/ \rC#\t/ F":,
…!#\t \r\t *  #"#/ \rC# C









460
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
5\b\t
#\t# #'##/ \rC# \r\r"\r\t"\t \r'\f !#\r,
\f#" \r# \t\tJ"\t  \r#/ %"/ \f#:" m10q. (\f#\t
'#, " #'## \rC#\t 'J" C#"@ %"
 \r'# \r\r \f#" '\f\r@\t, J\t \r"#"@
#\t\r C# m11q # %\f"#@J $#J m12q. \n#""##
:'\r #\f#, \r\f/  '\r/, ', " #'#\t
\f#"# ':#\t# # \f\r## \r###   CE#, " # 
C#, \fC  \r#  \f\r# \r" "\r \r# m8q.
", \r\t\r #'## \rC#\t \t'  #C# \r
  \f
461
#CJ" '\f"# "# :\r', " ##\r'#"""@
462
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
9\t\t\t8 9\t\t\n\f\t  \rM\b\b\t
\r\r\rJ' !"\t \fC \r# #' \r ## m22q.\r# ## #"# #'# "#"# !J"\t "/#, \r#\f\t  ##J \r\f$## J' @J # \r##J "\r:#\t !$# J', "# :\r', '-\f\t \r"\r !# ### \fC  \f" :' \n. +" !# \r #  \f"  \n1 #'-' 'C"# -! \r$## ##  \r\t !#\t \r\t J' m23q.\r# \n1 \fC\f\t C'  :  \r\t$## \r ##  ""  #'## \rC#\t, # :\r"\t \r\t$#\t J' C" '"@\t \r!,  \r'@""  \r@\t %\r"#\t \r\t$#\t \r"## 'C.  %" \r##  \r\t ## \r'  #'##/ \rC# " :J\f"\t #- ## #\r##\t.\b8 \r\f:\t8 \b 9\t\t\n\f\t  \rM\b\b\t8
 \f\t \b \t \f\t #  \b\t=\f \f
463
:"@ "@J : ! J' m25q.
\t[]9\n\n
\t-
\t[]9\n\n
\n;# 14.1.
P\n \r \t \t $\n\r \t&  \b \r \r\t\t
\b\t  \n  ( \r \n\t\t \t   \t\n )
464
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
 14.1
9@, (!+_`! % !'#%%!+ $%+ (_'@  !  #+
�!'!/"!; $*F%%!&
   \t \f  \b1\r  \b \t&-     \t&.'\t \f  \n\t  \t\b\t - \t.0, \r -\b \r \t\t
+\t\b, '\n \f\t \b \t' ' \f\t #  \b\t=\f \f
465
9\f\r, \t8=\t \b \r\f:\t= =\f
\b 9\t\t\n\f\t  \rM\b\b\t8
\r\f\r\t\n\t\f\t, \r\t\n\t 9\t\t\n\f\t7  \rM\b\b\t87
#\r# :
" #\r  \f" /\r"\r#'J"\t "\r\tJE##\t \r#\f#
\f# "#"#  #"#"@J " #' \f \r ##
"\f/. \t \f/ '\r/ J\f : ', " "
"# "#"# \r#\f#"  @! #C#J \r * 
\r#J  \r\r# #'### \rC#\t# \r
#"#"#   \r\t, " #  #'# "#"# m30q.
#J \r *. (\f# '\r/ m31q ', " '\f\t\t
###\t E "\r@  \r\r#" #"#
"#"#,  :\r" \r'@"" :#   #\f##
\r"  \n1 m32q. \rC#\t \r #"#"# F40k
G, ' "\r# \f \r#"  "\rC\r 
�# *  \r#\f   2   \rC# m33q. \f :
\f #\r " \f#"@\t "@ \f 90 #, # \f \r'@""
" :"@ \f"#"@# \f\t #'# "#"# \f:
466
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
+\t\b, '\n \f\t \b \t' ' \f\t #  \b\t=\f \f
467
5\r\t 9\f\r, \b\b  \r8:\t= =\f
 \r78 \r\b\t\r\f
7-(!/"!& %()
%) (_'@  !
468
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
!* ! "*!"%! !%"$(!%@; !%f3!&
\f : F\r"\r#G ## \f\t" \f #'##/
+\t\b, '\n \f\t \b \t' ' \f\t #  \b\t=\f \f
469
#\r : "\r:"\t #C# :J ### :'@
##. \f"\t #'#"@  @"\r\r" \f"#\t
\r\f "\r#\r \r\fC#"@"@J : 30 #. ='\f"#
"# #C#\t : #\f  '\r/ \b\r # ".
\r\f" #C#\t \r E"JE ##  75, 50 #
25k \r@ \f'. ("\r, ", /"\t #:@! #C#
: \t'  : # \r J'  \rC#,
!* *!`! ! "*!"%!  *!#
"\r:\t"@\t \r#\r ' 3…4  \f \r#, ": \f"@  \r\t
#"@\t # :#"@ # %\f \r'\r %\r## m59q.
+" : C \f\t \f#"@ #'# "#"#. M
# " :"@ # ' " "\r:#\t #" 
\f# F1…2  XUVG \r#\r ' 1  \f \r#z "#
C :\r' \tJ"\t \r'\r %\r## # :#"\t '
"\t ##'## # %"  :\f" \r"@\t \r\f\fE#
:J, \r#\t"  #E, #"  \r:"@ \f"@ 50k
:J, " \r\f#" "!# ##  \f  %"
470
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\r#"@ \f'"@", \r#\t"# #E# ' 3…4  \f "\r#\r#
" '"\t \r"# # : \r\t" \f ' 1…2 . +"
\f" #\f##\f@ \f:\r "\f \r: # !#: :
L# \f\t \r"\r #'# "#"# "\r:J"\t
# :"\r\f"JE#/ \f  #\f #". ('"##
', \f"\r'G :#" "#@ #  \r#J
 \f\r##, : $"\r#\r# #"#  \f\rC#
\r '\f\tJ" #  C\f # 'J"  \r"\r" m60q.
�\f \f #\f# ', " # 8, # 10k #'"##
#"# /\r! \r##@ # # \r\f"\r"#"@ #C#
*  \r\t '\t"# \r"  \f\r"  \n1 m61q. = " ,
\f  \r\f#"\t #C# \r\t ##, :H \f
:\t  \r\t \rC#. = $ \f\t \f/ '\r/  \n
 '##"# " "# #'# "#"# "\r:# \f
"\t" 1,0…1,5  XUV  "   m60q F":. 14.2G. 
!"JE \rC#\t, ## # \rC#\t \r\f\t"\t \r'
@   :J \f' F0,3…0,5  XUV  "
 G. \r# \f#"@/ \f "  \r\r"#\r
\t : 60 # m63q. \r# #\f## \r':\r'/ \f#"##/
"\r"# F'"\r# # \r# #E# \r\f "\r#\rG  \f\r"
@J: # ". \f"\r\f##, " \f #"# ! 
## \rC#\t#G \t'  @! ###  \r\t #
+\t\b, '\n \f\t \b \t' ' \f\t #  \b\t=\f \f
471
 14.2
\r"; E%!! 100 ( O420 5FQ  #+ $*F%%!& (+ &
" '%& #""& (. \n/!+, /  "%# U0h -`& E%!!
-"*/!"+ ' "/ $(, !% & "; E!(%%
U0 ( !(! 1^  $(
7"" (, 
20
40
U0
[\t\r G6
�2
26
S\t &
J6
56
�2
/\n\b\t \t  \r\b
26 4
�9
J6
�5
�2 4
�J
�5
�2
P \t\t
�5
�2
26
E
56
26

[
4
�5
�2
26
25 4
-
26
26
E\b\f\t  \r
G6
�2
26
P
G6
�2
26
% \t\t
G6 4 \t\r\r
��
�5
�2
=\r
�J
�5
�2
E\b\f\t
J 4
96
J6
G6
9 4
J6
G6
�5
#\f \r" \r#\f  \f :'\r m62q. = \f ":#$ ' \r#-
472
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
"  #\t"  ##  \r\t "#/
/::#,  \r C#,  & # ". #\f# \f/ J\f
 \n :' C#, \f#JE#/\t  " : 5000 , #
:\rC##, ", "\r\t  # %\r'"\r", ##@
�"\r:"@  ##. # "C \t##, " \r@ * F#
"\r:"#  ##G \r\t \r\r#\r  #"# "\r
%\b\t*\f \b \b\f #  \b\t=\f \f
473
\b\r7L\b \r8\r\b 9\t\t\n\f\t  \rM\b\b\t8
 60 # :E \r# "#"#  \f@, #' "\r/ 20 # „
#"#/ \f"#. = \r\f$#\t/ "C ', " \f\t
!#\t '\f\r@\t \f"\t F5…11 "G # \f\r" F12…17 "G
##  "# \f\t m73q. +" \r\t F\r#\r, \r\t \r\f %\rG
\t'  ! \r UbA1c  \f" # \f\r"  \n1
m74q. ('", " "\r \r !@# # \f\r" 
# „  m76q. = \f \f #\f## \f" # \f\r"
 \b\r'### : \t \t'@ C\f ! #'#
"#"@J # #!# ### "\r m77q, /"\t %"
474
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\n1 E"" C#"@\t \t'@ C\f ### " \r
\r\b\t\r\f\t
H\b \f\b
475
#:"#\t $#$#\t  #'## \rC#\t # \r"
476
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\t\be\f:\t\t 5 \r  5\bL
\rM\t7 \n \r78 \t\be\f:\t87\t \t\b\n\t\b  5\bL
\rM\t7 7\b\f\r\b \t\be\f:\t \t\t \t\b\n\t\b8 7 
! 
477
# :'@ \r@ \r\f"\t #'#"@ \f\t "\r#\r#,
\t \t\f7\t8
\r#\f\t"  #C "\r\r\t"\r "" \r$## 
(@'# &* # """JE\t \r$#\t  #C#
478
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
 14.3
-' #%3!& (�+ !'!/"! !%@; #(@; (_& " ";%@#
!-# *� *!(! !*(!#!! O*!% !' ""@(! [bU]Q
. %\b \n \t 10 \b $\n\r \t\r\f.
(\f  
479
5\b88 \t \t\f7\t8
  \rC#, :   #/ !
\f#"@"# # \r ##  #"#"# m97q. +"
"\r#\r #\f## \t ###\t "@
\b\t\n \f \r . 14.3
480
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\f\r\r\f\t\r\f 5 \t\b\n\t\b
C# #! #@ #'#"@ J \f' ##, ": #':C"@
####. = \r'@"" %" C" "\r\f"@ ":##
\r## \r\r"#\r#. = \r \f/ J\f  '\r" 10…18 "
= ":. 14.4 \fJ"\t \r#\r  \r\r"#\r :J/ \f'
C\f\f 
481
 14.4
!#@ "%!F%!+ !%"$(!% *! '%& !%%"!%"! $*F%%!&
\t%%"!%") $*F%%!&R0 #!%U0 #!%
\t\b\n\t\b 7 
482
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
# \r#\f#"  #\r###, "\r\t \f#"\t \r#\r 2  
\rC# m43q. C \f J'  ' \r# \f \rC#
:  \r,  $#"  ### #  \r#\f 
\rC# " #\r##\t, "\r\t \f#@ 2  m107q. +"
\r$#\t C" :"@ \r'\r, #  \r\t \rC#  :
#"@J \f' ## \r" \f"#\t  \r\t '  \r\f#
\rC# ## \r'  #/ '\r!#\t, \r#\r, \r\f ", 
\r#\t"@ \f!.  "/## ##/  " \r\f"#"@
:@! 'C" \f\t \r\f"\rE#\t ####, \t' 
"\r#\r#. = #\f## ASPIˆ^ : \r"\r 'C"@
#@'#\t "/## \r#"# \r# #' \r J'
\f\t J#\t , \f \r &* \f"#" '#\t 
"\r#\t, #\t \r,  \r#" ## :' \r#"#
\r# #' \r J'.   \f#\t #"
 ## \r\fC#"@"@ #### : #C m100q.
@! \r'#"# \r  \r'\r:" "\r/  
\r#", :/ J"@ # J"@ " ## \r#
\r#", \r# "\r/ J' @ #C \r, '##@
: *   *
483
\f\b
 \nL \t  \tL
484
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\r\t$#J J'  :\f/  \n ' " ##:#\r#\t
7\b\t\r\t\b
: *   *
485
#J #'# ###. \n"\r"\r#\r \f# '#,
"\t #"\r# ### \f' J '"@ 
486
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
\fL\b8 \f\t\b\nL \t \r8 58 5
\n \n\r\b7 5\t7
: *   *
487
488
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
�@ %#'\f "\tC ####. "\r#$"@ "
\r\t\b \n 58 \b\b \b8\t
: *   *
489
490
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
=\f \f \t\t\b\f \t \t
491
#'## \rC#\t, C" #C"@ \r\r"\r"@ \n2
"\r## \r\r"# @## F: \r\r"#
\nM\b\b\t8 \n\r\b 5\t
\n\r"@ #\f \r",  \r#,  \r\f"\tJ"
\r"#"# ## \r"# \f" #':"@ #'##/
\f!  . $#"  C#\t#  \r\t '\t"#
492
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
5\t \t \f\n\t
�J "#J-"\r' "  94,4k F "G m162q.= \r"# #\f## &# # ". F2012G \r"\r# '\f"# 90-#"/ "\r#\r   \r'  \fJ  "# 9  F#\r  \t, \rC#, \r# # #"#G  #-\r@J ""@ "  27 \f", :@/ \f#:", # 32 '\f\r/ \f" m163q.  "\r#\r,   \r\t\f '/  \f"\t  \f#:", " # :',  :#/ \r :# \f# '"# #\r@ ""# ", "\r :# '#"@ !,   \r,  "!  "\r#\r/.\f\b9\t\f \t\b\r\n
  \b\t\b
493
\n \t\n\f \t\r\r
1. ˆoberts ], ‰ones Yx, Zovrnier PA. ^ercise training and glyce|ic control in
adolescents witu poorly controlled type 1 diabetes |ellitvs. ‰ Pediatr ^ndocrinol 2002;
15; 621…627.
2. Sarnblad S, ^‚elvnd }, A|an ‰. Puysical acti~ity and energy inta‚e in adolescent
girls witu type 1 diabetes. Diabet `ed 2005; 22; 893…899.
3. ]igtenberg PX, Blans `, Uoe‚stra ‰B, ~an der Yweel I, ^r‚elens Dx. No eŠ
of long-ter| puysical acti~ity on tue glyce|ic control in type 1 diabetes patients; a
cross-sectional stvdy. Netu ‰ `ed 1999; 55; 59…63.
4. ˆv•ic ], Sporis [, `at‚o~ic Bˆ. Uigu ~olv|e-low intensity eercise ca|p and
glyce|ic control in diabetic cuildren. ‰ Paediatr Xuild Uealtu 2008; 44; 122…128.
5. Aovadi ˆ, \ualifa ˆ, Aovidet A et al. Aerobic training progra|s and glyce|ic
control in diabetic cuildren in relation to eercise frevency. ‰ Sports `ed Puys Zitness
2011; 51; 393…400.
6. Uerbst A, Bacuran ˆ, \apellen Y, Uoll ˆx. ^Š
ects of regvlar puysical acti~ity
on control of glyce|ia in pediatric patients witu type 1 diabetes |ellitvs. Arcu Pediatr
Adolesc `ed 2006; 160; 573…577.
7. hovn‚ ], Yate D, Da~is SN. Puysical acti~ity in adolescents witu type 1 diabetes;
is |ore better for glyce|ic control— Pediatr Diabetes 2009; 10; 231…233.
8. Nocon `, Uie|ann Y, `vller-ˆie|enscuneider Z, Yualav Z, ˆoll S, xillicu
SN. Association of puysical acti~ity witu all-cavse and cardio~ascvlar |ortality; a
syste|atic re~iew and |eta-analysis. ^vr ‰ Xardio~asc Pre~ ˆeuabil 2008; 15; 239…246.
9. ˆiddell `X, Per‚ins BA. Yype 1 diabetes and ~igorovs eercise; applications of
eercise puysiology to patient |anage|ent. Xan ‰ Diabetes 2006; 30; 63…71.
10. `argeirsdottir UD, ]arsen ‰ˆ, Brvnborg X, V~erby NX, Daul-‰orgensen \.
Uigu pre~alence of cardio~ascvlar ris‚ factors in cuildren and adolescents witu type 1
diabetes; a popvlation-based stvdy. Diabetologia 2008; 51; 554…561.
11. ˆocue D`, ^d|vnds S, Xable Y, Didi `, Stratton [. S‚in |icro~ascvlar
reacti~ity in cuildren and adolescents witu type 1 diabetes in relation to le~els of puysical
acti~ity and aerobic ”
tness. Pediatr ^erc Sci 2008; 20; 426…438.
12. Seeger ‰PU, Yu˜ ssen DU‰, Noorda| \, Xranen `^X, Uop|an `Y^,
N˜ uvis-~an der Sanden `x[. ^ercise training i|pro~es puysical ”
tness and ~ascvlar
fvnction in cuildren witu type 1 diabetes. Diabetes Vbes `etab 2011; 13; 382…384.
13. ˆeddigan ‰I, ˆiddell `X, \v‚ ‰]. Yue –oint association of puysical acti~ity and
glycae|ic control in predicting cardio~ascvlar deatu and all-cavse |ortality in tue }S
popvlation. Diabetologia 2012; 55; 632…635.
14. `anouar X, ]e~ine ‰A, Nandy D\ et al.Yue eŠ ect of wal‚ing on postprandial
glyce|ic ecvrsion in patients witu type 1 diabetes and uealtuy people. Diabetes Xare
2012; 35; 2493…2499.
15. Nordfeldt S, ]vd~igsson ‰. Zear and otuer distvrbances of se~ere uypoglycae|ia
in cuildren and adolescents witu type 1 diabetes |ellitvs. ‰ Pediatr ^ndocrinol 2005;
18; 83…91.
494
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
16. Artero ^[, ˆvi• ‰ˆ, Vrtega ZB et al. `vscvlar and cardiorespiratory ”
tness
are independently associated witu |etabolic ris‚ in adolescents; tue U^]^NA stvdy.
Pediatr Diabetes 2011; 12; 704…712.
17. ‰i|éne•-Pa~

n D, ˆvi• ‰ˆ, Vrtega ZB et al. Puysical acti~ity and |ar‚ers of
insvlin resistance in adolescents; role of cardiorespiratory ”
tness le~els … tue U^]^NA
stvdy. Pediatr Diabetes 2013; 14; 249…258.
18. Brovwer SI, Stol‚ ˆP, ]ie| ^Y, ]e||in‚ \AP`, Xorpele˜ n ^. Yue role of
tness in tue association between fatness and cardio|etabolic ris‚ fro| cuilduood to
adolescence. Pediatr Diabetes 2013; 14; 57…65.
19. ]v‚acs A, `ayer \, ‰vuas• ^, jarga B, Zodor B, Bar‚ai ]. ˆedvced puysical
tness in cuildren and adolescents witu type 1 diabetes. PediatrDiabetes 2012; 13;
432…437.
20. xillia|s B\, [vel”
\‰, ‰ones Yx, Da~is ^A. ]ower cardiorespiratory ”
tness
in cuildren witu type 1 diabetes. Diabet `ed 2011; 28; 1005…1007.
21. `ac`illan Z\A, `vtrie N, `attuews ], ˆobertson \, Savnders DU. A
syste|atic re~iew of puysical acti~ity and sedentary beua~iovr inter~ention stvdies
in yovtu witu type 1 diabetes; stvdy cuaracteristics, inter~ention design and ež
cacy.
Pediatr Diabetes 2014; 15; 175…189.
22. Yuorell A, Uirsu|an `Z, Nygren ‰ et al. ^ercise and insvlin cavse []}Y-4
translocation in uv|an s‚eletal |vscle. A| ‰ Puysiol 1999; 277 F4 Pt 1G; ^733…^741.
23. Zauey A‰, Para|alinga| N, Da~ey ˆ‰, Da~is ^A, ‰ones Yx, Zovrnier PA. Yue
ect of a suort sprint on posteercise wuole-body glvcose prodvction and vtili•ation rates
in indi~idvals witu type 1 diabetes |ellitvs. ‰ Xlin ^ndocrinol `etab 2012; 97; 4193…4200.
24. Ye|ple `h, Bar-Vr V, ˆiddell `X. Yue reliability and repeatability of tue
blood glvcose response to prolonged eercise in adolescent boys witu IDD`. Diabetes
Xare 1995; 18; 326…332.
25. Petersen \Z, Price YB, Bergeron ˆ. ˆegvlation of net uepatic glycogenolysis
and glvconeogenesis dvring eercise; i|pact of type 1 diabetes. ‰ Xlin ^ndocrinol
`etab 2004; 89; 4656…4664.
26. \o|atsv xˆ, [abbay `A], Xastro `] et al. Aerobic eercise capacity in
nor|al adolescents and tuose witu type 1 diabetes |ellitvs. Pediatr Diabetes 2005; 6;
145…149.
27. Adolfsson P, Nilsson S, Albertsson-xi‚land \, ]indblad B. Uor|onal response
dvring puysical eercise of diŠ
erent intensities in adolescents witu type 1 diabetes and
uealtuy controls. Pediatr Diabetes 2012; 13; 587…596.
28. Xvenca-[arcia `, ‰ago ˆ, Suield ‰PU, Bvrren XP. Uow does puysical acti~ity
and ”
tness in›
vence glycae|ic control in yovng peoplewitu type 1 diabetes— Diabet
`ed 2012; 29; e369…e376.
29. Arslanian S, Nion PA, Be
c‚er D,
Drasu A]. I|pact of puysical ”
tness and
glyce|ic control on in ~i~o insvlin action in adolescents wituIDD`.Diabetes Xare
1990; 13; 9…15.
30. [vel” \‰, ‰ones Yx, Zovrnier PA. Yue decline in blood glvcose le~els is less
witu inter|ittent uigu-intensity co|pared witu |oderate eercise in indi~idvals witu
type 1 diabetes. Diabetes Xare 2005; 28; 1289…1294.
  \b\t\b
495
31. `aran A, Pa~an P, Bonse|biante B et al. Xontinvovs glvcose |onitoring
re~eals delayed noctvrnal uypoglyce|ia after inter|ittent uiguintensity eercise in
nontrained patients witu type 1 diabetes. Diabetes Yecunol Yuer 2010; 12; 763…768.
32. Iscoe \^, ˆiddell `X. Xontinvovs |oderateintensity eercise witu or wituovt
inter|ittent uiguintensity wor‚; eŠ
ects on acvte and late glycae|ia in atuletes witu Yype
1 diabetes |ellitvs. Diabet `ed 2011; 28; 824…832.
33. Bvssav jA, Zerreira ]D, ‰ones Yx, Zovrnier PA. Yue 10-s |ai|al sprint; a
no~el approacu to covnter an eercise-|ediated fall in glyce|ia in indi~idvals witu type
1 diabetes. Diabetes Xare 2006; 29; 601…606.
34. Da~ey ˆ‰, Para|alinga| N, ˆetteratu A‰ et al. Antecedent uypoglycae|ia does
not di|inisu tue glycae|ia-increasing eŠ
ect and glvcoregvlatory responses of a 10 s
sprint in people witu type 1 diabetes. Diabetologia 2014; 57;
1111…1118.
35. `c`auon S\, Zerreira ]D, ˆatna| N et al. [lvcose revire|ents to |aintain
evglyce|ia after |oderate-intensity afternoon eercise in adolescents witu type 1
diabetes are increased in a bipuasic |anner.msee co||entq. ‰ Xlin ^ndocrinol `etab
2007; 92; 963…968.
36. Yonoli X, Uey|an ^, ˆoelands B et al. ^Š ects of diŠ erent types of acvte and
curonic FtrainingG eercise on glycae|ic control in type 1 diabetes |ellitvs; a |eta-
analysis. Sports `ed 2012; 42; 1059…1080.
37. hardley ‰^, \enny [P, Per‚ins BA et al. ^Š
ects of perfor|ing resistance
eercise before ~ersvs after aerobic eercise on glyce|ia in type 1 diabetes. Diabetes
Xare 2012; 35; 669…675.
38. hardley ‰^, Sigal ˆ‰, ˆiddell `X, Per‚ins BA, \enny [P. Perfor|ing resistance
eercise before ~ersvs after aerobic eercise in›
vences growtu uor|one secretion in type
1 diabetes. Appl Puysiol Nvtr `etab 2014; 39; 262…265.
39. ˆvege|er ‰‰, Svires ˆx, `arsu U` et al. DiŠ
erences between prebrea‚fast
and late afternoon glyce|ic responses to eercise in IDD` patients. Diabetes Xare
1990; 13; 104…110.
40. Berger `, Bercutold P, Xvppers U‰ et al. `etabolic and uor|onal eŠ
ects of
|vscvlar eercise in –v~enile type diabetics. Diabetologia 1977; 13; 355…365.
41. [alassetti P, ˆiddell `X. ^ercise and type 1 diabetes FY1D`G. Xo|pr Puysiol
2013; 3; 1309…1336. 42. \reis|an SU, Ualter ‰B, jranic `, `arliss ^B. Xo|bined
infvsion of epinepurine and norepinepurine dvring |oderate eercise reprodvces tue
glvcoregvlatory response of intense eercise. Diabetes 2003; 52; 1347…1354.
43. `arliss ^B, jranic `. Intense eercise uas vnive eŠ ects on botu insvlin release
and its roles in glvcoregvlation; i|plications for diabetes. Diabetes 2002; 51 FSvppl. 1G;
S271…S283.
44. Baldi ‰X, Xassvto NA, Zo-]vpo xY, xueatley X`, Snyder ^`. [lyce|ic
statvs aŠ
ects cardiopvl|onary eercise response in atuletes witu type I diabetes. `ed
Sci Sports ^erc 2010; 42; 1454…1459.
45. xan‚e Y, Avinger `, Zor|ane‚ D et al. Defecti~e endogenovs opioid response
to eercise in type I diabetic patients. `etabolis| 1996; 45; 137…142.
46. ˆiddell `X, Bar-Vr V, [erstein UX, Ueigenuavser [‰. Percei~ed eertion
witu glvcose ingestion in adolescent |ales witu IDD`.`ed Sci Sports ^erc 2000;
32; 167…173.
496
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
47. Bar-Vr V, xard S. ˆating of Percei~ed ^ertion in Xuildren. In; Bar-Vr V,
ed. Ad~ances in Pediatric Sports Science. Xua|paign, I];Uv|an\inetics, 1989, pp
151…168.
48. ‰enni S, Vetli‚er X, Alle|ann S et al. Zvel |etabolis| dvring eercise in
evglycae|ia and uyperglycae|ia in patients witu type 1 diabetes |ellitvs … a prospecti~e
single-blinded rando|ised crosso~er trial. Diabetologia 2008; 51; 1457…1465.
49. \elly D, Ua|ilton ‰\, ˆiddell `X. Blood glvcose le~els and perfor|ance in
a sports cA`P for adolescents witu type 1 diabetes |ellitvs; a ”
eld stvdy. Int ‰ Pediatr
2010 Fa~ailable fro| uttp;www.ncbi.nl|.niu.go~pvb|ed20811595G.
50. Uey|an ^, Briard D, [ratas-Dela|arcue A, Dela|arcue P, De \erdanet
`. Nor|al puysical wor‚ing capacity in prepvbertal cuildren witu type 1 diabetes
co|pared witu uealtuy controls. Acta Paediatr 2005; 94; 1389…1394.
51. Stettler X, ‰enni S, Alle|ann S et al. ^ercise capacity in svb–ects witu type 1
diabetes |ellitvs in evand uyperglycae|ia. Diabetes `etab ˆes ˆe~ 2006; 22; 300…306.
52. [onder-Zrederic‚ ]A, ‡rebiec ‰Z, Bavcuowit• A} et al. Xogniti~e fvnction
is disrvpted by botu uypo- and uyperglyce|ia in scuool-aged cuildren witu type 1
diabetes; a ” eld stvdy. Diabetes Xare 2009; 32; 1001…1006.
53. Yvo|inen ‰A, \aronen S], `ela|ies ], Bolli [, \oi~isto jA. ^ercise-
indvced uypoglycae|ia in IDD` patients treated witu a suort-acting insvlin analogve.
Diabetologia 1995; 38; 106…111.
54. xasser|an DU, \ang ], Ayala ‰^, Zveger PY, ]ee-hovng ˆS. Yue puysiological
regvlation of glvcose ›
v into |vscle in ~i~o. ‰ ^p Biol 2011; 214 FPt 2G; 254…262.
55. \oi~isto jA, Zelig P. ^Š
ects of leg eercise on insvlin absorption in diabetic
patients. N ^ngl ‰ `ed 1978; 298; 79…83.
56. Peter ˆ, ]v•io SD, Dvnseatu [ et al. ^Š ects of eercise on tue absorption of
insvlin glargine in patients witu type 1 diabetes. Diabetes Xare 2005; 28; 560…565.
57. Brac‚en
ˆ`, xest D‰, Stepuens ‰x, \ildvŠ ]P, ]v•io S, Bain SX. I|pact of
pre-eercise rapid-acting insvlin redvctions on ‚etogenesis following rvnning in type 1
diabetes. Diabet `ed 2011; 28; 218…222.
58. Arvtcuel~a| j, Ueise Y, Dellweg S, ^lbroend B, `inns I,Uo|ePD.Plas|a
glvcose and uypoglycae|ia following eercise in people witu type 1 diabetes; a
co|parison of turee basal insvlins. Diabet `ed 2009; 26; 1027…1032.
59. Xuv ], Ua|ilton ‰, ˆiddell `X. Xlinical |anage|ent of tue puysically acti~e
patient witu type 1 diabetes. Puys Sports|ed 2011; 39; 64…77.
60. ˆiddell `X, Iscoe \^. Puysical acti~ity, sport, and pediatric diabetes. Pediatr
Diabetes 2006; 7; 60…70.
61. Perrone X, ]aitano V, `eyer Z. ^Š
ect of carbouydrate ingestion on tue
glyce|ic response of type 1 diabetic adolescents dvring eercise. Diabetes Xare 2005;
28; 2537…2538.
62. ˆiddell `X, Bar-Vr V. Uandboo‚ of ^ercise in Diabetes; Xuildren and
Adolescents. 2nd edn. Aleandria, jA; A|erican Diabetes Association, 2002; ~ii; 699.
63. [ri|| ‰‰, hbarra ‰, Berne X, `vcunic‚ S, [olay A.Anew table for pre~ention
of uypoglycae|ia dvring puysical acti~ity in type 1 diabetic patients. Diabetes `etab
2004; 30; 465…470.
  \b\t\b
64. Dvbe `-X, ]a~oie X, [alibois I, xeisnagel S‰. Nvtritional strategies to pre~ent
uypoglyce|ia at eercise in diabetic adolescents. `ed Sci Sports ^erc 2012; 44; 1427…1432.
65. \alergis `, ScuiŠ rin A, [ovgeon ˆ, ‰ones P‰, hale ‰Z. I|pact of bedti|e
snac‚ co|position on pre~ention of noctvrnal uypoglyce|ia in advlts witu type 1
diabetes vndergoing intensi~e insvlin |anage|ent vsing lispro insvlin before |eals; a
rando|i•ed, placebo-controlled, crosso~er trial.Diabetes Xare 2003; 26; 9…15.
66. Uernande• ‰`, `occia Y, Zlvc‚ey ‰D, }lbrecut ‰S, Zarrell PA. Zlvid snac‚s
to uelp persons witu type 1 diabetes a~oid late onset posteercise uypoglyce|ia. `ed
Sci Sports ^erc 2000; 32; 904…910. 67. Zrid A, Vst|an ‰, ]inde B. Uypoglyce|ia
ris‚ dvring eercise after intra|vscvlar in–ection of insvlin in tuigu in IDD`. Diabetes
Xare 1990; 13; 473…477.
68. Berger `, Xvppers U‰, Uegner U, ‰orgens j, Bercutold P. Absorption ‚inetics
and biologic eŠ
ects of svbcvtaneovsly in–ected insvlin preparations. Diabetes Xare
1982; 5; 77…91.
69. de `ol P, de jries SY, de \oning ^‰P, [ans ˆVB, Yac‚ X‰, Bilo U‰[.
Increased insvlin revire|ents dvring eercise at ~ery uigu altitvde in type 1 diabetes.
Diabetes Xare 2011; 34; 591…595.
70. ˆa~e \, Ueise Y, xeyer X et al. Intra|vscvlar ~ersvs svbcvtaneovs in–ection of
solvble and lispro insvlin; co|parison of |etabolic eŠ
ects in uealtuy svb–ects. Diabet
`ed 1998; 15; 747…751.
71. Bailey ˆX, Vlson ‰, Pepper S], Pors•as• ‰, Barstow Y‰, Xooper D`. Yue le~el
and te|po of cuildrens puysical acti~ities; an obser~ation stvdy. `ed Sci Sports ^erc
1995; 27; 1033…1041.
72. ˆowland Y. Yue biological basis of puysical acti~ity. `ed Sci Sports ^erc 1998;
73. Yre|blay `S, ]eblanc A[, ‰anssen I et al. Xanadian sedentary beua~iovr
gvidelines for cuildren and yovtu. Appl Puysiol Nvtr `etab 2011; 36; 59…64 65…71.
74. [aller A, ]indav `, ^rnert A, Yuale|ann ˆ, ˆaile \. Associations between
|edia consv|ption uabits, puysical acti~ity, socioecono|ic statvs, and glyce|ic
control in cuildren, adolescents, and yovng advlts witu type 1 diabetes. Diabetes Xare
2011; 34; 2356…2359.
75. Bernardini A], janelli `, Xuiari [ et al. Aduerence to puysical acti~ity in
yovng people witu type 1 diabetes. Acta Bio|ed Ateneo Par|ense 2004; 75; 153…157.
76. Svndberg Z, Zorsander [, Zastu A, ^‚elvnd }. Xuildren yovnger tuan 7 years
witu type 1 diabetes are less puysically acti~e tuan uealtuy controls. Acta Paediatr 2012;
101; 1164…1169.
77. `icvlis XP, De Xa|pos x, Bogvs•wes‚i `X. Xorrelation between glyce|ic
control and puysical acti~ity le~el in type 1 diabetes adolescents and cuildren. ‰ Puys
ActUealtu 2014 Fa~ailable fro| uttp;www.ncbi. nl|.niu.go~pvb|ed24508755G.
78. Poort|ans ‰ˆ, Saerens P, ^del|an ˆ, jertongen Z, Dorcuy U. In› vence of tue
degree of|etabolic control on puysical ”
tness in type I diabetic adolescents. Int ‰ Sports
`ed 1986; 7; 232…235.
79. ^beling P, Yvo|inen ‰A, Bovrey ˆ, \oranyi ], \oi~isto jA. Atuletes witu
IDD` euibit i|paired |etabolic control and increased lipid vtili•ation witu no
increase in insvlin sensiti~ity. Diabetes 1995; 44; 471…477.
498
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
80. hardley ‰^, Sigal ˆ‰, Per‚ins BA, ˆiddell `X, \enny [P. ˆesistance eercise
in type 1 diabetes. Xan ‰ Diabetes 2013; 37; 420…426.
81. Borguovts ]B, \ei•er UA. ^ercise and insvlin sensiti~ity; a re~iew. Int ‰ Sports
`ed 2000; 21; 1…12. 82. [vl~e ^A, Spina ˆ‰. ^Š
ect of 7-10 days of cycle ergo|eter
eercise on s‚eletal |vscle []}Y-4 protein content. ‰ Appl Puysiol 1995; 79; 1562…
1566.
83. `i‚ines \‰, Sonne B, Yronier B, [albo U. ^Š ects of acvte eercise and
detraining on insvlin action in trained |en. ‰ Appl Puysiol 1989; 66; 704…711.
84. Da~ey ˆ‰, Uowe x, Para|alinga| N et al. Yue eŠ
ect of |idday |oderate-
intensity eercise on posteercise uypoglyce|ia ris‚ in indi~idvals witu type 1 diabetes.
‰ Xlin ^ndocrinol `etab 2013; 98; 2908…2914.
85. Ysali‚ian ^, `avras N, Bec‚ ˆx et al. I|pact of eercise on o~ernigut glyce|ic
control in cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr 2005; 147; 528…534.
86. Ya|borlane xj. Yriple –eopardy; noctvrnal uypoglyce|ia after eercise in tue
yovng witu diabetes. ‰ Xlin ^ndocrinol `etab 2007; 92; 815…816.
87. Berardi ‰`, Price YB, Noreen ^^, ]e|on Pxˆ. Posteercise |vscle glycogen
reco~ery enuanced witu a carbouydrate-protein svpple|ent. `ed Sci Sports ^erc
2006; 38; 1106…1113.
88. hardley ‰^, Iscoe \^, Sigal ˆ‰, \enny [P, Per‚ins BA, ˆiddell `X. Insvlin
pv|p tuerapy is associated witu less post-eercise uyperglyce|ia tuan |vltiple daily
in–ections; an obser~ational stvdy of puysically acti~e type 1 diabetes patients. Diabetes
Yecunol Yuer 2013; 15; 84…88.
89. Per‚ins BA, ˆiddell `X. Yype 1 diabetes and eercise vsing tue insvlin pv|p to
|ai|v| ad~antage. Xan ‰ Diabetes 2006; 30; 72…80.
90. Sando~al DA, [vy D]A, ˆicuardson `A, ^rtl AX, Da~is SN. ^Š
ects of
low and|oderate antecedent eercise on covnterregvlatory responses to svbsevent
uypoglyce|ia in type 1 diabetes. Diabetes 2004; 53; 1798…1806.
91. Bao S, Briscoe j‰, Yate DB, Da~is SN. ^Š ects of diŠ
ering antecedent increases
of plas|a cortisol on covnterregvlatory responses dvring svbsevent eercise in type 1
diabetes. Diabetes 2009; 58; 2100…2108.
92. [alassetti P, Yate D, Neill ˆA, `orrey S, xasser|an DU, Da~is SN. ^Š
of antecedent uypoglyce|ia on covnterregvlatory responses to svbsevent evglyce|ic
eercise in type 1 diabetes. Diabetes 2003; 52; 1761…1769.
93. Yansey `‰, Ysali‚ian ^, Bec‚ ˆx et al. Yue eŠ
ects of aerobic eercise on
glvcose and covnterregvlatory uor|one concentrations in cuildren witu type 1 diabetes.
Diabetes Xare 2006; 29; 20…25.
94. ˆiddell `X, Bar-Vr V, Ayvb Bj, Xal~ert ˆ^, Ueigenuavser [‰. [lvcose
ingestion |atcued witu total carbouydrate vtili•ation attenvates uypoglyce|ia dvring
eercise in adolescents witu IDD`. Int ‰ Sport Nvtr 1999; 9; 24…34.
95. ˆiddell `X, `illi‚en ‰. Pre~enting eercise-indvced uypoglyce|ia in type 1
diabetes vsing real-ti|e continvovs glvcose |onitoring and a new carbouydrate inta‚e
algoritu|; an obser~ational ”
eld stvdy. Diabetes Yecunol Yuer 2011; 13; 819…825.
96. Dorcuy U, Poort|ans ‰ˆ. ‰v~enile diabetes and sports. In; Bar-Vr V, ed. Yue
Xuild and Adolescent Atulete. Vford; Blac‚well Science, 1996.
  \b\t\b
499
97. `acDonald `‰. Posteercise late-onset uypoglyce|ia in insvlin-dependent
diabetic patients. Diabetes Xare 1987; 10; 584…588.
98. Adolfsson P, ]indblad B. [lvcose |onitoring dvring ~ariovs types of puysical
eercise in adolescents witu diabetes. A| ‰ Puysiol ^ndocrinol `etab 2002; 15 FSvppl.
4G; 1FPosterG.
99. ˆiddell `, Per‚ins BA. ^ercise and glvcose |etabolis| in persons witu
diabetes |ellitvs; perspecti~es on tue role for continvovs glvcose |onitoring. ‰ Diabetes
Sci Yecunol 2009; 3; 914…923.
100. [arg S, Bra•g ˆ], Bailey YS et al. ˆedvction in dvration of uypoglyce|ia by
avto|atic svspension of insvlin deli~ery; tue in-clinic ASPIˆ^ stvdy. Diabetes Yecunol
Yuer 2012; 14; 205…209.
101. [arg S\, Bra•g ˆ], Bailey YS et al. Uypoglyce|ia begets uypoglyce|ia; tue
order eŠ ect in tue ASPIˆ^ in-clinic stvdy. Diabetes Yecunol Yuer 2014; 16; 125…130.
102. Yaplin X^, Xobry ^, `esser ], `cZann \, Xuase UP, Ziallo-Scuarer ˆ.
Pre~enting post-eercise noctvrnal uypoglyce|ia in cuildren witu type 1 diabetes.
‰ Pediatr 2010; 157; 784…8.e1.
103. Sane Y, Uel~e ^, Pel‚onen ˆ, \oi~isto jA. Yue ad–vst|ent of diet and insvlin
dose dvring longter| endvrance eercise in type 1 Finsvlin-dependentG diabetic |en.
Diabetologia 1988; 31; 35…40.
104. ˆabasa-]uoret ˆ, Bovrve ‰, Dvcros Z, Xuiasson ‰]. [videlines for pre|eal
insvlin dose redvction for postprandial eercise of diŠ
erent intensities and dvrations
in type 1 diabetic svb–ects treated intensi~ely witu a basal-bolvs insvlin regi|en
Fvltralente-lisproG. Diabetes Xare 2001; 24; 625…630.
105. Zrounaver `, ]iv \, De~lin ‰. Ad–vst|ent of basal lispro insvlin in XSII
to |ini|i•e glyce|ic ›
vctvations cavsed by eercise. Diab ˆes Xlin Pract 2000; 50
FSvppl. 1G; S80FAbstractG.
106. Ad|on [, xeinstein h, Zal‚ B et al. ^ercise witu and wituovt an insvlin
pv|p a|ong cuildren and adolescents witu type 1 diabetes |ellitvs. Pediatrics 2005;
116; e348…e355.
107. `itcuell YU, Abraua| [, ScuiŠ rin A, ]eiter ]A, `arliss ^B. Uyperglyce|ia
after intense eercise in IDD` svb–ects dvring continvovs svbcvtaneovs insvlin
infvsion. Diabetes Xare 1988; 11; 311…317.
108. Danne Y, Ysioli X, \ordonovri V et al. Yue PI][ˆI` Stvdy; in silico
|odeling of a predicti~e low glvcose |anage|ent syste| and feasibility in yovtu witu
type 1 diabetes dvring eercise. Diabetes Yecunol Yuer 2014; 21 Fa~ailable fro| uttp;
www.ncbi.nl|. niu.go~pvb|ed24447074G.
109. xauren ‰, Zelig P, Uagenfeldt ]. Puysical eercise and fvel uo|eostasis in
diabetes|ellitvs.Diabetologia 1978; 14; 213…222.
110. [verci B, Yvbiana-ˆv” N, Bavdvceav B et al. Ad~antages to vsing capillary
blood betauydroybvtyrate deter|ination for tue detection and treat|ent of diabetic
‚etosis. Diabetes `etab 2005; 31 F4 Pt 1G; 401…406.
111. ]aŠ
el ]. \etone bodies; a re~iew of puysiology, patuopuysiology and application
of |onitoring to diabetes. Diabetes `etab ˆes ˆe~ 1999; 15; 412…426.
112. Sa|velsson }, ]vd~igsson ‰. xuen suovld deter|ination of ‚etone|ia be
reco||ended— Diabetes Yecunol Yuer 2002; 4; 645…650.
500
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
113. ]aŠ el ]`B, xent•ell \, ]ovgulin X, Yo~ar A, `olt• \, Brin‚ S. Sic‚ day
|anage|ent vsing blood 3-uydroybvtyrate F3-VUBG co|pared witu vrine ‚etone
|onitoring redvces uospital ~isits in yovng people witu Y1D`; a rando|i•ed clinical
trial. Diabet `ed 2006; 23; 278…284.
114. Scueiner [. Yuin‚ ]i‚e A Pancreas. New hor‚; `arlowe ¶ Xo|pany, 2004.
115. xalsu ‰, ˆoberts ˆ. Pv|ping Insvlin, 4tu edn. San Diego; Yorrey Pines Press,
2006.
116. ˆiddell `, Iscoe \. Puysical acti~ity, sport, and pediatric diabetes. Pediatr
Diabetes 2006; 7; 60…70.
117. Siler SŽ, Neese ˆA, Xuristiansen `P, Uellerstein `\. Yue inuibition of
glvconeogenesis following alcouol in uv|ans. A| ‰ Puysiol 1998; 275 F5 Pt 1G; ^897…^907.
118. Plovg|ann S, Ue–lesen V, Yvrner B, \err D, Xa~an D. Yue eŠ
ect of alcouol
on blood glvcose in type 1 diabetes … |etabolic |odelling and integration in a decision
svpport syste|. Int ‰ `ed Infor| 2003; 70; 337…344.
119. Yvrner BX, ‰en‚ins ^, \err D, Suerwin ˆS, Xa~an DA. Yue eŠ ect of e~ening
alcouol consv|ption on net-|orning glvcose control in type 1 diabetes. Diabetes
Xare 2001; 24; 1888…1893.
120. A~ogaro A, Beltra|ello P, [nvdi ] et al. Alcouol inta‚e i|pairs glvcose
covnterregvlation dvring acvte insvlin-indvced uypoglyce|ia in IDD` patients.
^~idence for a critical role of free fatty acids. Diabetes 1993; 42; 1626…1634.
121. xil‚ B, hvia U, Bar-Vr V. ^Š
ect of body uypouydration on aerobic
perfor|ance of boys wuo eercise in tue ueat. `ed Sci Sports ^erc 2002; 34 FSvppl.
122. Petrie U‰, Sto~er ^A, Uorswill XA. Nvtritional concerns for tue cuild and
adolescent co|petitor. Nvtrition 2004; 20; 620…631.
123. xuincvp [, `ilner ˆD. Prediction and|anage|ent of noctvrnal
uypoglycae|ia in diabetes. Arcu Dis Xuild 1987; 62; 333…337.
124. Adolfsson P, Nilsson S, ]indblad B. Xontinvovs glvcose |onitoring syste|
dvring puysical eercise in adolescents witu type 1 diabetes. Acta Paediatr 2011; 100;
1603…1609.
125. Vberg D, Vstenson X-[. Perfor|ance of glvcose deuydrogenase-and glvcose
oidase-based blood glvcose |eters at uigu altitvde and low te|peratvre. Diabetes
Xare 2005; 28; 1261.
126. `oore \, ji••ard N, Xole|an X, `c`auon ‰, Uayes ˆ, Yuo|pson X‰.
^tre|e altitvde |ovntaineering and type 1 diabetesz tueDiabetes Zederation of
Ireland \ili|an–aro ^pedition. Diabet `ed 2001; 18; 749…755.
127. \alson NS, Da~ies A‰, Sto‚es S et al. Xli|bers witu diabetes do well on `ovnt
\ili|an–aro. Diabet `ed 2007; 24; 1496.
128. Yvdor-]oc‚e X]S, `organ XZ, Beigule A, Pangra•i ˆP. Xuildrens pedo|eter-
deter|ined puysical acti~ity dvring tue seg|ented scuool day. `ed Sci Sports ^erc
2006; 38; 1732…1738.
129. [vinuovya BX, ]e|dani `, jiluel| X, Uvbert U, Apété [\, Dvrocuer
A. Uow scuool ti|e puysical acti~ity is tue ¤big one¤ for daily acti~ity a|ong
scuoolcuildren; a se|i-eperi|ental approacu. ‰ Puys Act Uealtu 2009; 6; 510…519.
  \b\t\b
501
130. `ota ‰, Sil~a P, Santos `P, ˆibeiro ‰X, Vli~eira ‰, Dvrate ‰A. Puysical acti~ity and
scuool recess ti|e; diŠ
erences between tue sees and tue relationsuip between cuildrens
playgrovnd puysical acti~ity and uabitval puysical acti~ity. ‰ Sports Sci 2005; 23; 269…275.
131. ]ong `x, Sobol A`, Xradoc‚ A], Svbra|anian Sj, Blendon ˆ‰, [ort|a‚er S].
Scuool-day and o~erall puysical acti~ity a|ong yovtu. A| ‰ Pre~`ed 2013; 45; 150…157.
132. xelcu I`, Brvce X, Uill S^, ˆead Nx. Dvodenal and ileal lipid svppresses
postprandial blood glvcose and insvlin responses in |an; possible i|plications for tue
dietary |anage|ent of diabetes |ellitvs. Xlin Sci 1987; 72; 209…216.
133. Santiprabuob ‰, ]i‚it|as‚vl S, Sriw˜ it‚a|ol A et al. I|pro~ed glyce|ic
control a|ong Yuai cuildren and yovng advlts witu type 1 diabetes participating in tue
diabetes ca|p. ‰ `ed Assoc Yuai 2005; 88 FSvppl. 8G; S38…S43.
134. Post ^`, `oore ‰D, Iur‚e ‰, Aisenberg ‰. Zrvctosa|ine le~els de|onstrate
i|pro~ed glyce|ic control for so|e cuildren attending a diabetes sv||er ca|p.
Pediatr Diabetes 2000; 1; 204…208.
135. Stric‚land A], `cZarland \Z, `vrtiasuaw `U, Yuorpe Sˆ, Baynes ‰x.
Xuanges in blood protein glycosylation dvring a diabetes sv||er ca|p. Diabetes Xare
1984; 7; 183…185.
136. Braat~edt [D, `ildenuall ], Patten X, Uarris [. Insvlin revire|ents and
|etabolic control in cuildren witu diabetes |ellitvs attending a sv||er ca|p. Diabet
`ed 1997; 14; 258…261.
137. `iller Aˆ, Nebesio YD, Di`eglio ]A. Insvlin dose cuanges in cuildren
attending a residential diabetes ca|p. Diabet `ed 2011; 28; 480…486.
138. Bryson P, ^dge X, ]indsay D, xillsuvrst P. Yue case for di~ing diabetics.
SP}`S ‰ 1994; 24; 11…13.
139. Da~ies D. SP}`S state|ent on diabetes. SP}`S ‰ 1992; 22; 31…32.
140. Polloc‚ N, }gvccioni D, Dear [, eds. Diabetes and recreational di~ing;
gvidelines for tue fvtvre. Proceedings of tue }ndersea and Uyperbaric `edical Society
Di~ers Alert Networ‚. Dvrua|, NX; Di~ers Alert Networ‚, 2005.
141. Dear [d], Polloc‚ Nx, }gvccioni D`, Do~enbarger ‰, Zeinglos `N, `oon
ˆ^. Plas|a glvcose responses in recreational di~ers witu insvlin-reviring diabetes.
}ndersea Uyperb `ed 2004; 31; 291…301.
142. Polloc‚ Nx, }gvccioni D`, Dear [, Bates S, Albvsuies Y`, Proster|an SA.
Plas|a glvcose response to recreational di~ing in no~ice teenage di~ers witu insvlin-
reviring diabetes |ellitvs. }ndersea Uyperb `ed 2006; 33; 125…133.
502
!\t\t 14. +  \f\t\b    \r  \b  \t\t\b\f \t 
1 \t\t 2�
5\b\t 5 \t 5\r\n\f
\n \n\r\b7 5\t7
\r\t \t\r\r\t\n\f\t 7L\n
Rhodes E.T., Gong C., Edge J.A., Wolfsdorf J.I., Hanas R. ]\b\b\b \b\b  \r\f\f \f\t \n
, Joseph I Wolfsdorf
Division of Endocrinology, Boston Childrens Hospital, Boston, MA, USA;
Department of Pediatrics,
Harvard Medical School, Boston, MA, USA;
504
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
\n\b\b M\b\t8 \t \r\f7\b5:\t\t
\t\f7\t\n\f\t :\t \r\t  \r:\t\t
:/\f# "\r#"@\t \f\f\rC#"@ \r@ *  \r\f/
:\b\f \r5 \t\r\r\t\n\f\t7 7L\n7


\r5 \r:\t\b\b 5  5L7\t \n \n\r\b7 5\t7
1B \t 2B \t 








\f\f = \f  \b  \f\t
505
5  \r78  \r:\t\t





\f#\t, \f" \f "# "\r#\t "" \r"\r
\n \r:\t\b\b 5
\n \n\t:\t\t
\r\tJ" \r# *, BVUB  \r# F 'C"#G ## " 
 #\t  #, # %" 'C, "\fJ" /#\r\r#
!"@" \f \r\r$## $#\r#\rJE :H # \f#$#"
506
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
:\t\b \n \n\r\b7 5\t7 2B \t  \b \r\rL\b
\r \r



\t \r\f7\b5:\t\t



!     \b  \b\t
507
\t\f7\t\n\f\t :\t \r\t  \r:\t\t
\f" ### $#  \r\t \r#\r$#
##  \f@ :@! \r$## #  "# \r#:#'#"@
\r# #\f## 23 000 $#"  1973 .  '\r/  \n \r#
\r$#/ \r/ #$# : ! \r#:#'#"@
� 10 \r' m8q. \f  \f #""# :'\r #"\r"\r 
'\r/  :\rC \f""/ \f'"@", \f"\rC\fJE#/
\f\t "\r\t #\r###  :@!#" \r#"## :@/
508
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
+"# '#\t \r# #\t# \r#"##/ #"$# # 
#J" \f : :!#\r :' \f#"\r##/ #\f# m12,
13q. \r#\r, =\r # ". '# : \r" \r\t
#"#'$##, #CJ #"@J \r$#J # #CJ
""JE#/ '\r" '# \r### m14q. ?  
40 k, ## ‘2,3 @G "#
#/ $"\r/ ##  \r## \f"  "\tC "\t## 
## "\r@  # '# '\f"#\t  
# '" ####,  "\r\f#$# ###
#'#\r/ ###/ #\f# "\r ##
"\r\t \r# #"# ##"\r##  \f"  \r#"#
"\t## \n\r## #  m13q '#, ", /"\t \r#:\r"\t
#$#\t #C@,  30-\f/ '"\t/ \r""#  :,
 \r\r"\r"@ #### '\r". \n/\f \r'@""
#'#\r/ #\f# '\r/; #"# "\r@ *
 \r#\r$# \r#\f  ' '#"@ !#\t
(\b  \b\t\f\f\r  \t  *  \t\t\b\f \t  1-  2- \t...
509
\f\n\n\t9\t\f:\t8 \r:5\r \t \r5 \r:\t\b\b8 :\b\f
7 \t\r\r\t\n\f\t 7L\n
L8 \t\r\r\t\n\f8  \r:\t8
\r5 \r:\t\b\b 5  5L7\t \n \n\r\b7
5\t7 1B \t 2B \t  \b \t\b\n\t\b\r \t\t

510
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
…= \t/, \f '\r#"\r#\r /\r!# "\r@, C"






…�:\t \r\f$#\t „ '\f\rC# " " #E#  "-

L \b \t\r\r\t\n\f 7L\n
(\b  \r. +)

…\r\f#" : \r \f# ## \f# ##
…\r\f#" #"\r# \r\t *, \r\t BVUB  \r# ###

(\b  \b\t\f\f\r  \t  *  \t\t\b\f \t  1-  2- \t...
511




 15.1
\r$" *� !%$'!%%& *!! *! ;!$!/"!; #?()";
\t \b ^58_. T  \t \r\r \r \f\n \r  \t\r
���6,J…6,[email protected] (88…2J  \f f{4 ). 0\r\r \n\t \t\r  \t\n\t 6,[email protected] \r 
�\t\r\t \r @ \b\r\n, \t \f      \b \t 6,[email protected]
7"" (,  -%")  F!"!a24 /
C\t \t&\b 2  &\bG…K266  4
C\t \t&\b 2  &\b26…56�3\t\f \b  \f 6  4
563\t\f \b  \f 56  4
512
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
7 \t\r\r\t\n\f\t 7L\n
(\b  \r. +)
"\r@ \r"# Q\r\f, ## \f"#\r ## ##

…"\r  \f@ \r$\f\r \f\t" 50k : "\r \f' #-
# \r\f \r\fC#"@"# \f"#\t FQG ## J
"\rJJ \f' ## \f#"@ \f"#\t F## \f"#\r
## ## \r#G. \r# #@'## '\r !
…\r ## \r" # @"\r\r" \f"#\t,
…#J" "\r# \f# C#\f", \f\rCE#/
…@"\r"# "\r#\t #'#\t ## C" :"@
\b\t\n \f \r . 15.1
(\b  \b\t\f\f\r  \t  *  \t\t\b\f \t  1-  2- \t...
513

…"\r  \f@ \r$\f\r \f\t" 50k : "\r \f'
…' ## \r" ## @"\r\r" \f"#\t :\f"
…@"\r"# C '#"@ 30…40k : "\r \f'
## \r" ## @"\r\r" \f"#\t F  \f"
\f#"@ ## \r\f \r\fC#"@"# ## \f#"@
\f"#\tG # #J" "\r#J #'#J ## ' 2  \f
…L# \r: C" H"@ # '"\r # "\r:\t"@ \r-

…"\r# \r$##
514
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
… \r$## F# %" @'\t #':C"@G



…\b'@ \r@ C" :"@ \r#" \r# :/\f#-



\t\b\r \r:\t\b\b 5
 \t
515
\n \r:\t\b\b 5
 \r$## #" \r\r@ \r# ## \r\fC#"
 ':#\t \r@ \r# #E#. \f  \r: :\f" -
\n \n\t:\t\t
\n\r\b8  \r:\t8
516
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
:\t\b \n \n\r\b7 5\t7 2B \t  \b \r\rL\b
\r \r
 !"@",  '##"# " "# ## \rC#. =\r\t
\r#"# "\r# \f\t \f#"\r##/ $#"  \f#:"
', \r# "\r ##"\t \r#  \f"""# m23q.
K"$#\f' \t\t"\t \r\f# #  \f\t C#'# \t#.  
\r\f\r$# \r$\f\r \r# m24, 25q. = \t'#  %"# \r#
:@! \r$## F\r\fC#"@"@J : 2 G, # "@ "\r,
!"@". =  \r \r$## # \f  \f \f'
\r!  24 , :/\f# \f\f\rC#"@ #\f\r"$#J \r\f"
"\r# \f#\t C#\f" \f,  \r\t #  \r$##. \r#
/ \r$#\t/ F\r\fC#"@"@J  2 G "\r# C
"\rC\f#\t "#\t \r@/ $# . \r\rEJ"
\r \f#"#\f#"#\f'-4 #  *-1  \f@ /#\r\r#
!"@". $#", "\tE#\t  /#\r\r# \r$\f\r
\r\fC#"@"@J : 2 , \f" "@ #'#J ##, 
\f# \f \b 
"\r# * C\f  # \r# \r!## 10 @ F180 \fkG \f\t"
\fC ## @"\r\r" \f"#\t F0,1 L "@ \f
\f=\b\t
5\r\b\n\t
F2014G. \n#" $# \f'"@" """" #@'
\f\b9\t\f \t\b\r\n
Merck
Bristol Myers Squibb
Novo Nordisk
Lilly
Sano“
Medtronic
Abbott
Unomedical and
518
!\t\t 15.   \f   \r  \b  \t\t\b\f \t ...
\n \t\n\f \t\r\r
1. Betts P, Brin‚ S, Silin‚ `, Swift P[, xolfsdorf ‰, Uanas ˆ. `anage|ent of
cuildren and adolescents witu diabetes reviring svrgery. Pediatr Diabetes 2009; 10
FSvppl. 12G; 169…174.
2. Xraig `^, Ywigg S`, Donaguve \X, Xuevng Nx, Xa|eron Z‰, Xonn ‰,
‰en‚ins A‰, Silin‚ `, for tue Avstralian Yype 1 Diabetes [videlines ^pert Ad~isory
[rovp. National e~idence-based clinical care gvidelines for type 1 diabetes in cuildren,
adolescents and advlts, Avstralian [o~ern|ent Depart|ent of Uealtu and Ageing,
Xanberra 2011 Fa~ailable fro| uttp;www. nu|rc.go~.avgvidelinespvblications
et4G.
3. xuerrett D, Uvot X, `itcuell B, Pacavd D. Xanadian Diabetes Association 2013
Xlinical Practice [videlines for tue pre~ention and |anage|ent of diabetes in Xanada;
type 1 diabetes in cuildren and adolescents. Xan ‰ Diabetes 2013; 37; S153…S162.
4. Association of Xuildrens Diabetes Xlinicians. Xare of cuildren vnder 18 years
witu diabetes |ellitvs vndergoing Svrgery 2013 Fa~ailable fro| uttp;www.ac-d-c.org
wp-contentvploads201208AXDX™svrgery™gvideline2014-pdf.pdfG.
5. ˆuodes ^Y, Zerrari ]ˆ, xolfsdorf ‰I. Perioperati~e |anage|ent of pediatric
svrgical patients witu diabetes |ellitvs. Anestu Analg 2005; 101; 986…999.
6. \avf|an Zˆ, De~gan S, ˆoe YZ, Xostin [. Perioperati~e |anage|ent witu
prolonged intra~enovs insvlin infvsion ~ersvs svbcvtaneovs insvlin in cuildren witu
type I diabetes |ellitvs. ‰ Diabetes Xo|plications 1996; 10; 6…11.
7. Dronge AS, Per‚al `Z, \ancir S, Xoncato ‰, Aslan `, ˆosentual ˆA. ]ong-
ter| glyce|ic control and postoperati~e infectiovs co|plications.Arcu Svrg 2006; 141;
375…380.
8. Xrvse P‰, Zoord ˆ. A ”
~e-year prospecti~e stvdy of 23,649 svrgical wovnds. Arcu
Svrg 1973; 107; 206…210.
9. \ao ]S, `ee‚s D, `oyer jA, ]ally \P. Perioperati~e glycae|ic control
regi|ens for pre~enting svrgical site infections in advlts. Xocurane Database Syst ˆe~
2009; 3; XD006806.
10. [riesdale D^, de Sov•a ˆ‰, ~an Da| ˆ` et al. Intensi~e insvlin tuerapy and
|ortality a|ong critically ill patients; a |eta-analysis inclvding NIX^-S}[Aˆ stvdy
data. X`A‰ 2009; 180; 821…827.
11. `oguissi ^S, \oryt‚ows‚i `Y, DiNardo ` et al. A|erican Association of
Xlinical ^ndocrinologists and A|erican Diabetes Association consensvs state|ent on
inpatient glyce|ic control. ^ndocr Pract 2009; 15; 353…369.
12. Agvs `S. Yigut glyce|ic control in cuildren … is tue target in sigut— N ^ngl ‰
`ed 2014; 370; 168…169.
13. Srini~asan j, Agvs `S. Yigut glvcose control in critically ill cuildren … a
syste|atic re~iew and |etaanalysis. Pediatr Diabetes 2014; 15; 75…83.
14. jlasselaers D, `ilants I, Des|et ] et al. Intensi~e insvlin tuerapy for patients
in paediatric intensi~e care; a prospecti~e, rando|ised controlled stvdy. ]ancet 2009;
373; 547…556.
  \b\t\b
519
15. `acrae D, [rie~e ˆ, Allen ^ et al. Arando|i•ed trial of uyperglyce|ic control
in pediatric intensi~e care. N ^ngl ‰ `ed 2014; 370; 107…118.
16. Bvculeitner A`, `artine•-Alonso `, Uernande• `, Sola I, `avricio D.
Perioperati~e glycae|ic control for diabetic patients vndergoing svrgery. Xocurane
Database Syst ˆe~ 2012; 9; XD007315.
17. Ue||erling Y`, Scu|id `X, Scu|idt ‰, \ern S, ‰acobi \^. Xo|parison of
a continvovs glvcoseinsvlin-potassiv| infvsion ~ersvs inter|ittent bolvs application of
insvlin on perioperati~e glvcose control and uor|one statvs in insvlin-treated type 2
diabetics. ‰ Xlin Anestu 2001; 13; 293…300.
18. Xuristiansen X], Scuvri•e‚ BA, `alling B, \nvdsen ], Alberti \[, Uer|ansen
\. Insvlin treat|ent of tue insvlin-dependent diabetic patient vndergoing |inor
svrgery. Xontinvovs intra~enovs infvsion co|pared witu svbcvtaneovs ad|inistration.
Anaestuesia 1988; 43; 533…537.
19. ˆavcovles-Ai|e `, ]vgrin D, Bovssofara `, [astavd P, Dolisi X, [ri|avd
D. Intraoperati~e glycae|ic control in non-insvlin-dependent and insvlin-dependent
diabetes. Br ‰ Anaestu 1994; 73; 443…449.
20. Brady `, \inn S, Ness j, Vˆovr‚e \, ˆanduawa N, Stvart P. Preoperati~e
fasting for pre~enting perioperati~e co|plications in cuildren. Xocurane Database Syst
ˆe~ 2009; 4; XD005285.
21. `vcua [Y, `er‚el S, Yuo|as x, Bantle ‰P. Zasting and insvlin glargine in
indi~idvals witu type 1 diabetes. Diabetes Xare 2004; 27; 1209…1210.
22. Al-\uawari `, Al-ˆvwayeu A, Al-Dovb \, Allgro~e ‰. Adolescents on basal-
bolvs insvlin can fast dvring ˆa|adan. Pediatr Diabetes 2010; 11; 96…100.
23. ^ppenga x], ]al|oua|ed A, [eerts AZ et al. ˆis‚ of lactic acidosis or ele~ated
lactate concentrations in |etfor|in vsers witu renal i|pair|ent; a popvlationbased
couort stvdy. Diabetes Xare 2014; m^pvb 19 `ay 2014q.
24. Baradari A[, Uabibi `ˆ, \ue•ri UD et al. Does uigu-dose |etfor|in
cavse lactic acidosis in type 2 diabetic pa
tients after XAB[
svrgery— A
rando|i•ed clinical trial. Ueart Int 2011; 6; e8.
25. Sir~ins‚as ^, \indvris S, \aptvravs‚as ‰, Sa|ala~icivs ˆ. Perioperati~e vse of
|etfor|in in cardiac svrgery. `edicina 2010; 46; 723…729.
26. ˆewers A, `cZann \, Xuase UP. Bedside |onitoring of blood beta-
uydroybvtyrate le~els in tue |anage|ent of diabetic ‚etoacidosis in cuildren. Diabetes
Yecunol Yuer 2006; 8; 671…676.
27. Xuoong \, \uo `^, `enon \, Boun D. Uypotonic ~ersvs isotonic saline in
uospitalised cuildren; a syste|atic re~iew. Arcu Dis Xuild 2006; 91; 828…835.
1 \t\t 29
\n\t\t\n\f8 7L 587 \t 5\r\n\f7
\n \n\r\b7 5\t7
Delamater A.M., de Wit M., McDarby V., Malik J., Acerini C.L. " \f\f\b  \r\f\f& \b 
\r\f\f  \n \b\f. "\b\b  \b 2014: 15 (Suppl. 20): 232…244.
Alan M Delamater
, Maartje de Wit
Department of Pediatrics, University of Miami Miller School of Medicine, Miami, FL, USA;
partment of Medical Psychology, EMGO Institute for Health \ Care Research, VU University Medical
\f\f = \f  \b  \f\t
521
\n\b\b M\b\t8 \t \r\f7\b5:\t\t
522
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 

…" C#'# C \fC $#"@, # %" #" :@!J
…�: C \r\f#"@ #"\r# !@ -
…:/\f# \r#\r"@ $###   -

\f#"@\t $ \f"$## # ##\t \r#\t \n, J\t
 $, :"# \r!#\t \r:, \r#\rC"@
\rC# "\r##, ""@ "\t"@ #\t #
\r" # \r\f :\r"", \f \f"#  #/ @\t/ :\r" 
:\t :\t'"#  "\t"@ \f#J \n,  :\f#
\f"" '\r# \f\t %"# "\t"@


"@ :\t'"  \f#J \n, \f\f\rC #
\f\f = \f  \b  \f\t
523

T@J C\f#$##\r \r \t\t"\t :E\t $





524
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
5\b\t
= \f# "\r# \f\t"#"#\t : \r'\r:" \r\t
#\f"@\t :', "\r\t \f"\rC\f" '#"@J \r@
#/# \f"$##, #/#"\r##/ ':#,
### \r:# # #"\r$#\t#  \f" # \f\r" 
'\r:" "C \f@!#, : \r" \r\f$##
\n\t\t\n\f8 5 :\t8 \t \n\t\t\n\f\t \r\n\n\r\n
( \t \t\t\t    \b\t\b\r\t
525
"\r\tJE#\t  : \r\f\rC  #/#"\r##
526
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
""""@ \f#"## \r#"\r#\t \r!# #E
\b\r\f\b\t\t\b8 \t \fL\b8 58L\b\nL
'# ##  \r#/# \f#$#" \r'
  \r\f #\f\f\b\t\f
527
\n7\b 9\b\f:\t\b\t\r\b\t
"\r \t\tJ"\t E"# \r# \f## \n  \f" m1q. '@""
\r\t\f \r\r"/ # \r"#/ #\f# '#, " \r#
"# :\t'"  \f#J \n, \f\f\rC # " \r!#J
\r: "J"\t ! :J\f# \rC# "\r## # "\r@
" # #"  \t'#  \r!#\t# \rC# \r#\f\t"  /\f!
:J\f#J \rC# "\r## # "\rJ ### m56…68q. \n
#" C\f \f"@# # #/ \r\f#"\t#  \r\r\f# :\t'"
,  #  !# %$#@ $##\r#\t m62, 69q.
M#  \r: "#@  :@!#"  \r#
###/ #\f#\t/ \f\r"  "\r\tJE#\t  m25, 64,
\f\r##/ "\r, "#/  \t @\t m72…74q, #'#
## \r:  "# \r: \f#' \n1. = \f
528
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
, \t'  \f#',  19k "J" \f#"\r " 1 \f 4 " 
 \f"$##  "# \f#' \r:, \r#\r  "\r"#
"\r ""\t '#"@\t \f\r#\t. ?   :@!#"
# \f#' \r: m83q. #/## \r:  "$ \f" 
" \f#' \n \r"\r##@  @! #"
#\f#. = \f #\f## : ', "  24k "\r
"\r"# "\r \r"\r" \r' 6 \f  "#
"# / "\r\t ###  \f" \r' 5 "  "#
\f#' m85q.  \r\f#" \f"  \n1 "C " :\rC#"\t
"\r/ #### m86q, " \t'  %$#@# \r:# #
\n:\tL\b8 55\rM\f
\b   \b*\t  \f
\n\r\n\n \t \rL \n \b\t7
530
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
\f\n M\t\b\t
\n\t\t\n\f\t \t 5\b\n\f\t 7L\n
"  \r\t\f "\r#\r/ #\f# \r\f"\r#\r
%"#"@ #/$#@/ # \f#/ !"@" 
(     \f   &\t *\t
531
'@"" %"#/ #\f# 'J", " \f#
!"@"   , "#  " $,
" \r@, '#"# \f\r#, \f# "\r",
532
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
 @"##" "\r## \f\r" #' :\f/ \r" 
&"#$# #"\r@J#\r# \t\t"\t :EJE#
'# !# ## "\r\t m173, 174q. 
 !#J \f\r "\r\t ### # "
(     \f   &\t *\t
533
@J, J\t  \r\t\r E#\t ###, \r# 
534
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
JE#/ :J\f#J \rC#  \fC#  \n1,  "\r : \f
15 \r:", \f"\r\tJE#/ \r#"\r#\t #' m187q. Q"\t \r'@""
'#  : %"  !## ## "\r\t, 
 \r$#, : : '" %". = :'\r #"\r$#,
\r#"#\r/  @#, : \r"\r \f\t"@ #\f# #
:\rC, " "# !"@" !J" ### "\r@
?C \r'@"" "\r#\r/ #\f# #"\r$#
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. Dela|ater A`. ISPAD Xlinical Practice Xonsensvs [videlines 2009
Xo|pendiv|; psycuological care of cuildren and adolescents witu diabetes. Pediatr
Diabetes 2009; 10 FSvppl. 12G; 175…184.
  \b\t\b
535
2. Sil~erstein ‰, \lingens|itu [, Xopeland \, et al. Xare of cuildren and adoles-
cents witu type 1 diabetes; a state|ent of tue A|erican Diabetes Association. Diabetes
Xare 2005; 28; 186…212.
3. Ua|pson S^, S‚inner Y, Uart ‰, et al. Beua~ioral inter~entions for adolescents
witu type 1 diabetes; uow eŠ ecti~e are tuey— Diabetes Xare 2000; 23; 1416…1422.
4. xin‚ley \, ]andav S, ^isler I, Is|ail \. Psycuological inter~entions to i|pro~e
glycae|ic control in patients witu type 1 diabetes; syste|atic re~iew and |eta-analysis
of rando|ised controlled trials. B`‰ 2006; 333; 65.
5. ]aron ‡, [alat•er A, \arger S. Psycuological aspects of diabetes in cuildren and
adolescents. Pediatr Adolesc ^ndocrinol 1982; 10; 1…247.
6. ISPAD. Xonsensvs [videlines for tue `anage|ent of Yype 1 Diabetes `ellitvs
in Xuildren and Adolescents, 2000.
7. ˆeynolds \, Uelgeson j. Xuildren witu diabetes co|pared to peers; depressed—
distressed— Ann Beua~ `ed 2011; 42; 29…41.
8. hovng j, ^iser X, ‰ounson B, et al. ^ating proble|s in adolescents witu type 1
diabetes; a syste|atic re~iew witu |eta-analysis. Diabet `ed 2013; 30; 189…198.
9. \o~acs `, Zeinberg Y, Pavlavs‚as S, Zin‚elstein ˆ, Polloc‚ `, Xrovse-No~a‚
`. Initial coping responses and psycuosocial cuaracteristics of cuildren witu insvlin-
dependent diabetes |ellitvs. ‰ Pediatr 1985; 106; 827…834.
10. [rey `, Xa|eron `^, ]ip|an YU, Yuvrber Zx, et al. Psycuosocial statvs
of cuildren witu diabetes in tue ”
rst 2 years after diagnosis. Diabetes Xare 1995; 18;
1330…1336.
11. ‰acobson A`, Uavser SY, ]a~ori P, et al. Za|ily en~iron|ent and glyce|ic
control; a fovr-year prospecti~e stvdy of cuildren and adolescents witu insvlin-depen-
dent diabetes |ellitvs. Psycuoso| `ed 1994; 56; 401…409.
12. \o~acs `, Uo j, Polloc‚ `U. Xriterion and predicti~e ~alidity of tue diagnosis
of ad–vst|ent disorder; a prospecti~e stvdy of yovtus witu new-onset insvlin-dependent
diabetes |ellitvs. A| ‰ Psycuiatr 1995; 152; 523…528.
13. Scuwart•
DD, Xline jD, Aelrod `^, Anderson B‰. Zeasibility, acceptability,
and predicti~e ~alidity of a psycuosocial screening progra| for cuildren and yovtu
newly diagnosed witu type 1 diabetes. Diabetes Xare 2011; 34; 326…331.
14. Nortua| ^A, Anderson P‰, xertuer [A, xarne [], Adler ˆ[, Andrewes
D. Nevropsycuological co|plications of idd| in cuildren 2 years after disease onset.
Diabetes Xare 1998; 21; 379…384.
15. Uelgeson jS, Snyder Pˆ, ^scobar V, Si|inerio ], Be
c‚er D. Xo|parison of
adolescents witu andwituovt diabetes on indices of psycuosocial fvnctioning for turee
years. ‰ Pediatr Psycuol 2007; 32; 794…806.
16. Uelgeson jS, Palladino D\, ˆeynolds \A, Be
c‚er
D‰, ^scobar V, Si|inerio
]. ˆelationsuips and uealtu a|ong e|erging advlts witu and wituovt type 1 diabetes.
Uealtu Psycuol 2014; in press.
17. Naar-\ing S, Idals‚i A, ^llis D, et al. [ender diŠ erences in aduerence and
|etabolic control in vrban yovtu witu poorly controlled type 1 diabetes; tue |ediating
role of |ental uealtu sy|pto|s. ‰ Pediatr Psycuol 2006; 31; 793…802.
536
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
18. Uol|es XS, Xuen ˆ, Streisand ˆ, et al. Predictors of yovtu diabetes care beua~-
iors and |etabolic control; a strvctvral evation |odeling approacu. ‰ Pediatr Psycuol
2006; 31; 770…784.
19. Uood \\, Uvestis S, `auer A, Bvtler D, jol‚ening ], ]aŠ el ]`B. Depressi~e
sy|pto|s in cuildren and adolescents witu type 1 diabetes; association witu diabetes-
speci”
c cuaracteristics. Diabetes Xare 2006; 29; 1389.
20. Uer•er `, Uood \\. Aniety sy|pto|s in adolescents witu type 1 diabetes;
association witu blood glvcose |onitoring and glyce|ic control. ‰ Pediatr Psycuol
2010; 35; 415…425.
21. ]awrence ‰`, Standiford DA, ]oots B, et al. Pre~alence and correlates of
depressed |ood a|ong yovtu witu diabetes; tue S^AˆXUfor diabetes in yovtu stvdy.
Pediatrics 2006; 117; 1348…1358.
22. \ong‚aew X, ‰a|pacuaisri \, Xuatvrong‚vl XA, Scuol”
eld XN. Depression
and aduerence to treat|ent in diabetic cuildren and adolescents; a syste|atic re~iew
and |eta-analysis of obser~ational stvdies. ^vr ‰ Pediatr 2014; 173; 203…212.
23. Uilliard `^, Uer•er `, Dolan ]`, Uood \\. Psycuological screening in
adolescents witu type 1 diabetes predicts ovtco|es one year later. Diabetes ˆes Xlin
Pract 2011; 94; 39…44.
24. Uilliard `^, xv hP, ˆavscu ‰, Dolan ]`, Uood \\. Predictors of deteriora-
tions in diabetes |anage|ent and control in adolescents witu type 1 diabetes. ‰ Adolesc
Uealtu 2013; 52; 28…34.
25. ]iss DS, xaller DA, \ennard BD, `cIntire D, Xapra P, Stepuens ‰. Psycuiatric
illness and fa|ily svpport in cuildren and adolescents witu diabetic ‚etoacidosis; a con-
trolled stvdy. ‰ A| Acad Xuild Adolesc Psycuiatry 1998; 37; 536…544.
26. Anderson B‰, `iller ‰P, Avslander xZ, Santiago ‰j. Za|ily cuaracteristics of
diabetic adolescents; relationsuip to |etabolic control. Diabetes Xare 1981; 4; 586…594.
27. `ali‚ ‰A, \oot U`. ^plaining tue ad–vst|ent of adolescents witu type 1
diabetes; role of diabetesspeci”
c and psycuosocial factors. Diabetes Xare 2009; 32;
774…779.
28. Dela|ater A`, Patiño-Zernande• A`, S|itu \^, Bvbb ‰. `easvre|ent of
diabetes stress in older cuildren and adolescents witu type 1 diabetes |ellitvs. Pediatr
Diabetes 2013; 14; 50…56.
29. Bryden \S, Pe~eler ˆX, Stein A, Neil A, `ayov ˆA, Dvnger DB. Xlinical and
psycuological covrse of diabetes fro| adolescence to yovng advltuood; a longitvdinal
couort stvdy. Diabetes Xare 2001; 24; 1536…1540.
30. xysoc‚i Y, Uovgu BS, xard \`, [reen ]B. Diabetes |ellitvs in tue transi-
tion to advltuood; ad–vst|ent, self-care, and uealtu statvs. ‰ De~ Beua~ Pediatr 1992;
13; 194…201.
31. Xolton PA, Vl|sted `P, Dane|an D, ˆodin [`. Depression, distvrbed
eating beua~ior, and |etabolic control in teenage girls witu type 1 diabetes. Pediatr
Diabetes 2013; 14; 372…376.
32. Bryden \S, Neil A, `ayov ˆA, Pe~eler ˆX, Zairbvrn X[, Dvnger DB. ^ating
uabits, body weigut, and insvlin |isvse. A longitvdinal stvdy of teenagers and yovng
advlts witu type 1 diabetes. Diabetes Xare 1999; 22; 1956…1960.
  \b\t\b
537
33. `elt•er ]‰, Bennett ‰ounson S, Prine ‰`, Ban‚s ˆA, Desrosiers P`,
Sil~erstein ‰U. Disordered eating, body |ass, and glyce|ic control in adolescents witu
type 1 diabetes. Diabetes Xare 2001; 24; 678…682.
34. xisting ], Zrøisland DU, S‚ri~aruavg Y, Daul-‰orgensen \, ˆø V. Distvrbed
eating beua~ior and o|ission of insvlin in adolescents recei~ing intensi”
ed insvlin treat-
|ent; a nationwide popvlation-based stvdy. Diabetes Xare 2013; 36; 3382…3387.
35. ˆydall AX, ˆodin [`, Vl|sted `P, De~enyi ˆ[, Dane|an D. Disordered
eating beua~ior and |icro~ascvlar co|plications in yovng wo|en witu insvlin-depen-
dent diabetes |ellitvs. N ^ngl ‰ `ed 1997; 336; 1849…1854.
36. [oebel-Zabbri A^, Zi‚‚an ‰, Zran‚o D], Pearson \, Anderson B‰, xeinger
\. Insvlin restriction and associated |orbidity and |ortality in wo|en witu type 1
diabetes. Diabetes Xare 2008; 31; 415…419.
37. hovng-Uy|an D], Da~is X]. Disordered eating beua~ior in indi~idvals witu diabe-
tes i|portance of contet, e~alvation, and classi”
cation. Diabetes Xare 2010; 33; 683…689.
38. Uol|es XS, ˆicu|an ]X. Xogniti~e pro”
les of cuildren witu insvlin-dependent
diabetes. ‰ De~ Beua~ Pediatr 1985; 6; 323…326.
39. ˆyan X, jega A, ]ongstreet X, Drasu A. Nevropsycuological cuanges in ado-
lescents witu insvlin-dependent diabetes. ‰ Xonsvlt Xlin Psycuol 1984; 52; 335…342.
40. ˆyan X, jega A, Drasu A. Xogniti~e de”
cits in adolescents wuo de~eloped dia-
betes early in life. Pediatrics 1985; 75; 921…927.
41. ˆo~et ‰Z, ^urlicu ˆ`, Uoppe `. Speci”
c intellectval de”
cits in cuildren witu
early onset diabetes |ellitvs. Xuild De~ 1988; 59; 226…234.
42. As~old BV, Sand Y, Uestad \, B–ørgaas `ˆ. Xogniti~e fvnction in type 1
diabetic advlts witu early eposvre to se~ere uypoglyce|ia; a 16-year follow-vp stvdy.
Diabetes Xare 2010; 33; 1945…1947.
43. Perantie DX, ]i| A, xv ‰, et al. ^Š ects of prior uypoglyce|ia and uyperglyce|ia
on cognition in cuildren witu type 1 diabetes |ellitvs. Pediatr Diabetes 2008; 9; 87…95.
44. Patiño-Zernande• A`, Dela|ater A`, Applegate ^B, et al. Nevrocogniti~e
fvnctioning in prescuool-age cuildren witu type 1 diabetes |ellitvs. Pediatr Diabetes
2010; 11; 424…430.
45. Uol|es XS, Dvnlap xP, Xuen ˆS, Xornwell ‰`. [ender diŠ erences in tue
learning statvs of diabetic cuildren. ‰ Xonsvlt Xlin Psycuol 1992; 60; 698…704.
46. Scuoenle ^‰, Scuoenle D, `olinari ], ]argo ˆU. I|paired intellectval de~el-
op|ent in cuildren witu type I diabetes; association witu UbA1 c, age at diagnosis and
se. Diabetologia 2002; 45; 108…114.
47. `cXartuy A` et al.Zactors associated witu acade|ic acuie~e|ent in cuildren
witu type 1 diabetes. Diabetes Xare 2003; 26; 112…117.
48. ˆyanX`.Searcuing for tue origin of brain dysfvnction in diabetic cuildren;
going bac‚ to tue beginning. Pediatr Diabetes 2008; 9; 527…530.
49. Parent \B, xodricu D], Uasan \S. Yype 1 diabetes |ellitvs and scuool; a
co|parison of patients and uealtuy siblings. Pediatr Diabetes 2009; 10; 554…562.
50. Nortua| ^A et al. Predictors of cuange in tue nevropsycuological pro”
of cuildren witu type 1 diabetes 2 years after disease onset. Diabetes Xare 1999; 22;
1438…1444.
538
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
51. ]in A et al. Nevropsycuological pro”
les of yovng people witu type 1 diabetes 12
yr after disease onset. Pediatr Diabetes 2010; 11; 235…243.
52. Nagvib ‰` et al. Nevro-cogniti~e perfor|ance in cuildren witu type 1 diabe-
tes … a |eta-analysis. ‰ Pediatr Psycuol 2009; 34; 271…282.
53. [avdieri PA, Xuen ˆ, [reer YZ, Uol|es XS. Xogniti~e fvnction in cuildren
witu type 1 diabetes; a |eta-analysis. Diabetes Xare 2008; 31; 1892…1897.
54. ‰acve• Z, Stovt S, Al~are•-Sal~at ˆ, et al. Parent perspecti~es of diabetes |an-
age|ent in scuools. Diabetes ^dvc 2008; 34; 996…1003.
55. xagner ‰, Ueapy A, ‰a|es A, Abbott [. Brief report; glyce|ic control, vality
of life, and scuool eperiences a|ong stvdents witu diabetes. ‰ Pediatr Psycuol 2006;
31; 764…769.
56. Ysiovli ^, Aleopovlos ^X, Stefana‚i X, Dar~iri X, Xurovsos [P. ^Š
ects of
diabetes-related fa|ily stress on glyce|ic control in yovng patients witu type 1 diabetes;
syste|atic re~iew. Xan Za| Puysician 2013; 59; 143…149.
57. `iller-‰ounson S, ^|ery ˆ^, `ar~in ˆS, Xlar‚e x, ]o~inger ˆ, `artin `.
Parent-culd relationsuips and tue |anage|ent of insvlin-dependent diabetes |ellitvs.
‰ Xonsvlt Xlin Psycuol 1994; 62; 603…610.
58. ]a [reca A`, Avslander xZ, [reco P, Spetter D, Zisuer ‰r. ^B, Santiago ‰j.
I get by witu a little uelp fro| |y fa|ily and friends; adolescents svpport for diabetes
care. ‰ Pediatr Psycuol 1995; 20; 449…476.
59. Anderson B,Uo ‰, Brac‚ett ‰, Zin‚elstein D, ]aŠ
el ]. Parental in~ol~e|ent
in diabetes |anage|ent tas‚s; relationsuips to blood glvcose |onitoring aduerence
and |etabolic control in yovng adolescents witu insvlin-dependent diabetes |ellitvs.
‰ Pediatr 1997; 130; 257…265.
60. Da~is X], Dela|ater A`, Suaw \U, et al. Parenting styles, regi|en aduerence,
and glyce|ic control in 4-to 10-year-old cuildren witu diabetes. ‰ Pediatr Psycuol 2001;
26; 123…129.
61. xysoc‚i Y, Iannotti ˆ, xeissberg-Bencuell ‰, et al. Diabetes proble| sol~ing by
yovtus witu type 1 diabetes and tueir caregi~ers; |easvre|ent, ~alidation, and longitv-
dinal associations witu glyce|ic control. ‰ Pediatr Psycuol 2008; 33; 875…884.
62. Uelgeson jS, ˆeynolds \A, Si|inerio ], ^scobar V, Be
c‚er D. Parent and
adolescent distribvtion of responsibility for diabetes self-care; lin‚s to uealtu ovtco|es.
‰ Pediatr Psycuol 2008; 33; 497…508.
63. xysoc‚i Y, Nansel Yˆ, Uol|bec‚ [N, et al. Xollaborati~e in~ol~e|ent of pri-
|ary and secondary caregi~ers; associations witu yovtus diabetes ovtco|es. ‰ Pediatr
Psycuol 2009; 34; 869…81.
64. Xa|eron Z‰, S‚inner YX, De Beavfort X^, et al. Are fa|ily factors vni~ersally
related to|etabolic ovtco|es in adolescents witu type 1 diabetes— Diabet `ed 2008;
ict in adolescents
  \b\t\b
539
witu diabetes-speci”
c fa|ily con›
ict and glyce|ic control. Uealtu Psycuol 2012; 31;
571…579.
67. ˆouan ‰`, ˆavscu ‰ˆ, Pendley ‰S, et al. Identi”
cation and prediction of grovp-
based glyce|ic control tra–ectories dvring tue transition to adolescence. Uealtu Psycuol
2014; in press.
68. Suorer `, Da~id ˆ, Scuoenberg-Ya• `, ]e~a~i-]a~i I, Puillip `, `eyero~itcu
‰. ˆole of parenting style in acuie~ing |etabolic control in adolescents witu type 1 dia-
betes. Diabetes Xare 2011; 34; 1735…1737.
69. Berg XA, Scuindler I, `auara–u S. Adolescents and |otuers perceptions of tue
cogniti~e and relational fvnctions of collaboration and ad–vst|ent in dealing witu type
1 diabetes. ‰ Za| Psycuol 2008; 22; 865…874.
70. Vrr DP, [olden `P, `yers [, `arrero D[. Xuaracteristics of adolescents witu
poorly controlled diabetes referred to a tertiary care center. Diabetes Xare 1983; 6; 170…175.
71. xuite \, \ol|an `], xeler P, Polin [, xinter ˆ‰. }nstable diabetes and
vnstable fa|ilies; a psycuosocial e~alvation of diabetic cuildren witu recvrrent ‚etoaci-
dosis. Pediatrics 1984; 73; 749…755.
72. Zorsander [A, Svndelin ‰, Persson B. In›
vence of tue initial |anage|ent regi-
|en and fa|ily social sitvation on glyce|ic control and |edical care in cuildren witu
type I diabetes |ellitvs. Acta Paediatr 2000; 89; 1462…1468.
73. V~erstreet S, [oins ‰, Xuen ˆS, et al. Za|ily en~iron|ent and tue interrelation
of fa|ily strvctvre, cuild beua~ior, and |etabolic control for cuildren witu diabetes.
‰ Pediatr Psycuol 1995; 20; 435…447.
74. Yuo|pson S‰, Avslander xZ, xuite NU. Xo|parison of single-|otuer and
two-parent fa|ilies on |etabolic control of cuildren witu diabetes. Diabetes Xare 2001;
24; 234…238.
75. Avslander xZ, Yuo|pson S, Dreit•er D, xuite NU, Santiago ‰j. Disparity in
glyce|ic control and aduerence between african-a|erican and Xavcasian yovtus witu
diabetes; fa|ily and co||vnity contets. Diabetes Xare 1997; 20; 1569…1575.
76. Dela|ater A`, Albrecut Dˆ, Postellon DX, [vtai ‰P. ˆacial diŠ
erences in
|etabolic control of cuildren and adolescents witu type i diabetes |ellitvs. Diabetes
Xare 1991; 14; 20…25.
77. Dela|ater A`, Suaw \U, Applegate ^B, et al.ˆis‚ for |etabolic control prob-
le|s in |inority yovtu witu diabetes. Diabetes Xare 1999; 22; 700…705.
78. [allegos-`acias Aˆ, `acias Sˆ, \avf|an ^, S‚ipper B, \alisu|an N.
ˆelationsuip between glyce|ic control, etunicity and socioecono|ic statvs in Uispanic and
wuite non-Uispanic yovtus witu type 1 diabetes |ellitvs. Pediatr Diabetes 2003; 4; 19…23.
79. Petitti DB, \lingens|itu [‰, Bell ˆA, et al. [lyce|ic control in yovtu witu
diabetes; tue S^AˆXU for diabetes in yovtu stvdy. ‰ Pediatr 2009; 155; 668…672 e3.
80. ˆedondo `‰, Xonnor X[, ˆvedy \‰, et al. Pediatric diabetes consortiv| type
1 diabetes new onset FNeVnG stvdy; factors associated witu UbA1c le~els one year after
diagnosis. Pediatr Diabetes 2014; 15; 294…302.
81. Xengi• ^, _ing D, xong ‰X, et al. Se~ere uypoglyce|ia and diabetic ‚etoaci-
dosis a|ong yovtu witu type 1 diabetes in tue Y1D ^cuange clinic registry. Pediatr
Diabetes 2013; 14; 447…454.
540
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
82. xuitte|ore ˆ, ‰aser S, Xuao A, ‰ang A, [rey `. Psycuological eperience of
parents of cuildren witu type 1 diabetes; a syste|atic |ied-stvdies re~iew. Diabetes
^dvc 2012; 38; 562…579.
83. \o~acs `, Zin‚elstein ˆ, Zeinberg Y], Xrovse-No~a‚ `, Pavlavs‚as S,
Polloc‚ `. Initial psycuologic responses of parents to tue diagnosis of insvlin depen-
dent diabetes |ellitvs in tueir cuildren. Diabetes Xare 1985; 8; 568…575.
84. ]andolt `A, ˆibi \, ]ai|bacuer ‰, jollratu `, [neu| U^, Sennuavser ZU.
Brief report; posttrav|atic stress disorder in parents of cuildren witu newly diagnosed
type 1 diabetes. ‰ Pediatr Psycuol 2002; 27; 647…652.
85. Zorsander [, Persson B, Svndelin ‰, Berglvnd ^, Snell|an \, Uellstro| ˆ.
`etabolic control in cuildren witu insvlin-dependent diabetes |ellitvs 5y after diagno-
sis. ^arly detection of patients at ris‚ for poor |etabolic control. Acta Pædiatrica 1998;
87; 857…864.
86. Barnard \, Yuo|as S, ˆoyle P, Noyes \, xavgu N. Zear of uypoglycae|ia in
parents of yovng cuildren witu type 1 diabetes; a syste|atic re~iew. B`X Pediatr 2010;
10; 50.
87. Uavgst~edt A, xent•el-]arsen Y, [rave `, Sø~i‚ V, ˆo‚ne B. Zear of uypo-
glycae|ia in |otuers and fatuers of cuildren witu type 1 diabetes is associated witu poor
glycae|ic control and parental e|otional distress; a popvlation-based stvdy. Diabet
`ed 2010; 27; 72…78.
88. Peters ]x, Naw˜ n ], ~an \esteren N. Uow adolescents witu diabetes eperience
social svpport fro| friends; two valitati~e stvdies. Scienti”
ca 2014; 2014.
89. `ali‚ ‰A, \oot U`. Assessing diabetes svpport in adolescents; factor strvctvre
of tue `odi”
ed Diabetes Social Svpport Žvestionnaire F`-DSSŽZa|ilyG. Pediatr
Diabetes 2011; 12; 258…265.
90. `ali‚ ‰A, \oot U`. Assessing diabetes svpport in adolescents; factor strvctvre
of tue |odi”
ed Diabetes Social SvpportŽvestionnaire FDSSŽ…ZriendsG. Diabet `ed
2012; 29; e232…e240.
91. ]a [reca A`, Bear|an \‰. Yue diabetes social svpport vestionnaire-fa|-
ily ~ersion; e~alvating adolescents diabetes-speci” c svpport fro| fa|ily |e|bers.
‰ Pediatr Psycuol 2002; 27; 665…676. 92. Uains AA, Berlin \S, Da~ies xU, S|otuers
`\, Sato AZ, Ale|•adeu ˆ. Attribvtions of adolescents witu type 1 diabetes related to
perfor|ing diabetes care arovnd friends and peers; tue |oderating role of friend svp-
port. ‰ Pediatr Psycuol 2007; 32; 561…570.
93. Uelgeson jS, Si|inerio ], ^scobar V, Be
c‚er D. Pre
dictors of |etabolic con-
trol a|ong adolescents witu diabetes; a 4-year longitvdinal stvdy. ‰ Pediatr Psycuol
2009; 34; 254…270.
94. Svlli~an-Bolyai S, Bo~a X, ]evng \, Yrvdeav A, ]ee `,[rvppvso P. Social
svpport to e|power parents FSY^PG; an inter~ention for parents of yovng cuildren
newly diagnosed witu type 1 diabetes. Diabetes ^dvc 2010; 36; 88…97.
  \b\t\b
541
97. xorrall-Da~ies A, Uolland P, Berg I, [oodyer I. Yue eŠ ect of ad~erse life e~ents
on glycae|ic control in cuildren witu insvlin dependent diabetes |ellitvs. ^vr Xuild
Adolesc Psycuiatry 1999; 8; 11…16.
98. Ue|a DA, ˆoper SV, Neuring ‰x, Xall A, `andleco B], Dycues YY. Daily
stressors and coping responses of cuildren and adolescents witu type 1 diabetes. Xuild
Xare Uealtu De~ 2009; 35; 330…339.
99. \vttner `‰, Dela|ater A`, Santiago ‰j. ]earned uelplessness in diabetic
yovtus. ‰ Pediatr Psycuol 1990; 15; 581…594.
100. Dela|ater A`, \vrt• S`, Bvbb ‰, xuite NU, Santiago ‰j. Stress and coping
in relation to |etabolic control of adolescents witu type 1 diabetes. ‰ De~ Beua~ Pediatr
1987; 8; 136…140.
101. [ross|an Uh, Brin‚ S, Uavser SY. Self-ež
cacy in adolescent girls and boys
witu insvlin-dependent diabetes |ellitvs. Diabetes Xare 1987; 10; 324…329.
102. [rave `, xent•el-]arsen Y, Brv ^, Uanestad Bˆ, Sø~i‚ V. Yue coping styles
of adolescents witu type 1 diabetes are associated witu degree of |etabolic control.
Diabetes Xare 2004; 27; 1313…1317.
103. ]vyc‚ \, SeiŠ
ge-\ren‚e I, Ua|pson S^. [lyce|ic control, coping, and
internali•ing and eternali•ing sy|pto|s in adolescents witu type 1 diabetes a cross-
lagged longitvdinal approacu. Diabetes Xare 2010; 33; 1424…1429.
104. hi-Zra•ier ‰P, haptangco `, Se|ana S, et al. Yue association of personal
resilience witu stress, coping, and diabetes ovtco|es in adolescents witu type 1 diabetes;
jariable- and person-focvsed approacues. ‰ Uealtu Psycuol 2014; in press.
105. jan Bvssel A, Nievwesteeg A, ‰anssen ^. [oal distvrbance and coping in cuil-
dren witu type I diabetes |ellitvs; relationsuips witu uealtu-related avality of life and
A1X. Xan ‰ Diabetes 2013; 37; 169…174.
106. S‚o·i¸ `, ˆvdan j, Bra–‚o~i¸ ], `ar·in‚o D. ˆelationsuip a|ong psycuopatuo-
logical di|ensions, coping |ecuanis|s, and glyce|ic control in a Xroatian sa|ple of
adolescents witu diabetes |ellitvs type 1. ^vr Xuild Adolesc Psycuiatry 2010; 19; 525…533.
107. Uanson X], Xigrang ‰A, Uarris `A, Xarle D], ˆelyea [, Bvrguen [A.
Xoping styles in yovtus witu insvlin-dependent diabetes|ellitvs. ‰ Xonsvlt Xlin Psycuol
1989; 57; 644…651.
108. ‰aser S, xuite ]. Xoping and resilience in adolescents witu type 1 diabetes.
Xuild Xare Uealtu De~ 2011; 37; 335…342.
109. Bond [[, Ai‚en ]S, So|er~ille SX. Yue uealtu belief |odel and adolescents
witu insvlin-dependent diabetes |ellitvs. Uealtu Psycuol 1992; 11; 190…198.
110. Brownlee-DvŠ
ec‚ `, Peterson ], Si|onds ‰Z, [oldstein D, \ilo X, Uoette S.
Yue role of uealtu beliefs in tue regi|en aduerence and |etabolic control of adolescents
and advlts witu diabetes |ellitvs. ‰ Xonsvlt Xlin Psycuol 1987; 55; 139…144.
111. Palardy N, [reening ], Vtt ‰, Uolderby A, Atcuison ‰. Adolescents uealtu
attitvdes and aduerence to treat|ent for insvlin-dependent diabetes |ellitvs. ‰ De~
Beua~ Pediatr 1998; 19; 31…37.
112. S‚inner YX, Ua|pson S^. Personal |odels of diabetes in relation to self-care,
well-being, and glyce|ic control; a prospecti~e stvdy in adolescence. Diabetes Xare
2001; 24; 828…833.
542
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
113. S‚inner YX, Ua|pson S^, Zife-Scuaw X. Personality, personal |odel beliefs,
and self-care in adolescents and yovng advlts witu type 1 diabetes.Uealtu Psycuol 2002;
21; 61…70.
114. Patino A`, Sancue• ‰, ^idson `, Dela|ater A`. Uealtu beliefs and regi|en
aduerence in |inority adolescents witu type 1 diabetes. ‰ Pediatr Psycuol 2005; 30; 503…512.
115. [rey `. Xoping and psycuosocial ad–vst|ent in |otuers of yovng cuildren
witu type 1 diabetes. ‰ Assoc Xare Xuild Uealtu 2009; 38; 91…106.
116. [rey `, ‰aser S, xuitte|ore ˆ, ‰eon S, ]inde|ann ^. Xoping s‚ills training
for parents of cuildren witu type 1 diabetes; 12-|ontu ovtco|es. Nvrs ˆes 2011; 60; 173.
117. ‰aser SS, ]ins‚y ˆ, [rey`.Xoping and psycuological distress in |otuers of
adolescents witu type 1 diabetes. `atern Xuild Uealtu ‰ 2014; 18; 101…108.
118. Pisvla ^, X•aplins‚a X. Xoping witu stress in adolescents witu type 1 diabetes
and tueir |otuers. ^vr ‰ `ed ˆes 2010; 15; 115…119.
119. Streisand ˆ, `ac‚ey ^ˆ, Uerge x. Associations of parent coping, stress, and
well-being in |otuers of cuildren witu diabetes; ea|ination of data fro| a national
sa|ple. `atern Xuild Uealtu ‰ 2010; 14; 612…617.
120. \orner A, xvr• ‰, Brosseav DX, Brauler ^, \apellen Y, \iess x. Parental
dyadic coping in fa|ilies of cuildren and adolescents witu type 1 diabetes. ‰ Pediatr
^ndocrinol `etab 2013; 26; 867…875.
121. Nievwesteeg A, Povwer Z, ~an der \a|p ˆ, ~an Ba‚el U, Aanstoot U‰,
Uart|an ^. Žvality of life of cuildren witu type 1 diabetes; a syste|atic re~iew. Xvrr
Diabetes ˆe~ 2012; 8; 434…443.
122. jarni ‰x, Bvrwin‚le Y`, ‰acobs ‰ˆ, [ottscual‚ `, \avf|an Z, ‰ones \].
Yue PedsŽ]£in type 1 and type 2 diabetes; reliability and ~alidity of tue Pediatric
Žvality of ]ife In~entory£generic core scales and type 1 diabetes |odvle. Diabetes
Xare 2003; 26; 631…637.
123. }pton P, ^iser X, Xuevng I, et al. `easvre|ent properties of tue }\-^nglisu
~ersion of tue Pediatric Žvality of ]ife In~entoryY` 4.0 FPedsŽ]Y`G generic core
scales. Uealtu Žval ]ife Vvtco|es 2005; 3; 22.
124. Ues‚etu \D, xa‚e `A, Xa|eron Z‰. Uealtu-related vality of life and |eta-
bolic control in cuildren witu type 1 diabetes; a prospecti~e couort stvdy. Diabetes Xare
2004; 27; 415…420.
125. xa‚e `, Ues‚etu \, Xa|eron Z. Yue Xuild Uealtu Žvestionnaire in cuildren
witu diabetes; cross-sectional svr~ey of parent and adolescent-reported fvnctional
uealtu statvs. Diabet `ed 2000; 17; 700…707.
126. Uassan \, ]oar ˆ, Anderson B‰, Ueptvlla ˆA. Yue role of socioecono|ic
statvs, depression, vality of life, and glyce|ic control in type 1 diabetes |ellitvs.
‰ Pediatr 2006; 149; 526…531.
  \b\t\b
543
129. Sand P, \l–a–i¸ `, Scualler ‰, Zorsander [. Yue reliability of tue uealtu related
vality of life vestionnaire PedsŽ] 3.0 Diabetes `odvle£ for Swedisu cuildren witu
type 1 diabetes. Acta Paediatr 2012; 101; e344…e349.
130. ]awrence ‰`, hi-Zra•ier ‰P, Blac‚ `U, et al. De|ograpuic and clinical cor-
relates of diabetes-related vality of life a|ong yovtu witu type 1 diabetes. ‰ Pediatr
2012; 161; 201…207 e2.
131. ]aŠ
el ]`B, Xonnell A, jangsness ], [oebel-Zabbri A, `ans”
eld A,
Anderson B‰.[eneral valityof life in yovtu witu type 1 diabetes relationsuipto patient
|anage|ent and diabetes-speci” c fa|ily con› ict. Diabetes Xare 2003; 26; 3067…3073.
132. ‰ounson Sˆ, Xooper `N, Da~is ^A, ‰ones Yx. Uypoglycae|ia, fear of uypo-
glycae|ia and vality of life in cuildren witu type 1 diabetes and tueir parents. Diabet
`ed 2013; 30; 1126…1131.
133. [rey `, Boland ^A, hv X, Svlli~an-Bolyai S, Ya|borlane xj. Personal and
fa|ily factors associated witu vality of life in adolescents witu diabetes. Diabetes Xare
1998; 21; 909…914.
134. [vtt|ann-Bav|an I, Zlauerty BP, Strvgger `, `c^~oy ˆX. `etabolic
control and vality-of-life self-assess|ent in adolescents witu IDD`. Diabetes Xare
1998; 21; 915…918.
135. Uoey U, Aanstoot U‰, Xuiarelli Z, et al. [ood |etabolic control is associated
witu better vality of life in 2,101 adolescents witu type 1 diabetes. Diabetes Xare 2001;
24; 1923…1928.
136. Uilliard `^, `ann \A, Pevgu ‰], Uood \\. Uow poorer vality of life in
adolescence predicts svbsevent type 1 diabetes |anage|ent and control. Patient ^dvc
Xovns 2013; 91; 120…125.
137. xagner j`, `üller-[odeŠ
roy ^, Sengbvscu S, Uäger S, Yuyen }. Age, |eta-
bolic control and type of insvlin regi|e in›
vences uealtu-related vality of life in cuil-
dren and adolescents witu type 1 diabetes |ellitvs. ^vr ‰ Pediatr 2005; 164; 491…496.
138. jalen•vela ‰`, Patino A`, `cXvllovgu ‰, et al. Insvlin pv|p tuerapy and
uealtu-related vality of life in cuildren and adolescents witu type 1 diabetes. ‰ Pediatr
Psycuol 2006; 31; 650…660.
139. ‰v~enile Diabetes ˆesearcu Zovndation Xontinvovs [lvcose `onitoring
Stvdy [rovp, Bec‚ ˆx, ]awrence ‰`, et al. Žvality-of-life |easvres in cuildren and
advlts witu type 1 diabetes; –v~enile diabetes researcu fovndation continvovs glvcose
|onitoring rando|i•ed trial. Diabetes Xare 2010; 33; 2175…2177.
140. Ua|pson S^, S‚inner YX, Uart ‰, et al. ^Š
ects of edvcational and psycuo-
social inter~entions for adolescents witu diabetes |ellitvs; a syste|atic re~iew. Uealtu
Yecunol Assess 2001; 5; 1…79.
141. `vrpuy Uˆ, ˆay|an [, S‚inner YX. Psycuoedvcational inter~entions for
cuildren and yovng people witu type 1 diabetes. Diabet `ed 2006; 23; 935…43.
142. Dela|ater A`, ‰acobson A`, Anderson B, et al. Psycuosocial tuerapies in
diabetes; report of tue psycuosocial tuerapies wor‚ing grovp. Diabetes Xare 2001; 24;
1286…1292.
143. Anderson B‰, Brac‚ett ‰, Uo ‰, ]aŠ
el ]`. An ož
ce-based inter~ention
to|aintain parent-adolescent tea|wor‚ in diabetes |anage|ent. I|pact on parent
544
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
in~ol~e|ent, fa|ily con›
ict, and svbsevent glyce|ic control. Diabetes Xare 1999;
22; 713…721.
144. xysoc‚i Y, `iller \`, [reco P, et al. Beua~ior tuerapy for fa|ilies of adoles-
cents witu diabetes;^Š
ects on directly obser~ed fa|ily interactions. Beua~ Yuer 1999;
145. xysoc‚i Y, Uarris `A, [reco P, et al. ˆando|i•ed, controlled trial of
beua~ior tuerapy for fa|ilies of adolescents witu insvlin-dependent diabetes |ellitvs.
‰ Pediatr Psycuol 2000; 25; 23…33.
146. xysoc‚i Y, [reco P, Uarris `A, Bvbb ‰, xuite NU. Beua~ior tuerapy for
fa|ilies of adolescents witu diabetes; |aintenance of treat|ent eŠ
ects. Diabetes Xare
2001; 24; 441…446.
147. xysoc‚i Y, Uarris `A, Bvc‚lou ]`, et al. ^Š ects of beua~ioral fa|ily syste|s
tuerapy for diabetes on adolescents fa|ily relationsuips, treat|ent aduerence, and
|etabolic control. ‰ Pediatr Psycuol 2006; 31; 928…938.
148. xysoc‚i Y, Uarris `A, Bvc‚lou ]`, et al. ˆando|i•ed trial of beua~ioral
fa|ily syste|s tuerapy for diabetes; |aintenance of eŠ
ects on diabetes ovtco|es in
adolescents. Diabetes Xare 2007; 30; 555…560.
149. xysoc‚i Y, Uarris `A, Bvc‚lou ]`, et al. ˆando|i•ed, controlled trial
of beua~ioral fa|ily syste|s tuerapy for diabetes; |aintenance and generali•ation of
ects on parent-adolescent co||vnication. Beua~ Yuer 2008; 39; 33…46.
150. ]aron ‡, [alat•er A, A|ir S, [il ˆ, \arp `, `i|ovni `. A |vltidisci-
plinary, co|preuensi~e, a|bvlatory treat|ent scue|e for diabetes |ellitvs in cuildren.
Diabetes Xare 1979; 2; 342…348.
151.
[alat•er A, A|ir S, [il ˆ, \arp `, ]aron ‡. Xrisis inter~ention progra| in
newly diagnosed diabetic cuildren. Diabetes Xare 1982; 5; 414…419.
152. Dela|ater A`, Bvbb ‰, Da~is S[, et al. ˆando|i•ed prospecti~e stvdy of self-
|anage|ent training witu newly diagnosed diabetic cuildren. Diabetes Xare 1990; 13;
153. Svndelin ‰, Zorsander [, `attson S^. Za|ilyoriented svpport at tue onset of
diabetes |ellitvs; a co|parison of two grovp conditions dvring 2 years following diag-
nosis. Acta Paediatr 1996; 85; 49…55.
154. Svlli~an Bolyai S, [rey `, Deatric‚ ‰, [rvppvso P, [iraitis P, Ya|boriane x.
Uelping otuer |otuers eŠ
ecti~ely wor‚ at raising yovng cuildren witu type 1 diabetes.
Diabetes ^dvc 2004; 30; 476…84.
155. xysoc‚i Y, Yaylor A, Uovgu BS, ]inscueid Yˆ, heates \V, Nagveri ‰A.
De~iation fro| de~elop|entally appropriate self-care avtono|y; association witu dia-
betes ovtco|es. Diabetes Xare 1996; 19; 119…125.
156. ]aŠ
el ]`B, jangsness ], Xonnell A, [oebel-Zabbri A, Bvtler D, Anderson
B. I|pact of a|bvlatory, fa|ily-focvsed tea|wor‚ inter~ention on glyce|ic control in
yovtu witu type 1 diabetes. ‰ Pediatr 2003; 142; 409…416.
157. S~oren B`, Bvlter B, ]e~ine B-S, Anderson B‰, ]aŠ el ]`B. ˆedvcing acvte
  \b\t\b
545
159. ^llis DA, Zrey `A, Naar-\ing S, Ye|plin Y, Xvnningua| PB, Xa‚an N. }se
of `vltisyste|ic tuerapy to i|pro~e regi|en aduerence a|ong adolescents witu type
1 diabetes in curonic poor |etabolic control; a rando|i•ed controlled trial. Diabetes
Xare 2005; 28; 1604…1610.
160. ^llis DA, Naar-\ing S, Zrey `, Ye|plin Y, ˆowland `, Xa‚an N.
`vltisyste|ic treat|ent of poorly controlled type 1 diabetes; eŠ
ects on |edical
resovrce vtili•ation. ‰ Pediatr Psycuol 2005; 30; 656…666.
161. ^llis DA, Naar-\ing S, Ye|plin Y, et al. `vltisyste|ic tuerapy for adolescents
witu poorly controlled type 1 diabetes; redvced diabetic ‚etoacidosis ad|issions and
related costs o~er 24 |ontus. Diabetes Xare 2008; 31; 1746…1747.
162. Anderson B‰, xolf Z`, Bvr‚uart `Y, Xornell ˆ[, Bacon [^. ^Š
ects of
peer-grovp inter~ention on |etabolic control of adolescents witu idd|; rando|i•ed
ovtpatient stvdy. Diabetes Xare 1989; 12; 179…183.
163. Boland ^A, [rey `, Vesterle A, Zredric‚son ], Ya|borlane xj. Xontinvovs
svbcvtaneovs insvlin infvsion. A new way to lower ris‚ of se~ere uypoglyce|ia,
i|pro~e|etabolic control, and enuance coping in adolescents witu type 1 diabetes.
Diabetes Xare 1999; 22; 1779…1784.
164. [rey `, Boland ^A, Da~idson `, hv X, Svlli~an-Bolyai S, Ya|borlane xj.
Suort-ter| eŠ ects of coping s‚ills training as ad–vnct to intensi~e tuerapy in adoles-
cents. Diabetes Xare 1998; 21; 902…908.
165. [rey `, Boland ^A, Da~idson `, ]i ‰, Ya|borlane xj. Xoping s‚ills training
for yovtu witu diabetes |ellitvs uas long-lasting eŠ
ects on |etabolic control and vality
of life. ‰ Pediatr 2000; 137; 107…113.
166. Boardway ˆU, Dela|ater A`, Yo|a‚ows‚y ‰, [vtai ‰. Stress |anage|ent
training for adolescents witu diabetes. ‰ Pediatr Psycuol 1993; 18; 29…45.
167. Uains AA, Da~ies x, Parton ^, Yot‚a ‰, A|oroso-Xa|arata ‰. A stress |anage-
|ent inter~ention for adolescents witu type i diabetes. Diabetes ^dvc 2000; 26; 417…424.
168. `énde• Z‰, Belénde• `. ^Š
ects of a beua~ioral inter~ention on treat|ent
aduerence and stress |anage|ent in adolescents witu IDD`.Diabetes Xare 1997; 20;
1370…1375.
169. Xoo‚ S, Uerold \, ^didin Dj, Briars ˆ. Increasing proble| sol~ing in ado-
lescents witu type 1 diabetes; tue cuoices diabetes progra|. Diabetes ^dvc 2002; 28;
115…124.
170. ‰acobson A`, Uavser SY, xillet ‰, xolfsdorf ‰I, Uer|an ]. Xonsevences of
irregvlar ~ersvs continvovs |edical follow-vp in cuildren and adolescents witu insvlin-
dependent diabetes |ellitvs. ‰ Pediatr 1997; 131; 727…733.
171. \avf|an Zˆ, Ual~orson `, Xarpenter S.Association between diabetes control
and ~isits to a |vltidisciplinary pediatric diabetes clinic. Pediatrics 1999; 103; 948…951.
172. ‰ounson SB, \elly `, Uenretta ‰X, Xvnningua| xˆ, Yo|er A, Sil~erstein ‰A.
A longitvdinal analysis of aduerence and uealtu statvs in cuilduood diabetes. ‰Pediatr
Psycuol 1992; 17; 537…553.
173. jiner ˆ`, Xuristie D, Yaylor j, Uey S. `oti~ationalsolvtion-focvsed inter-
~ention i|pro~es UbA1c in adolescents witu type 1 diabetes; a pilot stvdy. Diabet `ed
2003; 20; 739…742.
546
!\t\t 16. ( \t \n*    \b\t  \t\t\b\f \t 
174. Xuannon S, S|itu j‰, [regory ‰x. A pilot stvdy of |oti~ational inter~iewing
in adolescents witu diabetes. Arcu Dis Xuild 2003; 88; 680…683.
175. Xuannon S‰, Uvws-Yuo|as `, ˆollnic‚ S, et al. A |vlticenter rando|i•ed
controlled trial of |oti~ational inter~iewing in teenagers witu diabetes. Diabetes Xare
2007; 30; 1390…1395.
176. Nansel Yˆ, Iannotti ˆ‰, Si|ons-`orton B[, et al. Diabetes personal trainer
ovtco|es; suort-ter| and 1-year ovtco|es of a diabetes personal trainer inter~ention
a|ong yovtu witu type 1 diabetes. Diabetes Xare 2007; 30; 2471…7.
177. Nansel Yˆ, Iannotti ˆ‰, Si|ons-`orton B[, Plotnicu ]P, Xlar‚ ]`, ‡eit•oŠ
]. ]ong-ter| |aintenance of treat|ent ovtco|es; diabetes personal trainer inter~en-
tion for yovtu witu type 1 diabetes. Diabetes Xare 2009; 32; 807…809.
178. A|brosino ‰`, Zennie \, xuitte|ore ˆ, ‰aser S, Dowd `Z, [rey `. Suort-
ter| eŠ
ects of coping s‚ills training in scuool-age cuildren witu type 1 diabetes. Pediatr
Diabetes 2008; 9; 74…82.
179. [rey `, xuitte|ore ˆ, ‰aser S, et al. ^Š
ects of coping s‚ills training in scuool-
age cuildren witu type 1 diabetes. ˆes Nvrs Uealtu 2009; 32; 405…418.
180. De xit `, Dele|arre-jan de xaal UA, Povwer Z, [e|‚e ˆ‰B‰, Snoe‚ Z‰.
`onitoring and discvssing uealtu-related vality of life in adolescents witu type 1 dia-
betes i|pro~e psycuosocial well-being; a rando|i•ed controlled trial. Diabetes Xare
2008; 31; 1521…1526.
181.
`vrpuy Uˆ, xadua| X, ˆay|an [, S‚inner YX. Approacues to integrating pae-
diatric diabetes care and strvctvred edvcation; eperiences fro| tue Za|ilies, Adolescents,
and Xuildrens Yea|wor‚ Stvdy FZAXYSG. Diabet `ed 2007; 24; 1261…1268.
182. Nansel Yˆ, Anderson B‰, ]aŠ el ]`B, et al. A |vltisite trial of a clinic-
integrated inter~ention for pro|oting fa|ily |anage|ent of pediatric type 1 diabetes;
feasibility and design. Pediatr Diabetes 2009; 10; 105…115.
183. Nansel Yˆ, Iannotti ˆ‰, ]iv A. Xlinic-integrated beua~ioral inter~ention for
fa|ilies of yovtu witu type 1 diabetes; rando|i•ed clinical trial. Pediatrics 2012; 129;
e866…e873.
184. `vl~aney SA, ˆotu|an ˆ], xallston \A, ]ybarger X, Dietricu `S.An
internet-based progra| to i|pro~e self-|anage|ent in adolescents witu type 1 diabe-
tes. Diabetes Xare 2010; 33; 602…604.
185. `vl~aney SA, ˆotu|an ˆ], Vsborn Xh, ]ybarger X, Dietricu S, xallston \A.
Self-|anage|ent proble| sol~ing for adolescents witu type 1 diabetes; Inter~ention
processes associated witu an Internet progra|. Patient ^dvc Xovns 2011; 85; 140…142.
186. [rey `, xuitte|ore ˆ, ‰eon S, `vrpuy \, Zavl‚ner `S, Dela|ater A.
Internet psycuoedvcation progra|s i|pro~e ovtco|es in for yovtu witu type 1 diabetes.
Diabetes Xare 2013; 36; 2475…2482.
1 \t\t 28
\n\r\b 5\t  5\r\n\f7 \r\n
Cameron F.J., Amin R., de Beaufort C., Codner E., Acerini C.L. ISPAD Clinical Practice Consensus
Guidelines „ 2014: \n \b \t \r\f\f \f\t\f \t\f! \b. "\b\b  \b 2014: 15
Fergus J Cameron
, Rakesh Amin
, Carine de Beaufort
548
!\t\t 17. \t\t\b\f\r \t   \b \b\t
\n\b\b M\b\t8 \t \r\f7\b5:\t\t




 #/ \f\r" ""\t /\f!# ":#
" \r\t, " \t'  \fJE## "\r#;
…%\f\r## #'#\t#, \t'#  :\r"" \r#-
…/ \r#\rC"@J :J\f#J "\r## F\nGz
…\r!#\t# #E \f#\t FXGz
…\r# \f# F\n, LG.




\f \r\f#'#\r "\r#\r #\f#

'#"# \f\r#"@/ # "##\rJE#/ "!# C\f
\f#$### \r:"## # $#"#-\f\r"# # #/


E# C" :"@ ',  C \t#"@ $#@#
\f\f = \f  \b  \f\t
549

 #\t, J\t "\r"J \f##J, \r'\r!# \r:,







550
!\t\t 17. \t\t\b\f\r \t   \b \b\t








 \f \f \f  \f\r \n, \f\t*\f  \b
551
8\b\t \f7 \b\b 75\t:\t\b\n\f 7\t,
\b\t\fL\b 58 5\r\n\f
\r\f "\r"## '#\t E# " J"@




#, \f\t " ": \f""@ \r"# ##J

552
!\t\t 17. \t\t\b\f\r \t   \b \b\t



 17.1
\n!(! "*!%!+ * j. Stklnmkro [40] ! "-%+ !%*3!+
p. CkroBpkqqy O200XQ [41]
U\t\rR\t \t\n+\t
C\t\r\tC\n\t\r\t
E \b +m\r (\b)Q, \t\b+
"\r#"\r, C"# \r\f#"# "\fJ" \r#', "\t" #
 \f \f \f  \f\r \n, \f\t*\f  \b
553

"#"# \r##\t $##'#\r #/#

�:# :#\t  #@'# "\r"#, "\r



\r\fC# \r':\r'/ :\r'"@/ 'C",
J\t "\r"J, \r#"#\rJ  #"\r \f\r"
554
!\t\t 17. \t\t\b\f\r \t   \b \b\t

)##"$#\t "\r  \r"##  \f#:", ": #"@
\n \t7L\b 7\t\n\f\t \f\b\rL






*, \b \f  \t\b \n \f\f \b \t\b\t
555
8M8 \t \t\f7\t8
\f #'-' / ":# "\r\t, "\r /\f!"\t







&\f J\f\t :/\f# :H\t#"@ \r#E", "\r \f"
#"@ ####, ": \f\r"# # \r##"@ \r#@
 :/\f# :C\f"@  ", ": # \r'# # \f\r'@\t
 \r#/, #"/ # ## #### \r# #'## :
\fL, \f\r\b\t \t  \r\b\b \r \r
556
!\t\t 17. \t\t\b\f\r \t   \b \b\t



(\r#\r# F: \f!#/ \f\r"G  #\t##




= \f
557




 \r'\r!#J \r:, " $ # \r\f$#\t#
 \r'\r:" :"/ "\r"# #':#\t \r:, :
M5\b\t
 ## "#"@"@J, ":#@ ":##
\r#!"#  \f#"  \n1 m75…77q. (\f#\t "C
&\f/ J\f, #\rJE#/ #"@ \f#"@# \r,
:/\f# \r#"\r"#\r"@ "#"@ """JE#/


558
!\t\t 17. \t\t\b\f\r \t   \b \b\t

\r5\n\r\n




/\r!## \r:"##, # # \f"" '\r # "

…\b"@ #"@#  '#J E# :, J\t #-
…(':"@ 'C"# \r'#"#\t "\tC ####.
…\b"@ \r\f##  # \r:"\f" "#"@ \n.
…("@ $#@ \f#$# 'J# \f\t "$#@-
 \t*\f \b*
\n\f\nL\b 5\rL
\n" \f J\f\t  \r @ '\f\r@\t












560
!\t\t 17. \t\t\b\f\r \t   \b \b\t
\f\b\r: :\t8
*?\n \fC :"@ @ "#"@  \r##' #
@"\r \r, "\r " #\t"@  :\r "\f

)%@ #@




\n\r#$#\f #, 'C, ##J" %"#"@

#%()%@ ! ()%@ %3*!@

= \r! #"@, " \r# \r@/ "\r$"#,
 \t*\f \b*
561










562
!\t\t 17. \t\t\b\f\r \t   \b \b\t

#%()%@ !%f3!! *(%!%% &"!+


5("/%+ -!#+ %3*3!+


 \t 6\f7\b
( \b    \t\b \r =  \b\r  \f\r =
563
": \f\f\rC"@ %## "\t#  \r\t %'.
\r5  5\t\r\t\n\f \nM \f \r\n
75\t:\t\b\n\f \nM
564
!\t\t 17. \t\t\b\f\r \t   \b \b\t


\r\f"# :H\f# ### \f\t \f\r" ##




Q\r! '#\f"#, J\t #@ ###

  \b\t\b
565

='\r\t \f#$#\t C: \fC :"@ "\r "#
#!# \f# \r/\f  '\r \f#$## C:
\f\b9\t\f \t\b\r\n
\n \t\n\f \t\r\r
1. S‚inner YX, Xuannon S, Uowells ], `ce~illy A. Diabetes dvring adolescence.
In; SNoe‚ Z‰, S‚inner YX, eds. Psycuology in Diabetes Xare. Xuicuester, ^ngland;
‰oun xiley ¶ Sons, 2000; __…__.
2. xertuer [A, Xovrt ‰` F^dsG. Diabetes and tue Adolescent. `elbovrne;
`irano~a Pvblisuers, 1998.
3. `ortensen UB, ˆobertson \‰, Aanstoot U‰ et al. Insvlin |anage|ent and |eta-
bolic control of type 1 diabetes |ellitvs in cuilduood and adolescence in 18 covntries.
U~idore Stvdy [rovp on Xuilduood Diabetes. Diabet `ed 1998; 15; 752…759.
4. janelli `, Xuiarelli Z, Xuiari [ et al. `etabolic control in cuildren and adoles-
cents witu diabetes; eperience of two Italian ˆegional Xenters. ‰ Pediatr ^ndocrinol
`etab 1999; 12; 403…409.
5. Dabadguao P, jid|ar S, Xa|eron Z‰. Deteriorating diabetic control turovgu
adolescence … do tue origins lie in cuilduood— Diabet `ed 2001; 18; 889…894.
6. \ing PS, Berg XA, Bvtner ‰ et al. ]ongitvdinal tra–ectories of |etabolic control
across adolescence; associations witu parental in~ol~e|ent, adolescents psycuosocial
|atvrity, and uealtu care vtili•ation. ‰ Adolesc Uealtu 2012; 50; 491…496.
566
!\t\t 17. \t\t\b\f\r \t   \b \b\t
7. xebb \], Dobson A‰, VXonnell D] et al. Dietary co|pliance a|ong insvlin-
dependent diabetics. ‰ Xuronic Dis 1984; 37; 633…643.
8. ]o|an D[, [algani XA. Puysical acti~ity in adolescents witu diabetes. Diabetes
^dvc 1996; 22; 121…125.
9. Xer‚oney \A, Uart ]\. Yue relationsuip between tue uealtu belief|odel and
co|pliance of persons witu diabetes |ellitvs. Diabetes Xare 1980; 3; 594…598.
10. ]agreca A, Avslander x, [reco P, Spetter D, Zisuer ^, Santiago ‰. I get by witu
a little uelp fro| |y fa|ily and friends; adolescents svpport for diabetes care. ‰ Pediatr
Psycuol 1995; 20; 449…476.
11. Dv Pasvier-Zediae~s‚y ], Yvbiana-ˆv”
N. Discordance between puysician
and adolescent assess|ents of aduerence to treat|ent; in›
vence of UbA1c le~el. Yue
P^DIAB Xollaborati~e [rovp. Diabetes Xare 1999; 22; 1445…1449.
12. `orris AD, Boyle DI, `c|auon AD, [reene SA, `acdonald Y`, Newton ˆx.
Aduerence to insvlin treat|ent, glycae|ic control and ‚etacidosis in insvlindependent
diabetes |ellitvs. Yue DAˆYS`^`V Xollaboration. Diabetes Avdit and ˆesearcu in
Yayside, Scotland. `edicines`onitoring }nit. ]ancet 1997; 350; 1505…1510.
13. Bryden \S, Neil A, `ayov ˆA, Pe~eler ˆX, Zairbvrn X[, Dvnger DB. ^ating
uabits, body weigut, and insvlin |isvse. A longitvdinal stvdy of teenagers and yovng
advlts witu type 1 diabetes. Diabetes Xare 1999; 22; 1956…1960.
14. Sawyer S`, Drew S, heo `S, Britto `Y. Adolescents witu a curonic condition;
cuallenges li~ing, cuallenges treating. ]ancet 2007; 369; 1481…1489.
15. ˆodin [, ‰ounson ], [ar”
n‚el P, Dane|an D, \ensuole A. ^ating disorders
in fe|ale adolescents witu insvlin dependent diabetes |ellitvs. Int ‰ Psycuiatry `ed
1986; 16; 49…57.
16. Dane|an D, Vl|sted `, ˆydall A, `auara– S, ˆodin [. ^ating disorders in
yovng wo|enwitu type 1 diabetes. Pre~alence, proble|s and pre~ention. Uor| ˆes
1998; 50 FSvppl. 1G; 79…86.
17. ‰ones ‰`, ]awson `], Dane|an D, Vl|sted `P, ˆodin [. ^ating disorders
in adolescent fe|ales witu andwituovt type 1 diabetes; cross sectional stvdy. B`‰ 2000;
320; 1563…1566.
18. Pe~eler ˆX, Zairbvrn X, Boller I, Dvnger DB. ^ating disorders in adolescents
witu IDD`. Diabetes Xare 1992; 15; 1356…1360.
19. Pe~eler ˆX, Bryden \S, Neil UA et al. Yue relationsuip of disordered eating
uabits and attitvdes to clinical ovtco|es in yovng advlt fe|ales witu type 1 diabetes.
Diabetes Xare 2005; 28; 84…88.
20. Xolton PA, Vl|sted `P, Dane|an D, ˆodin [`. Depression, distvrbed
eating beua~ior, and |etabolic control in teenage girls witu type 1 diabetes. Pediatr
Diabetes 2013; 14; 372…376.
21. A|iel SA, Suerwin ˆS, Si|onson DX, ]vritano AA, Ya|borlane x. I|paired
insvlin action in pvberty; a contribvting factor to poor glyce|ic control in adolescents
witu diabetes. N ^ngl ‰ `ed 1986; 315; 1273…1280.
22. Bognetti ^, `acellaro P, No~elli D, `escui Z, Xiralli Z, Xuiv|ello [.
Pre~alence and correlates of obesity in insvlin dependent diabetic patients. Arcu Dis
Xuild 1995; 73; 239…242.
  \b\t\b
567
23. Do|argard A, Sarnblad S, \roon `, \arlsson I, S‚eppner [, A|an ‰.
Increased pre~alence of o~erweigut in adolescent girls witu type 1 diabetes |ellitvs.
Acta Paediatr 1999; 88; 1223…1228.
24. Ingberg X`, Sarnblad S, \roon `, \arlsson I, S‚eppner [, A|an ‰. Body
co|position in adolescent girls witu type 1 diabetes. Diabet `ed 2003; 20; 1005…1011.
25. Xodner ^, Barrera A, `oo‚-\ana|ori D et al. Ponderal gain, waist-to-uip
ratio and pvbertal de~elop|ent in girls witu type-1 diabetes |ellitvs. Pediatr Diabetes
2004; 5; 182…189.
26. Danielson \\, Palta `, Allen X, DAlessio D‰. Yue association of increased
glycosylated ue|oglobin le~els witu delayed age at |enarcue in yovng wo|en witu type
1 diabetes. ‰ Xlin ^ndocrinol `etab 2005; 90; 6466…6471.
27. xertuer [A, Xa|eron Z‰, Xovrt ‰`. In; Sperling `A, ed. Adolescent Diabetes
in Yype 1 Diabetes; ^tiology andYreat|ent.Vttowa; Uv|ana Press, 2003.
28. Xanadian Diabetes Association 2013. Xlinical practice gvidelines for tue pre~en-
tion and |anage|ent of diabetes in Xanada. Xanadian ‰ovrnal of Diabetes 2013; 37;
S153…S167.
29. Sil~erstein ‰, \lingens|itu [, Xopeland \ et al. Xare of cuildren and adoles-
cents witu type 1 diabetes; a state|ent of tue A|erican Diabetes Association FADA
State|entG. Diabetes Xare 2005; 28; 186…212.
30. National ^~idence Based Xlinical [videlines for Yype 1 Diabetes in Xuildren,
Adolescents and Advlts 2011 Fa~ailable fro| uttp;www.nu|rc. go~.avgvidelines
pvblicationset4G.
31. ˆesovrces to Svpport tue Deli~ery of Xare for Xuildren and hovng People xitu
Diabetes. Diabetes}\. 2005 Fa~ailable fro| uttp;www.diabetes.org.v‚ good™prac-
ticecuildrendownloadsresovrce.pdfG.
32. Yype 1 Diabetes; Diagnosis and `anage|ent of Yype 1 Diabetes in Xuildren,
hovng People and Advlts. National Institvte for Xlinical ^cellence; 2004 Fa~ailable
fro| uttp;www.nice.org.v‚pdf X[015NIX^gvideline.pdfG.
33. Xro|er BA, Yarnows‚i \‰. Nonco|pliance in adolescents; a re~iew. ‰ De~
Beua~ Pediatr 1989; 10; 207…215.
34. Svris ‰-X, `icuavd P-A, jiner ˆ. Yue adolescent witu a curonic condition. Part
I; de~elop|ental issves. Arcu Dis Xuild 2004; 89; 938…942.
35. `icuavd P-A, Svris ‰-X, jiner ˆ. Yue adolescent witu a curonic condition. Part
II; uealtucare pro~ision. Arcu Dis Xuild 2004; 89; 943…949.
36. Ua|pson S^, S‚inner YX, Uart ‰ et al. ^Š
ects of edvcational and psycuosocial
inter~entions for adolescents witu diabetes |ellitvs; a syste|atic re~iew. Uealtu Yecunol
Assess 2001; 5; 1…79.
37. xin‚ley \, ]andav S, ^isler I, Is|ail \. Psycuological inter~entions to i|pro~e
glycae|ic control in patients witu type 1 diabetes; syste|atic re~iew and |eta-analysis
of rando|ised controlled trials. B`‰ 2006; 333; 65…68.
38. ˆobling `, `cNa|ara ˆ, Bennert \ et al. Yue eŠ
ect of tue Yal‚ing Diabetes
consvlting s‚ills inter~ention on glycae|ic control and vality of life in cuildren witu
type 1 diabetes; clvster rando|i•ed controlled trial FD^PIXY^D stvdyG. B`‰ 2012;
344; e2359.
568
!\t\t 17. \t\t\b\f\r \t   \b \b\t
39. Xuannon S, S|itu j, Alcolado ‰, [regory ‰x. Xvrrent |etuods of transfer of
yovng people witu type 1 diabetes to advlt ser~ices.Diabet`ed 2003; 20; 1034.
40. \yngas U, Uentinen `, Barlow ‰U. Adolescents perceptions of puysicians,
nvrses, parents and friends; uelp or uindrance in co|pliancewitu diabetes self-care.
‰ Ad~ Nvrs 1998; 27; 760…769.
41. Patino A`, Sancue• ‰, ^idson `, Dela|ater A`. Uealtu beliefs and regi|en
aduerence in |inority adolescents witu type 1 diabetes. ‰ Pediatr Psycuol 2005; 30; 503…512.
42. Anderson B, Uo ‰, Brac‚ett ‰, Zin‚elstein D, ]aŠ
el ]. Parental in~ol~e|ent
in diabetes |anage|ent tas‚s; relationsuips to blood glvcose |onitoring aduerence
and |etabolic control in yovng adolescents witu insvlin-dependent diabetes |ellitvs.
‰ Pediatr 1997; 130; 257…265.
43. xuite \, \ol|an `], xeler P, Polin [, xinter ˆ‰. }nstable diabetes and
vnstable fa|ilies; a psycuosocial e~alvation of diabetic cuildren witu recvrrent ‚etoaci-
dosis. Pediatrics 1984; 73; 749…755.
44. Dv‚e DX, [eŠ ‚en [ˆ, ]ewin AB, xillia|s ]B, Storcu ^A, Sil~erstein ‰U.
[lyce|ic control in yovtu witu type 1 diabetes; fa|ily predictors and |ediators.
‰ Pediatr Psycuol 2008; 33; 719…727.
\Š ‚en [ˆ, Dv‚e A et al. Za|ily fvnctioning and aduerence in
yovtu witu type 1 diabetes; a latent growtu |odel of glyce|ic control. Xuild Uealtu
Xare 2010; 39; 279…295.
46. Uelgeson jS, Si|inerio ], ^scobar V, Be
c‚er D. Pre
dictors of |etabolic con-
trol a|ong adolescents witu diabetes; a 4-year longitvdinal stvdy. ‰ Pediatr Psycuol
2008; 34; 254…270.
47. SeiŠ ge-\ren‚e I, ]avrsen B, Dic‚son D‰, Uartl AX. Declining |etabolic con-
trol and decreasing parental svpport a|ong fa|ilies witu adolescents witu diabetes; tue
ris‚ of restricti~eness. ‰ Pediatr Psycuol 2013; 38; 518…530.
48. Xa|eron Z‰, S‚inner YX, de Beavfort X^ et al. Are fa|ily factors vni~ersally
related to |etabolic ovtco|es in adolescents witu type 1 diabetes— Diabet `ed 2008;
49. Steinberg ]. Yue fa|ily at adolescence; transition and transfor|ation. ‰ Adolesc
Uealtu 2000; 27; 170…178.
50. Nortua| ^A, Yodd S, Xa|eron Z‰. Inter~entions to pro|ote opti|al uealtu
ovtco|es in cuildren witu type 1 diabetes. Diabet `ed 2006; 23; 113…121.
51. [oldenring ‰`, ˆosen DS. [etting into adolescents ueads; an essential vpdate.
Xonte|p Pediatr 2004; 21; 64.
52. Uowells ], xilson A, S‚inner YX, Newton ˆ, `orris AD, [reen SA. A ran-
do|ised control trial of tue eŠ
ect of negotiated telepuone svpport on glycae|ic control
in yovng people witu type 1 diabetes. Diabet `ed 2002; 19; 643…648.
53. De xit `, Dela|arre-jan D^, xaal U, Bo‚|a ‰A et al. `onitoring and
discvssing uealtu-related vality of life in adolescents witu type 1 diabetes i|pro~e
psycuosocial well-being. Diabetes Xare 2008; 31; 1521…1526.
54. Swift P[, S‚inner YX, de Beavfort X^ et al. Yarget setting in intensi~e insvlin
|anage|ent is associated witu |etabolic control; tue U~idoere cuilduood diabetes
stvdy grovp centre diŠ
erences stvdy 2005. Pediatr Diabetes 2010; 11; 271…278.
  \b\t\b
569
55. Zran‚lin j], xaller A, Pagliari X, [reene SA. A rando|ised controlled trial of
570
!\t\t 17. \t\t\b\f\r \t   \b \b\t
72. International Diabetes Zederation FIDZG. Diabetes and Yobacco }se; A Uar|fvl
Xo|bination. Position State|ent 2003 Fa~ailable fro| uttp;www.idf.orgG.
73. Sinua ˆN, Patric‚ Ax, ˆicuardson ], xal-]y|au|ed `, `acfarlane IA.
A si-year followvp stvdy of s|o‚ing uabits and |icro~ascvlar co|plications in yovng
advlts witu type 1 diabetes. Postgrad `ed ‰ 1997; 73; 293…294.
74. In‚ster B, Zrier B`. Diabetes and dri~ing. Diabetes Vbes `etab 2013; 15;
775…783.
75. Diabetes and Dri~ing; Infor|ation Sueet. 2005 Fa~ailable fro| www.diabetes.
org.v‚G 76. Xo D‰, Penbertuy ‰Z, ‡rebiec ‰ et al. Diabetes and dri~ing |isuapsz
frevency and correlations fro| a |vltinational svr~ey. Diabetes Xare 2003; 26;
2329…2334.
77. Uypoglyce|ia and ^|ploy|ent]icensvre. A|erican Diabetes Association;
position state|ent. Diabetes Xare 2006; 29 FSvppl. 1G; S67.
78. A|erican Diabetes Association, Anderson ‰^, [reene `A et al.Diabetes and
e|ploy|ent.Diabetes Xare 2014; 37 FSvppl. 1G; S112…S117.
79. Xodner ^, Soto N, `erino P`. Xontraception, and pregnancy in adolescents
witu type 1 diabetes; a re~iew. Pediatr Diabetes 2012; 13; 108…123.
80. ˆay ‰[, VBrien Y^, Xuan xS. Preconception care and tue ris‚ of congenital
ano|alies in tue oŠ spring of wo|en witu diabetes |ellitvs; a |eta-analysis. Ž‰` 2001;
94; 435…444.
81. xendland ^`, Yorloni `ˆ, Zala~igna ` et al. [estational diabetes and preg-
nancy ovtco|es…a syste|atic re~iew of tue xorld Uealtu Vrgani•ation FxUVG and tue
International Association of Diabetes in Pregnancy Stvdy [rovps FIADPS[G diagnos-
tic criteria. B`X Pregnancy Xuildbirtu 2012; 12; 23.
82. Vwens ]A, A~alos [, \irwan B, Xar|ody ], Dvnne Z, AY]ANYIX DIP.
Xlosing tue loop. Diabetes Xare 2012; 35; 1669…1671.
83. Negrato XA, `attar ˆ, [o|es `B. Ad~erse pregnancy ovtco|es in wo|en
witu diabetes. Diabetol `etab Syndr 2012; 4; 41.
84. Bis|vtu ^, Bovcue X, Xali|an X et al. `anage|ent of pregnancy in wo|en
witu type 1 diabetes |ellitvs; gvidelines of tue Zrencu-Spea‚ing Diabetes Society
FSociete francopuone dv diabete mSZDqG. Diabetes `etab 2012; 38; 205…216.
85. Xodner ^, ^y•agvirre ZX, Inigve• [ et al. V~vlation rate in adolescents witu
type 1 diabetes |ellitvs. Zertil Steril 2011; 95; 197…202.e1.
86. `erino P`, ˆivel|e ‰^, Xodner ^. Addressing fertility and reprodvcti~e
issves in fe|ale adolescents witu diabetes. Diabetes `anage 2012; 2; 479…482.
87. Xodner ^, `erino P`, Yena-Se|pere `. Ze|ale reprodvction and type 1 dia-
betes; fro| |ecuanis|s to clinical ”
ndings. Uv| ˆeprod }pdate 2012; 18; 568…585.
88. Zedele D, Xoscelli X, Xvcinotta D et al. Incidence of erectile dysfvnction in
Italian |en witu diabetes. ‰ }rol 2001; 166; 1368…1371.
89. Ziscul AZ, Uer|an xU, Serei‚a S` et al. I|pact of a preconception covnsel-
ing progra| for teens witu type 1 diabetes Fˆ^ADh-[irlsG on patient-pro~ider interac-
tion, resovrce vtili•ation, and cost. Diabetes Xare 2010; 33; 701…705.
90. Xuarron-Procuowni‚ D, Uannan `Z, Ziscul Aˆ, Slocv| ‰`. Preconception
planning; are we |a‚ing progress— Xvrr Diab ˆep 2008; 8; 294…298.
  \b\t\b
571
91. Xatalano P`, `cIntyre UD, Xrvic‚suan‚ ‰\ et al. Yue uyperglyce|ia and
ad~erse pregnancy ovtco|e stvdy; associations of[D`and obesity witu pregnancy
ovtco|es. Diabetes Xare 2012; 35; 780…786.
92. Steel ‰`, Dvncan ]‰. Seriovs co|plications of oral contraception in insvlin-
dependent diabetics. Xontraception 1978; 17; 291…295.
93. jisser ‰, Snel `, jan jliet UA. Uor|onal ~ersvs non-uor|onal contracepti~es
in wo|en witu diabetes |ellitvs type 1 and 2. Xocurane Database Syst ˆe~ 2006; 4;
XD003990.
94. [arg S\, Xuase UP, `arsuall [, Uoops S], Uol|es D], ‰ac‚son x^. Vral
contracepti~es and renal and retinal co|plications in yovng wo|en witu insvlin-depen-
dent diabetes |ellitvs. ‰A`A 1994; 271; 1099…1102.
95. Snell-Bergeon ‰\, Dabelea D, Vgden ][ et al. ˆeprodvcti~e uistory and uor-
|onal birtu control vse are associated witu coronary calciv| progression in wo|en
witu type 1 diabetes |ellitvs. ‰ Xlin ^ndocrinol `etab 2008; 93; 2142…2148.
96. \lein B^, \lein ˆ, `oss S^.`ortality and uor|onerelated eposvres in
wo|en witu diabetes. Diabetes Xare 1999; 22; 248…252.
97. \lein B^, \lein ˆ, `oss S^. ^ogenovs estrogen eposvres and cuanges in dia-
betic retinopatuy. Yue xisconsin epide|iologic stvdy of diabetic retinopatuy. Diabetes
Xare 1999; 22; 1984…1987.
98. Di~ision of ˆeprodvcti~e Uealtu NXfXDP, Uealtu Pro|otion XfDX,
Pre~ention. }.S. selected practice reco||endations for contracepti~e vse, 2013Adapted
fro| tue xorld Uealtu Vrgani•ation selected practice reco||endations for contracep-
ti~e vse, 2nd edn. ``xˆ ˆeco|| ˆep 2013; 62; 1…60.
99. xUV. `edical ^ligibility Xriteria for Xontracepti~e }se. 4tu edn. [ene~a;
xUV, 2009.
100. ^sure Xapri xor‚suop [rovp. jenovs turo|boe|bolis| in wo|en; a speci”
reprodvcti~e uealtu ris‚. Uv| ˆeprod }pdate 2013; 19; 471…482.
101. ]idegaard V, ]o‚‚egaard ^, S~endsen A], Agger X. Uor|onal contraception
and ris‚ of ~enovs turo|boe|bolis|; national follow-vp stvdy. B`‰ 2009; 339; b2890.
102. ]egro ˆS, Arslanian SA, ^ur|ann DA et al. Diagnosis and treat|ent of
polycystic o~ary syndro|e; an endocrine society clinical practice gvideline. ‰ Xlin
^ndocrinol `etab 2013; 98; 4565…4592.
103. `artin \A, Xuang ˆ‰, ^ur|ann DA et al. ^~alvation and treat|ent of uirsvt-
is| in pre|enopavsal wo|en; an endocrine society clinical practice gvideline. ‰ Xlin
^ndocrinol `etab 2008; 93; 1105…1120.
104. `astora‚os [, \oliopovlos X, Xreatsas [. Androgen and lipid pro”
les in ado-
lescents witu polycystic o~ary syndro|e wuo were treated witu two for|s of co|bined
oral contracepti~es. Zertil Steril 2002; 77; 919…927.
105. jeruaegue ‰. Xlinical practice; contraception in adolescents. ^vr ‰ Pediatr
2012; 171; 895…899.
106. [ovrdy P. Diabetes and oral contraception. Best Pract ˆes Xlin ^ndocrinol
`etab 2013; 27; 67…76.
107. Xo||ittee on Adolescent Uealtu Xare ]ong-Acting ˆe~ersible Xontraception
xor‚ing [rovp YAXoV, [ynecologists. Xo||ittee opinion no. 539; adolescents and
572
!\t\t 17. \t\t\b\f\r \t   \b \b\t
long-acting re~ersible contraception; i|plants and intravterine de~ices. Vbstet [ynecol
2012; 120; 983…988.
108. }paduya \\. Xontraception for adolescents. Pediatr ˆe~ 2013; 34; 384…394.
109. ˆyan X`, Atcuison ‰, Pvc•yns‚i S, Pvc•yns‚i `, Arslanian S, Be
c‚er D.
`ild uypoglyce|ia associated witu deterioration of |ental ež
ciency in cuildren witu
insvlin-dependent diabetes |ellitvs. ‰ Pediatr 1990; 117; 32…38.
110. `cXri||on ˆ‰, ˆyan X`, Zrier B`. Diabetes and cogniti~e dysfvnction.
]ancet 2012; 379; 2291…2299.
111. Da~is ^A, Soong SA, Byrne [X, ‰ones Yx. Acvte uyperglycae|ia i|pairs cog-
niti~e fvnction in cuildren witu IDD`. ‰ Pediatr ^ndocrinol `etab 1996; 9; 455…461.
112. [onder-Zrederic‚ ]A, ‡rebiec ‰Z, Bavcuowit• A} et al. Xogniti~e fvnction is
disrvpted by botu uypo- and uyperglyce|ia in scuool-aged cuildren witu type 1 diabe-
tes; a ” eld stvdy. Diabetes Xare 2009; 32; 1001…1006.
113. Uill|an XU, \a|˜ o \, Scvdder `. A re~iew of curonic and acvte puysical
acti~ity participation on nevroelectric |easvres of brain uealtu and cognition dvring
cuilduood. Pre~ `ed 2011; 52 FSvppl. 1G; S21…S28.
114. Xovrt ‰`. Issves of transition to advlt care. ‰ Pediatr 1993; 29 FSvppl. 1G;
115. Pacavd D, `cconnell B, Uvot X, Aebi X, hale ‰.
Yransition fro| pediatric care to advlt care for insvlindependent diabetes patients.
Xan ‰ Diabetes 1996; 20; 14…20.
116. xeissberg-Bencuell ‰, xolpert U, Anderson B‰. Yransitioning fro| pediatric to
advlt care. Diabetes Xare 2007; 30; 2441…2446.
117. \ipps S, Bauv Y, Vng \ et al. Xvrrent |etuods of transfer of yovng people witu
type 1 diabetes to advlt ser~ices. Diabet `ed 2002; 19; 649…654.
118. ˆoberts S^, [oldacre `‰, Neil UAx. `ortality of yovng people ad|itted to
uospital for diabetes; database stvdy. B`‰ 2004; 328; 741…742.
119. Peters A, ]aŠ
el ], A|erican Diabetes Association Yransitions xor‚ing [rovp.
Diabetes care for e|erging advlts; reco||endations for transition fro| pediatric to advlt
diabetes care syste|s; a position state|ent of tue A|erican Diabetes Association, witu
representation by tue A|erican Xollege of Vsteopatuic Za|ily Puysicians, tue A|erican
Acade|y of Pediatrics, tue A|erican Association of Xlinical ^ndocrinologists, tue
A|erican Vsteopatuic Association, tue Xenters for Disease Xontrol and Pre~ention,
Xuildren witu Diabetes, Yue ^ndocrine Society, tue International Society for Pediatric
and Adolescent Diabetes, ‰v~enile Diabetes ˆesearcu Zovndation International, tue
National Diabetes ^dvcation Progra|, and tue Pediatric ^ndocrine Society Ffor|erly
]awson xil‚ins Pediatric ^ndocrine SocietyG. Diabetes Xare 2011; 34; 2477…2485.
120. Xarson X. Adolescence to advltuood; uow to ‚eep adolescents in tue syste|.
‰ Diabetes Nvrs 2003; 7; 24…27.
121. xills X‰, Scott A, Swift P[Z, Da~ies `‰, `ac‚ie ADˆ, `ansell P.
ˆetrospecti~e re~iew of care and ovtco|es in yovng advlts witu type 1 diabetes. B`‰
2003; 327; 260…261.
122. ]aing SP, Swerdlow A‰, Slater SD et al. Yue Britisu Diabetic Association
Xouort Stvdy. I; allcavse|ortality in patientswitu insvlin-treated diabetes |ellitvs.
Diabet `ed 1999; 16; 459…465.
  \b\t\b
573
123. ]yons S\, Be
c‚er
D‰, Uelgeson jS. Yransfer fro| pediatric to advlt uealtu
care; eŠ
ects on diabetes ovtco|es. Pediatr Diabetes 2014; 15; 10…17.
124. Spaic Y, `auon ‰], Ura|ia‚ I et al. `vlticentre rando|i•ed controlled trial of
strvctvred transition on diabetes care |anage|ent co|pared to standard diabetes care
in adolescents and yovng advlts witu type 1 diabetes FYransition YrialG. B`X Pediatr
2013; 13; 163.
1 \t\t 2
7\t\f\r\b\t \t\n\f\t \t 7\f\r\b\t \t\n\f\t
\nM\b\b\t8 \r\t \n\r\b7 5\t
 5 \t 5\r\n\f
, R Paul Wadwa
, Tien Y Wong
, Francesco
Chiarelli
, M Loredana Marcovecchio
, Jamal Raza
, Paul L Hofman
E Craig
\f\f = \f  \b  \f\t
575
\n\b\b M\b\t8 \t \r\f7\b5:\t\t
\r9\t\f\t\f


\n\f\r\t\b\t\b
\r\t\b \t8



" \r C" \r\f#"@\t \f-"\r#\r# 1 \r'  2


576
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
 18.1
\n!%!%,� @ !" ! #?()" *! ""$!"@; "(F%%!+;
\f %/!%) "!%!%7@ "!%!%9@ !"'#F% #?()B
S\t/&\b, \t\t \r 26 ,
7 +   \f
C$\t/&\b, \t\t \r 26 ,
7 +   \f
'& 3C\tC \b \t\n  L
7 +   \f
D\t\t\t%\r  \n\t\r\t 26 R\b $ \f \t&-
\f\f = \f  \b  \f\t
577
7\t\f\rL7\t\b\r\t8

LC\f \r##  #\r@:#\r#J \fC \r\f#"@\t
 #@'# \f #' \fJE#/ "\f, "#/  \r
"\r# \r: #  "!# @:# # \r"##,


\r\r\tL\b 5\b\t




\t \t5

\f""@ "\tE #\r/"\r##, \r##
578
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...


\r M\t\b\t
7\f\r\b\t \t\t
\r\t\r \r##  \f\r# \r\r \r#"##/
\n\r\b 5\t 2B \t 
5\b\t



C\f \b \f\f\f  \t\f \f \f#
\b\t\f\f \f\b   579

\t\b\r\b:\t\b\b \t\n\n5\b\t8 \t\b\b\n\t9\t:\t\r\b\b
\f\b\r8 \t\f7\t\t
580
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
 \r#J  "\r\f#$# #"#\t "\r#\t  :E
^DIX \r#E" #"# ##"\r##  "!##
5\r\t 9\f\r \r\t\n\f \r\t\t8 \nM\b\b\t
$\t  \t \b \f\t
581
%"# \f\t #C#\t \r\f-\f#" ':"# #
##\r"##\t  #\f#\t/ DXXY^DIX $##\r"\t
5\t\t\n\f8 \r\t\b \t8
582
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
\r\r\n\n\t\r\b\t \r\t\b \t\t
"#G, #\r\f#"# \r!#\t# ""#, \rE# #
$\t  \t \b \f\t
583
:\b\f \r\t\b \t\t
 #: "#"@ "\f \f#"## \r"#"##
+/@ #\f# \r"#"## : \r\f 
584
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
\r\b \b\t \r\t\b \t\t
$\t  \t \f #\b\t
585
\r\r\f\t\f5\t\t\n\f8 \b9\r \t8
 \t# \f#:"# \r"## # \r
:\b\f \b\t\b=\n8 \b9\r \t\t




586
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
:/\f# #J#"@ \f\r# \r## @:#\r##, "#  IgA
$\t  \t \f #\b\t
587
\b\t\t \r\b\t\b8 \r \t8 58 \r9\t\f\t\f\t \r\t\t8
\b9\r \t\t
588
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
5\t\t\n\f8 \b\r \t8
: \r\r"\r \r#' \r"#, #  %"
\r"#\t». +" #\r"#\t, @ \r#""" \f#'
\r/ # ""#/. ? \rC\f# \t\t"\t :#" #
\r\r#\r", /\r"\r#'"\t  #C# \r/ $#
# '\f "\r" "\r $##  \r\r\f#  "#  #
)\t\b\t\f\t  \t \t\f
589
:\b\f \b\r \t\t
##\t $ J" :\r ', : #"\r##
\r!# "#"@"#, \r\fC#"@ :# ## \r"'#z
:H"# :\f# /# \r, $ ""#@ #
"" \r\f/ \rE# \r# : \f/##, \r# \r
C#\t C  C# "\t, \r# \r: =@@, $
, \r"""##/ #'#  # ""/
\r##/ \r J" $  #@'# #"
#:\r$##, \r '# "\r"\r "#"@"# # \r
\r\f#"#. +"# "\f $# \r#E" #@'J"\t \r#
"@ \r#\r# \r"## "\t" "  10 "@ \f 27k
m5, 94, 95q, /"\t "@ %"#/ \r'## C" :"@ \t'  \r'##
7\f\r\b\t \t\n\f\t \b\t8
\f-\f#" ':#\t  :@/  \n  \r#J  J\[email protected]# :'
590
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
"\r\r' #" \r'#"@\t  \f" # \f\r"
('#\t \r ##\f, $##\r  !
 \f # \f## \f"# 50k  \f/ '\r/ m103q.
5\b\t 5\t\n\t \t57\t\t
)\t\b\t\f\t  \t \t\f
591
""#, ""# # \r""# %"# # :' \f\t \f"
# \f\r" m109…111q.  : " '# "#
#\t#\t  \r", '"# \r\f$##  '\r#\t  ?\r,
 #   # ! \r" m112q. +"#"@ #
:'"@ ""#  \f"  \n1 "\r:" \f#"@ $#
\r# \r\f#'#\r/ #\f#\t/ \r\t\f  \r\f# '\r"
\f# \f#"@ #""#, \t'  ! # \f##"@
=# \r@ /"\r# \r\f\t"\t  : 2,6 @
F100 kG FLG. L# %" ", \f" \r\f\r#\t"@ \f"#\t  !#J
 K \f  4,1 @ m## ‘3,4 @ F130 kG J \f#
\f# \r"\r"@ \r  '## ""# \f"\t "\r! 10 ",
/"\t \f\r \r"\r :'"#  ". T
 18.2
:(@ $%! (+ '(!/%@; *#  3(+; "%!F%!+ !"
#!%!*!! ! "/%B""$!"@; '-(%!& $ & ! *"
" ";%@# !-# 1B !*
HbA2c (\r\t\b\t Fuuk)��\8,@ (\  \f4 \f) \n &   
592
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
P\n\r\t \t\r\f?2   $\n\r \t\r &\b
D\t \b& \t\n &\n\5  &\b
 18.3
\r#%$#@ *@ $%! (+ '(!/%@; *#
#?()" ! *!/% #?()"
3 \K6-   \b  \n\t\r\t,  \t  \r\tQ\n \t\n\t &\n
5,9  \f4 (266 @)3\t
9\b\f:\t\bL\b \t7\b\b\t8  \n\r5\b \t \r\t9\r\t\n\f
\n\n5\t\n 9\b\f:\t\t
#:" "C \t'  #'#\t#  \r\f # \r#\r#
\f#" $##.  '\r/ \f#:" \t'  ! \r#
\r\f-\f#"/ ':# # #'# \r\f-\f#"
 \r"\r## m114q. #"#\t \f#$#\t /\r"\r#'"\t
#C \r# \f#"## \r:#, #'#\t# 
""\r/ #\t C\f m115, 116q, !# \f#\t
\b\t\n \f \r . 18.2
)\t\b\t\f\t  \t \t\f
593
594
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
5\t 2B \t  \t \nM\b\b\t8
�C#\t "#  \r\r"\r#  "##'$#
\f\b9\t\f \t\b\r\n
  \b\t\b
595
\n \t\n\f \t\r\r
1. DXXY ˆesearcu [rovp FDiabetes Xontrol and Xo|plications Yrial ˆesearcu
[rovpG. ^Š
ect of intensi~e diabetes treat|ent on tue de~elop|ent and progression
of long-ter| co|plications in adolescents witu insvlin-dependent diabetes |ellitvs;
Diabetes Xontrol and Xo|plications Yrial. ‰ Pediatr 1994; 125; 177…188.
2. Bo–estig `, Arn~ist U‰, Uer|ansson [, \arlberg B^, ]vd~igsson ‰. Declining
incidence of nepuropatuy in insvlin-dependent diabetes |ellitvs. N ^ngl ‰ `ed 1994;
330; 15…18.
3. `ousin Z et al. Discordant trends in |icro~ascvlar co|plications in adolescents
witu type 1 diabetes fro| 1990 to 2002. Diabetes Xare 2005; 28; 1974…1980.
4. ˆossing P, Uovgaard P, Par~ing UU. ˆis‚ factors for de~elop|ent of incipient
and o~ert diabetic nepuropatuy in type 1 diabetic patients; a 10-year prospecti~e obser-
~ational stvdy. Diabetes Xare 2002; 25; 859…864.
5. Downie ^ et al. Xontinved redvction in tue pre~alence of retinopatuy in adoles-
cents witu type 1 diabetes; role of insvlin tuerapy and glyce|ic control. Diabetes Xare
2011; 34; 2368…2373.
6. Xuo hU, Xraig `^, Uing S, [allego PU, Poon `, Xuan A, Donaguve \X.
`icro~ascvlar co|plications assess|ent in adolescents witu 2- to 5-yr dvration of type
1 diabetes fro| 1990 to 2006. Pediatric Diabetes 2011; 12F8G; 682…689.
7. hav ‰x et al.[lobal pre~alence and|a–or ris‚ factors of diabetic retinopatuy.
Diabetes Xare 2012; 35F3G; 556…564.
8. xong Yh et al. ˆates of progression in diabetic retinopatuy dvring diŠ
erent ti|e
periods; a syste|atic re~iew and |eta-analysis. Diabetes Xare 2009; 32F12G; 2307…2313.
9. Xuevng N, `itcuell P, xong Yh. Diabetic retinopatuy. ]ancet 2010; 376F9735G;
124…136.
10. `oua|ed Ž, [illies `X, xong Yh. `anage|ent of diabetic retinopatuy; a
syste|atic re~iew. ‰ovrnal of tue A|erican `edical Association 2007; 298F8G; 902…916.
11. Xraig `^ et al. Diabetes care, glyce|ic control, and co|plications in cuil-
dren witu type 1 diabetes fro| Asia and tue xestern Paci”
c ˆegion. ‰ Diabetes
Xo|plications 2007; 21; 280…287.
12. `a–aliwa ^S et al. Svr~ey on acvte and curonic co|plications in cuildren and
adolescents witu type 1 diabetes at `vui|bili National Uospital in Dar es Salaa|,
Yan•ania. Diabetes Xare 2007; 30; 2187…2192.
13. DXXY ˆesearcu [rovp. Yue eŠ
ect of intensi~e treat|ent of diabetes on tue
de~elop|ent and progression of long-ter| co|plications in insvlindependent diabetes
|ellitvs. N ^ngl ‰ `ed 1993; 329; 977…986.
14. Natuan D` et al. Intensi~e diabetes treat|ent and cardio~ascvlar disease in
patients witu type 1 diabetes. N ^ngl ‰ `ed 2005; 353; 2643…2653.
15. xuite NU, Xleary PA, Dau|s x, [oldstein D, `alone ‰, Ya|borlane
xjz Diabetes Xontrol and Xo|plications Yrial FDXXYG^pide|iology of Diabetes
Inter~entions and Xo|plications F^DIXG ˆesearcu [rovp. Bene”
cial eŠ
ects of intensi~e
tuerapy of diabetes dvring adolescence; ovtco|es after tue conclvsion of tue Diabetes
Xontrol and Xo|plications Yrial FDXXYG. Yue ‰ovrnal of Pediatrics 2001;139; 804…812.
596
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
16. DXXY ˆesearcu [rovp. ^arly worsening of diabetic retinopatuy in tue Diabetes
Xontrol and Xo|plications Yrial. Arcu Vputual|ol 1998; 116; 874…886.
17. xuite NU et al. ^Š ect of prior intensi~e tuerapy in type 1 diabetes on 10-year
progression of retinopatuy in tue DXXY^DIX; co|parison of advlts and adolescents.
Diabetes 2010; 59; 1244…1253.
18. \rolews‚i AS et al. Yue cuanging natvral uistory of nepuropatuy in type I dia-
betes. A| ‰ `ed 1985; 78; 785…794.
19. Donaguve \X et al. Do all prepvbertal years of diabetes dvration contribvte
evally to diabetes co|plications— Diabetes Xare 2003; 26; 1224…1229.
20. Xuo hU, Xraig `^, Donaguve \X. Pvberty as an accelerator for diabetes co|-
plications. Pediatr Diabetes 2014; 15; 18…26.
21. Donaguve \X et al. Pre~alence of diabetes co|plications 6 years after diagnosis
in an incident couort of cuilduood diabetes. Diabet `ed 2005; 22; 711…718.
22. A|in ˆ et al. ˆis‚ of |icroalbv|invria and progression to |acroalbv|invria
in a couort witu cuilduood onset type 1 diabetes; prospecti~e obser~ational stvdy. B`‰
2008; 336; 697…701.
23. Uietala \ et al. Age at onset and tue ris‚ of proliferati~e retinopatuy in type 1
diabetes. Diabetes Xare 2010; 33; 1315…1319.
24. `argeirsdottir UD et al. Uigu pre~alence of cardio~ascvlar ris‚ factors in cuil-
dren and adolescents witu type 1 diabetes; a popvlation-based stvdy. Diabetologia 2008;
51; 554…561.
25. xood ‰ˆ et al.`ost yovtu witu type 1 diabetes in tue Y1D ^cuange Xlinic
ˆegistry do not |eet A|erican Diabetes Association or International Society for Pediatric
and Adolescent Diabetes clinical gvidelines. Diabetes Xare 2013; 36; 2035…2037.
26. Xovper ‰‰ et al. ˆelationsuip of s|o‚ing and albv|invria in cuildren witu
insvlin-dependent diabetes. Diabet `ed 1994; 11; 666…669.
27. [aedt Yuorlvnd ` et al. Is s|o‚ing a ris‚ factor for proliferati~e diabetic reti-
nopatuy in type 1 diabetes— Vputual|ologica 2013; 230; 50…54.
28. xong Xx et al. \idney and eye diseases; co||on ris‚ factors, etiological
|ecuanis|s, and patuways. \idney Int 2014; 85; 1290…1302.
29. [ay ^X et al. S|o‚ers witu IDD` eperience ecess |orbidity. Yue Xolorado
IDD` ˆegistry. Diabetes Xare 1992; 15; 947…952.
30. ]vrbe ^ et al. Increase in noctvrnal blood pressvre and progression to |icroal-
bv|invria in type 1 diabetes. N ^ngl ‰ `ed 2002; 347; 797…805.
31. `arco~eccuio `] et al. A|bvlatory blood pressvre |easvre|ents are related to
albv|in ecretion and are predicti~e for ris‚ of |icroalbv|invria in yovng people witu
type 1 diabetes. Diabetologia 2009; 52; 1173…1
32. [allego PU et al. ˆole of blood pressvre in de~elop|ent of early retinopatuy in
adolescents witu type 1 diabetes; prospecti~e couort stvdy. B`‰ 2008; 337; a918.
33. Sta|ler ‰ et al. Diabetes, otuer ris‚ factors, and 12-yr cardio~ascvlar |ortality
for |en screened in tue `vltiple ˆis‚ Zactor Inter~ention Yrial. Diabetes Xare 1993;
16; 434…444.
34. Uansson ] et al. ^Š ects of intensi~e blood-pressvre lowering and low-dose
aspirin in patients witu uypertension; principal resvlts of tue Uypertension Vpti|al
Yreat|ent FUVYG rando|ised trial. UVY Stvdy [rovp. ]ancet 1998; 351; 1755…1762.
  \b\t\b
597
35. ‰en‚ins A‰ et al. ]ipoproteins in tue DXXY^DIX couort; associations witu
diabetic nepuropatuy. \idney Int 2003; 64; 817…828.
36. ]yons Y‰ et al. Diabetic retinopatuy and serv| lipoprotein svbclasses in tue
DXXY^DIX couort. In~est Vputual|ol jis Sci 2004; 45; 910…918.
37. Seavist ^ˆ et al. Za|ilial clvstering of diabetic ‚idney disease. ^~idence for
genetic svsceptibility to diabetic nepuropatuy. N ^ngl ‰ `ed 1989; 320; 1161…1165.
38. Soergel ` et al. Vscillo|etric twenty-fovr-uovr a|bvlatory blood pressvre
~alves in uealtuy cuildren and adolescents; a |vlticenter trial inclvding 1141 svb–ects.
‰ Pediatr 1997; 130; 178…184.
39. Dorcuy U, Xlaes X, jerovgstraete X. ˆis‚ factors of de~eloping proliferati~e
retinopatuy in type 1 diabetic patients; role of B`I. Diabetes Xare 2002; 25; 798…799.
40. De Bloc‚ X^, De ]eevw IU, jan [aal ]Z. I|pact of o~erweigut on curonic |icro-
~ascvlar co|plications in type 1 diabetic patients. Diabetes Xare 2005; 28; 1649…1655.
41. Stone `] et al. Natvral uistory and ris‚ factors for |icroalbv|invria in ado-
lescents witu type 1 diabetes; a longitvdinal stvdy.Diabetes Xare 2006; 29; 2072…2077.
42. \oi~isto jA et al. Xardio~ascvlar disease and its ris‚ factors in IDD` in ^vrope.
^}ˆVDIAB IDD` Xo|plications Stvdy [rovp. Diabetes Xare 1996; 19; 689…697.
43. ˆodrigves YX et al. Vbesity and coronary artery calciv| in diabetes; tue
Xoronary Artery Xalci”
cation in Yype 1 Diabetes FXAXYIG stvdy. Diabetes Yecunol
Yuer 2011; 13; 991…996.
44. `oy XS et al. Insvlin-dependent diabetes |ellitvs, puysical acti~ity, and deatu.
A| ‰ ^pide|iol 1993; 137; 74…81.
45. `agvire A et al. Yue case for biennial retinopatuy screening in cuildren and
adolescents. Diabetes Xare 2005; 28; 509…513.
46. SoŠ er B et al.
ble-blind, placebo-controlled, dos
e-response stvdy of tue
ecti~eness and safety of lisinopril for cuildren witu uypertension. A| ‰ Uypertens
2003; 16; 795…800.
47. `agvire A et al. Yue case for biennial retinopatuy screening in cuildren and
adolescents; response to Stefansson. Diabetes Xare 2006; 29; 178…179.
48. \lein ˆ et al. Yue xisconsin epide|iologic stvdy of diabetic retinopatuy. II.
Pre~alence and ris‚ of diabetic retinopatuy wuen age at diagnosis is less tuan 30 years.
Arcu Vputual|ol 1984; 102; 520…526.
49. ]eXaire Y‰ et al. Assessing progress in retinopatuy ovtco|es in type 1 diabetes;
co|paring ”
ndings fro| tue xisconsin Diabetes ˆegistry Stvdy and tue xisconsin
^pide|iologic Stvdy of Diabetic ˆetinopatuy. Diabetes Xare 2013; 36; 631…637.
50. Anony|ovs. Puotocoagvlation treat|ent of proliferati~e diabetic retinopatuy; tue
second report of diabetic retinopatuy stvdy ” ndings. Vputual|ology 1978; 85; 82…106.
51. `itcuell P, Zoran S, xong Yh, Xuva B, Patel I, V–ai|i ^. [videlines for
tue `anage|ent of Diabetic ˆetinopatuy. National Uealtu and `edical ˆesearcu
Xovncil FAvstraliaG; BartonAXY2008 Fa~ailable fro|; uttps;www.nu|rc.go~.av™
les™nu|rcpvblications attacu|entsdi15.pdfG.
52. Scanlon PU et al. Xo|parison of two reference standards in ~alidating two ”
eld
|ydriatic digital puotograpuy as a |etuod of screening for diabetic retinopatuy. Br ‰
Vputual|ol 2003; 87; 1258…1263.
598
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
53. Vlson ‰A et al. A co|parati~e e~alvation of digital i|aging, retinal puotograpuy
and opto|etrist ea|ination in screening for diabetic retinopatuy. Diabet `ed 2003;
20; 528…534.
54. ]in Dh et al. Yue sensiti~ity and speci” city of single”
eld non|ydriatic |ono-
curo|atic digital fvndvs puotograpuy witu re|ote i|age interpretation for diabetic
retinopatuy screening; a co|parison witu oputual|oscopy and standardi•ed |ydriatic
color puotograpuy. A| ‰ Vputual|ol 2002; 134; 204…213.
55. `vrgatroyd U et al. ^Š
ect of |ydriasis and diŠ
erent ”
eld strategies on digital
i|age screening of diabetic eye disease. Br ‰ Vputual|ol 2004; 88; 920…924.
56. Bailey XX et al. Yue national diabetic retinopatuy laser treat|ent avdit. III.
Xlinical ovtco|es. ^ye F]ondG 1999; 13 FPt 2G; 151…159.
57. Zerris Z. ^arly puotocoagvlation in patients witu eituer type I or type II diabetes.
Yrans A| Vputual|ol Soc 1996; 94; 505…537.
58. `ogensen X^ et al. Pre~ention of diabetic renal disease witu special reference
to |icroalbv|invria. ]ancet 1995; 346; 1080…1084.
59. Scuvlt• X‰ et al. `icroalbv|invria pre~alence ~aries witu age, se, and pvberty
in cuildren witu type 1 diabetes followed fro| diagnosis in a longitvdinal stvdy. Vford
ˆegional Prospecti~e Stvdy [rovp. Diabetes Xare 1999; 22; 495…502.
60. [roop PU et al. Yue presence and se~erity of curonic ‚idney disease predicts
all-cavse |ortality in type 1 diabetes. Diabetes 2009; 58; 1651…1658.
61. Vrcuard Y‰ et al. In tue absence of renal disease, 20 year |ortality ris‚ in type
1 diabetes is co|parable to tuat of tue general popvlation; a report fro| tue Pittsbvrgu
^pide|iology of Diabetes Xo|plications Stvdy. Diabetologia 2010; 53; 2312…2319.
62. Ywy|an S et al. ]ongitvdinal stvdy of vrinary albv|in ecretion in yovng dia-
betic patients-xesse Diabetic Nepuropatuy Pro–ect. Diabet `ed 2001; 18; 402…408.
63. `ogensen X^ et al. Pre~ention of diabetic renal disease witu special reference
to |icroalbv|invria. ]ancet 1995; 346F8982G; 1080…1084.
64. Association AD. Standards of |edical care in diabetes … 2014. Diabetes Xare
2014; 37 FSvppl. 1G; S14…S80.
65. ˆossing P. Yue cuanging epide|iology of diabetic |icroangiopatuy in type 1
diabetes.Diabetologia 2005; 48; 1439…1444.
66. ˆvggenenti P, ˆe|v••i [. \idney failvre stabili•es after a two-decade increase;
i|pact on global Frenal and cardio~ascvlarG uealtu. Xlin ‰ A| Soc Nepurol 2007; 2;
146…150.
67. `atuiesen ^ˆ et al. Incipient nepuropatuy in type 1 Finsvlin-dependentG diabe-
tes. Diabetologia 1984; 26; 406…410.
68. `ogensen X^, Xuristensen X\. Predicting diabetic nepuropatuy in insvlin-
dependent patients. N ^ngl ‰ `ed 1984; 311; 89…93.
69. jiberti [X et al. `icroalbv|invria as a predictor of clinical nepuropatuy in
insvlin-dependent diabetes |ellitvs. ]ancet 1982; 1; 1430…1432.
70. Borcu-‰ounsen \, Andersen P\, De
c‚ert Y. Yue eŠ
ect of proteinvria on relati~e
|ortality in type 1 Finsvlin-dependentG diabetes |ellitvs. Diabetologia 1985; 28; 590…596.
71. jaldorf-Uansen Z et al. Xardio~ascvlar ris‚ factors in type I Finsvlin-dependentG
diabetic patients witu and wituovt proteinvria. Acta `ed Scand 1987; 222; 439…4.
  \b\t\b
599
72. A|in ˆ et al. Yue relationsuip between |icroalbv|invria and glo|ervlar ”
tration rate in yovng type 1 diabetic svb–ects; tue Vford ˆegional Prospecti~e Stvdy.
\idney Int 2005; 68; 1740…1749.
73. Xovper ‰‰ et al. Progression of borderline increases in albv|invria in adoles-
cents witu insvlin-dependent diabetes |ellitvs. Diabet `ed 1997; 14; 766…771.
74. ]vrbe ^, Sorof ‰`, Daniels Sˆ.Xlinical and researcu aspects of a|bvlatory
blood pressvre |onitoring in cuildren. ‰ Pediatr 2004; 144; 7…16.
75. Per‚ins BA et al. ˆegression of |icroalbv|invria in type 1 diabetes. N ^ngl ‰
`ed 2003; 348; 2285…2293.
76. ˆvdberg S, Daulvist [. Deter|inants of progression of |icroalbv|invria in
adolescents witu IDD`. Diabetes Xare 1996; 19; 369…371.
77. ‡erbini [ et al. Persistent renal uypertropuy and faster decline of glo|ervlar ”
tration rate precede tue de~elop|ent of |icroalbv|invria in type 1 diabetes. Diabetes
2006; 55; 2620…2625.
78. Zinne P et al. Incidence of end-stage renal disease in patients witu type 1 diabe-
tes. ‰A`A 2005; 294; 1782…1787.
79. National Uigu Blood Pressvre ^dvcation Progra| xor‚ing [rovp on Uigu
Blood Pressvre in Xuildren and Adolescents. Yue fovrtu report on tue diagnosis,
e~alvation, and treat|ent of uigu blood pressvre in cuildren and adolescents. Pediatrics
2004; 114 F2 Svppl. 4tu ˆeportG; 555…576.
80. Par~ing UU. I|pact of blood pressvre and antiuypertensi~e treat|ent on incipi-
ent and o~ert nepuropatuy, retinopatuy, and endotuelial per|eability in diabetes |el-
litvs. Diabetes Xare 1991; 14; 260…269.
81. Astrvp AS et al. I|pro~ed prognosis in type 1 diabetic patients witu nepuropa-
tuy; a prospecti~e follow-vp stvdy. \idney Int 2005; 68; 1250…1257.
82. xells Y et al.
ble-blind, placebo-controlled, dos
e-response stvdy of tue
ecti~eness and safety of enalapril for cuildren witu uypertension. ‰ Xlin Puar|acol
83. Strippoli [Z et al. ^Š ects of angiotensin con~erting en•y|e inuibitors and
angiotensin II receptor antagonists on |ortality and renal ovtco|es in diabetic
nepuropatuy; syste|atic re~iew. Br `ed ‰ 2004; 329; 828.
84. ]~ ‰ et al. Antiuypertensi~e agents for pre~enting diabetic ‚idney disease.
Xocurane Database Syst ˆe~ 2012; 12; XD004136.
85. xv Uh et al. Xo|parati~e eŠ
ecti~eness of reninangiotensin syste| blo
c‚ers and
otuer antiuypertensi~e drvgs in patients witu diabetes; syste|atic re~iew and bayesian
networ‚|eta-analysis.B`‰2013; 347; f6008.
86. Strippoli [Z et al. Angiotensin con~erting en•y|e inuibitors and angiotensin II
receptor antagonists for pre~enting tue progression of diabetic ‚idney disease. Xocurane
Database Syst ˆe~ 2006; 4; XD006257.
87. AX^I Yrialist [rovp FAX^ Inuibitors in Diabetic Nepuropatuy Yrialist [rovpG.
Suovld all patients witu type 1 diabetes |ellitvs and |icroalbv|invria recei~e angio-
tensin-con~erting en•y|e inuibitors— A |etaanalysis of indi~idval patient data. Ann
Intern `ed 2001; 134; 370…379.
88. I••o ‰], xeir `ˆ. Angiotensin-con~erting en•y|e inuibitors. ‰ Xlin Uypertens
F[reenwicuG 2011; 13; 667…675.
600
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
89. Bvllo ` et al. Pregnancy ovtco|e following eposvre to angiotensin-con-
~erting en•y|e inuibitors or angiotensin receptor antagonists; a syste|atic re~iew.
Uypertension 2012; 60; 444…450.
90. Yesfaye S et al. Diabetic nevropatuies; vpdate on de”
nitions, diagnostic criteria,
esti|ation of se~erity, and treat|ents. Diabetes Xare 2010; 33; 2285…2293.
91. Breiner A et al. Does tue pre~ailing uypotuesis tuat s|all-”
ber dysfvnction
precedes large-”
ber dysfvnction apply to type 1 diabetic patients— Diabetes Xare 2014;
37; 1418…1424.
92. `aser ˆ^ et al. Yue association between cardio~ascvlar avtono|ic nevropatuy
and |ortality in indi~idvals witu diabetes; a |eta-analysis. Diabetes Xare 2003; 26;
1895…1901.
93. Yang ` et al. Avtono|ic nevropatuy in yovng people witu type 1 diabetes; a
syste|atic re~iew. Pediatr Diabetes 2013; 14; 239…248.
94. ‰aiswal ` et al. Peripueral nevropatuy in adolescents and yovng advlts witu type
1 and type 2 diabetes fro| tue S^AˆXU for Diabetes in hovtu follow-vp couort; a pilot
stvdy. Diabetes Xare 2013; 36; 3903…3908.
95. ^ppens `X et al. Pre~alence of diabetes co|plications in adolescents witu type
2 co|pared witu type 1 diabetes. Diabetes Xare 2006; 29; 1300…1306.
96. ‰aiswal`et al. ˆedvced ueart rate ~ariability a|ong yovtu witu type 1 diabetes;
tue S^AˆXU XjD stvdy. Diabetes Xare 2013; 36; 157…162.
97. ]aing SP et al. `ortality fro| ueart disease in a couort of 23,000 patients witu
insvlin-treated diabetes. Diabetologia 2003; 46; 760…765.
98. `ä‚i|attila S et al. Za|ily uistories of type II diabetes and uypertension predict
inti|a-|edia tuic‚ness in patients witu type I diabetes. Diabetologia 2002; 45; 711…718.
99. Uarrington ‰ et al. Aortic inti|a |edia tuic‚ness is an early|ar‚er of atueroscle-
rosis in cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr 2010; 156; 237…241.
100. ]arsen ‰ et al. Silent coronary atuero|atosis in type 1 diabetic patients and its
relation to long-ter| glyce|ic control. Diabetes 2002; 51; 2637…2641.
101. ‰en‚ins A‰ et al. Serv| lipoproteins in tue diabetes control and co|plications
trialepide|iology of diabetes inter~ention and co|plications couort; associations witu
gender and glyce|ia. Diabetes Xare 2003; 26; 810…818.
102. Id•ior-xalvs B et al. Zactors associated witu plas|a lipids and lipoproteins in
type 1 diabetes |ellitvs; tue ^}ˆVDIAB IDD`Xo|plications Stvdy. Diabet `ed
2001; 18; 786…796.
103. xadwa ˆP et al. Awareness and treat|ent of dyslipide|ia in yovng advlts witu
type 1 diabetes. Diabetes Xare 2005; 28; 1051…1056.
104. `aaus D` et al. Yotal cuolesterol and uigu-density lipoprotein le~els in pedi-
atric svb–ects witu type 1 diabetes |ellitvs. ‰ Pediatr 2005; 147; 544…546.
105. [vy ‰ et al. ]ipid and lipoprotein pro”
les in yovtu witu and wituovt type 1
diabetes; tue S^AˆXU for Diabetes in hovtu case-control stvdy. Diabetes Xare 2009;
32; 416…420.
106. `a•anderani AB, xise S‰, Yildesley UD. Apolipoprotein B le~els in advlts
witu type 1 diabetes not recei~ing lipid-lowering tuerapy. Xlin Biocue| 2009; 42;
1218…1221.
  \b\t\b
601
107. Xollins ˆ et al. `ˆXBUZUeart Protection Stvdy of cuolesterol-lowering witu
si|~astatin in 5963 people witu diabetes; a rando|ised placebo-controlled trial. ]ancet
2003; 361; 2005…2016.
108. XYY Xollaborators FXuolesterol Yreat|ent Yrialists XollaboratorsG et al.
cacy of cuolesterol-lowering tuerapy in 18,686 people witu diabetes in 14 ran-
do|ised trials of statins; a |eta-analysis. ]ancet 2008; 371; 117…125.
109. xieg|an A et al. ^ž cacy and safety of statin tuerapy in cuildren witu fa|ilial
uypercuolesterole|ia; a rando|i•ed controlled trial. ‰A`A 2004; 292; 331…337.
110. Stein ^A et al. ^ž
cacy and safety of lo~astatin in adolescent |ales witu uet-
ero•ygovs fa|ilial uypercuolesterole|ia; a rando|i•ed controlled trial. ‰A`A 1999;
281; 137…144.
111. de ‰ongu S et al. ^ž
cacy and safety of statin tuerapy in cuildren witu fa|ilial
uypercuolesterole|ia; a
rando|i•e
ble-blind, placebo-controlled trial witu si|~-
astatin. Xircvlation 2002; 106; 2231…2237.
112. Ualler `‰ et al. Pediatric Ator~astatin in Diabetes Yrial FPADIYG; a pilot stvdy
to deter|ine tue eŠ
ect of ator~astatin on arterial stiŠ
ness and endotuelial fvnction in
cuildren witu type 1 diabetes |ellitvs. ‰ Pediatr ^ndocrinol `etab 2009; 22; 65…68.
113. [raua| D‰ et al. Incidence of uospitali•ed ruabdo|yolysis in patients treated
witu lipid-lowering drvgs. ‰A`A 2004; 292; 2585…2590.
114. Zang ‡h, Prins ‰B, `arwic‚ YU. Diabetic cardio|yopatuy; e~idence, |ecua-
nis|s, and tuerapevtic i|plications. ^ndocr ˆe~ 2004; 25; 543…567.
115. ˆae~ DX. ]eft ~entricvlar fvnction and speci”
c diabetic co|plications in otuer
target organs in yovng insvlin-dependent diabetics; an ecuocardiograpuic stvdy. Ueart
jessels 1994; 9; 121…128.
116. Zraser [^ et al. Xo|parison of ecuocardiograpuic ~ariables between type I
diabetics and nor|al controls. A| ‰ Xardiol 1995; 75; 141…145.
117. ˆegensteiner ‰[ et al. Xardiac dysfvnction dvring eercise in vnco|plicated
type 2 diabetes. `ed Sci Sports ^erc 2009; 41; 977…984.
118. ]alande S, Uof|an P], Baldi ‰X. ^Š
ect of redvced total blood ~olv|e on
left ~entricvlar ~olv|es and ‚inetics in type 2 diabetes. Acta Puysiol FVfG 2010; 199;
23…30.
119. Danielsen ˆ. Zactors contribvting to left ~entricvlar diastolic dysfvnction in
long-ter| type I diabetic svb–ects. Acta `ed Scand 1988; 224; 249…256.
120. Poirier P et al. I|pact of left ~entricvlar diastolic dysfvnction on |ai|al
tread|ill perfor|ance in nor|otensi~e svb–ects witu well-controlled type 2 diabetes
|ellitvs. A| ‰ Xardiol 2000; 85; 473…477.
121. [vsso S et al. I|paired stro‚e ~olv|e and aerobic capacity in fe|ale adoles-
cents witu type 1 and type 2 diabetes |ellitvs. Diabetologia 2008; 51; 1317…1320.
122. \o|atsv xˆ et al. Aerobic eercise capacity in nor|al adolescents and tuose
witu type 1 diabetes |ellitvs. Pediatr Diabetes 2005; 6; 145…149.
123. [vsso S et al. Diastolic fvnction is redvced in adolescents witu type 1 diabetes
in response to eercise. Diabetes Xare 2012; 35; 2089…2094.
124. ˆoss ˆ. Yue patuogenesis of atuerosclerosis; a perspecti~e for tue 1990s.
Natvre 1993; 362; 801…809.
602
!\t\t 18. )\b\t\f\t   \t\b\t\f\t  =\f \f...
125. `ee‚ing Dˆ et al. ^ndotuelial dysfvnction in type 2 diabetic svb–ects witu and
wituovt |icroalbv|invria. Diabet `ed 1999; 16; 841…847.
126. ^luadd YA et al. In›
vence of pvberty on endotuelial dysfvnction and oidati~e
stress in yovng patients witu type 1 diabetes. Diabetes Xare 1998; 21; 1990…1996.
127. `c]aren ` et al. ^le~ated plas|a ~ascvlar endotuelial cell growtu factor and
turo|bo|odvlin in –v~enile diabetic patients. Xlin Appl Yuro|b Ue|ost 1999; 5;
21…24.
128. Xouen ˆ. Dysfvnction of tue ~ascvlar endotueliv| in diabetes |ellitvs.
Xircvlation 1993; 87 FSvppl. jG; j67…j76.
129. Steuovwer XD et al. ^ndotuelial dysfvnction precedes de~elop|ent of |icro-
albv|invria in IDD`. Diabetes 1995; 44; 561…564.
130. }rbina ^` et al. Pre~alence of increased arterial stiŠ ness in cuildren witu type
1 diabetes |ellitvs diŠ
ers by |easvre|ent site and se; tue S^AˆXU for Diabetes in
hovtu Stvdy. ‰ Pediatr 2010; 156; 731…737 737.e1.
131. `ac\en•ie \^ et al. Zolate and ~ita|in B6 rapidly nor|ali•e endotuelial
dysfvnction in cuildren witu type 1 diabetes |ellitvs. Pediatrics 2006; 118; 242…253.
132. Çiftel ` et al. In~estigation of endotuelial dysfvnction and arterial stiŠ
ness
in cuildren witu type 1 diabetes |ellitvs and tue association witu diastolic ysfvnction.
Diab jasc Dis ˆes 2014; 11; 19…25.
133. Babar [S et al. I|paired endotuelial fvnction in preadolescent cuildren witu
type 1 diabetes. Diabetes Xare 2011; 34; 681…685.
134. Peña AS et al. Uypoglyce|ia, bvt not glvcose ~ariability, relates to ~ascvlar
fvnction in cuildren witu type 1 diabetes. Diabetes Yecunol Yuer 2012; 14; 457…462.
135. Dye AS et al. Uyperglyce|ia increases |vscle blood › ow and alters endotuelial
fvnction in adolescents witu type 1 diabetes. ^p Diabetes ˆes 2012; 2012; 170380.
136. Peña AS et al. Zolate forti”
cation and svpple|entation do not pro~ide ~ascvlar
uealtu bene”
ts in type 1 diabetes. ‰ Pediatr 2013; 163; 255…260.
137. `aaus D` et al. Uiguer pre~alence of ele~ated albv|in ecretion in yovtu witu
type 2 tuan type 1 diabetes; tue S^AˆXU for Diabetes in hovtu stvdy. Diabetes Xare
2007; 30; 2593…2598.
138. Xonstantino `I et al. ]ong-ter| co|plications and |ortality in yovng-onset
diabetes; type 2 diabetes is |ore ua•ardovs and letual tuan type 1 diabetes. Diabetes
Xare 2013; 36; 3863…3869.
139. xong ‰ et al. Yi|ing is e~erytuing; age of onset in› vences long-ter| retinopa-
tuy ris‚ in type 2 diabetes, independent of traditional ris‚ factors. Diabetes Xare 2008;
31; 1985…1990.
1 \t\t 2K
5\r\t \nM\b\b\t8 \t \n\n:\t\t\r\b\b
\n\n8\b\t8 \r\t \n\r\b7 5\t  5
\t 5\r\n\f
Kordonouri O., Klingensmith G., Knip M., Holl R.W., Menon P.S.N., Aanstoot H.J., Craig M.E. =\b
Olga Kordonouri
, Georgeann Klingensmith
, Mikael Knip
, Reinhard W Holl
Aanstoot
, Puthezhath SN Menon
and Maria E Craig
604
!\t\t 19. $\b =\f \f  \t\b\t\f\f \f...
\n\b\b M\b\t8 \t \r\f7\b5:\t\t










/, \f\t\b \t  \t   \b\t\f \b\t
605
\r\n, \b\r 7\n\n  \t \r\b \r\t\t
606
!\t\t 19. $\b =\f \f  \t\b\t\f\f \f...
\r\t\r\f#"  '\f \f\r" '\r" ## \r '\r"# m24, 25q.\n\n:\t\t\r\b\b \t77\b\b \n\n8\b\t8
 " FIXAG,  "C ""#"  ##, \f\r:#-
' "# #" F[AD65G, : \t' 
protein tyrosine phosphatase
FPYPG
related molecules
IA-2 FIXA512G # IA-2W F\r#G ### $#-"\r\r"\r-8 F‡nY-8G
\b\t\f\f \t\f\f \f
607
 \f\r:#' "# #" # ‡nY-8A $##\r 
\t \t\r
 \r\t :\f "#\r# # ! \r\t ??*.
\t \r\t\r
608
!\t\t 19. $\b =\f \f  \t\b\t\f\f \f...
:\t\f\t8
\b\t\f\f \t\f\f \f
609
 U]A-DŽ2 # U]A-DŽ8, @ $##\t \r\t", #
FDˆ3 # Dˆ4G /\f\t"\t  \r $##  DŽ2 # DŽ8,
%" "##\r# U]A \r\t" #J#" $##J "@ 
\r@ \r##  #@'# tY[-A ## ^|A \r'@""
FtY[, ## ^` Ig[, ## :#/G. +" : C, "  $##\t
\r# ! \r "#" :/\f# :##\t "
## #"  \f"  ## "#"\r# tY[-A F:   10 \r'
%\f#'#@ \r@ IgA "C C#"@ # $#" \t\t"-
\t #" U]A DŽ2 ## DŽ8 m56, 62q. ?# #'#\t  \r"#,
610
!\t\t 19. $\b =\f \f  \t\b\t\f\f \f...
\t\t\t
=#"## „ \r#:\r" \r!# #"$##, "\r
\r\t\b8 \b5 \b\t\f8 \b5\n\b\nL
O\bL 55\t\n\bQ
 #""#"# FU]AG  I $@-\t'  
m76q. "# #\f\t\r #\f\r I "#, "C
# /\r"\r#'"\t \r'#"# \f# \f"""#,
FAIˆ^G  /\r 2122.3 m77, 78q.
\b#ᤓ&#x#17 ; \t\b#   \b\b#?
611
 \f"""# \r \f# # \r'#"## \r#
\t 5\t\n\r9\t8 O\t \r9\t8 \t\t \t \t \r\r9\t8Q
C#. K#"\r#\t "C #  \t'#  "#\r#\f#"
612
!\t\t 19. $\b =\f \f  \t\b\t\f\f \f...
\t \t5\b \b\f\r\t \r\t \n\r\b7 5\t
NECROBIOSIS LIPOIDICA DIABETICORUM
#"### C#\t#, J\t \r"#"#J # \r"#J
 "\r #\f "\r##  \r# %"#"@J, J\t
"#, #" ## "\r# \f# "\r#\f, "\r#J
G F \f##\r#\f ## :'
G, $#\r#, #" "#, #"# #",
## # \r\f C#, '\r /#\r\r#, #\r:\r#
\r # "#J P}jA-"/##"\r#J m93, 96q. "\r #' #\f
\r\b\t\b\b8 5\tM\b\nL \n\n
#\f#\t 'J", " \r#\t \f#C"@ "
 
613
\r" "\f :\f#\t \t\t"\t $ 'C"#
= "\r#,   :### C#, "J"\t "#
#:\r:" # \rC\t #\r#'$#\t   !\r/"
#J C""# \r#\r"#\t\r # C   #C#
"# \f#C"#. )\r$$#\t C , "\rCJE\t
# ":#@/ / \r\f" \r$## ##\r#\t 
"##, ':# \f # \r# \f#C"@J " m105,
�106q. \r#\t \f#C"@